1	Psychopharmacology	NN	O	psychopharmacology	dep	5	SENT_1	[p1l40t81r365b115],
2	(	CD	NUMBER	(	dep	1	SENT_1	[p1l377t81r475b113],
3	2002	CD	DATE	2002	dep	5	SENT_1	[p1l377t81r475b113],
4	)	CD	NUMBER	)	num	5	SENT_1	[p1l377t81r475b113],
5	162267-73	CD	NUMBER	162267-73	dep	9	SENT_1	[p1l490t81r646b107],
6	DOI	NNP	O	DOI	dep	5	SENT_1	[p1l40t119r106b146],
7	10.1007	CD	NUMBER	10.1007	num	6	SENT_1	[p1l121t119r547b146],
8	/	:	O	/	punct	9	SENT_1	[p1l121t119r547b146],
9	sOO213-002-1059-5	NN	O	soo213-002-1059-5	_	0	SENT_1	[p1l121t119r547b146],

1	ORIGINAL	JJ	O	original	amod	2	SENT_2	[p1l40t188r1056b272],
2	INVESTIGATION	NN	O	investigation	_	0	SENT_2	[p1l362t215r784b245],

1	Peeter	NNP	PERSON	Peeter	nn	2	SENT_3	[p1l40t348r160b378],
2	Jaanson	NNP	PERSON	Jaanson	_	0	SENT_3	[p1l171t348r325b382],
3	-	:	O	-	_	0	SENT_3	[p1l339t359r346b367],
4	Toomas	NNP	PERSON	Toomas	nn	5	SENT_3	[p1l361t348r504b378],
5	Marandi	NNP	PERSON	Marandi	dep	2	SENT_3	[p1l517t347r682b378],
6	-	:	O	-	_	0	SENT_3	[p1l696t359r703b367],
7	Raul-Allan	NNP	PERSON	Raul-Allan	nn	10	SENT_3	[p1l717t347r924b378],
8	Kiivet	NNP	PERSON	Kiivet	nn	10	SENT_3	[p1l937t347r1052b378],
9	Veiko	NNP	PERSON	Veiko	nn	10	SENT_3	[p1l40t393r145b425],
10	Vasar	NNP	PERSON	Vasar	dep	5	SENT_3	[p1l158t394r266b425],
11	-	:	O	-	_	0	SENT_3	[p1l279t405r287b413],
12	Siiri	NNP	LOCATION	Siiri	nn	13	SENT_3	[p1l301t393r380b425],
13	Vaéin	NNP	LOCATION	Vaéin	dep	10	SENT_3	[p1l393t394r492b425],
14	-	:	O	-	_	0	SENT_3	[p1l506t405r513b413],
15	J	NNP	O	J	nn	21	SENT_3	[p1l526t394r547b428],
16	an-Olof	NNP	O	an-Olof	nn	21	SENT_3	[p1l549t393r696b425],
17	Svensson	NNP	PERSON	Svensson	nn	21	SENT_3	[p1l706t393r876b425],
18	Marja-Liisa	NNP	PERSON	Marja-Liisa	nn	21	SENT_3	[p1l40t438r267b478],
19	Dahl	NNP	PERSON	Dahl	nn	21	SENT_3	[p1l280t439r369b470],
20	Maintenance	NNP	O	Maintenance	nn	21	SENT_3	[p1l43t512r416b565],
21	therapy	NN	O	therapy	dep	10	SENT_3	[p1l435t512r657b575],
22	with	IN	O	with	_	0	SENT_3	[p1l675t512r794b565],
23	zuclopenthixol	NN	O	zuclopenthixol	nn	24	SENT_3	[p1l817t512r1234b575],
24	decanoate	NN	O	decanoate	prep_with	21	SENT_3	[p1l1257t512r1575b565],
25	:	:	O	:	_	0	SENT_3	[p1l1257t512r1575b565],
26	associations	NNS	O	association	dep	10	SENT_3	[p1l41t610r397b663],
27	between	IN	O	between	_	0	SENT_3	[p1l420t610r653b663],
28	plasma	NN	O	plasma	nn	29	SENT_3	[p1l678t610r879b674],
29	concentrations	NNS	O	concentration	prep_between	26	SENT_3	[p1l901t610r1347b674],
30	,	,	O	,	_	0	SENT_3	[p1l901t610r1347b674],
31	neurological	JJ	O	neurological	amod	33	SENT_3	[p1l1372t610r1721b673],
32	side	JJ	O	side	amod	33	SENT_3	[p1l1743t610r1859b663],
33	effects	NNS	O	effect	prep_between	26	SENT_3	[p1l1880t609r2075b663],
34	and	CC	O	and	_	0	SENT_3	[p1l41t710r144b763],
35	CYP2D6	NN	O	cyp2d6	nn	36	SENT_3	[p1l172t709r414b763],
36	genotype	NN	O	genotype	prep_between	26	SENT_3	[p1l427t712r690b773],

1	Received	VBN	O	receive	_	0	SENT_4	[p1l40t828r188b854],
2	:	:	O	:	_	0	SENT_4	[p1l40t828r188b854],
3	23	CD	DATE	23	num	4	SENT_4	[p1l202t828r236b855],
4	November	NNP	DATE	November	dep	1	SENT_4	[p1l249t828r408b854],
5	2000	CD	DATE	2000	num	4	SENT_4	[p1l419t828r514b855],
6	/	:	O	/	punct	7	SENT_4	[p1l419t828r514b855],
7	Accepted	JJ	O	accepted	dep	4	SENT_4	[p1l524t828r674b862],
8	:	:	O	:	_	0	SENT_4	[p1l524t828r674b862],
9	17	CD	DATE	17	dep	7	SENT_4	[p1l691t828r722b854],
10	July	NNP	DATE	July	tmod	9	SENT_4	[p1l734t828r796b862],
11	2001	CD	DATE	2001	num	10	SENT_4	[p1l808t828r878b855],
12	/	:	O	/	punct	7	SENT_4	[p1l892t828r903b855],
13	Published	VBN	O	publish	partmod	4	SENT_4	[p1l913t828r1061b854],
14	online	NN	O	online	prep	13	SENT_4	[p1l1072t828r1174b854],
15	:	:	O	:	_	0	SENT_4	[p1l1072t828r1174b854],
16	20	CD	DATE	20	num	17	SENT_4	[p1l1187t828r1223b855],
17	April	NNP	DATE	April	dep	4	SENT_4	[p1l1234t828r1313b862],
18	2002	CD	DATE	2002	num	17	SENT_4	[p1l1324t828r1398b855],
19	©	NNP	O	©	nn	20	SENT_4	[p1l12t872r66b927],
20	Springer	NNP	PERSON	Springer	dep	17	SENT_4	[p1l92t871r596b943],
21	.	.	O	.	_	0	SENT_4	[p1l92t871r596b943],

1	—	NN	O	—	_	0	SENT_5	[p1l92t871r596b943],
2	.	.	O	.	_	0	SENT_5	[p1l92t871r596b943],

1	Verlag	NNP	O	Verlag	_	0	SENT_6	[p1l92t871r596b943],
2	2002	CD	DATE	2002	dep	1	SENT_6	[p1l621t872r776b927],

1	Abstract	JJ	O	abstract	amod	2	SENT_7	[p1l9t1101r345b1166],
2	Rationale	NN	O	rationale	_	0	SENT_7	[p1l387t1101r763b1165],
3	:	:	O	:	_	0	SENT_7	[p1l387t1101r763b1165],
4	Several	JJ	O	several	amod	6	SENT_7	[p1l795t1101r1061b1166],
5	antipsychotic	JJ	O	antipsychotic	amod	6	SENT_7	[p1l1088t1101r1562b1184],
6	drugs	NNS	O	drug	nsubjpass	8	SENT_7	[p1l1589t1101r1784b1184],
7	are	VBP	O	be	auxpass	8	SENT_7	[p1l1813t1122r1919b1165],
8	metabolised	VBN	O	metabolise	dep	2	SENT_7	[p1l1944t1111r2145b1165, p1l9t1199r277b1263],
9	by	IN	O	by	_	0	SENT_7	[p1l317t1199r407b1282],
10	the	DT	O	the	det	14	SENT_7	[p1l449t1199r559b1263],
11	polymorphic	JJ	O	polymorphic	amod	14	SENT_7	[p1l600t1199r1073b1282],
12	cytochrome	NN	O	cytochrome	nn	14	SENT_7	[p1l1116t1199r1552b1282],
13	P450	NN	O	p450	nn	14	SENT_7	[p1l1592t1201r1745b1286],
14	CYP2D6	NN	O	cyp2d6	agent	8	SENT_7	[p1l1787t1199r2143b1263],
15	.	.	O	.	_	0	SENT_7	[p1l1787t1199r2143b1263],

1	The	DT	O	the	det	2	SENT_8	[p1l10t1297r151b1361],
2	impact	NN	O	impact	nsubjpass	20	SENT_8	[p1l194t1297r447b1380],
3	of	IN	O	of	_	0	SENT_8	[p1l489t1297r569b1361],
4	the	DT	O	the	det	5	SENT_8	[p1l606t1297r716b1361],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_8	[p1l758t1297r1301b1380],
6	on	IN	O	on	_	0	SENT_8	[p1l1344t1318r1433b1361],
7	the	DT	O	the	det	9	SENT_8	[p1l1476t1297r1586b1361],
8	plasma	NN	O	plasma	nn	9	SENT_8	[p1l1628t1297r1892b1380],
9	levels	NNS	O	level	prep_on	5	SENT_8	[p1l1934t1297r2146b1361],
10	and	CC	O	and	_	0	SENT_8	[p1l12t1395r142b1459],
11	the	DT	O	the	det	12	SENT_8	[p1l176t1395r286b1459],
12	occurrence	NN	O	occurrence	conj_and	5	SENT_8	[p1l323t1415r727b1459],
13	of	IN	O	of	_	0	SENT_8	[p1l763t1395r843b1459],
14	side	JJ	O	side	amod	15	SENT_8	[p1l874t1395r1018b1459],
15	effects	NNS	O	effect	prep_of	12	SENT_8	[p1l1054t1395r1295b1459],
16	have	VBP	O	have	aux	20	SENT_8	[p1l1331t1395r1504b1459],
17	not	RB	O	not	neg	20	SENT_8	[p1l1539t1404r1657b1459],
18	been	VBN	O	be	auxpass	20	SENT_8	[p1l1688t1395r1863b1459],
19	clearly	RB	O	clearly	advmod	20	SENT_8	[p1l1898t1395r2148b1478],
20	established	VBN	O	establish	_	0	SENT_8	[p1l11t1493r440b1557],
21	.	.	O	.	_	0	SENT_8	[p1l11t1493r440b1557],

1	Objective	NN	O	objective	_	0	SENT_9	[p1l488t1493r865b1575],
2	:	:	O	:	_	0	SENT_9	[p1l488t1493r865b1575],
3	To	TO	O	to	aux	4	SENT_9	[p1l909t1495r1002b1557],
4	investigate	VB	O	investigate	dep	1	SENT_9	[p1l1042t1493r1443b1576],
5	the	DT	O	the	det	6	SENT_9	[p1l1483t1493r1593b1557],
6	impact	NN	O	impact	dobj	4	SENT_9	[p1l1632t1493r1885b1576],
7	of	IN	O	of	_	0	SENT_9	[p1l1924t1493r2004b1557],
8	the	DT	O	the	det	10	SENT_9	[p1l2036t1493r2147b1557],
9	CYP2D6	NN	O	cyp2d6	nn	10	SENT_9	[p1l11t1591r346b1655],
10	polymorphism	NN	O	polymorphism	prep_of	6	SENT_9	[p1l419t1591r961b1674],
11	on	IN	O	on	_	0	SENT_9	[p1l1033t1611r1122b1655],
12	the	DT	O	the	det	17	SENT_9	[p1l1194t1591r1304b1655],
13	steady	JJ	O	steady	amod	17	SENT_9	[p1l1380t1591r1814b1674],
14	—	NN	O	—	nn	17	SENT_9	[p1l1380t1591r1814b1674],
15	state	NN	O	state	nn	17	SENT_9	[p1l1380t1591r1814b1674],
16	plasma	NN	O	plasma	nn	17	SENT_9	[p1l1885t1591r2149b1674],
17	concentrations	NNS	O	concentration	prep_on	4	SENT_9	[p1l11t1689r549b1753],
18	of	IN	O	of	_	0	SENT_9	[p1l593t1689r673b1753],
19	zuclopenthixol	NN	O	zuclopenthixol	prep_of	17	SENT_9	[p1l709t1689r1259b1772],
20	and	CC	O	and	_	0	SENT_9	[p1l1303t1689r1433b1753],
21	the	DT	O	the	det	22	SENT_9	[p1l1473t1689r1584b1753],
22	occurrence	NN	O	occurrence	nsubj	27	SENT_9	[p1l1627t1710r2031b1753],
23	of	IN	O	of	_	0	SENT_9	[p1l2074t1689r2153b1753],
24	extrapyramidal	JJ	O	extrapyramidal	amod	26	SENT_9	[p1l11t1787r571b1870],
25	side	JJ	O	side	amod	26	SENT_9	[p1l606t1787r749b1851],
26	effects	NNS	O	effect	prep_of	22	SENT_9	[p1l782t1787r1023b1851],
27	(	VBP	O	(	conj_and	4	SENT_9	[p1l1059t1787r1273b1866],
28	EPS	NN	O	ep	nn	29	SENT_9	[p1l1059t1787r1273b1866],
29	)	NN	O	)	dobj	27	SENT_9	[p1l1059t1787r1273b1866],
30	and	CC	O	and	_	0	SENT_9	[p1l1309t1787r1439b1851],
31	tardive	JJ	O	tardive	amod	32	SENT_9	[p1l1469t1787r1725b1851],
32	dyskinesia	NN	O	dyskinesium	dobj	27	SENT_9	[p1l1758t1787r2149b1870],
33	(	CD	NUMBER	(	num	35	SENT_9	[p1l13t1886r190b1965],
34	TD	NN	O	td	nn	35	SENT_9	[p1l13t1886r190b1965],
35	)	NN	O	)	dep	32	SENT_9	[p1l13t1886r190b1965],
36	during	IN	O	during	_	0	SENT_9	[p1l250t1885r488b1968],
37	treatment	NN	O	treatment	prep_during	27	SENT_9	[p1l545t1895r896b1949],
38	with	IN	O	with	_	0	SENT_9	[p1l951t1885r1113b1949],
39	zuclopenthixol-decanoate	NN	O	zuclopenthixol-decanoate	prep_with	37	SENT_9	[p1l1170t1885r2143b1968],
40	.	.	O	.	_	0	SENT_9	[p1l1170t1885r2143b1968],

1	Methods	NNS	O	method	_	0	SENT_10	[p1l7t1983r354b2047],
2	:	:	O	:	_	0	SENT_10	[p1l7t1983r354b2047],
3	Fifty	CD	NUMBER	fifty	num	4	SENT_10	[p1l402t1983r751b2066],
4	—	CD	NUMBER	—	dep	1	SENT_10	[p1l402t1983r751b2066],
5	two	CD	NUMBER	two	num	9	SENT_10	[p1l402t1983r751b2066],
6	clinically	RB	O	clinically	advmod	7	SENT_10	[p1l796t1983r1139b2066],
7	stable	JJ	O	stable	amod	9	SENT_10	[p1l1187t1983r1398b2047],
8	schizophrenic	JJ	O	schizophrenic	amod	9	SENT_10	[p1l1445t1983r1955b2066],
9	outpatients	NNS	O	outpatient	npadvmod	4	SENT_10	[p1l2001t1992r2145b2047, p1l9t2081r295b2164],
10	on	IN	O	on	_	0	SENT_10	[p1l337t2102r426b2145],
11	monotherapy	NN	O	monotherapy	prep_on	4	SENT_10	[p1l464t2081r952b2164],
12	with	IN	O	with	_	0	SENT_10	[p1l992t2081r1155b2145],
13	zuclopenthiXol	NN	O	zuclopenthixol	nn	16	SENT_10	[p1l1193t2081r2147b2164],
14	—	CD	NUMBER	—	num	16	SENT_10	[p1l1193t2081r2147b2164],
15	decanoate	NN	O	decanoate	nn	16	SENT_10	[p1l1193t2081r2147b2164],
16	(	NN	O	(	prep_with	11	SENT_10	[p1l13t2179r363b2258],
17	100	CD	NUMBER	100	num	21	SENT_10	[p1l13t2179r363b2258],
18	—	CD	NUMBER	—	num	21	SENT_10	[p1l13t2179r363b2258],
19	4OO	NN	O	4oo	nn	21	SENT_10	[p1l13t2179r363b2258],
20	mg/4	NN	O	mg/4	nn	21	SENT_10	[p1l396t2179r584b2262],
21	weeks	NNS	DURATION	week	nsubjpass	24	SENT_10	[p1l618t2179r875b2258],
22	)	CD	NUMBER	)	dep	21	SENT_10	[p1l618t2179r875b2258],
23	were	VBD	O	be	auxpass	24	SENT_10	[p1l911t2199r1088b2243],
24	genotyped	VBN	O	genotype	rcmod	4	SENT_10	[p1l1122t2179r1506b2262],
25	for	IN	O	for	_	0	SENT_10	[p1l1539t2179r1646b2243],
26	the	DT	O	the	det	30	SENT_10	[p1l1676t2179r1787b2243],
27	CYPZD6	NN	O	cypzd6	nn	30	SENT_10	[p1l1825t2178r2151b2243],
28	variants	NNS	O	variant	nn	30	SENT_10	[p1l10t2277r300b2341],
29	C	NN	O	c	nn	30	SENT_10	[p1l334t2279r392b2342],
30	YPZD6	NN	O	ypzd6	prep_for	24	SENT_10	[p1l397t2277r661b2341],
31	*	CD	NUMBER	*	number	32	SENT_10	[p1l671t2278r749b2341],
32	3	CD	NUMBER	3	dep	30	SENT_10	[p1l671t2278r749b2341],
33	and	CC	O	and	_	0	SENT_10	[p1l779t2277r910b2341],
34	C	NN	O	c	nn	35	SENT_10	[p1l940t2279r998b2342],
35	YPZD6	NN	O	ypzd6	prep_for	24	SENT_10	[p1l1003t2277r1267b2341],
36	*	CD	NUMBER	*	number	37	SENT_10	[p1l1277t2278r1375b2341],
37	4	CD	NUMBER	4	dep	35	SENT_10	[p1l1277t2278r1375b2341],
38	.	.	O	.	_	0	SENT_10	[p1l1277t2278r1375b2341],

1	Steady	JJ	O	steady	amod	5	SENT_11	[p1l1409t2277r1859b2360],
2	—	NN	O	—	nn	5	SENT_11	[p1l1409t2277r1859b2360],
3	state	NN	O	state	nn	5	SENT_11	[p1l1409t2277r1859b2360],
4	plasma	NN	O	plasma	nn	5	SENT_11	[p1l1886t2277r2149b2360],
5	levels	NNS	O	level	nsubjpass	9	SENT_11	[p1l10t2375r223b2439],
6	of	IN	O	of	_	0	SENT_11	[p1l293t2375r373b2439],
7	zuclopenthixol	NN	O	zuclopenthixol	prep_of	5	SENT_11	[p1l435t2375r985b2458],
8	were	VBD	O	be	auxpass	9	SENT_11	[p1l1053t2395r1230b2439],
9	analysed	VBN	O	analyse	_	0	SENT_11	[p1l1300t2375r1622b2458],
10	using	VBG	O	use	xcomp	9	SENT_11	[p1l1687t2375r1886b2458],
11	highperformance	JJ	O	highperformance	amod	13	SENT_11	[p1l1954t2375r2146b2458, p1l9t2473r468b2556],
12	liquid	JJ	O	liquid	amod	13	SENT_11	[p1l497t2473r708b2556],
13	chromatography	NN	O	chromatography	dobj	10	SENT_11	[p1l736t2473r1343b2556],
14	.	.	O	.	_	0	SENT_11	[p1l736t2473r1343b2556],

1	Assessments	NNS	O	assessment	nsubjpass	9	SENT_12	[p1l1375t2474r1837b2537],
2	of	IN	O	of	_	0	SENT_12	[p1l1869t2473r1948b2537],
3	EPS	NN	O	ep	prep_of	1	SENT_12	[p1l1969t2474r2144b2549],
4	,	,	O	,	_	0	SENT_12	[p1l1969t2474r2144b2549],
5	TD	NN	O	td	prep_of	1	SENT_12	[p1l10t2572r129b2634],
6	and	CC	O	and	_	0	SENT_12	[p1l167t2571r298b2635],
7	psychopathology	NN	O	psychopathology	conj_and	3	SENT_12	[p1l330t2571r965b2654],
8	were	VBD	O	be	auxpass	9	SENT_12	[p1l1000t2591r1177b2635],
9	performed	VBN	O	perform	_	0	SENT_12	[p1l1211t2571r1598b2654],
10	twice	RB	O	twice	advmod	9	SENT_12	[p1l1631t2571r1830b2635],
11	with	IN	O	with	_	0	SENT_12	[p1l1866t2571r2029b2635],
12	an	DT	O	a	det	14	SENT_12	[p1l2065t2591r2148b2635],
13	8-week	JJ	DURATION	8-week	amod	14	SENT_12	[p1l14t2669r283b2733],
14	interval	NN	O	interval	prep_with	9	SENT_12	[p1l347t2669r630b2733],
15	using	VBG	O	use	partmod	14	SENT_12	[p1l696t2669r894b2752],
16	the	DT	O	the	det	20	SENT_12	[p1l962t2669r1073b2733],
17	extrapyramidal	JJ	O	extrapyramidal	amod	20	SENT_12	[p1l1141t2669r1701b2752],
18	symptoms	NNS	O	symptom	nn	20	SENT_12	[p1l1771t2679r2146b2752],
19	rating	NN	O	rating	nn	20	SENT_12	[p1l9t2767r224b2850],
20	scale	NN	O	scale	dobj	15	SENT_12	[p1l270t2767r471b2843],
21	,	,	O	,	_	0	SENT_12	[p1l270t2767r471b2843],
22	the	DT	O	the	det	26	SENT_12	[p1l517t2767r628b2831],
23	abnormal	JJ	O	abnormal	amod	26	SENT_12	[p1l673t2767r1019b2831],
24	involuntary	JJ	O	involuntary	amod	26	SENT_12	[p1l1062t2767r1488b2850],
25	movement	NN	O	movement	nn	26	SENT_12	[p1l1532t2776r1923b2831],
26	scale	NN	O	scale	conj_and	20	SENT_12	[p1l1967t2767r2147b2831],
27	and	CC	O	and	_	0	SENT_12	[p1l12t2865r142b2929],
28	the	DT	O	the	det	32	SENT_12	[p1l168t2865r279b2929],
29	brief	JJ	O	brief	amod	32	SENT_12	[p1l306t2865r486b2929],
30	psychiatric	JJ	O	psychiatric	amod	32	SENT_12	[p1l506t2865r912b2948],
31	rating	NN	O	rating	nn	32	SENT_12	[p1l939t2865r1154b2948],
32	scale	NN	O	scale	conj_and	20	SENT_12	[p1l1186t2865r1385b2929],
33	.	.	O	.	_	0	SENT_12	[p1l1186t2865r1385b2929],

1	Results	NNS	O	result	nsubj	8	SENT_13	[p1l1414t2865r1709b2929],
2	:	:	O	:	_	0	SENT_13	[p1l1414t2865r1709b2929],
3	Thirty	CD	NUMBER	thirty	num	6	SENT_13	[p1l1741t2865r2147b2948],
4	—	CD	NUMBER	—	num	6	SENT_13	[p1l1741t2865r2147b2948],
5	five	CD	NUMBER	five	num	6	SENT_13	[p1l1741t2865r2147b2948],
6	patients	NNS	O	patient	dep	1	SENT_13	[p1l9t2963r295b3046],
7	were	VBD	O	be	cop	8	SENT_13	[p1l393t2983r570b3027],
8	homozygous	JJ	O	homozygous	dep	24	SENT_13	[p1l666t2963r1137b3046],
9	extensive	JJ	O	extensive	amod	10	SENT_13	[p1l1235t2963r1583b3027],
10	metabolisers	NNS	O	metaboliser	nsubj	11	SENT_13	[p1l1679t2963r2146b3027],
11	(	VBP	O	(	ccomp	8	SENT_13	[p1l13t3062r265b3140],
12	EMs	NNS	MISC	em	nsubj	17	SENT_13	[p1l13t3062r265b3140],
13	)	CD	NUMBER	)	num	12	SENT_13	[p1l13t3062r265b3140],
14	,	,	O	,	_	0	SENT_13	[p1l13t3062r265b3140],
15	13	CD	NUMBER	13	appos	12	SENT_13	[p1l330t3062r407b3125],
16	were	VBD	O	be	cop	17	SENT_13	[p1l465t3082r642b3125],
17	heterozygous	JJ	O	heterozygous	ccomp	11	SENT_13	[p1l695t3061r1187b3144],
18	EMS	NNP	ORGANIZATION	EMS	nsubj	23	SENT_13	[p1l1242t3063r1413b3125],
19	and	CC	O	and	_	0	SENT_13	[p1l1470t3061r1600b3125],
20	4	CD	NUMBER	4	conj_and	18	SENT_13	[p1l1652t3062r1695b3124],
21	were	VBD	O	be	cop	23	SENT_13	[p1l1749t3082r1927b3125],
22	poor	JJ	O	poor	amod	23	SENT_13	[p1l1979t3082r2149b3144],
23	metabolisers	NNS	O	metaboliser	ccomp	17	SENT_13	[p1l10t3158r476b3222],
24	(	VBP	O	(	_	0	SENT_13	[p1l540t3159r785b3238],
25	PMs	NNS	O	pm	dobj	24	SENT_13	[p1l540t3159r785b3238],
26	)	CD	NUMBER	)	nsubj	24	SENT_13	[p1l540t3159r785b3238],
27	.	.	O	.	_	0	SENT_13	[p1l540t3159r785b3238],

1	While	IN	O	while	mark	3	SENT_14	[p1l847t3158r1072b3223],
2	there	EX	O	there	expl	3	SENT_14	[p1l1131t3158r1314b3222],
3	were	VBD	O	be	_	0	SENT_14	[p1l1372t3179r1550b3223],
4	no	DT	O	no	det	7	SENT_14	[p1l1608t3179r1697b3222],
5	significant	JJ	O	significant	amod	7	SENT_14	[p1l1760t3158r2149b3242],
6	genotype	NN	O	genotype	nn	7	SENT_14	[p1l11t3257r614b3340],
7	—	NN	O	—	nsubj	3	SENT_14	[p1l11t3257r614b3340],
8	related	JJ	O	related	amod	9	SENT_14	[p1l11t3257r614b3340],
9	differences	NNS	O	difference	nsubj	23	SENT_14	[p1l640t3257r1033b3321],
10	in	IN	O	in	_	0	SENT_14	[p1l1061t3257r1130b3320],
11	the	DT	O	the	det	12	SENT_14	[p1l1155t3257r1264b3321],
12	doses	NNS	O	dose	prep_in	9	SENT_14	[p1l1291t3257r1486b3321],
13	of	IN	O	of	_	0	SENT_14	[p1l1516t3257r1594b3321],
14	zuclopenthixol	NN	O	zuclopenthixol	nn	15	SENT_14	[p1l1615t3257r2147b3340],
15	decanoate	NN	O	decanoate	prep_of	12	SENT_14	[p1l11t3354r396b3430],
16	,	,	O	,	_	0	SENT_14	[p1l11t3354r396b3430],
17	PMs	NNS	O	pm	appos	15	SENT_14	[p1l427t3356r591b3418],
18	as	RB	O	as	_	0	SENT_14	[p1l623t3375r693b3418],
19	well	RB	O	well	_	0	SENT_14	[p1l723t3354r880b3419],
20	as	IN	O	as	_	0	SENT_14	[p1l909t3375r980b3418],
21	heterozygous	JJ	O	heterozygous	amod	22	SENT_14	[p1l1009t3355r1496b3438],
22	EMS	NNP	ORGANIZATION	EMS	prep_of	12	SENT_14	[p1l1526t3356r1696b3418],
23	had	VBD	O	have	rcmod	7	SENT_14	[p1l1725t3354r1857b3418],
24	significantly	RB	O	significantly	advmod	25	SENT_14	[p1l1887t3354r2145b3438, p1l11t3453r232b3536],
25	higher	JJR	O	higher	amod	30	SENT_14	[p1l258t3453r494b3536],
26	steady	JJ	O	steady	amod	30	SENT_14	[p1l522t3453r951b3536],
27	—	NN	O	—	nn	30	SENT_14	[p1l522t3453r951b3536],
28	state	NN	O	state	nn	30	SENT_14	[p1l522t3453r951b3536],
29	plasma	NN	O	plasma	nn	30	SENT_14	[p1l976t3453r1238b3536],
30	levels	NNS	O	level	dobj	23	SENT_14	[p1l1263t3453r1473b3517],
31	of	IN	O	of	_	0	SENT_14	[p1l1503t3453r1582b3517],
32	zuclopenthixol	NN	O	zuclopenthixol	prep_of	30	SENT_14	[p1l1603t3453r2147b3536],

1	P.	NNP	O	P.	nn	2	SENT_15	[p1l10t3641r59b3694],
2	J	NNP	O	J	_	0	SENT_15	[p1l85t3641r115b3694],
3	aanson	NN	O	aanson	rcmod	2	SENT_15	[p1l119t3657r336b3694],
4	(	CD	NUMBER	(	num	5	SENT_15	[p1l361t3640r493b3707],
5	E	NN	O	e	dep	3	SENT_15	[p1l361t3640r493b3707],
6	)	SYM	O	)	dep	3	SENT_15	[p1l361t3640r493b3707],
7	-	:	O	-	_	0	SENT_15	[p1l522t3668r532b3677],
8	V.	NNP	PERSON	V.	nn	9	SENT_15	[p1l559t3640r619b3694],
9	Vasar	NNP	PERSON	Vasar	dep	2	SENT_15	[p1l646t3641r823b3694],
10	-	:	O	-	_	0	SENT_15	[p1l848t3668r857b3678],
11	S.	NNP	ORGANIZATION	S.	nn	13	SENT_15	[p1l886t3639r942b3694],
12	Vaan	NNP	ORGANIZATION	Vaan	nn	13	SENT_15	[p1l969t3640r1134b3694],
13	Department	NNP	ORGANIZATION	Department	dep	9	SENT_15	[p1l10t3735r385b3806],
14	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l408t3734r476b3789],
15	Psychiatry	NNP	ORGANIZATION	Psychiatry	nn	17	SENT_15	[p1l493t3734r841b3806],
16	,	,	O	,	_	0	SENT_15	[p1l493t3734r841b3806],
17	University	NNP	ORGANIZATION	University	prep_of	13	SENT_15	[p1l866t3734r1201b3806],
18	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1225t3734r1293b3789],
19	Tartu	NNP	ORGANIZATION	Tartu	prep_of	2	SENT_15	[p1l1311t3735r1493b3800],
20	,	,	O	,	_	0	SENT_15	[p1l1311t3735r1493b3800],
21	31	CD	NUMBER	31	num	23	SENT_15	[p1l1521t3734r1589b3789],
22	Raja	NNP	PERSON	Raja	nn	23	SENT_15	[p1l1618t3734r1763b3806],
23	St.	NNP	PERSON	St.	appos	19	SENT_15	[p1l1787t3734r1887b3800],
24	,	,	O	,	_	0	SENT_15	[p1l1787t3734r1887b3800],

1	50417	CD	NUMBER	50417	_	0	SENT_16	[p2l11t18r204b73],
2	Tartu	NNP	LOCATION	Tartu	dep	1	SENT_16	[p2l229t19r412b83],
3	,	,	O	,	_	0	SENT_16	[p2l229t19r412b83],
4	Estonia	NNP	LOCATION	Estonia	appos	2	SENT_16	[p2l437t18r676b73],
5	e-mail	VB	O	e-mail	rcmod	4	SENT_16	[p2l11t111r228b167],
6	:	:	O	:	_	0	SENT_16	[p2l11t111r228b167],
7	Peeter.Jaanson@kliinikum.ee	NN	O	peeter.jaanson@kliinikum.ee	dep	1	SENT_16	[p2l257t111r1197b167],

1	Tel.	NNP	O	Tel.	_	0	SENT_17	[p2l10t206r145b261],
2	:	:	O	:	_	0	SENT_17	[p2l10t206r145b261],
3	+372	CD	NUMBER	+372	number	4	SENT_17	[p2l174t206r685b271],
4	-7	CD	NUMBER	-7	num	5	SENT_17	[p2l174t206r685b271],
5	-448760	CD	NUMBER	-448760	dep	1	SENT_17	[p2l174t206r685b271],
6	,	,	O	,	_	0	SENT_17	[p2l174t206r685b271],
7	Fax	NNP	O	Fax	appos	5	SENT_17	[p2l711t208r845b261],
8	:	:	O	:	_	0	SENT_17	[p2l711t208r845b261],
9	+372	CD	NUMBER	+372	number	10	SENT_17	[p2l874t206r1367b262],
10	-7	CD	NUMBER	-7	dep	5	SENT_17	[p2l874t206r1367b262],
11	-380256	CD	NUMBER	-380256	dep	10	SENT_17	[p2l874t206r1367b262],

1	T.	NNP	PERSON	T.	nn	4	SENT_18	[p2l10t338r66b392],
2	Marandi	NNP	PERSON	Marandi	nn	4	SENT_18	[p2l92t336r360b392],
3	Mustamae	NNP	PERSON	Mustamae	nn	4	SENT_18	[p2l9t417r339b471],
4	Hospital	NNP	PERSON	Hospital	_	0	SENT_18	[p2l362t416r648b488],
5	,	,	O	,	_	0	SENT_18	[p2l362t416r648b488],
6	Tallinn	NNP	LOCATION	Tallinn	appos	4	SENT_18	[p2l674t416r913b481],
7	,	,	O	,	_	0	SENT_18	[p2l674t416r913b481],
8	Estonia	NNP	ORGANIZATION	Estonia	nn	11	SENT_18	[p2l939t416r1178b471],
9	T.	NNP	ORGANIZATION	T.	nn	11	SENT_18	[p2l10t515r66b568],
10	Marandi	NNP	ORGANIZATION	Marandi	nn	11	SENT_18	[p2l92t513r360b568],
11	Department	NNP	ORGANIZATION	Department	appos	4	SENT_18	[p2l10t594r385b665],
12	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l408t593r476b648],
13	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	11	SENT_18	[p2l493t593r964b665],
14	,	,	O	,	_	0	SENT_18	[p2l493t593r964b665],
15	University	NNP	ORGANIZATION	University	appos	4	SENT_18	[p2l990t593r1324b664],
16	of	IN	ORGANIZATION	of	_	0	SENT_18	[p2l1348t593r1417b648],
17	Tartu	NNP	ORGANIZATION	Tartu	nn	22	SENT_18	[p2l1434t594r1617b658],
18	,	,	O	,	_	0	SENT_18	[p2l1434t594r1617b658],
19	Tartu	NNP	LOCATION	Tartu	appos	22	SENT_18	[p2l1642t594r1824b658],
20	,	,	O	,	_	0	SENT_18	[p2l1642t594r1824b658],
21	Estonia	NNP	LOCATION	Estonia	appos	22	SENT_18	[p2l1849t593r2088b648],
22	J	NNP	O	J	prep_of	15	SENT_18	[p2l9t692r39b746],
23	.	.	O	.	_	0	SENT_18	[p2l45t691r159b746],

1	-	:	O	-	_	0	SENT_19	[p2l45t691r159b746],
2	O.	NNP	PERSON	O.	nn	3	SENT_19	[p2l45t691r159b746],
3	Svensson	NNP	PERSON	Svensson	_	0	SENT_19	[p2l188t691r485b746],
4	-	:	O	-	_	0	SENT_19	[p2l512t720r521b729],
5	M.-L	NN	O	m.-l	dep	3	SENT_19	[p2l547t692r727b746],
6	.	.	O	.	_	0	SENT_19	[p2l547t692r727b746],

1	Dahl	NNP	ORGANIZATION	Dahl	nn	2	SENT_20	[p2l754t691r907b746],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_20	[p2l10t773r385b843],
3	of	IN	ORGANIZATION	of	_	0	SENT_20	[p2l408t771r476b827],
4	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_20	[p2l493t771r752b827],
5	Laboratory	NNP	ORGANIZATION	Laboratory	nn	6	SENT_20	[p2l775t772r1127b843],
6	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	2	SENT_20	[p2l1152t771r1425b827],
7	and	CC	ORGANIZATION	and	_	0	SENT_20	[p2l1452t771r1563b827],
8	Technology	NNP	ORGANIZATION	Technology	prep_of	2	SENT_20	[p2l1586t771r1971b843],
9	,	,	O	,	_	0	SENT_20	[p2l1586t771r1971b843],
10	Division	NNP	O	Division	appos	2	SENT_20	[p2l10t852r283b908],
11	of	IN	O	of	_	0	SENT_20	[p2l306t852r375b908],
12	Clinical	JJ	O	clinical	amod	13	SENT_20	[p2l393t852r642b908],
13	Pharmacology	NN	O	pharmacology	prep_of	10	SENT_20	[p2l665t852r1136b924],
14	,	,	O	,	_	0	SENT_20	[p2l665t852r1136b924],
15	Karolinska	NNP	LOCATION	Karolinska	nn	16	SENT_20	[p2l1163t852r1511b908],
16	Institutet	NNP	LOCATION	Institutet	appos	2	SENT_20	[p2l1532t852r1832b918],
17	,	,	O	,	_	0	SENT_20	[p2l1532t852r1832b918],
18	Huddinge	NNP	ORGANIZATION	Huddinge	nn	20	SENT_20	[p2l10t933r321b1005],
19	University	NNP	ORGANIZATION	University	nn	20	SENT_20	[p2l344t933r679b1005],
20	Hospital	NNP	ORGANIZATION	Hospital	appos	2	SENT_20	[p2l702t933r988b1005],
21	,	,	O	,	_	0	SENT_20	[p2l702t933r988b1005],
22	Stockholm	NNP	LOCATION	Stockholm	appos	2	SENT_20	[p2l1016t933r1374b999],
23	,	,	O	,	_	0	SENT_20	[p2l1016t933r1374b999],
24	Sweden	NNP	LOCATION	Sweden	nn	25	SENT_20	[p2l1402t933r1650b989],
25	R.	NNP	O	R.	appos	2	SENT_20	[p2l10t1032r181b1086],
26	.	.	O	.	_	0	SENT_20	[p2l10t1032r181b1086],

1	—	NN	O	—	_	0	SENT_21	[p2l10t1032r181b1086],
2	.	.	O	.	_	0	SENT_21	[p2l10t1032r181b1086],

1	A.	NN	ORGANIZATION	a.	nn	3	SENT_22	[p2l10t1032r181b1086],
2	Kiivet	NNP	ORGANIZATION	Kiivet	nn	3	SENT_22	[p2l209t1031r406b1086],
3	Department	NNP	ORGANIZATION	Department	_	0	SENT_22	[p2l10t1112r385b1183],
4	of	IN	ORGANIZATION	of	_	0	SENT_22	[p2l408t1111r476b1166],
5	Public	NNP	ORGANIZATION	Public	nn	6	SENT_22	[p2l493t1111r694b1166],
6	Health	NNP	ORGANIZATION	Health	prep_of	3	SENT_22	[p2l718t1111r946b1177],
7	,	,	ORGANIZATION	,	_	0	SENT_22	[p2l718t1111r946b1177],
8	University	NNP	ORGANIZATION	University	appos	3	SENT_22	[p2l971t1111r1306b1183],
9	of	IN	ORGANIZATION	of	_	0	SENT_22	[p2l1330t1111r1398b1166],
10	Tartu	NNP	ORGANIZATION	Tartu	prep_of	8	SENT_22	[p2l1416t1112r1598b1176],
11	,	,	O	,	_	0	SENT_22	[p2l1416t1112r1598b1176],
12	Tartu	NNP	LOCATION	Tartu	appos	3	SENT_22	[p2l1624t1112r1806b1177],
13	,	,	O	,	_	0	SENT_22	[p2l1624t1112r1806b1177],
14	Estonia	NNP	LOCATION	Estonia	nsubj	18	SENT_22	[p2l1831t1111r2070b1166],
15	than	IN	O	than	_	0	SENT_22	[p2l7t1201r165b1265],
16	homozygous	JJ	O	homozygous	amod	17	SENT_22	[p2l206t1201r678b1284],
17	EMs	NNS	O	em	prep_than	14	SENT_22	[p2l723t1203r894b1265],
18	(	VBP	O	(	dep	3	SENT_22	[p2l942t1201r1242b1281],
19	median	JJ	O	median	dobj	18	SENT_22	[p2l942t1201r1242b1281],
20	9.5	CD	NUMBER	9.5	num	21	SENT_22	[p2l1286t1201r1394b1266],
21	nmol/l	NN	O	nmol/l	dep	19	SENT_22	[p2l1441t1201r1704b1277],
22	;	:	O	;	_	0	SENT_22	[p2l1441t1201r1704b1277],
23	8.2	CD	NUMBER	8.2	num	24	SENT_22	[p2l1754t1202r1863b1266],
24	nmol/l	NN	O	nmol/l	dep	19	SENT_22	[p2l1907t1201r2147b1266],
25	and	CC	O	and	_	0	SENT_22	[p2l9t1300r139b1364],
26	5.9	CD	NUMBER	5.9	num	27	SENT_22	[p2l173t1300r283b1365],
27	nmol/l	NN	O	nmol/l	dep	19	SENT_22	[p2l317t1300r578b1376],
28	,	,	O	,	_	0	SENT_22	[p2l317t1300r578b1376],
29	respectively	RB	O	respectively	advmod	18	SENT_22	[p2l613t1300r1077b1383],
30	,	,	O	,	_	0	SENT_22	[p2l613t1300r1077b1383],
31	P	NN	O	p	dep	32	SENT_22	[p2l1111t1300r1433b1379],
32	<	JJR	O	<	appos	3	SENT_22	[p2l1111t1300r1433b1379],
33	0.05	CD	NUMBER	0.05	num	34	SENT_22	[p2l1111t1300r1433b1379],
34	)	NN	O	)	dep	32	SENT_22	[p2l1111t1300r1433b1379],
35	.	.	O	.	_	0	SENT_22	[p2l1111t1300r1433b1379],

1	The	DT	O	the	det	5	SENT_23	[p2l1470t1300r1612b1364],
2	median	JJ	O	median	amod	5	SENT_23	[p2l1644t1300r1916b1364],
3	dosecorrected	JJ	O	dosecorrected	amod	5	SENT_23	[p2l1949t1300r2145b1364, p2l8t1399r352b1463],
4	plasma	NN	O	plasma	nn	5	SENT_23	[p2l391t1399r655b1482],
5	concentrations	NNS	O	concentration	nsubj	7	SENT_23	[p2l696t1399r1234b1463],
6	were	VBD	O	be	cop	7	SENT_23	[p2l1277t1420r1455b1463],
7	0.029	CD	NUMBER	0.029	dep	36	SENT_23	[p2l1497t1400r1724b1475],
8	,	,	O	,	_	0	SENT_23	[p2l1497t1400r1724b1475],
9	0.038	CD	NUMBER	0.038	dep	36	SENT_23	[p2l1769t1400r1972b1464],
10	and	CC	O	and	_	0	SENT_23	[p2l2018t1399r2148b1463],
11	0.048	CD	NUMBER	0.048	num	14	SENT_23	[p2l8t1498r211b1563],
12	nmol-l	JJ	O	nmol-l	amod	14	SENT_23	[p2l252t1494r757b1582],
13	—	NN	O	—	nn	14	SENT_23	[p2l252t1494r757b1582],
14	1-mg-1	NN	O	1-mg-1	conj_and	7	SENT_23	[p2l252t1494r757b1582],
15	in	IN	O	in	_	0	SENT_23	[p2l800t1498r870b1562],
16	homozygous	JJ	O	homozygous	amod	17	SENT_23	[p2l907t1498r1379b1582],
17	EMS	NNP	ORGANIZATION	EMS	prep_in	7	SENT_23	[p2l1419t1500r1612b1575],
18	,	,	O	,	_	0	SENT_23	[p2l1419t1500r1612b1575],
19	heterozygous	JJ	O	heterozygous	amod	20	SENT_23	[p2l1653t1498r2146b1582],
20	EMs	NNS	O	em	prep_in	7	SENT_23	[p2l7t1600r177b1662],
21	and	CC	O	and	_	0	SENT_23	[p2l215t1598r346b1662],
22	PMs	NNS	O	pm	prep_in	7	SENT_23	[p2l378t1600r566b1674],
23	,	,	O	,	_	0	SENT_23	[p2l378t1600r566b1674],
24	respectively	RB	O	respectively	advmod	7	SENT_23	[p2l602t1598r1065b1681],
25	,	,	O	,	_	0	SENT_23	[p2l602t1598r1065b1681],
26	with	IN	O	with	_	0	SENT_23	[p2l1103t1598r1266b1662],
27	statistically	RB	O	statistically	advmod	28	SENT_23	[p2l1302t1598r1722b1681],
28	significant	JJ	O	significant	amod	29	SENT_23	[p2l1759t1598r2149b1681],
29	differences	NNS	O	difference	prep_with	7	SENT_23	[p2l8t1697r415b1761],
30	between	IN	O	between	_	0	SENT_23	[p2l446t1697r755b1761],
31	homozygous	JJ	O	homozygous	amod	32	SENT_23	[p2l784t1697r1256b1780],
32	EMs	NNS	O	em	prep_between	29	SENT_23	[p2l1288t1698r1459b1761],
33	and	CC	O	and	_	0	SENT_23	[p2l1493t1697r1624b1761],
34	heterozygous	JJ	O	heterozygous	amod	35	SENT_23	[p2l1652t1697r2146b1780],
35	EMs	NNS	O	em	conj_and	32	SENT_23	[p2l7t1798r178b1860],
36	(	VBP	O	(	_	0	SENT_23	[p2l267t1797r643b1876],
37	P	NN	O	p	dobj	36	SENT_23	[p2l267t1797r643b1876],
38	=	JJ	O	=	amod	41	SENT_23	[p2l267t1797r643b1876],
39	0.0	CD	NUMBER	0.0	tmod	38	SENT_23	[p2l267t1797r643b1876],
40	l4	NN	O	l4	nn	41	SENT_23	[p2l267t1797r643b1876],
41	)	NN	O	)	dep	37	SENT_23	[p2l267t1797r643b1876],
42	and	CC	O	and	_	0	SENT_23	[p2l732t1796r863b1860],
43	homozygous	JJ	O	homozygous	amod	44	SENT_23	[p2l945t1796r1421b1879],
44	EMs	NNS	O	em	conj_and	37	SENT_23	[p2l1506t1798r1678b1860],
45	and	CC	O	and	_	0	SENT_23	[p2l1765t1796r1897b1860],
46	PMs	NNS	O	pm	conj_and	44	SENT_23	[p2l1979t1798r2145b1860],
47	(	CD	NUMBER	(	num	48	SENT_23	[p2l10t1895r358b1974],
48	P	NN	O	p	npadvmod	49	SENT_23	[p2l10t1895r358b1974],
49	=	JJ	O	=	amod	44	SENT_23	[p2l10t1895r358b1974],
50	0.03	CD	NUMBER	0.03	num	51	SENT_23	[p2l10t1895r358b1974],
51	)	NN	O	)	nsubj	36	SENT_23	[p2l10t1895r358b1974],
52	.	.	O	.	_	0	SENT_23	[p2l10t1895r358b1974],

1	Patients	NNS	O	patient	nsubj	8	SENT_24	[p2l412t1895r703b1959],
2	with	IN	O	with	_	0	SENT_24	[p2l754t1895r917b1959],
3	neurological	JJ	O	neurological	amod	5	SENT_24	[p2l966t1895r1429b1978],
4	side	JJ	O	side	amod	5	SENT_24	[p2l1482t1895r1626b1959],
5	effects	NNS	O	effect	prep_with	1	SENT_24	[p2l1677t1895r1918b1959],
6	were	VBD	O	be	cop	8	SENT_24	[p2l1970t1915r2147b1959],
7	significantly	RB	O	significantly	advmod	8	SENT_24	[p2l10t1994r471b2077],
8	older	JJR	O	older	_	0	SENT_24	[p2l506t1994r695b2058],
9	than	IN	O	than	_	0	SENT_24	[p2l726t1994r884b2058],
10	patients	NNS	O	patient	prep_than	8	SENT_24	[p2l916t1994r1203b2077],
11	without	IN	O	without	_	0	SENT_24	[p2l1238t1994r1522b2058],
12	(	CD	NUMBER	(	num	13	SENT_24	[p2l1556t1995r1853b2073],
13	P	NN	O	p	prep_without	8	SENT_24	[p2l1556t1995r1853b2073],
14	=	JJ	O	=	amod	13	SENT_24	[p2l1556t1995r1853b2073],
15	0.02	CD	NUMBER	0.02	tmod	14	SENT_24	[p2l1556t1995r1853b2073],
16	in	IN	O	in	_	0	SENT_24	[p2l1887t1994r1957b2057],
17	case	NN	O	case	prep_in	14	SENT_24	[p2l1991t2015r2147b2058],
18	of	IN	O	of	_	0	SENT_24	[p2l8t2093r88b2157],
19	parkinsonism	NN	O	parkinsonism	prep_of	17	SENT_24	[p2l133t2093r636b2176],
20	and	CC	O	and	_	0	SENT_24	[p2l688t2093r819b2157],
21	P	NN	O	p	prep_of	17	SENT_24	[p2l869t2093r1140b2157],
22	=	JJ	O	=	amod	13	SENT_24	[p2l869t2093r1140b2157],
23	0.04	CD	NUMBER	0.04	tmod	22	SENT_24	[p2l869t2093r1140b2157],
24	in	IN	O	in	_	0	SENT_24	[p2l1193t2093r1263b2156],
25	case	NN	O	case	_	0	SENT_24	[p2l1316t2113r1473b2157],
26	of	IN	O	of	_	0	SENT_24	[p2l1527t2093r1607b2157],
27	TD	NN	O	td	nn	28	SENT_24	[p2l1653t2094r1824b2172],
28	)	NN	O	)	prep_in_case_of	8	SENT_24	[p2l1653t2094r1824b2172],
29	.	.	O	.	_	0	SENT_24	[p2l1653t2094r1824b2172],

1	Mutant	JJ	O	mutant	amod	3	SENT_25	[p2l1881t2094r2149b2157],
2	C	NN	O	c	nn	3	SENT_25	[p2l11t2194r70b2257],
3	YPZD6	NN	O	ypzd6	nsubj	10	SENT_25	[p2l73t2192r334b2256],
4	*	CD	NUMBER	*	number	5	SENT_25	[p2l343t2193r420b2256],
5	3	CD	NUMBER	3	dep	3	SENT_25	[p2l343t2193r420b2256],
6	and	CC	O	and	_	0	SENT_25	[p2l449t2192r578b2256],
7	*	CD	NUMBER	*	number	8	SENT_25	[p2l614t2193r692b2255],
8	4	CD	NUMBER	4	num	9	SENT_25	[p2l614t2193r692b2255],
9	alleles	NNS	O	allele	nsubj	10	SENT_25	[p2l721t2192r947b2256],
10	tended	VBD	O	tend	_	0	SENT_25	[p2l975t2192r1217b2256],
11	to	TO	O	to	aux	12	SENT_25	[p2l1242t2201r1310b2256],
12	occur	VB	O	occur	xcomp	10	SENT_25	[p2l1338t2213r1539b2256],
13	more	RBR	O	more	advmod	14	SENT_25	[p2l1563t2213r1749b2256],
14	frequently	RB	O	frequently	advmod	12	SENT_25	[p2l1775t2192r2147b2275],
15	in	IN	O	in	_	0	SENT_25	[p2l7t2291r77b2354],
16	patients	NNS	O	patient	prep_in	12	SENT_25	[p2l111t2291r398b2374],
17	with	IN	O	with	_	0	SENT_25	[p2l437t2291r600b2355],
18	neurological	JJ	O	neurological	amod	20	SENT_25	[p2l636t2291r1099b2374],
19	side	JJ	O	side	amod	20	SENT_25	[p2l1139t2291r1283b2355],
20	effects	NNS	O	effect	prep_with	16	SENT_25	[p2l1320t2291r1582b2355],
21	.	.	O	.	_	0	SENT_25	[p2l1320t2291r1582b2355],

1	An	DT	O	a	det	2	SENT_26	[p2l1623t2291r1734b2354],
2	odds	NNS	O	odds	dep	37	SENT_26	[p2l1771t2291r1941b2355],
3	ratio	NN	O	ratio	nn	6	SENT_26	[p2l1978t2291r2147b2355],
4	(	CD	NUMBER	(	num	6	SENT_26	[p2l10t2391r193b2469],
5	OR	NN	O	or	nn	6	SENT_26	[p2l10t2391r193b2469],
6	)	NN	O	)	dep	16	SENT_26	[p2l10t2391r193b2469],
7	of	IN	O	of	_	0	SENT_26	[p2l225t2390r305b2454],
8	2.3	CD	PERCENT	2.3	number	9	SENT_26	[p2l329t2391r437b2455],
9	(	CD	PERCENT	(	amod	12	SENT_26	[p2l473t2390r665b2469],
10	95	CD	PERCENT	95	num	11	SENT_26	[p2l473t2390r665b2469],
11	%	NN	PERCENT	%	dep	9	SENT_26	[p2l473t2390r665b2469],
12	confidence	NN	O	confidence	prep_of	6	SENT_26	[p2l699t2390r1104b2454],
13	interval	NN	O	interval	dep	16	SENT_26	[p2l1134t2390r1416b2455],
14	0.7-6	CD	NUMBER	0.7-6	num	13	SENT_26	[p2l1446t2390r1751b2469],
15	.9	CD	NUMBER	.9	num	16	SENT_26	[p2l1446t2390r1751b2469],
16	)	NN	O	)	dep	30	SENT_26	[p2l1446t2390r1751b2469],
17	for	IN	O	for	_	0	SENT_26	[p2l1782t2390r1890b2454],
18	development	NN	O	development	prep_for	16	SENT_26	[p2l1918t2390r2145b2454, p2l8t2498r285b2572],
19	of	IN	O	of	_	0	SENT_26	[p2l322t2489r402b2553],
20	parkinsonism	NN	O	parkinsonism	prep_of	18	SENT_26	[p2l432t2489r935b2572],
21	and	CC	O	and	_	0	SENT_26	[p2l973t2489r1104b2553],
22	an	DT	O	a	det	23	SENT_26	[p2l1143t2509r1226b2553],
23	OR	NN	O	or	conj_and	16	SENT_26	[p2l1265t2489r1390b2553],
24	of	IN	O	of	_	0	SENT_26	[p2l1428t2489r1508b2553],
25	1.7	CD	PERCENT	1.7	number	26	SENT_26	[p2l1548t2489r1650b2553],
26	(	CD	PERCENT	(	amod	29	SENT_26	[p2l1694t2488r1886b2568],
27	95	CD	PERCENT	95	num	28	SENT_26	[p2l1694t2488r1886b2568],
28	%	NN	PERCENT	%	dep	26	SENT_26	[p2l1694t2488r1886b2568],
29	confidence	NN	O	confidence	prep_of	23	SENT_26	[p2l1928t2489r2145b2553, p2l8t2588r221b2652],
30	interval	NN	O	interval	dep	37	SENT_26	[p2l251t2588r533b2653],
31	0.5-4	CD	NUMBER	0.5-4	num	30	SENT_26	[p2l563t2588r868b2667],
32	.9	CD	NUMBER	.9	num	33	SENT_26	[p2l563t2588r868b2667],
33	)	NN	O	)	nsubjpass	37	SENT_26	[p2l563t2588r868b2667],
34	for	IN	O	for	_	0	SENT_26	[p2l900t2588r1007b2652],
35	TD	NN	O	td	prep_for	33	SENT_26	[p2l1035t2590r1154b2651],
36	was	VBD	O	be	auxpass	37	SENT_26	[p2l1185t2609r1325b2652],
37	calculated	VBN	O	calculate	_	0	SENT_26	[p2l1357t2588r1733b2652],
38	in	IN	O	in	_	0	SENT_26	[p2l1761t2588r1831b2651],
39	an	DT	O	a	det	46	SENT_26	[p2l1862t2609r1945b2652],
40	individual	JJ	O	individual	amod	46	SENT_26	[p2l1974t2588r2145b2652, p2l7t2687r237b2751],
41	with	IN	O	with	_	0	SENT_26	[p2l287t2687r450b2752],
42	at	IN	O	at	quantmod	44	SENT_26	[p2l500t2697r564b2751],
43	least	JJS	O	least	mwe	42	SENT_26	[p2l612t2687r782b2751],
44	one	CD	NUMBER	one	prep_with	40	SENT_26	[p2l831t2707r961b2751],
45	mutated	VBN	O	mutate	partmod	44	SENT_26	[p2l1010t2687r1309b2751],
46	allele	NN	O	allele	prep_in	37	SENT_26	[p2l1359t2687r1575b2751],
47	.	.	O	.	_	0	SENT_26	[p2l1359t2687r1575b2751],

1	However	RB	O	however	advmod	8	SENT_27	[p2l1629t2688r1984b2763],
2	,	,	O	,	_	0	SENT_27	[p2l1629t2688r1984b2763],
3	the	DT	O	the	det	4	SENT_27	[p2l2036t2687r2147b2751],
4	ORs	NNS	O	or	nsubj	8	SENT_27	[p2l9t2787r167b2850],
5	were	VBD	O	be	cop	8	SENT_27	[p2l205t2807r383b2850],
6	not	RB	O	not	neg	8	SENT_27	[p2l418t2795r537b2850],
7	statistically	RB	O	statistically	advmod	8	SENT_27	[p2l574t2786r994b2869],
8	significant	JJ	O	significant	_	0	SENT_27	[p2l1033t2786r1440b2869],
9	.	.	O	.	_	0	SENT_27	[p2l1033t2786r1440b2869],

1	Conclusions	NNS	O	conclusion	_	0	SENT_28	[p2l1485t2786r1965b2851],
2	:	:	O	:	_	0	SENT_28	[p2l1485t2786r1965b2851],
3	The	DT	O	the	det	10	SENT_28	[p2l2006t2786r2147b2850],
4	higher	JJR	O	higher	amod	10	SENT_28	[p2l6t2885r244b2968],
5	zuclopenthixol	NN	O	zuclopenthixol	nn	10	SENT_28	[p2l272t2885r822b2968],
6	steady	JJ	O	steady	amod	10	SENT_28	[p2l854t2885r1288b2968],
7	—	NN	O	—	nn	10	SENT_28	[p2l854t2885r1288b2968],
8	state	NN	O	state	nn	10	SENT_28	[p2l854t2885r1288b2968],
9	plasma	NN	O	plasma	nn	10	SENT_28	[p2l1315t2885r1579b2968],
10	concentrations	NNS	O	concentration	dep	1	SENT_28	[p2l1607t2885r2146b2949],
11	in	IN	O	in	_	0	SENT_28	[p2l7t2984r77b3047],
12	heterozygous	JJ	O	heterozygous	amod	13	SENT_28	[p2l138t2984r631b3067],
13	EM	NN	O	em	prep_in	10	SENT_28	[p2l696t2986r831b3047],
14	and	CC	O	and	_	0	SENT_28	[p2l896t2984r1027b3048],
15	PM	NN	O	pm	conj_and	13	SENT_28	[p2l1088t2986r1219b3047],
16	schizophrenic	JJ	O	schizophrenic	amod	17	SENT_28	[p2l1285t2984r1796b3067],
17	patients	NNS	O	patient	nsubj	26	SENT_28	[p2l1858t2984r2146b3067],
18	receiving	VBG	O	receive	partmod	17	SENT_28	[p2l6t3083r350b3166],
19	monotherapy	NN	O	monotherapy	dobj	18	SENT_28	[p2l414t3083r903b3166],
20	with	IN	O	with	_	0	SENT_28	[p2l966t3083r1129b3147],
21	zuclopenthixol-decanoate	NN	O	zuclopenthixol-decanoate	prep_with	18	SENT_28	[p2l1192t3083r2147b3166],
22	than	IN	O	than	prep	18	SENT_28	[p2l7t3182r165b3246],
23	in	IN	O	in	pcomp	22	SENT_28	[p2l201t3182r271b3245],
24	homozygous	JJ	O	homozygous	amod	25	SENT_28	[p2l306t3182r778b3265],
25	EMs	NNS	O	em	pobj	23	SENT_28	[p2l816t3184r987b3246],
26	indicates	VBZ	O	indicate	rcmod	10	SENT_28	[p2l1026t3182r1353b3246],
27	a	DT	O	a	det	29	SENT_28	[p2l1393t3203r1431b3246],
28	significant	JJ	O	significant	amod	29	SENT_28	[p2l1469t3182r1859b3265],
29	role	NN	O	role	dobj	26	SENT_28	[p2l1893t3182r2036b3246],
30	of	IN	O	of	_	0	SENT_28	[p2l2074t3182r2154b3246],
31	CYPZD6	NN	O	cypzd6	prep_of	29	SENT_28	[p2l8t3280r344b3345],
32	in	IN	O	in	_	0	SENT_28	[p2l382t3280r453b3344],
33	the	DT	O	the	det	35	SENT_28	[p2l490t3281r600b3344],
34	systemic	JJ	O	systemic	amod	35	SENT_28	[p2l642t3280r961b3364],
35	elimination	NN	O	elimination	prep_in	26	SENT_28	[p2l1001t3280r1423b3344],
36	of	IN	O	of	_	0	SENT_28	[p2l1461t3280r1541b3344],
37	zuclopenthixol	NN	O	zuclopenthixol	prep_of	35	SENT_28	[p2l1573t3281r2143b3364],
38	.	.	O	.	_	0	SENT_28	[p2l1573t3281r2143b3364],

1	The	DT	O	the	det	2	SENT_29	[p2l7t3380r148b3444],
2	tendencies	NNS	O	tendency	nsubj	22	SENT_29	[p2l179t3380r568b3444],
3	for	IN	O	for	_	0	SENT_29	[p2l601t3380r709b3444],
4	patients	NNS	O	patient	prep_for	2	SENT_29	[p2l736t3380r1023b3463],
5	carrying	VBG	O	carry	partmod	4	SENT_29	[p2l1056t3380r1363b3463],
6	at	IN	O	at	quantmod	8	SENT_29	[p2l1396t3390r1460b3444],
7	least	JJS	O	least	mwe	6	SENT_29	[p2l1489t3380r1659b3444],
8	one	CD	NUMBER	one	dobj	5	SENT_29	[p2l1689t3401r1819b3444],
9	mutated	VBN	O	mutate	partmod	8	SENT_29	[p2l1850t3380r2149b3444],
10	C	NN	O	c	nn	12	SENT_29	[p2l11t3480r69b3543],
11	YPZD6	NN	O	ypzd6	nn	12	SENT_29	[p2l74t3478r338b3542],
12	gene	NN	O	gene	dobj	9	SENT_29	[p2l367t3499r539b3562],
13	to	TO	O	to	aux	14	SENT_29	[p2l570t3488r639b3542],
14	have	VB	O	have	xcomp	9	SENT_29	[p2l671t3479r844b3543],
15	an	DT	O	a	det	17	SENT_29	[p2l878t3499r961b3542],
16	increased	VBN	O	increase	amod	17	SENT_29	[p2l992t3478r1343b3542],
17	risk	NN	O	risk	dobj	14	SENT_29	[p2l1372t3478r1513b3542],
18	of	IN	O	of	_	0	SENT_29	[p2l1543t3478r1622b3542],
19	parkinsonism	NN	O	parkinsonism	prep_of	17	SENT_29	[p2l1646t3478r2149b3562],
20	and	CC	O	and	_	0	SENT_29	[p2l9t3578r139b3642],
21	TD	NN	O	td	prep_of	17	SENT_29	[p2l186t3580r305b3641],
22	are	VBP	O	be	_	0	SENT_29	[p2l356t3599r464b3642],
23	in	IN	O	in	_	0	SENT_29	[p2l512t3578r582b3641],
24	accordance	NN	O	accordance	_	0	SENT_29	[p2l631t3578r1045b3642],
25	with	IN	O	with	_	0	SENT_29	[p2l1093t3578r1256b3642],
26	previous	JJ	O	previous	amod	27	SENT_29	[p2l1301t3578r1619b3661],
27	studies	NNS	O	study	prep_in_accordance_with	22	SENT_29	[p2l1672t3578r1943b3642],
28	.	.	O	.	_	0	SENT_29	[p2l1672t3578r1943b3642],

1	Age	NN	O	age	nsubj	6	SENT_30	[p2l1995t3579r2147b3661],
2	was	VBD	O	be	cop	6	SENT_30	[p2l7t3697r147b3741],
3	a	DT	O	a	det	6	SENT_30	[p2l177t3697r215b3740],
4	significant	JJ	O	significant	amod	6	SENT_30	[p2l243t3676r634b3760],
5	risk	NN	O	risk	nn	6	SENT_30	[p2l658t3676r798b3740],
6	factor	NN	O	factor	_	0	SENT_30	[p2l822t3676r1039b3740],
7	for	IN	O	for	_	0	SENT_30	[p2l1064t3676r1172b3740],
8	neurological	JJ	O	neurological	amod	10	SENT_30	[p2l1196t3676r1660b3760],
9	side	JJ	O	side	amod	10	SENT_30	[p2l1690t3676r1834b3740],
10	effects	NNS	O	effect	prep_for	6	SENT_30	[p2l1862t3676r2124b3741],
11	.	.	O	.	_	0	SENT_30	[p2l1862t3676r2124b3741],

1	Keywords	NNPS	O	Keywords	nn	2	SENT_31	[p3l8t85r407b166],
2	Zuclopenthixol	NNP	O	Zuclopenthixol	_	0	SENT_31	[p3l457t84r1025b168],
3	-	:	O	-	_	0	SENT_31	[p3l1057t119r1067b129],
4	Steady	NNP	O	Steady	dep	2	SENT_31	[p3l1101t85r1552b168],
5	.	.	O	.	_	0	SENT_31	[p3l1101t85r1552b168],

1	—	NN	O	—	_	0	SENT_32	[p3l1101t85r1552b168],
2	.	.	O	.	_	0	SENT_32	[p3l1101t85r1552b168],

1	State	NNP	O	State	_	0	SENT_33	[p3l1101t85r1552b168],
2	plasma	NN	O	plasma	nn	3	SENT_33	[p3l1578t85r1842b168],
3	concentration	NN	O	concentration	dep	1	SENT_33	[p3l8t183r513b247],
4	-	:	O	-	_	0	SENT_33	[p3l544t217r555b228],
5	Neurological	JJ	O	neurological	amod	10	SENT_33	[p3l585t183r1070b266],
6	Side	NN	O	side	nn	10	SENT_33	[p3l1100t183r1244b247],
7	effect	NN	O	effect	nn	10	SENT_33	[p3l1272t183r1480b247],
8	C	NN	O	c	nn	10	SENT_33	[p3l1510t217r1521b228, p3l11t283r69b346],
9	YPZD6	NN	O	ypzd6	nn	10	SENT_33	[p3l74t281r338b345],
10	genotype	NN	O	genotype	dep	1	SENT_33	[p3l363t291r700b365],
11	-	:	O	-	_	0	SENT_33	[p3l732t316r743b326],
12	Schizophrenia	NNP	O	Schizophrenia	dep	10	SENT_33	[p3l777t281r1307b365],

1	Introduction	NN	O	introduction	_	0	SENT_34	[p3l10t548r506b622],

1	Many	JJ	O	many	amod	4	SENT_35	[p3l7t757r220b838],
2	traditional	JJ	O	traditional	amod	4	SENT_35	[p3l263t755r645b819],
3	antipsychotic	JJ	O	antipsychotic	amod	4	SENT_35	[p3l689t755r1180b838],
4	agents	NNS	O	agent	nsubjpass	10	SENT_35	[p3l1226t765r1480b838],
5	,	,	O	,	_	0	SENT_35	[p3l1226t765r1480b838],
6	including	VBG	O	include	_	0	SENT_35	[p3l1525t755r1874b838],
7	zuclopenthixol	NN	O	zuclopenthixol	prep_including	4	SENT_35	[p3l1918t755r2145b819, p3l6t854r377b937],
8	,	,	O	,	_	0	SENT_35	[p3l1918t755r2145b819, p3l6t854r377b937],
9	are	VBP	O	be	auxpass	10	SENT_35	[p3l433t874r541b918],
10	metabolised	VBN	O	metabolise	_	0	SENT_35	[p3l592t854r1041b918],
11	by	IN	O	by	_	0	SENT_35	[p3l1089t854r1180b937],
12	the	DT	O	the	det	16	SENT_35	[p3l1231t854r1342b918],
13	hepatic	JJ	O	hepatic	amod	16	SENT_35	[p3l1392t854r1658b937],
14	cytochrome	NN	O	cytochrome	nn	16	SENT_35	[p3l1711t854r2147b937],
15	P450	NN	O	p450	nn	16	SENT_35	[p3l6t956r159b1041],
16	isozyme	NN	O	isozyme	agent	10	SENT_35	[p3l192t953r499b1037],
17	CYP2D6	NN	O	cyp2d6	nn	19	SENT_35	[p3l534t953r869b1019],
18	(	CD	NUMBER	(	num	19	SENT_35	[p3l907t953r1113b1033],
19	Dahl	NNP	PERSON	Dahl	dep	16	SENT_35	[p3l907t953r1113b1033],
20	et	FW	O	et	nn	21	SENT_35	[p3l1147t963r1212b1018],
21	al.	FW	O	al.	dep	19	SENT_35	[p3l1246t953r1327b1018],
22	1991	CD	DATE	1991	dep	19	SENT_35	[p3l1373t954r1571b1030],
23	;	:	O	;	_	0	SENT_35	[p3l1373t954r1571b1030],
24	Bertilsson	NNP	PERSON	Bertilsson	dep	19	SENT_35	[p3l1607t953r1983b1018],
25	and	CC	O	and	_	0	SENT_35	[p3l2018t953r2149b1018],
26	Dahl	NNP	PERSON	Dahl	dep	19	SENT_35	[p3l7t1053r184b1117],
27	1996	CD	DATE	1996	num	28	SENT_35	[p3l224t1053r447b1132],
28	)	CD	NUMBER	)	dep	24	SENT_35	[p3l224t1053r447b1132],
29	.	.	O	.	_	0	SENT_35	[p3l224t1053r447b1132],

1	The	DT	O	the	det	2	SENT_36	[p3l483t1053r623b1117],
2	activity	NN	O	activity	nsubjpass	7	SENT_36	[p3l658t1053r929b1136],
3	of	IN	O	of	_	0	SENT_36	[p3l963t1053r1042b1117],
4	CYP2D6	NN	O	cyp2d6	prep_of	2	SENT_36	[p3l1069t1053r1402b1117],
5	is	VBZ	O	be	auxpass	7	SENT_36	[p3l1435t1053r1492b1117],
6	bimodally	RB	O	bimodally	advmod	7	SENT_36	[p3l1525t1053r1897b1136],
7	distributed	VBN	O	distribute	_	0	SENT_36	[p3l1931t1053r2145b1117, p3l6t1152r212b1216],
8	in	IN	O	in	_	0	SENT_36	[p3l240t1152r310b1215],
9	the	DT	O	the	det	10	SENT_36	[p3l338t1152r449b1216],
10	population	NN	O	population	prep_in	7	SENT_36	[p3l477t1152r895b1235],
11	,	,	O	,	_	0	SENT_36	[p3l477t1152r895b1235],
12	and	CC	O	and	_	0	SENT_36	[p3l929t1152r1060b1216],
13	individuals	NNS	O	individual	nsubjpass	16	SENT_36	[p3l1087t1152r1498b1216],
14	can	MD	O	can	aux	16	SENT_36	[p3l1529t1173r1655b1216],
15	be	VB	O	be	auxpass	16	SENT_36	[p3l1682t1152r1768b1216],
16	classified	VBN	O	classify	conj_and	7	SENT_36	[p3l1798t1152r2149b1216],
17	as	IN	O	as	mark	21	SENT_36	[p3l9t1271r80b1315],
18	either	DT	O	either	det	20	SENT_36	[p3l112t1251r323b1315],
19	extensive	JJ	O	extensive	amod	20	SENT_36	[p3l351t1251r699b1315],
20	metabolisers	NNS	O	metaboliser	nsubj	21	SENT_36	[p3l729t1251r1196b1315],
21	(	VBP	O	(	advcl	16	SENT_36	[p3l1230t1252r1460b1330],
22	EMS	NNP	O	EMS	dobj	21	SENT_36	[p3l1230t1252r1460b1330],
23	)	CD	NUMBER	)	num	22	SENT_36	[p3l1230t1252r1460b1330],
24	or	CC	O	or	_	0	SENT_36	[p3l1493t1271r1568b1315],
25	poor	JJ	O	poor	amod	26	SENT_36	[p3l1595t1271r1765b1334],
26	metaboli68	NN	O	metaboli68	conj_or	22	SENT_36	[p3l1793t1251r2145b1315, p3l9t1374r82b1429],

1	sers	NNS	O	ser	_	0	SENT_37	[p3l11t1546r148b1589],
2	(	CD	NUMBER	(	num	4	SENT_37	[p3l208t1526r454b1604],
3	PMS	NN	O	pm	nn	4	SENT_37	[p3l208t1526r454b1604],
4	)	NN	O	)	dep	1	SENT_37	[p3l208t1526r454b1604],
5	.	.	O	.	_	0	SENT_37	[p3l208t1526r454b1604],

1	The	DT	O	the	det	2	SENT_38	[p3l513t1525r655b1589],
2	prevalence	NN	O	prevalence	nsubj	7	SENT_38	[p3l709t1525r1111b1608],
3	of	IN	O	of	_	0	SENT_38	[p3l1168t1525r1248b1589],
4	the	DT	O	the	det	6	SENT_38	[p3l1296t1525r1407b1589],
5	PM	NN	O	pm	nn	6	SENT_38	[p3l1462t1527r1593b1588],
6	phenotype	NN	O	phenotype	prep_of	2	SENT_38	[p3l1647t1525r2034b1608],
7	is	VBZ	O	be	ccomp	21	SENT_38	[p3l2089t1525r2146b1589],
8	about	IN	O	about	_	0	SENT_38	[p3l10t1623r213b1687],
9	7	CD	PERCENT	7	num	10	SENT_38	[p3l244t1624r360b1688],
10	%	NN	PERCENT	%	prep_about	7	SENT_38	[p3l244t1624r360b1688],
11	in	IN	O	in	_	0	SENT_38	[p3l395t1623r466b1687],
12	different	JJ	O	different	amod	13	SENT_38	[p3l498t1623r815b1687],
13	Caucasian	JJ	MISC	caucasian	prep_in	10	SENT_38	[p3l847t1624r1246b1700],
14	,	,	O	,	_	0	SENT_38	[p3l847t1624r1246b1700],
15	including	VBG	O	include	_	0	SENT_38	[p3l1280t1623r1629b1707],
16	Estonian	JJ	MISC	estonian	prep_including	7	SENT_38	[p3l1661t1623r1986b1687],
17	and	CC	O	and	_	0	SENT_38	[p3l2019t1624r2149b1687],
18	Russian	JJ	LOCATION	russian	conj_and	16	SENT_38	[p3l8t1723r320b1799],
19	,	,	O	,	_	0	SENT_38	[p3l8t1723r320b1799],
20	populations	NNS	O	population	nsubj	21	SENT_38	[p3l372t1723r803b1806],
21	(	VBP	O	(	_	0	SENT_38	[p3l857t1723r1111b1802],
22	Alvan	NNP	PERSON	Alvan	dobj	21	SENT_38	[p3l857t1723r1111b1802],
23	et	FW	O	et	nn	24	SENT_38	[p3l1160t1733r1225b1787],
24	al.	FW	O	al.	dep	22	SENT_38	[p3l1274t1723r1356b1787],
25	1990	CD	DATE	1990	dep	24	SENT_38	[p3l1418t1724r1615b1799],
26	;	:	O	;	_	0	SENT_38	[p3l1418t1724r1615b1799],
27	Kiivet	NNP	O	Kiivet	dep	24	SENT_38	[p3l1669t1723r1900b1787],
28	et	FW	O	et	nn	29	SENT_38	[p3l1948t1733r2013b1787],
29	al.	FW	O	al.	dep	27	SENT_38	[p3l2062t1723r2144b1787],
30	1993	CD	DATE	1993	dep	27	SENT_38	[p3l16t1822r213b1898],
31	;	:	O	;	_	0	SENT_38	[p3l16t1822r213b1898],
32	Marandi	NNP	PERSON	Marandi	dep	24	SENT_38	[p3l264t1821r577b1886],
33	et	FW	O	et	nn	34	SENT_38	[p3l625t1831r691b1886],
34	al.	FW	O	al.	dep	32	SENT_38	[p3l738t1821r820b1886],
35	1996	CD	DATE	1996	tmod	21	SENT_38	[p3l880t1821r1075b1898],
36	,	,	DATE	,	_	0	SENT_38	[p3l880t1821r1075b1898],
37	1997	CD	DATE	1997	num	38	SENT_38	[p3l1134t1822r1359b1901],
38	)	NN	O	)	appos	35	SENT_38	[p3l1134t1822r1359b1901],
39	.	.	O	.	_	0	SENT_38	[p3l1134t1822r1359b1901],

1	The	DT	O	the	det	5	SENT_39	[p3l1411t1821r1552b1886],
2	most	RBS	O	most	advmod	3	SENT_39	[p3l1600t1831r1780b1886],
3	common	JJ	O	common	amod	5	SENT_39	[p3l1826t1842r2149b1886],
4	defect	NN	O	defect	nn	5	SENT_39	[p3l9t1921r234b1985],
5	allele	NN	O	allele	nsubj	16	SENT_39	[p3l261t1921r459b1985],
6	associated	VBN	O	associate	partmod	5	SENT_39	[p3l488t1921r868b1985],
7	with	IN	O	with	_	0	SENT_39	[p3l894t1921r1057b1985],
8	the	DT	O	the	det	10	SENT_39	[p3l1083t1921r1194b1985],
9	PM	NN	O	pm	nn	10	SENT_39	[p3l1220t1923r1351b1984],
10	phenotype	NN	O	phenotype	prep_with	6	SENT_39	[p3l1378t1921r1764b2004],
11	in	IN	O	in	_	0	SENT_39	[p3l1791t1921r1861b1984],
12	Caucasian	JJ	LOCATION	caucasian	amod	13	SENT_39	[p3l1888t1921r2146b1985, p3l11t2020r156b2083],
13	populations	NNS	O	population	prep_in	10	SENT_39	[p3l188t2019r620b2103],
14	is	VBZ	O	be	cop	16	SENT_39	[p3l656t2020r713b2083],
15	C	NN	O	c	nn	16	SENT_39	[p3l754t2021r812b2084],
16	YPZD6	NN	O	ypzd6	_	0	SENT_39	[p3l817t2019r1081b2083],
17	*	CD	NUMBER	*	number	18	SENT_39	[p3l1091t2020r1191b2096],
18	4	CD	NUMBER	4	dep	16	SENT_39	[p3l1091t2020r1191b2096],
19	,	,	O	,	_	0	SENT_39	[p3l1091t2020r1191b2096],
20	with	IN	O	with	_	0	SENT_39	[p3l1229t2019r1392b2084],
21	an	DT	O	a	det	23	SENT_39	[p3l1427t2040r1511b2083],
22	allele	NN	O	allele	nn	23	SENT_39	[p3l1546t2019r1744b2083],
23	frequency	NN	O	frequency	prep_with	16	SENT_39	[p3l1778t2019r2148b2103],
24	of	IN	O	of	prep	23	SENT_39	[p3l9t2119r89b2183],
25	about	IN	O	about	pcomp	24	SENT_39	[p3l165t2119r369b2183],
26	21	CD	PERCENT	21	num	27	SENT_39	[p3l450t2119r635b2183],
27	%	NN	PERCENT	%	pobj	25	SENT_39	[p3l450t2119r635b2183],
28	.	.	O	.	_	0	SENT_39	[p3l450t2119r635b2183],

1	Other	JJ	O	other	amod	4	SENT_40	[p3l722t2119r932b2183],
2	common	JJ	O	common	amod	4	SENT_40	[p3l1011t2139r1334b2183],
3	defect	NN	O	defect	nn	4	SENT_40	[p3l1415t2119r1641b2183],
4	alleles	NNS	O	allele	nsubj	6	SENT_40	[p3l1722t2119r1954b2183],
5	are	VBP	O	be	cop	6	SENT_40	[p3l2039t2139r2148b2183],
6	CYP2D6	NN	O	cyp2d6	_	0	SENT_40	[p3l12t2217r427b2282],
7	*	CD	NUMBER	*	number	8	SENT_40	[p3l12t2217r427b2282],
8	3	CD	NUMBER	3	dep	6	SENT_40	[p3l12t2217r427b2282],
9	and	CC	O	and	_	0	SENT_40	[p3l477t2217r608b2281],
10	C	NN	O	c	nn	11	SENT_40	[p3l658t2219r716b2282],
11	YPZD6	NN	O	ypzd6	conj_and	6	SENT_40	[p3l721t2217r985b2281],
12	*	CD	NUMBER	*	number	13	SENT_40	[p3l995t2219r1095b2293],
13	5	CD	NUMBER	5	dep	11	SENT_40	[p3l995t2219r1095b2293],
14	,	,	O	,	_	0	SENT_40	[p3l995t2219r1095b2293],
15	with	IN	O	with	mark	37	SENT_40	[p3l1145t2218r1308b2282],
16	allele	NN	O	allele	nn	17	SENT_40	[p3l1356t2218r1553b2281],
17	frequencies	NNS	O	frequency	dep	28	SENT_40	[p3l1600t2217r2025b2301],
18	of	IN	O	of	_	0	SENT_40	[p3l2075t2217r2154b2281],
19	approximately	RB	O	approximately	quantmod	24	SENT_40	[p3l10t2317r543b2400],
20	2	CD	PERCENT	2	number	24	SENT_40	[p3l597t2317r713b2381],
21	%	NN	PERCENT	%	dep	24	SENT_40	[p3l597t2317r713b2381],
22	and	CC	O	and	_	0	SENT_40	[p3l771t2317r902b2381],
23	5	CD	PERCENT	5	conj_and	24	SENT_40	[p3l954t2317r1094b2393],
24	%	NN	PERCENT	%	prep_of	17	SENT_40	[p3l954t2317r1094b2393],
25	,	,	O	,	_	0	SENT_40	[p3l954t2317r1094b2393],
26	respectively	RB	O	respectively	advmod	24	SENT_40	[p3l1149t2317r1598b2400],
27	(	CD	NUMBER	(	dep	28	SENT_40	[p3l1654t2317r1891b2400],
28	Broly	NNP	O	Broly	dep	37	SENT_40	[p3l1654t2317r1891b2400],
29	et	FW	O	et	nn	30	SENT_40	[p3l1944t2326r2010b2381],
30	al.	FW	O	al.	dep	28	SENT_40	[p3l2062t2317r2144b2381],
31	1991	CD	DATE	1991	dep	30	SENT_40	[p3l16t2416r213b2491],
32	;	:	O	;	_	0	SENT_40	[p3l16t2416r213b2491],
33	Dahl	NNP	PERSON	Dahl	dep	30	SENT_40	[p3l256t2416r434b2479],
34	et	FW	O	et	nn	35	SENT_40	[p3l473t2425r538b2479],
35	al.	FW	O	al.	dep	33	SENT_40	[p3l577t2416r658b2480],
36	1992	CD	DATE	1992	num	37	SENT_40	[p3l710t2416r935b2495],
37	)	CD	NUMBER	)	advcl	6	SENT_40	[p3l710t2416r935b2495],
38	.	.	O	.	_	0	SENT_40	[p3l710t2416r935b2495],

1	In	IN	O	in	_	0	SENT_41	[p3l978t2417r1053b2479],
2	addition	NN	O	addition	prep_in	14	SENT_41	[p3l1093t2415r1415b2491],
3	,	,	O	,	_	0	SENT_41	[p3l1093t2415r1415b2491],
4	a	DT	O	a	det	6	SENT_41	[p3l1458t2436r1496b2479],
5	large	JJ	O	large	amod	6	SENT_41	[p3l1533t2416r1714b2499],
6	number	NN	O	number	nsubjpass	14	SENT_41	[p3l1753t2416r2037b2479],
7	of	IN	O	of	_	0	SENT_41	[p3l2075t2415r2154b2479],
8	other	JJ	O	other	amod	11	SENT_41	[p3l9t2515r198b2579],
9	rare	JJ	O	rare	amod	11	SENT_41	[p3l235t2535r377b2579],
10	defect	NN	O	defect	nn	11	SENT_41	[p3l417t2515r643b2579],
11	alleles	NNS	O	allele	prep_of	6	SENT_41	[p3l683t2515r915b2579],
12	have	VBP	O	have	aux	14	SENT_41	[p3l955t2515r1128b2579],
13	been	VBN	O	be	auxpass	14	SENT_41	[p3l1166t2515r1341b2579],
14	described	VBN	O	describe	_	0	SENT_41	[p3l1381t2515r1735b2579],
15	(	CD	NUMBER	(	num	16	SENT_41	[p3l1776t2515r2044b2594],
16	Griese	NNP	PERSON	Griese	dobj	14	SENT_41	[p3l1776t2515r2044b2594],
17	et	FW	O	et	nn	18	SENT_41	[p3l2085t2524r2150b2579],
18	al.	FW	O	al.	tmod	14	SENT_41	[p3l10t2614r91b2678],
19	1998	CD	DATE	1998	num	20	SENT_41	[p3l139t2614r363b2693],
20	)	CD	NUMBER	)	dep	18	SENT_41	[p3l139t2614r363b2693],
21	.	.	O	.	_	0	SENT_41	[p3l139t2614r363b2693],

1	About	IN	O	about	_	0	SENT_42	[p3l401t2614r633b2677],
2	1	CD	NUMBER	1	num	3	SENT_42	[p3l674t2614r875b2678],
3	—	NN	O	—	prep_about	9	SENT_42	[p3l674t2614r875b2678],
4	2	CD	PERCENT	2	num	5	SENT_42	[p3l674t2614r875b2678],
5	%	NN	PERCENT	%	nsubj	9	SENT_42	[p3l674t2614r875b2678],
6	of	IN	O	of	_	0	SENT_42	[p3l914t2613r994b2677],
7	Swedish	JJ	MISC	swedish	amod	8	SENT_42	[p3l1024t2614r1335b2678],
8	Subjects	NNS	MISC	subject	prep_of	5	SENT_42	[p3l1372t2614r1664b2697],
9	carry	VBP	O	carry	_	0	SENT_42	[p3l1701t2634r1888b2697],
10	multiple	JJ	O	multiple	amod	11	SENT_42	[p3l1923t2614r2146b2677, p3l7t2713r118b2796],
11	copies	NNS	O	copy	dobj	9	SENT_42	[p3l185t2713r417b2796],
12	of	IN	O	of	_	0	SENT_42	[p3l486t2713r565b2777],
13	a	DT	O	a	det	16	SENT_42	[p3l626t2733r664b2777],
14	functional	JJ	O	functional	amod	16	SENT_42	[p3l727t2713r1103b2777],
15	CYP2D6	NN	O	cyp2d6	nn	16	SENT_42	[p3l1173t2713r1500b2778],
16	allele	NN	O	allele	prep_of	11	SENT_42	[p3l1563t2713r1760b2777],
17	and	CC	O	and	_	0	SENT_42	[p3l1827t2713r1958b2777],
18	can	MD	O	can	aux	20	SENT_42	[p3l2023t2733r2149b2777],
19	be	VB	O	be	auxpass	20	SENT_42	[p3l6t2812r92b2875],
20	classified	VBN	O	classify	conj_and	9	SENT_42	[p3l158t2811r508b2875],
21	as	IN	O	as	_	0	SENT_42	[p3l574t2832r645b2875],
22	ultrarapid	NN	O	ultrarapid	nn	23	SENT_42	[p3l711t2811r1073b2895],
23	metabolisers	NNS	O	metaboliser	prep_as	20	SENT_42	[p3l1137t2811r1604b2875],
24	of	IN	O	of	_	0	SENT_42	[p3l1672t2811r1752b2875],
25	CYP2D6	NN	O	cyp2d6	nn	27	SENT_42	[p3l1811t2811r2147b2876],
26	(	CD	NUMBER	(	num	27	SENT_42	[p3l10t2911r217b2990],
27	Dahl	NNP	PERSON	Dahl	prep_of	23	SENT_42	[p3l10t2911r217b2990],
28	et	FW	O	et	nn	29	SENT_42	[p3l244t2920r310b2975],
29	al.	FW	O	al.	dep	27	SENT_42	[p3l337t2911r418b2975],
30	1995	CD	DATE	1995	num	31	SENT_42	[p3l458t2911r683b2990],
31	)	NN	O	)	dep	29	SENT_42	[p3l458t2911r683b2990],
32	.	.	O	.	_	0	SENT_42	[p3l458t2911r683b2990],

1	In	IN	O	in	mark	10	SENT_43	[p3l120t3012r195b3073],
2	case	NN	O	case	dep	10	SENT_43	[p3l229t3031r386b3074],
3	the	DT	O	the	det	4	SENT_43	[p3l420t3010r531b3074],
4	elimination	NN	O	elimination	nsubj	10	SENT_43	[p3l566t3010r988b3074],
5	of	IN	O	of	_	0	SENT_43	[p3l1023t3010r1103b3074],
6	a	DT	O	a	det	7	SENT_43	[p3l1133t3031r1171b3074],
7	drug	NN	O	drug	prep_of	4	SENT_43	[p3l1204t3010r1370b3093],
8	is	VBZ	O	be	cop	10	SENT_43	[p3l1405t3010r1462b3074],
9	highly	RB	O	highly	advmod	10	SENT_43	[p3l1498t3010r1733b3093],
10	dependent	JJ	O	dependent	advcl	23	SENT_43	[p3l1769t3010r2150b3093],
11	on	IN	O	on	_	0	SENT_43	[p3l9t3129r98b3173],
12	the	DT	O	the	det	14	SENT_43	[p3l135t3109r246b3173],
13	polymorphic	JJ	O	polymorphic	amod	14	SENT_43	[p3l283t3109r756b3192],
14	CYP2D6	NN	O	cyp2d6	prep_on	10	SENT_43	[p3l796t3109r1153b3185],
15	,	,	O	,	_	0	SENT_43	[p3l796t3109r1153b3185],
16	a	DT	O	a	det	18	SENT_43	[p3l1196t3129r1234b3173],
17	lower	JJR	O	lower	amod	18	SENT_43	[p3l1270t3109r1481b3173],
18	clearance	NN	O	clearance	nsubjpass	23	SENT_43	[p3l1518t3109r1866b3173],
19	of	IN	O	of	_	0	SENT_43	[p3l1905t3109r1985b3173],
20	this	DT	O	this	det	21	SENT_43	[p3l2016t3109r2146b3173],
21	compound	NN	O	compound	prep_of	18	SENT_43	[p3l8t3208r392b3291],
22	is	VBZ	O	be	auxpass	23	SENT_43	[p3l417t3208r474b3272],
23	seen	VBN	O	see	_	0	SENT_43	[p3l506t3229r663b3272],
24	in	IN	O	in	_	0	SENT_43	[p3l688t3208r758b3271],
25	PMs	NNS	O	pm	prep_in	23	SENT_43	[p3l783t3210r947b3272],
26	than	IN	O	than	prep	23	SENT_43	[p3l975t3208r1131b3272],
27	in	IN	O	in	pcomp	26	SENT_43	[p3l1157t3208r1226b3271],
28	EMS	NNP	O	EMS	pobj	27	SENT_43	[p3l1251t3210r1440b3272],
29	.	.	O	.	_	0	SENT_43	[p3l1251t3210r1440b3272],

1	AS	IN	O	as	amod	3	SENT_44	[p3l1471t3209r1568b3272],
2	a	DT	O	a	det	3	SENT_44	[p3l1599t3229r1636b3272],
3	consequence	NN	O	consequence	nsubjpass	16	SENT_44	[p3l1662t3229r2145b3291],
4	,	,	O	,	_	0	SENT_44	[p3l1662t3229r2145b3291],
5	higher	JJR	O	higher	amod	10	SENT_44	[p3l7t3307r245b3390],
6	steady	JJ	O	steady	amod	10	SENT_44	[p3l276t3307r710b3390],
7	—	NN	O	—	nn	10	SENT_44	[p3l276t3307r710b3390],
8	state	NN	O	state	nn	10	SENT_44	[p3l276t3307r710b3390],
9	plasma	NN	O	plasma	nn	10	SENT_44	[p3l739t3307r1003b3390],
10	concentrations	NNS	O	concentration	appos	3	SENT_44	[p3l1031t3307r1570b3371],
11	per	IN	O	per	_	0	SENT_44	[p3l1600t3327r1719b3390],
12	given	VBN	O	give	amod	13	SENT_44	[p3l1748t3307r1952b3390],
13	dose	NN	O	dose	prep_per	10	SENT_44	[p3l1982t3307r2148b3371],
14	would	MD	O	would	aux	16	SENT_44	[p3l8t3406r238b3470],
15	be	VB	O	be	auxpass	16	SENT_44	[p3l288t3406r373b3470],
16	expected	VBN	O	expect	_	0	SENT_44	[p3l426t3406r755b3489],
17	in	IN	O	in	_	0	SENT_44	[p3l805t3406r876b3469],
18	PMS	NN	O	pm	prep_in	16	SENT_44	[p3l926t3408r1092b3470],
19	than	IN	O	than	prep	16	SENT_44	[p3l1145t3406r1303b3470],
20	in	IN	O	in	pcomp	19	SENT_44	[p3l1354t3406r1424b3469],
21	EMS	NNP	O	EMS	pobj	20	SENT_44	[p3l1474t3408r1667b3470],
22	.	.	O	.	_	0	SENT_44	[p3l1474t3408r1667b3470],

1	Thus	RB	O	thus	advmod	5	SENT_45	[p3l1722t3406r1926b3482],
2	,	,	O	,	_	0	SENT_45	[p3l1722t3406r1926b3482],
3	PMS	NN	O	pm	nsubj	5	SENT_45	[p3l1981t3408r2146b3470],
4	might	MD	O	might	aux	5	SENT_45	[p3l8t3505r224b3588],
5	have	VB	O	have	_	0	SENT_45	[p3l253t3505r426b3569],
6	an	DT	O	a	det	8	SENT_45	[p3l459t3525r543b3569],
7	increased	VBN	O	increase	amod	8	SENT_45	[p3l573t3505r924b3569],
8	risk	NN	O	risk	nsubj	12	SENT_45	[p3l953t3505r1094b3569],
9	of	IN	O	of	_	0	SENT_45	[p3l1124t3505r1204b3569],
10	concentration	NN	O	concentration	nn	11	SENT_45	[p3l1229t3505r2150b3588],
11	—	NN	O	—	prep_of	8	SENT_45	[p3l1229t3505r2150b3588],
12	dependent	JJ	O	dependent	xcomp	5	SENT_45	[p3l1229t3505r2150b3588],
13	side	JJ	O	side	amod	14	SENT_45	[p3l11t3604r153b3668],
14	effects	NNS	O	effect	nsubj	20	SENT_45	[p3l183t3604r422b3668],
15	at	IN	O	at	_	0	SENT_45	[p3l454t3614r518b3668],
16	conventionally	RB	O	conventionally	advmod	17	SENT_45	[p3l546t3604r1091b3687],
17	prescribed	VBN	O	prescribe	amod	19	SENT_45	[p3l1119t3604r1502b3687],
18	dosage	NN	O	dosage	nn	19	SENT_45	[p3l1531t3604r1784b3687],
19	regimens	NNS	O	regimen	prep_at	14	SENT_45	[p3l1811t3604r2146b3687],
20	(	VBP	O	(	ccomp	12	SENT_45	[p3l10t3703r415b3782],
21	Bertilsson	NN	PERSON	bertilsson	dobj	20	SENT_45	[p3l10t3703r415b3782],
22	and	CC	O	and	_	0	SENT_45	[p3l444t3703r574b3767],
23	Dahl	NNP	PERSON	Dahl	conj_and	21	SENT_45	[p3l600t3703r777b3767],
24	1996	CD	DATE	1996	num	23	SENT_45	[p3l813t3703r1038b3782],
25	)	CD	NUMBER	)	dep	23	SENT_45	[p3l813t3703r1038b3782],
26	.	.	O	.	_	0	SENT_45	[p3l813t3703r1038b3782],

1	Several	JJ	O	several	amod	2	SENT_46	[p4l122t17r397b82],
2	studies	NNS	O	study	nsubj	4	SENT_46	[p4l429t17r680b81],
3	have	VBP	O	have	aux	4	SENT_46	[p4l710t17r883b81],
4	explored	VBN	O	explore	_	0	SENT_46	[p4l913t17r1237b100],
5	the	DT	O	the	det	7	SENT_46	[p4l1264t17r1375b81],
6	possible	JJ	O	possible	amod	7	SENT_46	[p4l1403t17r1707b100],
7	association	NN	O	association	dobj	4	SENT_46	[p4l1738t17r2149b81],
8	between	IN	O	between	_	0	SENT_46	[p4l6t116r316b180],
9	the	DT	O	the	det	10	SENT_46	[p4l352t116r463b180],
10	incidence	NN	O	incidence	prep_between	7	SENT_46	[p4l500t116r854b180],
11	and	CC	O	and	_	0	SENT_46	[p4l893t116r1024b180],
12	severity	NN	O	severity	conj_and	10	SENT_46	[p4l1063t116r1351b199],
13	of	IN	O	of	_	0	SENT_46	[p4l1390t116r1470b180],
14	neurological	JJ	O	neurological	amod	16	SENT_46	[p4l1500t116r1964b199],
15	side	JJ	O	side	amod	16	SENT_46	[p4l2004t116r2148b180],
16	effects	NNS	O	effect	prep_of	10	SENT_46	[p4l8t215r250b279],
17	induced	VBN	O	induce	partmod	16	SENT_46	[p4l326t215r620b279],
18	by	IN	O	by	_	0	SENT_46	[p4l692t215r783b298],
19	conventional	JJ	O	conventional	amod	20	SENT_46	[p4l858t215r1337b279],
20	antipsychotics	NNS	O	antipsychotic	agent	17	SENT_46	[p4l1413t215r1940b298],
21	and	CC	O	and	_	0	SENT_46	[p4l2019t215r2149b279],
22	impaired	JJ	O	impaired	amod	23	SENT_46	[p4l8t314r337b397],
23	metabolic	JJ	O	metabolic	amod	24	SENT_46	[p4l379t314r742b378],
24	capacity	NN	O	capacity	agent	17	SENT_46	[p4l787t314r1094b397],
25	of	IN	O	of	_	0	SENT_46	[p4l1138t314r1218b378],
26	CYPZD6	NN	O	cypzd6	nn	28	SENT_46	[p4l1255t314r1591b378],
27	(	CD	NUMBER	(	num	28	SENT_46	[p4l1637t314r1913b393],
28	Arthur	NNP	PERSON	Arthur	prep_of	24	SENT_46	[p4l1637t314r1913b393],
29	et	FW	O	et	nn	30	SENT_46	[p4l1954t324r2019b378],
30	al.	FW	O	al.	dep	28	SENT_46	[p4l2062t314r2144b378],
31	1995	CD	DATE	1995	num	32	SENT_46	[p4l16t413r241b493],
32	)	NN	O	)	dep	30	SENT_46	[p4l16t413r241b493],
33	.	.	O	.	_	0	SENT_46	[p4l16t413r241b493],

1	They	PRP	O	they	nsubj	2	SENT_47	[p4l280t413r468b496],
2	found	VBD	O	find	dep	28	SENT_47	[p4l503t413r718b477],
3	a	DT	O	a	det	4	SENT_47	[p4l753t434r791b477],
4	relationship	NN	O	relationship	dobj	2	SENT_47	[p4l822t413r1261b496],
5	between	IN	O	between	_	0	SENT_47	[p4l1295t413r1605b478],
6	the	DT	O	the	det	8	SENT_47	[p4l1638t413r1749b477],
7	metabolic	JJ	O	metabolic	amod	8	SENT_47	[p4l1783t413r2147b477],
8	capacity	NN	O	capacity	prep_between	4	SENT_47	[p4l8t512r315b595],
9	of	IN	O	of	_	0	SENT_47	[p4l352t512r432b576],
10	CYP2D6	NN	O	cyp2d6	prep_of	8	SENT_47	[p4l463t512r798b576],
11	and	CC	O	and	_	0	SENT_47	[p4l837t512r967b576],
12	the	DT	O	the	det	13	SENT_47	[p4l1002t512r1112b576],
13	severity	NN	O	severity	prep_between	4	SENT_47	[p4l1151t512r1440b595],
14	of	IN	O	of	_	0	SENT_47	[p4l1478t512r1557b576],
15	extrapyramidal	JJ	O	extrapyramidal	amod	17	SENT_47	[p4l1587t512r2148b595],
16	side	JJ	O	side	amod	17	SENT_47	[p4l11t611r155b675],
17	effects	NNS	O	effect	prep_of	13	SENT_47	[p4l206t611r447b675],
18	in	IN	O	in	_	0	SENT_47	[p4l500t611r570b674],
19	a	DT	O	a	det	21	SENT_47	[p4l621t632r659b675],
20	pilot	NN	O	pilot	nn	21	SENT_47	[p4l706t611r878b694],
21	study	NN	O	study	prep_in	2	SENT_47	[p4l929t611r1125b694],
22	in	IN	O	in	_	0	SENT_47	[p4l1175t611r1246b674],
23	schizophrenic	JJ	O	schizophrenic	amod	24	SENT_47	[p4l1298t611r1809b694],
24	patients	NNS	O	patient	prep_in	21	SENT_47	[p4l1859t611r2146b694],
25	with	IN	O	with	_	0	SENT_47	[p4l8t710r171b774],
26	antipsychotic	JJ	O	antipsychotic	amod	27	SENT_47	[p4l248t710r1069b793],
27	—	NN	O	—	prep_with	2	SENT_47	[p4l248t710r1069b793],
28	induced	VBD	O	induce	_	0	SENT_47	[p4l248t710r1069b793],
29	tardive	JJ	O	tardive	amod	30	SENT_47	[p4l1143t710r1399b774],
30	dyskinesia	NN	O	dyskinesium	dobj	28	SENT_47	[p4l1476t710r1868b793],
31	(	CD	NUMBER	(	num	33	SENT_47	[p4l1944t710r2144b789],
32	TD	NN	O	td	nn	33	SENT_47	[p4l1944t710r2144b789],
33	)	NN	O	)	nsubj	28	SENT_47	[p4l1944t710r2144b789],
34	.	.	O	.	_	0	SENT_47	[p4l1944t710r2144b789],

1	Armstrong	NNP	O	Armstrong	dep	4	SENT_48	[p4l7t810r408b892],
2	et	FW	O	et	nn	4	SENT_48	[p4l455t819r521b873],
3	al.	FW	O	al.	nn	4	SENT_48	[p4l567t809r649b873],
4	(	FW	O	(	dep	7	SENT_48	[p4l702t810r942b888],
5	1997	CD	DATE	1997	num	6	SENT_48	[p4l702t810r942b888],
6	)	CD	NUMBER	)	nsubj	7	SENT_48	[p4l702t810r942b888],
7	found	VBD	O	find	_	0	SENT_48	[p4l991t809r1207b873],
8	that	IN	O	that	complm	14	SENT_48	[p4l1252t809r1391b873],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_48	[p4l1440t809r1767b874],
10	genotype	NN	O	genotype	nsubj	14	SENT_48	[p4l1811t819r2148b892],
11	was	VBD	O	be	cop	14	SENT_48	[p4l8t928r148b972],
12	not	RB	O	not	neg	14	SENT_48	[p4l181t917r299b972],
13	a	DT	O	a	det	14	SENT_48	[p4l331t928r369b972],
14	determinant	NN	O	determinant	ccomp	7	SENT_48	[p4l400t908r844b972],
15	of	IN	O	of	_	0	SENT_48	[p4l875t908r955b972],
16	susceptibility	NN	O	susceptibility	prep_of	14	SENT_48	[p4l984t908r1476b991],
17	to	TO	O	to	_	0	SENT_48	[p4l1508t917r1576b972],
18	acute	JJ	O	acute	amod	20	SENT_48	[p4l1611t917r1803b972],
19	dystonic	JJ	O	dystonic	amod	20	SENT_48	[p4l1836t908r2147b991],
20	reactions	NNS	O	reaction	prep_to	16	SENT_48	[p4l7t1007r340b1071],
21	induced	VBN	O	induce	partmod	20	SENT_48	[p4l380t1007r674b1071],
22	by	IN	O	by	_	0	SENT_48	[p4l710t1007r801b1090],
23	antipsychotics	NNS	O	antipsychotic	agent	21	SENT_48	[p4l842t1007r1392b1090],
24	,	,	O	,	_	0	SENT_48	[p4l842t1007r1392b1090],
25	but	CC	O	but	_	0	SENT_48	[p4l1433t1007r1552b1071],
26	may	MD	O	may	aux	30	SENT_48	[p4l1589t1028r1746b1090],
27	be	VB	O	be	cop	30	SENT_48	[p4l1784t1007r1869b1071],
28	a	DT	O	a	det	30	SENT_48	[p4l1910t1028r1948b1071],
29	contributing	JJ	O	contributing	amod	30	SENT_48	[p4l1986t1028r2146b1071, p4l7t1106r326b1189],
30	factor	NN	O	factor	conj_but	7	SENT_48	[p4l354t1106r571b1170],
31	in	IN	O	in	_	0	SENT_48	[p4l596t1106r666b1169],
32	other	JJ	O	other	amod	37	SENT_48	[p4l694t1106r884b1170],
33	antipsychotic	JJ	O	antipsychotic	amod	37	SENT_48	[p4l911t1106r1732b1189],
34	—	NN	O	—	nn	37	SENT_48	[p4l911t1106r1732b1189],
35	induced	VBD	O	induce	amod	37	SENT_48	[p4l911t1106r1732b1189],
36	movement	NN	O	movement	nn	37	SENT_48	[p4l1758t1115r2150b1170],
37	disorders	NNS	O	disorder	prep_in	30	SENT_48	[p4l9t1205r345b1269],
38	including	VBG	O	include	_	0	SENT_48	[p4l375t1205r724b1288],
39	TD	NN	O	td	prep_including	37	SENT_48	[p4l753t1207r893b1269],
40	.	.	O	.	_	0	SENT_48	[p4l753t1207r893b1269],

1	This	DT	O	this	det	2	SENT_49	[p4l926t1205r1087b1269],
2	finding	NN	O	finding	nsubj	15	SENT_49	[p4l1117t1205r1383b1288],
3	was	VBD	O	be	cop	15	SENT_49	[p4l1412t1226r1552b1269],
4	in	IN	O	in	_	0	SENT_49	[p4l1582t1205r1652b1268],
5	concordance	NN	O	concordance	prep_in	15	SENT_49	[p4l1681t1205r2148b1269],
6	with	IN	O	with	_	0	SENT_49	[p4l8t1304r171b1368],
7	the	DT	O	the	det	8	SENT_49	[p4l211t1304r322b1368],
8	results	NNS	O	result	prep_with	5	SENT_49	[p4l362t1304r602b1368],
9	of	IN	O	of	_	0	SENT_49	[p4l646t1304r726b1368],
10	Andreassen	NNP	PERSON	Andreassen	dep	13	SENT_49	[p4l760t1304r1193b1368],
11	et	FW	O	et	nn	13	SENT_49	[p4l1234t1313r1300b1368],
12	al.	FW	O	al.	nn	13	SENT_49	[p4l1341t1304r1422b1368],
13	(	FW	O	(	prepc_of	8	SENT_49	[p4l1470t1304r1733b1383],
14	1997	CD	DATE	1997	num	15	SENT_49	[p4l1470t1304r1733b1383],
15	)	CD	NUMBER	)	_	0	SENT_49	[p4l1470t1304r1733b1383],
16	,	,	O	,	_	0	SENT_49	[p4l1470t1304r1733b1383],
17	indicating	VBG	O	indicate	partmod	15	SENT_49	[p4l1777t1304r2147b1387],
18	that	IN	O	that	complm	27	SENT_49	[p4l8t1403r146b1467],
19	genetically	RB	O	genetically	advmod	20	SENT_49	[p4l199t1403r604b1486],
20	impaired	JJ	O	impaired	amod	22	SENT_49	[p4l658t1403r987b1486],
21	CYPZD6	NN	O	cypzd6	nn	22	SENT_49	[p4l1041t1403r1377b1468],
22	activity	NN	O	activity	nsubj	27	SENT_49	[p4l1433t1403r1708b1486],
23	may	MD	O	may	aux	27	SENT_49	[p4l1761t1424r1919b1486],
24	be	VB	O	be	cop	27	SENT_49	[p4l1971t1403r2056b1467],
25	a	DT	O	a	det	27	SENT_49	[p4l2112t1424r2150b1467],
26	contributing	JJ	O	contributing	amod	27	SENT_49	[p4l8t1502r460b1585],
27	factor	NN	O	factor	ccomp	17	SENT_49	[p4l490t1502r707b1566],
28	for	IN	O	for	_	0	SENT_49	[p4l734t1502r842b1566],
29	the	DT	O	the	det	30	SENT_49	[p4l869t1502r980b1566],
30	development	NN	O	development	prep_for	27	SENT_49	[p4l1009t1502r1489b1585],
31	of	IN	O	of	_	0	SENT_49	[p4l1518t1502r1597b1566],
32	persistent	JJ	O	persistent	amod	33	SENT_49	[p4l1619t1502r1977b1585],
33	TD	NN	O	td	prep_of	30	SENT_49	[p4l2004t1503r2144b1566],
34	.	.	O	.	_	0	SENT_49	[p4l2004t1503r2144b1566],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_50	[p4l7t1601r491b1677],
2	,	,	O	,	_	0	SENT_50	[p4l7t1601r491b1677],
3	Kapitany	NNP	PERSON	Kapitany	nsubj	9	SENT_50	[p4l543t1601r880b1684],
4	et	FW	O	et	dep	3	SENT_50	[p4l928t1611r993b1665],
5	al.	FW	O	al.	nn	6	SENT_50	[p4l1040t1601r1121b1665],
6	(	FW	O	(	dep	3	SENT_50	[p4l1176t1602r1416b1680],
7	1998	CD	DATE	1998	num	8	SENT_50	[p4l1176t1602r1416b1680],
8	)	CD	NUMBER	)	dep	6	SENT_50	[p4l1176t1602r1416b1680],
9	demonstrated	VBD	O	demonstrate	_	0	SENT_50	[p4l1466t1601r1965b1665],
10	that	IN	O	that	complm	22	SENT_50	[p4l2011t1601r2150b1665],
11	patients	NNS	O	patient	nsubj	22	SENT_50	[p4l7t1700r293b1783],
12	who	WP	O	who	nsubj	14	SENT_50	[p4l368t1700r523b1764],
13	were	VBD	O	be	cop	14	SENT_50	[p4l597t1720r774b1764],
14	heterozygous	JJ	O	heterozygous	rcmod	11	SENT_50	[p4l845t1700r1338b1783],
15	for	IN	O	for	_	0	SENT_50	[p4l1412t1700r1520b1764],
16	the	DT	O	the	det	21	SENT_50	[p4l1589t1700r1700b1764],
17	functional	JJ	O	functional	amod	21	SENT_50	[p4l1773t1700r2148b1764],
18	CYPZD6	NN	O	cypzd6	nn	21	SENT_50	[p4l12t1799r340b1864],
19	*	NN	O	*	nn	21	SENT_50	[p4l349t1800r422b1862],
20	1	CD	NUMBER	1	num	21	SENT_50	[p4l349t1800r422b1862],
21	allele	NN	O	allele	prep_for	14	SENT_50	[p4l482t1799r679b1863],
22	had	VBD	O	have	ccomp	9	SENT_50	[p4l729t1799r863b1863],
23	a	DT	O	a	det	25	SENT_50	[p4l914t1820r952b1863],
24	higher	JJR	O	higher	amod	25	SENT_50	[p4l1001t1799r1239b1882],
25	incidence	NN	O	incidence	dobj	22	SENT_50	[p4l1288t1799r1642b1863],
26	of	IN	O	of	_	0	SENT_50	[p4l1695t1799r1774b1863],
27	TD	NN	O	td	prep_of	25	SENT_50	[p4l1819t1801r1938b1862],
28	than	IN	O	than	_	0	SENT_50	[p4l1990t1799r2149b1863],
29	patients	NNS	O	patient	prep_than	22	SENT_50	[p4l7t1898r293b1981],
30	homozygous	JJ	O	homozygous	amod	29	SENT_50	[p4l321t1898r793b1981],
31	for	IN	O	for	_	0	SENT_50	[p4l822t1898r930b1962],
32	this	DT	O	this	det	33	SENT_50	[p4l954t1898r1084b1962],
33	allele	NN	O	allele	prep_for	30	SENT_50	[p4l1115t1898r1331b1962],
34	.	.	O	.	_	0	SENT_50	[p4l1115t1898r1331b1962],

1	Benefits	NNS	O	benefit	nsubjpass	18	SENT_51	[p4l120t1997r423b2061],
2	of	IN	O	of	_	0	SENT_51	[p4l452t1997r531b2061],
3	long	JJ	O	long	amod	7	SENT_51	[p4l551t1997r914b2080],
4	—	JJ	O	—	amod	7	SENT_51	[p4l551t1997r914b2080],
5	term	NN	O	term	nn	7	SENT_51	[p4l551t1997r914b2080],
6	depot	NN	O	depot	nn	7	SENT_51	[p4l939t1997r1142b2080],
7	treatment	NN	O	treatment	prep_of	1	SENT_51	[p4l1166t2006r1514b2061],
8	of	IN	O	of	_	0	SENT_51	[p4l1540t1997r1619b2061],
9	schizophrenia	NN	O	schizophrenia	prep_of	1	SENT_51	[p4l1642t1997r2150b2080],
10	using	VBG	O	use	partmod	9	SENT_51	[p4l7t2096r206b2179],
11	the	DT	O	the	det	15	SENT_51	[p4l241t2096r351b2160],
12	lowest	JJS	O	lowest	amod	15	SENT_51	[p4l386t2096r628b2160],
13	effective	JJ	O	effective	amod	15	SENT_51	[p4l661t2096r982b2160],
14	dose	NN	O	dose	nn	15	SENT_51	[p4l1018t2096r1184b2160],
15	approach	NN	O	approach	dobj	10	SENT_51	[p4l1221t2096r1558b2179],
16	are	VBP	O	be	auxpass	18	SENT_51	[p4l1594t2116r1702b2160],
17	well	RB	O	well	advmod	18	SENT_51	[p4l1737t2096r1894b2160],
18	established	VBN	O	establish	_	0	SENT_51	[p4l1929t2096r2146b2160, p4l8t2195r229b2259],
19	(	CD	NUMBER	(	num	20	SENT_51	[p4l276t2196r582b2274],
20	Burnett	NNP	PERSON	Burnett	nsubj	22	SENT_51	[p4l276t2196r582b2274],
21	et	FW	O	et	nn	22	SENT_51	[p4l626t2204r692b2259],
22	al.	FW	O	al.	xcomp	18	SENT_51	[p4l737t2195r818b2259],
23	1993	CD	DATE	1993	dep	22	SENT_51	[p4l876t2196r1073b2271],
24	;	:	O	;	_	0	SENT_51	[p4l876t2196r1073b2271],
25	Gerlach	NNP	PERSON	Gerlach	dep	22	SENT_51	[p4l1123t2195r1415b2260],
26	1995	CD	DATE	1995	dep	25	SENT_51	[p4l1467t2195r1664b2271],
27	;	:	O	;	_	0	SENT_51	[p4l1467t2195r1664b2271],
28	Kane	NNP	PERSON	Kane	dep	22	SENT_51	[p4l1715t2197r1906b2259],
29	et	FW	O	et	nn	30	SENT_51	[p4l1952t2205r2017b2259],
30	al.	FW	O	al.	dep	28	SENT_51	[p4l2062t2195r2144b2259],
31	1998	CD	DATE	1998	num	32	SENT_51	[p4l16t2294r241b2373],
32	)	CD	NUMBER	)	dep	22	SENT_51	[p4l16t2294r241b2373],
33	.	.	O	.	_	0	SENT_51	[p4l16t2294r241b2373],

1	One	CD	NUMBER	one	num	3	SENT_52	[p4l280t2294r430b2358],
2	important	JJ	O	important	amod	3	SENT_52	[p4l463t2294r824b2377],
3	aspect	NN	O	aspect	nsubj	7	SENT_52	[p4l857t2303r1087b2377],
4	in	IN	O	in	_	0	SENT_52	[p4l1118t2294r1188b2357],
5	this	DT	O	this	det	6	SENT_52	[p4l1219t2294r1349b2358],
6	approach	NN	O	approach	prep_in	3	SENT_52	[p4l1386t2294r1724b2377],
7	is	VBZ	O	be	_	0	SENT_52	[p4l1755t2294r1812b2358],
8	to	TO	O	to	_	0	SENT_52	[p4l1847t2303r1916b2358],
9	minimise	NN	O	minimise	prep_to	7	SENT_52	[p4l1949t2294r2146b2357, p4l8t2393r180b2457],
10	disabling	VBG	O	disable	amod	12	SENT_52	[p4l213t2393r551b2476],
11	side	JJ	O	side	amod	12	SENT_52	[p4l586t2393r730b2457],
12	effects	NNS	O	effect	dep	7	SENT_52	[p4l762t2393r1004b2457],
13	of	IN	O	of	_	0	SENT_52	[p4l1038t2393r1118b2457],
14	antipsychotic	JJ	O	antipsychotic	amod	15	SENT_52	[p4l1145t2393r1636b2476],
15	treatment	NN	O	treatment	prep_of	12	SENT_52	[p4l1669t2403r2038b2457],
16	.	.	O	.	_	0	SENT_52	[p4l1669t2403r2038b2457],

1	In	IN	O	in	_	0	SENT_53	[p4l2074t2395r2149b2456],
2	this	DT	O	this	det	3	SENT_53	[p4l7t2492r138b2556],
3	context	NN	O	context	prep_in	12	SENT_53	[p4l184t2501r475b2568],
4	,	,	O	,	_	0	SENT_53	[p4l184t2501r475b2568],
5	the	DT	O	the	det	9	SENT_53	[p4l522t2492r633b2556],
6	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_53	[p4l676t2492r1294b2575],
7	and	CC	O	and	_	0	SENT_53	[p4l1341t2492r1472b2556],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_53	[p4l1513t2492r2147b2575],
9	properties	NNS	O	property	nsubj	12	SENT_53	[p4l7t2591r376b2674],
10	may	MD	O	may	aux	12	SENT_53	[p4l405t2612r562b2674],
11	be	VB	O	be	cop	12	SENT_53	[p4l587t2591r673b2655],
12	important	JJ	O	important	_	0	SENT_53	[p4l700t2591r1079b2674],
13	.	.	O	.	_	0	SENT_53	[p4l700t2591r1079b2674],

1	The	DT	O	the	det	2	SENT_54	[p4l120t2690r262b2753],
2	elimination	NN	O	elimination	nsubjpass	12	SENT_54	[p4l312t2689r738b2753],
3	of	IN	O	of	_	0	SENT_54	[p4l787t2689r867b2753],
4	zuclopenthixol	NN	O	zuclopenthixol	prep_of	2	SENT_54	[p4l910t2689r1467b2773],
5	after	IN	O	after	_	0	SENT_54	[p4l1518t2689r1688b2753],
6	single	JJ	O	single	amod	9	SENT_54	[p4l1737t2689r1956b2773],
7	oral	JJ	O	oral	amod	9	SENT_54	[p4l2006t2690r2148b2753],
8	dose	NN	O	dose	nn	9	SENT_54	[p4l9t2789r177b2853],
9	administration	NN	O	administration	prep_after	4	SENT_54	[p4l212t2789r753b2853],
10	has	VBZ	O	have	aux	12	SENT_54	[p4l784t2789r905b2853],
11	been	VBN	O	be	auxpass	12	SENT_54	[p4l938t2789r1114b2853],
12	shown	VBN	O	show	_	0	SENT_54	[p4l1149t2789r1389b2853],
13	to	TO	O	to	aux	15	SENT_54	[p4l1421t2799r1490b2853],
14	be	VB	O	be	cop	15	SENT_54	[p4l1522t2789r1608b2853],
15	dependent	JJ	O	dependent	xcomp	12	SENT_54	[p4l1642t2789r2027b2872],
16	on	IN	O	on	_	0	SENT_54	[p4l2059t2810r2149b2853],
17	CYPZD6	NN	O	cypzd6	prep_on	15	SENT_54	[p4l9t2887r347b2952],
18	activity	NN	O	activity	nn	20	SENT_54	[p4l379t2888r657b2971],
19	(	CD	NUMBER	(	num	20	SENT_54	[p4l689t2887r898b2967],
20	Dahl	NNP	PERSON	Dahl	dep	17	SENT_54	[p4l689t2887r898b2967],
21	et	FW	O	et	nn	22	SENT_54	[p4l927t2897r993b2951],
22	al.	FW	O	al.	tmod	15	SENT_54	[p4l1022t2888r1104b2952],
23	1991	CD	DATE	1991	num	24	SENT_54	[p4l1146t2888r1373b2967],
24	)	CD	NUMBER	)	dep	22	SENT_54	[p4l1146t2888r1373b2967],
25	.	.	O	.	_	0	SENT_54	[p4l1146t2888r1373b2967],

1	Jerling	VBG	O	jerl	dep	8	SENT_55	[p4l1406t2888r1659b2971],
2	et	FW	O	et	nn	4	SENT_55	[p4l1690t2897r1755b2951],
3	al.	FW	O	al.	nn	4	SENT_55	[p4l1785t2888r1867b2952],
4	(	FW	O	(	dobj	1	SENT_55	[p4l1903t2887r2146b2967],
5	1996	CD	DATE	1996	num	6	SENT_55	[p4l1903t2887r2146b2967],
6	)	CD	NUMBER	)	nsubj	8	SENT_55	[p4l1903t2887r2146b2967],
7	consequently	RB	O	consequently	advmod	8	SENT_55	[p4l8t2987r502b3070],
8	demonstrated	VBD	O	demonstrate	_	0	SENT_55	[p4l570t2987r1075b3051],
9	a	DT	O	a	det	13	SENT_55	[p4l1142t3008r1180b3051],
10	two	CD	NUMBER	two	number	11	SENT_55	[p4l1245t2987r1568b3051],
11	—	CD	NUMBER	—	num	13	SENT_55	[p4l1245t2987r1568b3051],
12	fold	NN	O	fold	nn	13	SENT_55	[p4l1245t2987r1568b3051],
13	difference	NN	O	difference	dobj	8	SENT_55	[p4l1635t2987r2011b3051],
14	in	IN	O	in	_	0	SENT_55	[p4l2078t2987r2149b3050],
15	zuclopenthixol	NN	O	zuclopenthixol	nn	16	SENT_55	[p4l9t3085r565b3169],
16	clearance	NN	O	clearance	prep_in	8	SENT_55	[p4l603t3086r955b3149],
17	between	IN	O	between	_	0	SENT_55	[p4l990t3085r1302b3150],
18	EM	NNP	O	EM	nn	21	SENT_55	[p4l1337t3087r1474b3149],
19	and	CC	O	and	_	0	SENT_55	[p4l1512t3086r1644b3149],
20	PM	NNP	O	PM	conj_and	18	SENT_55	[p4l1679t3087r1810b3149],
21	subjects	NNS	O	subject	prep_between	16	SENT_55	[p4l1850t3085r2146b3169],
22	on	IN	O	on	_	0	SENT_55	[p4l9t3206r99b3249],
23	continuous	JJ	O	continuous	amod	25	SENT_55	[p4l178t3185r586b3249],
24	oral	JJ	O	oral	amod	25	SENT_55	[p4l668t3185r811b3249],
25	treatment	NN	O	treatment	prep_on	8	SENT_55	[p4l890t3195r1245b3249],
26	with	IN	O	with	_	0	SENT_55	[p4l1323t3185r1488b3249],
27	zuclopenthixol	NN	O	zuclopenthixol	prep_with	25	SENT_55	[p4l1567t3185r2144b3268],
28	.	.	O	.	_	0	SENT_55	[p4l1567t3185r2144b3268],

1	No	DT	O	no	det	2	SENT_56	[p4l7t3285r118b3348],
2	data	NNS	O	datum	nsubj	4	SENT_56	[p4l171t3284r325b3347],
3	are	VBP	O	be	cop	4	SENT_56	[p4l376t3304r486b3347],
4	available	JJ	O	available	_	0	SENT_56	[p4l539t3283r875b3348],
5	about	IN	O	about	_	0	SENT_56	[p4l928t3283r1134b3347],
6	the	DT	O	the	det	7	SENT_56	[p4l1183t3284r1294b3347],
7	role	NN	O	role	prep_about	4	SENT_56	[p4l1345t3284r1489b3347],
8	of	IN	O	of	_	0	SENT_56	[p4l1542t3283r1622b3347],
9	CYPZD6	NN	O	cypzd6	prep_of	7	SENT_56	[p4l1667t3283r2006b3348],
10	on	IN	O	on	_	0	SENT_56	[p4l2059t3304r2149b3347],
11	the	DT	O	the	det	13	SENT_56	[p4l7t3383r119b3447],
12	clinical	JJ	O	clinical	amod	13	SENT_56	[p4l158t3383r432b3447],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	4	SENT_56	[p4l468t3383r1130b3466],
14	and	CC	O	and	_	0	SENT_56	[p4l1171t3383r1302b3447],
15	effects	NNS	O	effect	conj_and	13	SENT_56	[p4l1339t3383r1583b3447],
16	of	IN	O	of	_	0	SENT_56	[p4l1624t3383r1704b3447],
17	depot	NN	O	depot	nn	18	SENT_56	[p4l1736t3383r1943b3466],
18	antipsychotics	NNS	O	antipsychotic	prep_of	13	SENT_56	[p4l1980t3383r2146b3447, p4l7t3481r422b3565],
19	.	.	O	.	_	0	SENT_56	[p4l1980t3383r2146b3447, p4l7t3481r422b3565],

1	Table	NNP	O	Table	_	0	SENT_57	[p4l9t3591r193b3647],
2	1	CD	NUMBER	1	num	4	SENT_57	[p4l220t3591r250b3646],
3	Demographic	JJ	MISC	demographic	amod	4	SENT_57	[p4l296t3591r727b3663],
4	data	NNS	O	datum	nsubj	8	SENT_57	[p4l752t3591r883b3646],
5	of	IN	O	of	_	0	SENT_57	[p4l906t3591r974b3646],
6	the	DT	O	the	det	7	SENT_57	[p4l991t3591r1087b3646],
7	population	NN	O	population	prep_of	4	SENT_57	[p4l1109t3591r1450b3663],
8	studied	VBN	O	study	rcmod	1	SENT_57	[p4l1475t3591r1702b3646],
9	(	CD	NUMBER	(	num	10	SENT_57	[p4l1726t3591r1937b3659],
10	n	NN	O	n	nsubj	13	SENT_57	[p4l1726t3591r1937b3659],
11	=	JJ	O	=	amod	13	SENT_57	[p4l1726t3591r1937b3659],
12	52	CD	NUMBER	52	num	13	SENT_57	[p4l1726t3591r1937b3659],
13	)	NN	O	)	xcomp	8	SENT_57	[p4l1726t3591r1937b3659],

1	Patient	NN	O	patient	nn	2	SENT_58	[p4l7t3753r229b3808],
2	characteristics	NNS	O	characteristic	_	0	SENT_58	[p4l251t3753r704b3808],

1	Age	NNP	O	Age	nn	3	SENT_59	[p5l7t104r137b175],
2	[	CD	NUMBER	[	num	3	SENT_59	[p5l166t105r373b175],
3	years	NNS	NUMBER	year	_	0	SENT_59	[p5l166t105r373b175],
4	;	:	O	;	_	0	SENT_59	[p5l166t105r373b175],
5	mean	VB	O	mean	dep	3	SENT_59	[p5l399t121r570b158],
6	(	JJ	O	(	amod	9	SENT_59	[p5l594t103r743b172],
7	SD	NN	O	sd	nn	9	SENT_59	[p5l594t103r743b172],
8	)	NN	O	)	nn	9	SENT_59	[p5l594t103r743b172],
9	range	NN	O	range	nsubj	12	SENT_59	[p5l766t105r964b175],
10	]	CD	NUMBER	]	number	11	SENT_59	[p5l766t105r964b175],
11	43	CD	NUMBER	43	num	12	SENT_59	[p5l1608t103r1681b159],
12	(	NN	O	(	xcomp	5	SENT_59	[p5l1711t104r1837b172],
13	12	CD	NUMBER	12	number	14	SENT_59	[p5l1711t104r1837b172],
14	)	CD	NUMBER	)	num	12	SENT_59	[p5l1711t104r1837b172],
15	20-70	CD	NUMBER	20-70	num	18	SENT_59	[p5l1863t103r2058b159],
16	Gender	NN	O	gender	nn	18	SENT_59	[p5l9t185r242b240],
17	(	NN	O	(	nn	18	SENT_59	[p5l265t185r701b253],
18	female/male	NN	O	female/male	dep	12	SENT_59	[p5l265t185r701b253],
19	;	:	O	;	_	0	SENT_59	[p5l265t185r701b253],
20	n	NN	O	n	dep	12	SENT_59	[p5l727t185r789b253],
21	)	CD	NUMBER	)	number	22	SENT_59	[p5l727t185r789b253],
22	33/19	CD	NUMBER	33/19	num	23	SENT_59	[p5l1610t185r1786b241],
23	Duration	NN	O	duration	dep	20	SENT_59	[p5l7t265r290b321],
24	of	IN	O	of	_	0	SENT_59	[p5l313t265r382b321],
25	disorder	NN	O	disorder	prep_of	23	SENT_59	[p5l400t265r660b321],
26	[	CD	NUMBER	[	num	27	SENT_59	[p5l687t267r894b337],
27	years	NNS	NUMBER	year	tmod	23	SENT_59	[p5l687t267r894b337],
28	;	:	O	;	_	0	SENT_59	[p5l687t267r894b337],

1	mean	JJ	O	mean	amod	3	SENT_60	[p5l87t364r258b402],
2	(	JJ	O	(	amod	3	SENT_60	[p5l283t347r431b415],
3	SD	NN	O	sd	dep	8	SENT_60	[p5l283t347r431b415],
4	)	NN	O	)	dep	3	SENT_60	[p5l283t347r431b415],
5	range	NN	O	range	dep	8	SENT_60	[p5l455t348r653b418],
6	]	CD	NUMBER	]	num	5	SENT_60	[p5l455t348r653b418],
7	15.4	CD	NUMBER	15.4	num	8	SENT_60	[p5l1616t346r1745b402],
8	(	NN	O	(	_	0	SENT_60	[p5l1771t347r1917b415],
9	9.3	CD	NUMBER	9.3	number	10	SENT_60	[p5l1771t347r1917b415],
10	)	CD	NUMBER	)	dep	8	SENT_60	[p5l1771t347r1917b415],
11	1-37	CD	NUMBER	1-37	dep	10	SENT_60	[p5l1950t347r2097b402],

1	Total	JJ	O	total	amod	2	SENT_61	[p5l8t426r168b481],
2	time	NN	O	time	_	0	SENT_61	[p5l191t426r330b481],
3	on	IN	O	on	dep	2	SENT_61	[p5l355t444r431b481],
4	treatment	NN	O	treatment	pobj	3	SENT_61	[p5l453t434r755b481],
5	with	IN	O	with	_	0	SENT_61	[p5l777t426r917b482],
6	zuclopenthiXol	NN	O	zuclopenthixol	nn	8	SENT_61	[p5l88t508r907b580],
7	—	NN	O	—	nn	8	SENT_61	[p5l88t508r907b580],
8	decanoate	NN	O	decanoate	prep_with	4	SENT_61	[p5l88t508r907b580],
9	at	IN	O	at	_	0	SENT_61	[p5l932t516r987b563],
10	study	NN	O	study	nn	11	SENT_61	[p5l1011t508r1178b580],
11	entry	NN	O	entry	prep_at	8	SENT_61	[p5l1202t516r1363b580],
12	[	CD	NUMBER	[	num	13	SENT_61	[p5l93t589r366b656],
13	months	NNS	NUMBER	month	tmod	8	SENT_61	[p5l93t589r366b656],
14	;	:	O	;	_	0	SENT_61	[p5l93t589r366b656],
15	mean	VB	O	mean	dep	4	SENT_61	[p5l392t606r563b644],
16	(	JJ	O	(	amod	19	SENT_61	[p5l588t589r736b657],
17	SD	NN	O	sd	nn	19	SENT_61	[p5l588t589r736b657],
18	)	NN	O	)	nn	19	SENT_61	[p5l588t589r736b657],
19	range	NN	O	range	dobj	15	SENT_61	[p5l760t590r957b661],
20	]	CD	NUMBER	]	num	22	SENT_61	[p5l760t590r957b661],
21	31	CD	NUMBER	31	num	22	SENT_61	[p5l1610t589r1679b644],
22	(	NN	O	(	dep	19	SENT_61	[p5l1711t589r1837b657],
23	18	CD	NUMBER	18	number	24	SENT_61	[p5l1711t589r1837b657],
24	)	CD	NUMBER	)	num	25	SENT_61	[p5l1711t589r1837b657],
25	4-62	CD	NUMBER	4-62	dep	22	SENT_61	[p5l1862t589r2018b644],

1	ZuclopenthiXol	NN	O	zuclopenthixol	nn	4	SENT_62	[p5l7t669r840b741],
2	—	NN	O	—	nn	4	SENT_62	[p5l7t669r840b741],
3	decanoate	NN	O	decanoate	nn	4	SENT_62	[p5l7t669r840b741],
4	dose	NN	O	dose	_	0	SENT_62	[p5l864t669r1007b725],
5	per	IN	O	per	dep	4	SENT_62	[p5l1029t687r1132b741],

1	4	CD	DURATION	4	num	2	SENT_63	[p5l87t750r124b805],
2	weeks	NNS	DURATION	week	_	0	SENT_63	[p5l148t750r343b805],
3	[	CD	NUMBER	[	num	4	SENT_63	[p5l373t751r513b822],
4	mg	NN	O	mg	dep	2	SENT_63	[p5l373t751r513b822],
5	;	:	O	;	_	0	SENT_63	[p5l373t751r513b822],
6	mean	VB	O	mean	dep	2	SENT_63	[p5l539t768r709b805],
7	(	JJ	O	(	amod	6	SENT_63	[p5l734t750r882b819],
8	SD	NN	O	sd	dep	7	SENT_63	[p5l734t750r882b819],
9	)	NN	O	)	nn	10	SENT_63	[p5l734t750r882b819],
10	range	NN	O	range	dep	6	SENT_63	[p5l907t752r1104b822],
11	]	NN	O	]	nn	13	SENT_63	[p5l907t752r1104b822],
12	220	CD	NUMBER	220	num	13	SENT_63	[p5l1569t750r1685b806],
13	(62) 100-400	NN	O	(62) 100-400	dep	2	SENT_63	[p5l1869t750r2138b806],[p5l1711t750r1837b819],

1	Smokers	NNS	O	smoker	_	0	SENT_64	[p5l10t832r283b888],
2	/	:	O	/	punct	1	SENT_64	[p5l306t832r329b888],
3	non	JJ	O	non	amod	5	SENT_64	[p5l350t849r467b887],
4	—	JJ	O	—	amod	5	SENT_64	[p5l489t866r529b871],
5	smokers	NNS	O	smoker	nsubj	6	SENT_64	[p5l553t832r812b887],
6	(	VBP	O	(	dep	1	SENT_64	[p5l839t833r925b900],
7	n	NN	O	n	dobj	6	SENT_64	[p5l839t833r925b900],
8	)	CD	NUMBER	)	number	9	SENT_64	[p5l839t833r925b900],
9	15/37	CD	NUMBER	15/37	num	11	SENT_64	[p5l1616t832r1785b888],
10	Anticholinergic	JJ	O	anticholinergic	amod	11	SENT_64	[p5l7t912r499b984],
11	prescribed/not	NN	O	prescribed/not	nsubj	12	SENT_64	[p5l522t912r974b984],
12	prescribed	VBN	O	prescribe	rcmod	7	SENT_64	[p5l993t912r1323b983],
13	(	NN	O	(	nn	14	SENT_64	[p5l1347t912r1432b980],
14	n	NN	O	n	tmod	12	SENT_64	[p5l1347t912r1432b980],
15	)	CD	NUMBER	)	num	16	SENT_64	[p5l1347t912r1432b980],
16	25/27	CD	NUMBER	25/27	dep	14	SENT_64	[p5l1609t911r1785b967],

1	The	DT	O	the	det	2	SENT_65	[p5l120t1202r261b1265],
2	aim	NN	O	aim	nsubj	6	SENT_65	[p5l295t1201r432b1265],
3	of	IN	O	of	_	0	SENT_65	[p5l463t1201r543b1265],
4	the	DT	O	the	det	5	SENT_65	[p5l568t1202r679b1265],
5	study	NN	O	study	prep_of	2	SENT_65	[p5l714t1202r910b1285],
6	was	VBD	O	be	_	0	SENT_65	[p5l943t1222r1082b1266],
7	to	TO	O	to	aux	8	SENT_65	[p5l1116t1211r1184b1265],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_65	[p5l1218t1202r1525b1266],
9	the	DT	O	the	det	10	SENT_65	[p5l1557t1202r1668b1265],
10	associations	NNS	O	association	dobj	8	SENT_65	[p5l1702t1201r2146b1265],
11	between	IN	O	between	_	0	SENT_65	[p5l6t1301r316b1365],
12	the	DT	O	the	det	14	SENT_65	[p5l350t1301r461b1365],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_65	[p5l502t1301r829b1366],
14	genotype	NN	O	genotype	prep_between	10	SENT_65	[p5l861t1311r1219b1384],
15	,	,	O	,	_	0	SENT_65	[p5l861t1311r1219b1384],
16	drug	NN	O	drug	nn	18	SENT_65	[p5l1259t1301r1425b1384],
17	plasma	NN	O	plasma	nn	18	SENT_65	[p5l1460t1301r1724b1384],
18	concentrations	NNS	O	concentration	prep_between	10	SENT_65	[p5l1758t1311r2146b1365, p5l8t1399r184b1463],
19	and	CC	O	and	_	0	SENT_65	[p5l238t1400r368b1463],
20	neurological	JJ	O	neurological	amod	22	SENT_65	[p5l416t1400r880b1483],
21	side	JJ	O	side	amod	22	SENT_65	[p5l933t1400r1077b1463],
22	effects	NNS	O	effect	conj_and	14	SENT_65	[p5l1127t1399r1369b1463],
23	in	IN	O	in	_	0	SENT_65	[p5l1420t1399r1490b1463],
24	clinically	RB	O	clinically	advmod	25	SENT_65	[p5l1540t1399r1884b1483],
25	stable	JJ	O	stable	amod	27	SENT_65	[p5l1937t1400r2148b1463],
26	schizophrenic	JJ	O	schizophrenic	amod	27	SENT_65	[p5l11t1499r522b1582],
27	outpatients	NNS	O	outpatient	prep_in	8	SENT_65	[p5l580t1499r984b1582],
28	receiving	VBG	O	receive	partmod	27	SENT_65	[p5l1040t1499r1384b1582],
29	monotherapy	NN	O	monotherapy	dobj	28	SENT_65	[p5l1441t1499r1929b1582],
30	with	IN	O	with	_	0	SENT_65	[p5l1986t1499r2149b1563],
31	zuclopenthiXol	NN	O	zuclopenthixol	nn	33	SENT_65	[p5l9t1597r983b1681],
32	—	NN	O	—	nn	33	SENT_65	[p5l9t1597r983b1681],
33	decanoate	NN	O	decanoate	prep_with	28	SENT_65	[p5l9t1597r983b1681],
34	.	.	O	.	_	0	SENT_65	[p5l9t1597r983b1681],

1	Materials	NNPS	O	Materials	_	0	SENT_66	[p5l11t1864r390b1938],
2	and	CC	O	and	_	0	SENT_66	[p5l420t1864r565b1938],
3	methods	NNS	O	method	conj_and	1	SENT_66	[p5l601t1864r947b1938],

1	Patients	NNS	O	patient	_	0	SENT_67	[p5l7t2060r257b2115],
2	and	CC	O	and	_	0	SENT_67	[p5l283t2060r395b2115],
3	clinical	JJ	O	clinical	amod	4	SENT_67	[p5l418t2060r650b2115],
4	ratings	NNS	O	rating	conj_and	1	SENT_67	[p5l672t2060r887b2132],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_68	[p5l7t2219r257b2275],
2	were	VBD	O	be	auxpass	3	SENT_68	[p5l288t2237r440b2275],
3	recruited	VBN	O	recruit	_	0	SENT_68	[p5l469t2219r753b2275],
4	from	IN	O	from	_	0	SENT_68	[p5l781t2219r936b2275],
5	the	DT	O	the	det	6	SENT_68	[p5l964t2220r1059b2275],
6	population	NN	O	population	nsubj	11	SENT_68	[p5l1087t2219r1428b2291],
7	of	IN	O	of	_	0	SENT_68	[p5l1459t2219r1527b2275],
8	schizophrenic	JJ	O	schizophrenic	amod	9	SENT_68	[p5l1554t2219r1992b2291],
9	outpatients	NNS	O	outpatient	prep_of	6	SENT_68	[p5l2023t2228r2146b2275, p5l7t2300r252b2372],
10	already	RB	O	already	advmod	11	SENT_68	[p5l291t2300r521b2372],
11	receiving	VBG	O	receive	prepc_from	3	SENT_68	[p5l556t2300r851b2372],
12	maintenance	NN	O	maintenance	nn	13	SENT_68	[p5l887t2300r1288b2356],
13	monotherapy	NN	O	monotherapy	dobj	11	SENT_68	[p5l1323t2300r1742b2372],
14	with	IN	O	with	_	0	SENT_68	[p5l1777t2300r1917b2356],
15	zuclo	NN	O	zuclo	nn	18	SENT_68	[p5l1952t2300r2146b2356],
16	—	CD	NUMBER	—	num	18	SENT_68	[p5l1952t2300r2146b2356],
17	penthiXol	NN	O	penthixol	nn	18	SENT_68	[p5l7t2381r654b2453],
18	—	NN	O	—	prep_with	11	SENT_68	[p5l7t2381r654b2453],
19	decanoate	NN	O	decanoate	nn	22	SENT_68	[p5l7t2381r654b2453],
20	(	CD	NUMBER	(	num	22	SENT_68	[p5l696t2382r848b2450],
21	ZD	NN	O	zd	nn	22	SENT_68	[p5l696t2382r848b2450],
22	)	NN	O	)	tmod	11	SENT_68	[p5l696t2382r848b2450],
23	at	IN	O	at	_	0	SENT_68	[p5l891t2390r946b2436],
24	Tartu	NNP	ORGANIZATION	Tartu	nn	27	SENT_68	[p5l984t2383r1149b2436],
25	University	NNP	ORGANIZATION	University	nn	27	SENT_68	[p5l1188t2381r1523b2453],
26	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	27	SENT_68	[p5l1563t2381r1915b2453],
27	Clinic	NNP	ORGANIZATION	Clinic	prep_at	22	SENT_68	[p5l1956t2381r2147b2437],
28	and	CC	O	and	_	0	SENT_68	[p5l9t2463r121b2518],
29	J'amejala	NNP	ORGANIZATION	J'amejala	nn	33	SENT_68	[p5l156t2463r435b2535],
30	Psychiatric	NNP	ORGANIZATION	Psychiatric	nn	33	SENT_68	[p5l470t2463r822b2535],
31	Hospital	NNP	ORGANIZATION	Hospital	nn	33	SENT_68	[p5l859t2463r1145b2535],
32	,	,	O	,	_	0	SENT_68	[p5l859t2463r1145b2535],
33	Estonia	NNP	LOCATION	Estonia	prep_at	22	SENT_68	[p5l1183t2463r1438b2518],
34	.	.	O	.	_	0	SENT_68	[p5l1183t2463r1438b2518],

1	All	DT	O	all	det	2	SENT_69	[p5l1477t2463r1577b2517],
2	patients	NNS	O	patient	nsubj	3	SENT_69	[p5l1612t2463r1858b2535],
3	were	VBD	O	be	_	0	SENT_69	[p5l1896t2481r2048b2518],
4	of	IN	O	of	_	0	SENT_69	[p5l2085t2463r2154b2518],
5	Estonian	JJ	MISC	estonian	amod	8	SENT_69	[p5l7t2544r286b2599],
6	or	CC	O	or	_	0	SENT_69	[p5l314t2561r379b2599],
7	Russian	JJ	MISC	russian	conj_or	5	SENT_69	[p5l405t2544r656b2599],
8	origin	NN	O	origin	prep_of	3	SENT_69	[p5l685t2544r873b2616],
9	and	CC	O	and	_	0	SENT_69	[p5l902t2544r1014b2599],
10	they	PRP	O	they	nsubjpass	12	SENT_69	[p5l1042t2544r1176b2615],
11	were	VBD	O	be	auxpass	12	SENT_69	[p5l1205t2561r1357b2599],
12	informed	VBN	O	inform	conj_and	3	SENT_69	[p5l1385t2544r1677b2599],
13	of	IN	O	of	_	0	SENT_69	[p5l1705t2544r1773b2599],
14	their	PRP$	O	they	poss	15	SENT_69	[p5l1796t2544r1942b2599],
15	rights	NNS	O	rights	prep_of	12	SENT_69	[p5l1967t2544r2147b2616],
16	under	IN	O	under	_	0	SENT_69	[p5l7t2624r189b2680],
17	the	DT	O	the	det	18	SENT_69	[p5l213t2624r308b2680],
18	Declaration	NN	O	declaration	prep_under	12	SENT_69	[p5l334t2624r705b2680],
19	of	IN	O	of	_	0	SENT_69	[p5l732t2624r800b2680],
20	Helsinki	NNP	LOCATION	Helsinki	prep_of	18	SENT_69	[p5l821t2624r1107b2690],
21	,	,	O	,	_	0	SENT_69	[p5l821t2624r1107b2690],
22	as	RB	O	as	_	0	SENT_69	[p5l1137t2642r1197b2680],
23	well	RB	O	well	_	0	SENT_69	[p5l1225t2624r1360b2680],
24	as	IN	O	as	_	0	SENT_69	[p5l1388t2642r1449b2680],
25	of	IN	O	of	_	0	SENT_69	[p5l1478t2624r1546b2680],
26	the	DT	O	the	det	27	SENT_69	[p5l1566t2624r1661b2680],
27	objectives	NNS	O	objective	prep_of	12	SENT_69	[p5l1689t2624r2008b2696],
28	and	CC	O	and	_	0	SENT_69	[p5l2037t2624r2149b2680],
29	risks	NNS	O	risk	conj_and	27	SENT_69	[p5l7t2705r155b2760],
30	of	IN	O	of	_	0	SENT_69	[p5l204t2705r272b2760],
31	the	DT	O	the	det	32	SENT_69	[p5l313t2705r408b2760],
32	study	NN	O	study	prep_of	27	SENT_69	[p5l458t2705r637b2777],
33	.	.	O	.	_	0	SENT_69	[p5l458t2705r637b2777],

1	The	DT	O	the	det	4	SENT_70	[p5l687t2705r809b2760],
2	Ethics	NNP	ORGANIZATION	Ethics	nn	4	SENT_70	[p5l855t2705r1052b2760],
3	Review	NNP	ORGANIZATION	Review	nn	4	SENT_70	[p5l1100t2705r1341b2760],
4	Committee	NNP	ORGANIZATION	Committee	nsubj	22	SENT_70	[p5l1389t2705r1740b2761],
5	of	IN	ORGANIZATION	of	_	0	SENT_70	[p5l1788t2705r1856b2760],
6	Clinical	JJ	ORGANIZATION	clinical	amod	8	SENT_70	[p5l1898t2705r2148b2761],
7	Research	NN	ORGANIZATION	research	nn	8	SENT_70	[p5l7t2787r293b2842],
8	Studies	NNS	ORGANIZATION	study	prep_of	4	SENT_70	[p5l316t2787r540b2842],
9	at	IN	O	at	_	0	SENT_70	[p5l565t2795r619b2842],
10	the	DT	O	the	det	11	SENT_70	[p5l639t2787r732b2842],
11	University	NNP	ORGANIZATION	University	prep_at	8	SENT_70	[p5l754t2787r1081b2859],
12	of	IN	ORGANIZATION	of	_	0	SENT_70	[p5l1104t2787r1172b2842],
13	Tartu	NNP	ORGANIZATION	Tartu	prep_of	11	SENT_70	[p5l1188t2788r1349b2842],
14	and	CC	O	and	_	0	SENT_70	[p5l1372t2787r1483b2842],
15	the	DT	O	the	det	17	SENT_70	[p5l1503t2787r1597b2842],
16	ethics	NNS	O	ethic	nn	17	SENT_70	[p5l1619t2787r1797b2842],
17	committee	NN	O	committee	prep_at	8	SENT_70	[p5l1821t2787r2148b2842],
18	at	IN	O	at	_	0	SENT_70	[p5l9t2876r64b2923],
19	Huddinge	NNP	ORGANIZATION	Huddinge	nn	21	SENT_70	[p5l94t2868r406b2940],
20	University	NNP	ORGANIZATION	University	nn	21	SENT_70	[p5l437t2868r772b2939],
21	Hospital	NNP	ORGANIZATION	Hospital	prep_at	17	SENT_70	[p5l803t2868r1072b2940],
22	approved	VBD	O	approve	_	0	SENT_70	[p5l1104t2868r1399b2940],
23	the	DT	O	the	det	24	SENT_70	[p5l1428t2868r1523b2923],
24	study	NN	O	study	dobj	22	SENT_70	[p5l1557t2868r1736b2940],
25	.	.	O	.	_	0	SENT_70	[p5l1557t2868r1736b2940],

1	All	DT	O	all	det	2	SENT_71	[p5l1771t2868r1871b2922],
2	patients	NNS	O	patient	nsubjpass	4	SENT_71	[p5l1901t2868r2147b2940],
3	were	VBD	O	be	auxpass	4	SENT_71	[p5l8t2966r160b3004],
4	included	VBN	O	include	_	0	SENT_71	[p5l183t2948r457b3004],
5	after	IN	O	after	_	0	SENT_71	[p5l481t2948r624b3004],
6	obtaining	VBG	O	obtain	prepc_after	4	SENT_71	[p5l647t2948r945b3020],
7	the	DT	O	the	det	9	SENT_71	[p5l968t2948r1063b3004],
8	informed	VBN	O	inform	amod	9	SENT_71	[p5l1086t2948r1378b3004],
9	consent	NN	O	consent	dobj	6	SENT_71	[p5l1401t2957r1658b3004],
10	.	.	O	.	_	0	SENT_71	[p5l1401t2957r1658b3004],

1	Inclusion	NN	O	inclusion	nn	2	SENT_72	[p5l120t3029r415b3085],
2	criteria	NNS	O	criterion	nsubj	3	SENT_72	[p5l460t3029r685b3085],
3	were	VBD	O	be	_	0	SENT_72	[p5l728t3047r881b3085],
4	as	IN	O	as	mark	5	SENT_72	[p5l927t3047r987b3085],
5	follows	VBZ	O	follow	advcl	3	SENT_72	[p5l1034t3029r1288b3085],
6	:	:	O	:	_	0	SENT_72	[p5l1034t3029r1288b3085],
7	clinically	RB	O	clinically	advmod	8	SENT_72	[p5l1338t3029r1633b3101],
8	stabilised	VBN	O	stabilise	parataxis	3	SENT_72	[p5l1680t3029r1979b3085],
9	outpatients	NNS	O	outpatient	dobj	8	SENT_72	[p5l2023t3038r2146b3085, p5l7t3111r252b3183],
10	with	IN	O	with	_	0	SENT_72	[p5l279t3111r419b3166],
11	a	DT	O	a	det	12	SENT_72	[p5l445t3129r477b3166],
12	diagnosis	NN	O	diagnosis	prep_with	9	SENT_72	[p5l501t3111r798b3183],
13	of	IN	O	of	_	0	SENT_72	[p5l826t3111r894b3166],
14	schizophrenia	NN	O	schizophrenia	nn	16	SENT_72	[p5l916t3111r1357b3183],
15	(	CD	NUMBER	(	num	16	SENT_72	[p5l1382t3111r1553b3179],
16	F20	NN	O	f20	prep_of	12	SENT_72	[p5l1382t3111r1553b3179],
17	)	CD	NUMBER	)	num	16	SENT_72	[p5l1382t3111r1553b3179],
18	or	CC	O	or	_	0	SENT_72	[p5l1580t3129r1645b3166],
19	schizoaffective	JJ	O	schizoaffective	amod	21	SENT_72	[p5l1671t3111r2148b3166],
20	disorder	NN	O	disorder	nn	21	SENT_72	[p5l8t3191r269b3246],
21	(	NN	O	(	conj_or	12	SENT_72	[p5l299t3191r469b3259],
22	F25	CD	NUMBER	f25	number	23	SENT_72	[p5l299t3191r469b3259],
23	)	CD	NUMBER	)	dep	21	SENT_72	[p5l299t3191r469b3259],
24	according	VBG	O	accord	_	0	SENT_72	[p5l503t3191r813b3263],
25	to	TO	O	to	prepc_according_to	8	SENT_72	[p5l843t3199r902b3246],
26	International	NNP	ORGANIZATION	International	nn	28	SENT_72	[p5l931t3191r1339b3246],
27	Statistical	NNP	ORGANIZATION	Statistical	nn	28	SENT_72	[p5l1370t3191r1682b3246],
28	Classification	NN	ORGANIZATION	classification	pobj	8	SENT_72	[p5l1712t3191r2149b3246],
29	of	IN	ORGANIZATION	of	_	0	SENT_72	[p5l8t3271r77b3327],
30	Diseases	NNS	ORGANIZATION	disease	prep_of	28	SENT_72	[p5l101t3271r377b3327],
31	and	CC	O	and	_	0	SENT_72	[p5l410t3272r522b3327],
32	Related	NNP	O	Related	nn	33	SENT_72	[p5l551t3272r794b3327],
33	Health	NNP	O	Health	conj_and	28	SENT_72	[p5l823t3271r1034b3327],
34	Problems	NNS	O	problem	nsubj	35	SENT_72	[p5l1063t3272r1361b3327],
35	(	VBP	O	(	rcmod	33	SENT_72	[p5l1395t3272r1680b3340],
36	ICD-10	NN	O	icd-10	dobj	35	SENT_72	[p5l1395t3272r1680b3340],
37	;	:	O	;	_	0	SENT_72	[p5l1395t3272r1680b3340],
38	World	NNP	ORGANIZATION	World	nn	40	SENT_72	[p5l1712t3272r1909b3327],
39	Health	NNP	ORGANIZATION	Health	nn	40	SENT_72	[p5l1938t3272r2149b3327],
40	Organization	NNP	ORGANIZATION	Organization	conj_and	33	SENT_72	[p5l9t3352r422b3424],
41	1992	CD	DATE	1992	num	42	SENT_72	[p5l456t3353r650b3421],
42	)	CD	NUMBER	)	dep	40	SENT_72	[p5l456t3353r650b3421],
43	,	,	O	,	_	0	SENT_72	[p5l456t3353r650b3421],
44	age	NN	O	age	conj_and	33	SENT_72	[p5l681t3370r788b3424],
45	between	IN	O	between	_	0	SENT_72	[p5l814t3352r1079b3408],
46	18	CD	DURATION	18	num	47	SENT_72	[p5l1114t3353r1181b3408],
47	years	NNS	NUMBER	year	prep_between	44	SENT_72	[p5l1211t3370r1375b3424],
48	and	CC	O	and	_	0	SENT_72	[p5l1406t3352r1518b3408],
49	70	CD	DURATION	70	num	50	SENT_72	[p5l1545t3353r1621b3408],
50	years	NNS	NUMBER	year	conj_and	47	SENT_72	[p5l1648t3370r1813b3424],
51	and	CC	O	and	_	0	SENT_72	[p5l1844t3352r1956b3408],
52	duration	NN	O	duration	conj_and	33	SENT_72	[p5l1983t3352r2146b3408, p5l7t3432r129b3487],
53	of	IN	O	of	_	0	SENT_72	[p5l153t3432r221b3487],
54	fixed	VBN	O	fix	amod	57	SENT_72	[p5l240t3432r401b3487],
55	dose	NN	O	dose	nn	57	SENT_72	[p5l425t3432r566b3487],
56	ZD	NN	O	zd	nn	57	SENT_72	[p5l590t3434r693b3487],
57	treatment	NN	O	treatment	prep_of	52	SENT_72	[p5l718t3440r1016b3487],
58	of	IN	O	of	_	0	SENT_72	[p5l1039t3432r1108b3487],
59	at	IN	DURATION	at	quantmod	61	SENT_72	[p5l1127t3441r1182b3487],
60	least	JJS	DURATION	least	mwe	59	SENT_72	[p5l1205t3432r1349b3487],
61	4	CD	DURATION	4	num	62	SENT_72	[p5l1371t3432r1408b3487],
62	months	NNS	NUMBER	month	prep_of	57	SENT_72	[p5l1433t3432r1679b3487],
63	.	.	O	.	_	0	SENT_72	[p5l1433t3432r1679b3487],

1	The	DT	O	the	dep	126	SENT_73	[p5l1707t3432r1827b3487],
2	stabilised	VBN	O	stabilise	dep	126	SENT_73	[p5l1854t3432r2149b3487],
3	condition	NN	O	condition	dep	126	SENT_73	[p6l8t20r308b75],
4	was	VBD	O	be	dep	126	SENT_73	[p6l346t38r465b75],
5	determined	VBN	O	determine	dep	126	SENT_73	[p6l505t20r863b75],
6	by	IN	O	by	dep	126	SENT_73	[p6l898t20r976b92],
7	the	DT	O	the	dep	126	SENT_73	[p6l1014t20r1110b75],
8	use	NN	O	use	dep	126	SENT_73	[p6l1147t38r1251b75],
9	of	IN	O	of	dep	126	SENT_73	[p6l1291t20r1359b75],
10	slightly	RB	O	slightly	dep	126	SENT_73	[p6l1394t20r1629b92],
11	modified	VBN	O	modify	dep	126	SENT_73	[p6l1667t20r1954b75],
12	(	NN	O	(	dep	126	SENT_73	[p6l1993t21r2146b92, p6l8t101r249b173],
13	prolonging	VBG	O	prolong	dep	126	SENT_73	[p6l1993t21r2146b92, p6l8t101r249b173],
14	the	DT	O	the	dep	126	SENT_73	[p6l283t101r378b156],
15	requirements	NNS	O	requirement	dep	126	SENT_73	[p6l411t101r826b173],
16	for	IN	O	for	dep	126	SENT_73	[p6l861t101r954b156],
17	unchanged	JJ	O	unchanged	dep	126	SENT_73	[p6l986t101r1331b173],
18	dose	NN	O	dose	dep	126	SENT_73	[p6l1365t101r1507b156],
19	of	IN	O	of	dep	126	SENT_73	[p6l1543t101r1611b156],
20	drug	NN	O	drug	dep	126	SENT_73	[p6l1641t101r1783b173],
21	used	VBN	O	use	dep	126	SENT_73	[p6l1817t101r1962b156],
22	from	IN	O	from	dep	126	SENT_73	[p6l1996t101r2150b156],
23	2	CD	DURATION	2	dep	126	SENT_73	[p6l9t182r44b236],
24	months	NNS	NUMBER	month	dep	126	SENT_73	[p6l93t181r324b237],
25	to	TO	O	to	dep	126	SENT_73	[p6l374t189r432b237],
26	4	CD	DURATION	4	dep	126	SENT_73	[p6l481t182r518b236],
27	months	NNS	NUMBER	month	dep	126	SENT_73	[p6l567t181r824b250],
28	)	RB	O	)	dep	126	SENT_73	[p6l567t181r824b250],
29	criteria	NNS	O	criterion	dep	126	SENT_73	[p6l875t181r1100b237],
30	for	IN	O	for	dep	126	SENT_73	[p6l1147t181r1240b237],
31	stabilisation	NN	O	stabilisation	dep	126	SENT_73	[p6l1289t181r1671b237],
32	described	VBN	O	describe	dep	126	SENT_73	[p6l1720t181r2024b237],
33	by	IN	O	by	dep	126	SENT_73	[p6l2070t181r2148b253],
34	Marder	NNP	PERSON	Marder	dep	126	SENT_73	[p6l7t262r236b317],
35	et	FW	O	et	dep	126	SENT_73	[p6l256t270r311b317],
36	al.	FW	O	al.	dep	126	SENT_73	[p6l333t262r401b317],
37	(	FW	O	(	dep	126	SENT_73	[p6l429t263r629b331],
38	1991	CD	DATE	1991	dep	126	SENT_73	[p6l429t263r629b331],
39	)	CD	NUMBER	)	dep	126	SENT_73	[p6l429t263r629b331],
40	—	NN	O	—	dep	126	SENT_73	[p6l652t296r692b301],
41	(	CD	NUMBER	(	dep	126	SENT_73	[p6l715t263r794b331],
42	a	DT	O	a	dep	126	SENT_73	[p6l715t263r794b331],
43	)	NN	O	)	dep	126	SENT_73	[p6l715t263r794b331],
44	stability	NN	O	stability	dep	126	SENT_73	[p6l820t262r1064b334],
45	on	IN	O	on	dep	126	SENT_73	[p6l1087t280r1162b317],
46	the	DT	O	the	dep	126	SENT_73	[p6l1183t262r1276b317],
47	psychosis	NN	O	psychosis	dep	126	SENT_73	[p6l1298t262r1596b334],
48	scores	NNS	O	score	dep	126	SENT_73	[p6l1622t280r1809b317],
49	(	VBP	O	(	dep	126	SENT_73	[p6l1835t262r2148b334],
50	including	VBG	O	include	dep	126	SENT_73	[p6l1835t262r2148b334],
51	cluster	NN	O	cluster	dep	126	SENT_73	[p6l8t344r220b399],
52	scores	NNS	O	score	dep	126	SENT_73	[p6l255t362r447b399],
53	for	IN	O	for	dep	126	SENT_73	[p6l483t344r575b399],
54	thought	VBN	O	think	dep	126	SENT_73	[p6l606t344r850b416],
55	disturbance	NN	O	disturbance	dep	126	SENT_73	[p6l883t344r1248b399],
56	and	CC	O	and	dep	126	SENT_73	[p6l1283t344r1395b399],
57	paranoia	NN	O	paranoia	dep	126	SENT_73	[p6l1427t344r1725b416],
58	)	NN	O	)	dep	126	SENT_73	[p6l1427t344r1725b416],
59	of	IN	O	of	dep	126	SENT_73	[p6l1761t344r1830b399],
60	the	DT	O	the	dep	126	SENT_73	[p6l1858t344r1953b399],
61	Brief	JJ	O	brief	dep	126	SENT_73	[p6l1986t344r2154b399],
62	Psychiatric	JJ	O	psychiatric	dep	126	SENT_73	[p6l7t425r360b496],
63	Rating	NNP	O	Rating	dep	126	SENT_73	[p6l386t425r596b497],
64	Scale	NNP	O	Scale	dep	126	SENT_73	[p6l624t425r792b480],
65	(	CD	NUMBER	(	dep	126	SENT_73	[p6l820t425r1061b493],
66	BPRS	NNP	O	BPRS	dep	126	SENT_73	[p6l820t425r1061b493],
67	)	CD	NUMBER	)	dep	126	SENT_73	[p6l820t425r1061b493],
68	(	CD	NUMBER	(	dep	126	SENT_73	[p6l1091t425r1353b493],
69	Overall	JJ	O	overall	dep	126	SENT_73	[p6l1091t425r1353b493],
70	and	CC	O	and	dep	126	SENT_73	[p6l1379t425r1492b480],
71	Gorham	NNP	O	Gorham	dep	126	SENT_73	[p6l1517t425r1776b480],
72	1962	CD	DATE	1962	dep	126	SENT_73	[p6l1808t425r1982b493],
73	)	CD	NUMBER	)	dep	126	SENT_73	[p6l1808t425r1982b493],
74	over	IN	O	over	dep	126	SENT_73	[p6l2010t442r2150b480],
75	at	IN	DURATION	at	dep	126	SENT_73	[p6l9t514r64b561],
76	least	JJS	DURATION	least	dep	126	SENT_73	[p6l86t506r232b561],
77	2	CD	DURATION	2	dep	126	SENT_73	[p6l254t506r290b560],
78	months	NNS	NUMBER	month	dep	126	SENT_73	[p6l314t505r563b571],
79	,	,	O	,	_	0	SENT_73	[p6l314t505r563b571],
80	with	IN	O	with	dep	126	SENT_73	[p6l590t505r730b561],
81	no	DT	O	no	dep	126	SENT_73	[p6l752t523r829b561],
82	single	JJ	O	single	dep	126	SENT_73	[p6l855t505r1041b577],
83	item	NN	O	item	dep	126	SENT_73	[p6l1064t505r1205b561],
84	increase	NN	O	increase	dep	126	SENT_73	[p6l1227t505r1486b561],
85	by	IN	O	by	dep	126	SENT_73	[p6l1509t505r1587b577],
86	more	JJR	O	more	dep	126	SENT_73	[p6l1610t523r1771b561],
87	than	IN	O	than	dep	126	SENT_73	[p6l1794t505r1930b561],
88	one	CD	NUMBER	one	dep	126	SENT_73	[p6l1954t523r2065b561],
89	in	IN	O	in	dep	126	SENT_73	[p6l2089t505r2149b560],
90	any	DT	O	any	dep	126	SENT_73	[p6l9t604r120b658],
91	consecutive	JJ	O	consecutive	dep	126	SENT_73	[p6l153t586r527b642],
92	ratings	NNS	O	rating	dep	126	SENT_73	[p6l559t586r795b658],
93	;	:	O	;	_	0	SENT_73	[p6l559t586r795b658],
94	(	CD	NUMBER	(	dep	126	SENT_73	[p6l833t586r919b655],
95	b	NN	O	b	dep	126	SENT_73	[p6l833t586r919b655],
96	)	NN	O	)	dep	126	SENT_73	[p6l833t586r919b655],
97	living	NN	O	living	dep	126	SENT_73	[p6l953t586r1137b658],
98	in	IN	O	in	dep	126	SENT_73	[p6l1170t586r1230b641],
99	a	DT	O	a	dep	126	SENT_73	[p6l1264t604r1296b642],
100	stable	JJ	O	stable	dep	126	SENT_73	[p6l1330t586r1511b642],
101	community	NN	O	community	dep	126	SENT_73	[p6l1544t586r1905b658],
102	setting	VBG	O	set	dep	126	SENT_73	[p6l1940t586r2148b658],
103	for	IN	O	for	dep	126	SENT_73	[p6l8t667r100b722],
104	2	CD	DURATION	2	dep	126	SENT_73	[p6l137t668r173b722],
105	months	NNS	NUMBER	month	dep	126	SENT_73	[p6l211t667r463b733],
106	;	:	O	;	_	0	SENT_73	[p6l211t667r463b733],
107	and	CC	O	and	dep	126	SENT_73	[p6l505t667r617b722],
108	(	NN	O	(	dep	126	SENT_73	[p6l657t668r738b736],
109	c	NN	O	c	dep	126	SENT_73	[p6l657t668r738b736],
110	)	CD	NUMBER	)	dep	126	SENT_73	[p6l657t668r738b736],
111	no	DT	O	no	dep	126	SENT_73	[p6l778t685r854b722],
112	change	NN	O	change	dep	126	SENT_73	[p6l894t667r1116b739],
113	in	IN	O	in	dep	126	SENT_73	[p6l1155t667r1214b722],
114	the	DT	O	the	dep	126	SENT_73	[p6l1252t667r1347b722],
115	dose	NN	O	dose	dep	126	SENT_73	[p6l1386t667r1528b722],
116	of	IN	O	of	dep	126	SENT_73	[p6l1567t667r1636b722],
117	ZD	NN	O	zd	dep	126	SENT_73	[p6l1667t669r1770b722],
118	during	IN	O	during	dep	126	SENT_73	[p6l1810t667r2015b739],
119	the	DT	DURATION	the	dep	126	SENT_73	[p6l2053t667r2148b722],
120	4	CD	DURATION	4	dep	126	SENT_73	[p6l7t749r44b803],
121	months	NNS	NUMBER	month	dep	126	SENT_73	[p6l69t749r300b804],
122	before	IN	O	before	dep	126	SENT_73	[p6l326t749r529b804],
123	admission	NN	O	admission	dep	126	SENT_73	[p6l555t749r876b804],
124	to	TO	O	to	dep	126	SENT_73	[p6l900t757r959b804],
125	the	DT	O	the	dep	126	SENT_73	[p6l985t749r1080b804],
126	study	NN	O	study	_	0	SENT_73	[p6l1107t749r1287b821],
127	.	.	O	.	_	0	SENT_73	[p6l1107t749r1287b821],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_74	[p6l1315t749r1633b804],
2	criteria	NNS	O	criterion	nsubj	3	SENT_74	[p6l1658t749r1884b804],
3	were	VBD	O	be	_	0	SENT_74	[p6l1907t766r2059b804],
4	as	IN	O	as	dep	5	SENT_74	[p6l2086t766r2147b804],
5	follows	VBZ	O	follow	advcl	3	SENT_74	[p6l8t829r262b885],
6	:	:	O	:	_	0	SENT_74	[p6l8t829r262b885],
7	total	JJ	O	total	amod	8	SENT_74	[p6l293t829r433b885],
8	duration	NN	O	duration	dobj	5	SENT_74	[p6l459t829r723b885],
9	of	IN	O	of	_	0	SENT_74	[p6l750t829r818b885],
10	the	DT	O	the	det	11	SENT_74	[p6l838t829r933b885],
11	illness	NN	O	illness	prep_of	8	SENT_74	[p6l959t829r1159b885],
12	less	RBR	DURATION	less	advmod	13	SENT_74	[p6l1187t829r1303b885],
13	than	IN	DURATION	than	quantmod	14	SENT_74	[p6l1330t829r1466b885],
14	1	CD	DURATION	1	num	11	SENT_74	[p6l1499t830r1521b884],
15	year	NN	NUMBER	year	nn	20	SENT_74	[p6l1553t847r1703b901],
16	,	,	O	,	_	0	SENT_74	[p6l1553t847r1703b901],
17	drug	NN	O	drug	conj_or	15	SENT_74	[p6l1733t830r1875b901],
18	or	CC	O	or	_	0	SENT_74	[p6l1903t847r1967b885],
19	alcohol	NN	O	alcohol	conj_or	15	SENT_74	[p6l1993t829r2146b885, p6l7t910r107b966],
20	abuse	NN	O	abuse	nsubj	5	SENT_74	[p6l132t910r328b976],
21	,	,	O	,	_	0	SENT_74	[p6l132t910r328b976],
22	pregnancy	NN	O	pregnancy	nn	24	SENT_74	[p6l353t928r685b982],
23	and/or	JJ	O	and/or	amod	24	SENT_74	[p6l710t910r912b966],
24	breast	NN	O	breast	appos	20	SENT_74	[p6l933t910r1124b966],
25	feeding	NN	O	feeding	nn	29	SENT_74	[p6l1147t910r1402b982],
26	,	,	O	,	_	0	SENT_74	[p6l1147t910r1402b982],
27	serious	JJ	O	serious	amod	29	SENT_74	[p6l1431t910r1651b966],
28	somatic	JJ	O	somatic	amod	29	SENT_74	[p6l1679t910r1921b966],
29	illness	NN	O	illness	nn	34	SENT_74	[p6l1946t910r2147b966],
30	and	CC	O	and	_	0	SENT_74	[p6l9t991r121b1046],
31	known	JJ	O	known	nn	34	SENT_74	[p6l143t991r359b1046],
32	organic	JJ	O	organic	amod	34	SENT_74	[p6l384t991r617b1063],
33	brain	NN	O	brain	nn	34	SENT_74	[p6l641t991r805b1046],
34	disease	NN	O	disease	dep	24	SENT_74	[p6l829t991r1073b1046],
35	.	.	O	.	_	0	SENT_74	[p6l829t991r1073b1046],

1	Fifty	CD	NUMBER	fifty	num	2	SENT_75	[p6l1100t991r1400b1063],
2	—	CD	NUMBER	—	nsubj	5	SENT_75	[p6l1100t991r1400b1063],
3	two	CD	NUMBER	two	num	4	SENT_75	[p6l1100t991r1400b1063],
4	patients	NNS	O	patient	dep	2	SENT_75	[p6l1424t991r1669b1063],
5	matched	VBD	O	match	_	0	SENT_75	[p6l1695t991r1963b1046],
6	these	DT	O	these	det	7	SENT_75	[p6l1986t991r2148b1046],
7	criteria	NNS	O	criterion	dobj	5	SENT_75	[p6l8t1073r248b1128],
8	.	.	O	.	_	0	SENT_75	[p6l8t1073r248b1128],

1	Fifteen	CD	NUMBER	fifteen	num	2	SENT_76	[p6l277t1073r502b1128],
2	subjects	NNS	O	subject	nsubj	4	SENT_76	[p6l529t1073r780b1145],
3	were	VBD	O	be	cop	4	SENT_76	[p6l807t1091r959b1128],
4	smokers	NNS	O	smoker	ccomp	20	SENT_76	[p6l987t1073r1265b1138],
5	,	,	O	,	_	0	SENT_76	[p6l987t1073r1265b1138],
6	those	DT	O	those	det	7	SENT_76	[p6l1293t1073r1459b1128],
7	smoking	NN	O	smoking	nsubj	20	SENT_76	[p6l1487t1073r1756b1145],
8	steadily	RB	O	steadily	advmod	20	SENT_76	[p6l1785t1073r2028b1145],
9	ten	CD	NUMBER	ten	num	12	SENT_76	[p6l2053t1081r2149b1128],
10	or	CC	O	or	_	0	SENT_76	[p6l8t1171r73b1209],
11	more	JJR	O	more	num	12	SENT_76	[p6l93t1171r254b1209],
12	cigarettes	NNS	O	cigarette	nsubj	20	SENT_76	[p6l277t1154r576b1226],
13	per	IN	O	per	_	0	SENT_76	[p6l599t1171r700b1226],
14	day	NN	DURATION	day	prep_per	12	SENT_76	[p6l722t1154r833b1225],
15	and	CC	O	and	_	0	SENT_76	[p6l858t1154r969b1209],
16	the	DT	O	the	prep_per	12	SENT_76	[p6l991t1154r1085b1209],
17	remaining	VBG	O	remain	partmod	14	SENT_76	[p6l1106t1154r1425b1226],
18	37	CD	NUMBER	37	dobj	17	SENT_76	[p6l1451t1154r1523b1209],
19	were	VBD	O	be	cop	20	SENT_76	[p6l1548t1171r1699b1209],
20	non-smokers	NNS	O	non-smoker	_	0	SENT_76	[p6l1722t1154r2145b1209],
21	.	.	O	.	_	0	SENT_76	[p6l1722t1154r2145b1209],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_77	[p6l7t1234r439b1306],
2	data	NNS	O	datum	nsubjpass	8	SENT_77	[p6l491t1234r622b1290],
3	of	IN	O	of	_	0	SENT_77	[p6l673t1234r741b1290],
4	the	DT	O	the	det	6	SENT_77	[p6l786t1234r881b1290],
5	patient	NN	O	patient	nn	6	SENT_77	[p6l931t1234r1149b1306],
6	population	NN	O	population	prep_of	2	SENT_77	[p6l1197t1234r1538b1306],
7	are	VBP	O	be	auxpass	8	SENT_77	[p6l1590t1252r1683b1290],
8	presented	VBN	O	present	_	0	SENT_77	[p6l1733t1234r2039b1306],
9	in	IN	O	in	_	0	SENT_77	[p6l2089t1234r2149b1289],
10	Table	NNP	O	Table	prep_in	8	SENT_77	[p6l8t1314r181b1369],
11	1	CD	NUMBER	1	num	10	SENT_77	[p6l212t1315r258b1369],
12	.	.	O	.	_	0	SENT_77	[p6l212t1315r258b1369],

1	No	DT	O	no	det	2	SENT_78	[p6l119t1397r214b1451],
2	attempts	NNS	O	attempt	nsubjpass	4	SENT_78	[p6l264t1404r529b1468],
3	were	VBD	O	be	auxpass	4	SENT_78	[p6l579t1414r731b1451],
4	made	VBN	O	make	_	0	SENT_78	[p6l779t1396r949b1451],
5	to	TO	O	to	aux	6	SENT_78	[p6l997t1404r1056b1451],
6	change	VB	O	change	xcomp	4	SENT_78	[p6l1105t1396r1328b1468],
7	antipsychotic	JJ	O	antipsychotic	amod	12	SENT_78	[p6l1378t1396r1800b1468],
8	treatment	NN	O	treatment	nn	12	SENT_78	[p6l1849t1404r2150b1451],
9	regimen	NN	O	regimen	nn	12	SENT_78	[p6l6t1477r268b1549],
10	(	CD	NUMBER	(	num	12	SENT_78	[p6l294t1477r420b1545],
11	ZD	NN	O	zd	nn	12	SENT_78	[p6l294t1477r420b1545],
12	dosage	NN	O	dosage	dobj	6	SENT_78	[p6l447t1477r665b1549],
13	and	CC	O	and	_	0	SENT_78	[p6l691t1477r803b1532],
14	the	DT	O	the	det	15	SENT_78	[p6l827t1477r922b1532],
15	length	NN	O	length	conj_and	12	SENT_78	[p6l946t1477r1144b1549],
16	of	IN	O	of	_	0	SENT_78	[p6l1169t1477r1237b1532],
17	the	DT	O	the	det	20	SENT_78	[p6l1256t1477r1351b1532],
18	injection	NN	O	injection	nn	20	SENT_78	[p6l1375t1477r1654b1549],
19	interval	NN	O	interval	nn	20	SENT_78	[p6l1678t1477r1963b1545],
20	)	NN	O	)	prep_of	15	SENT_78	[p6l1678t1477r1963b1545],
21	.	.	O	.	_	0	SENT_78	[p6l1678t1477r1963b1545],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_79	[p6l1992t1477r2146b1532, p6l8t1557r286b1613],
2	treatment	NN	O	treatment	nsubjpass	11	SENT_79	[p6l320t1566r621b1613],
3	with	IN	O	with	_	0	SENT_79	[p6l656t1557r796b1613],
4	benzodiazepines	NNS	O	benzodiazepine	prep_with	2	SENT_79	[p6l830t1557r1356b1629],
5	and	CC	O	and	_	0	SENT_79	[p6l1394t1557r1506b1613],
6	the	DT	O	the	det	9	SENT_79	[p6l1541t1557r1636b1613],
7	anticholinergic	JJ	O	anticholinergic	amod	9	SENT_79	[p6l1674t1557r2147b1629],
8	drug	NN	O	drug	nn	9	SENT_79	[p6l8t1638r151b1710],
9	trihexyphenidyl	NN	O	trihexyphenidyl	conj_and	4	SENT_79	[p6l183t1638r687b1710],
10	was	VBD	O	be	auxpass	11	SENT_79	[p6l719t1656r839b1694],
11	allowed	VBN	O	allow	_	0	SENT_79	[p6l874t1638r1124b1694],
12	according	VBG	O	accord	_	0	SENT_79	[p6l1157t1638r1467b1710],
13	to	TO	O	to	prepc_according_to	11	SENT_79	[p6l1499t1647r1558b1694],
14	the	DT	O	the	det	15	SENT_79	[p6l1591t1638r1686b1694],
15	judgement	NN	O	judgement	pobj	11	SENT_79	[p6l1711t1638r2054b1710],
16	of	IN	O	of	_	0	SENT_79	[p6l2085t1638r2154b1694],
17	the	DT	O	the	det	18	SENT_79	[p6l7t1719r102b1774],
18	psychiatrist	NN	O	psychiatrist	prep_of	15	SENT_79	[p6l144t1719r513b1791],
19	currently	RB	DATE	currently	advmod	20	SENT_79	[p6l554t1719r840b1791],
20	responsible	JJ	O	responsible	amod	18	SENT_79	[p6l881t1719r1244b1791],
21	for	IN	O	for	_	0	SENT_79	[p6l1287t1719r1379b1774],
22	the	DT	O	the	det	23	SENT_79	[p6l1419t1719r1514b1774],
23	treatment	NN	O	treatment	prep_for	18	SENT_79	[p6l1557t1727r1858b1774],
24	of	IN	O	of	_	0	SENT_79	[p6l1900t1719r1968b1774],
25	each	DT	O	each	det	26	SENT_79	[p6l2005t1719r2149b1774],
26	patient	NN	O	patient	prep_of	23	SENT_79	[p6l6t1801r239b1873],
27	.	.	O	.	_	0	SENT_79	[p6l6t1801r239b1873],

1	Twenty-five	CD	NUMBER	twenty-five	nsubj	5	SENT_80	[p6l275t1801r662b1873],
2	of	IN	O	of	_	0	SENT_80	[p6l696t1801r765b1856],
3	the	DT	O	the	det	4	SENT_80	[p6l792t1801r887b1856],
4	patients	NNS	O	patient	prep_of	1	SENT_80	[p6l918t1801r1164b1873],
5	received	VBD	O	receive	_	0	SENT_80	[p6l1197t1801r1467b1856],
6	trihexyphenidyl	NN	O	trihexyphenidyl	nsubj	9	SENT_80	[p6l1499t1801r2003b1873],
7	and	CC	O	and	_	0	SENT_80	[p6l2038t1801r2149b1856],
8	ten	CD	NUMBER	ten	nsubj	9	SENT_80	[p6l7t1890r103b1937],
9	received	VBD	O	receive	ccomp	5	SENT_80	[p6l125t1881r395b1937],
10	benzodiazepines	NNS	O	benzodiazepine	dobj	9	SENT_80	[p6l416t1881r941b1953],
11	during	IN	O	during	_	0	SENT_80	[p6l967t1881r1171b1953],
12	the	DT	O	the	det	14	SENT_80	[p6l1195t1882r1290b1937],
13	study	NN	O	study	nn	14	SENT_80	[p6l1316t1881r1483b1953],
14	period	NN	O	period	prep_during	9	SENT_80	[p6l1505t1881r1725b1953],
15	.	.	O	.	_	0	SENT_80	[p6l1505t1881r1725b1953],

1	Clinical	JJ	O	clinical	amod	2	SENT_81	[p6l121t1962r370b2018],
2	condition	NN	O	condition	nsubjpass	4	SENT_81	[p6l417t1962r716b2018],
3	was	VBD	O	be	auxpass	4	SENT_81	[p6l762t1980r882b2018],
4	assessed	VBN	O	assess	_	0	SENT_81	[p6l931t1962r1198b2018],
5	using	VBG	O	use	conj_and	5	SENT_81	[p6l1243t1962r1413b2034],
6	different	JJ	O	different	amod	7	SENT_81	[p6l1461t1962r1733b2018],
7	instruments	NNS	O	instrument	dobj	5	SENT_81	[p6l1777t1962r2147b2018],
8	twice	RB	O	twice	advmod	5	SENT_81	[p6l7t2043r178b2098],
9	during	IN	O	during	_	0	SENT_81	[p6l217t2043r422b2115],
10	the	DT	O	the	det	11	SENT_81	[p6l460t2043r555b2098],
11	study	NN	O	study	prep_during	5	SENT_81	[p6l596t2043r776b2115],
12	,	,	O	,	_	0	SENT_81	[p6l596t2043r776b2115],
13	at	IN	O	at	_	0	SENT_81	[p6l818t2052r873b2098],
14	week	NN	DURATION	week	nn	15	SENT_81	[p6l910t2043r1077b2098],
15	o	NN	O	o	prep_at	5	SENT_81	[p6l1114t2043r1150b2099],
16	(	CD	NUMBER	(	num	17	SENT_81	[p6l1191t2044r1377b2115],
17	entry	NN	O	entry	dep	15	SENT_81	[p6l1191t2044r1377b2115],
18	into	IN	O	into	_	0	SENT_81	[p6l1414t2043r1536b2098],
19	the	DT	O	the	det	21	SENT_81	[p6l1574t2043r1669b2098],
20	study	NN	O	study	nn	21	SENT_81	[p6l1710t2043r1903b2115],
21	)	NN	O	)	prep_into	17	SENT_81	[p6l1710t2043r1903b2115],
22	and	CC	O	and	_	0	SENT_81	[p6l1944t2043r2056b2098],
23	at	IN	O	at	_	0	SENT_81	[p6l2095t2051r2150b2098],
24	week	NN	DURATION	week	prep_at	5	SENT_81	[p6l7t2124r170b2180],
25	8	CD	NUMBER	8	num	24	SENT_81	[p6l194t2125r243b2180],
26	.	.	O	.	_	0	SENT_81	[p6l194t2125r243b2180],

1	Rating	NNP	O	Rating	nn	2	SENT_82	[p6l269t2124r471b2196],
2	instruments	NNS	O	instrument	nsubj	5	SENT_82	[p6l494t2124r849b2179],
3	were	VBD	O	be	cop	5	SENT_82	[p6l873t2142r1020b2179],
4	—	CD	NUMBER	—	num	5	SENT_82	[p6l1042t2158r1082b2163],
5	BPRS	NNS	O	bpr	_	0	SENT_82	[p6l1102t2125r1287b2180],
6	18	CD	NUMBER	18	number	7	SENT_82	[p6l1320t2124r1551b2180],
7	—	CD	NUMBER	—	num	8	SENT_82	[p6l1320t2124r1551b2180],
8	item	NN	O	item	dep	5	SENT_82	[p6l1320t2124r1551b2180],
9	Version	NNP	O	Version	dep	55	SENT_82	[p6l1572t2124r1812b2190],
10	,	,	O	,	_	0	SENT_82	[p6l1572t2124r1812b2190],
11	Abnormal	JJ	O	abnormal	amod	16	SENT_82	[p6l1836t2124r2148b2179],
12	Involuntary	JJ	O	involuntary	amod	16	SENT_82	[p6l7t2206r373b2278],
13	Movement	NNP	O	Movement	nn	16	SENT_82	[p6l410t2207r753b2261],
14	Scale	NNP	O	Scale	nn	16	SENT_82	[p6l791t2206r958b2261],
15	(	CD	NUMBER	(	num	16	SENT_82	[p6l998t2206r1234b2274],
16	AIMS	NNS	O	aim	dep	55	SENT_82	[p6l998t2206r1234b2274],
17	,	,	O	,	_	0	SENT_82	[p6l998t2206r1234b2274],
18	US	NNP	ORGANIZATION	US	nn	19	SENT_82	[p6l1274t2206r1369b2261],
19	Department	NNP	ORGANIZATION	Department	conj_and	9	SENT_82	[p6l1410t2207r1783b2278],
20	of	IN	ORGANIZATION	of	_	0	SENT_82	[p6l1819t2206r1887b2261],
21	Health	NNP	ORGANIZATION	Health	prep_of	19	SENT_82	[p6l1920t2206r2145b2271],
22	,	,	ORGANIZATION	,	_	0	SENT_82	[p6l1920t2206r2145b2271],
23	Education	NNP	ORGANIZATION	Education	prep_of	19	SENT_82	[p6l6t2287r326b2342],
24	and	CC	O	and	_	0	SENT_82	[p6l355t2287r466b2342],
25	Welfare	NNP	O	Welfare	prep_of	19	SENT_82	[p6l493t2287r740b2342],
26	1976	CD	DATE	1976	num	27	SENT_82	[p6l776t2287r948b2355],
27	)	CD	NUMBER	)	dep	19	SENT_82	[p6l776t2287r948b2355],
28	and	CC	O	and	_	0	SENT_82	[p6l981t2287r1092b2342],
29	Research	NNP	O	Research	nn	30	SENT_82	[p6l1119t2287r1408b2342],
30	Diagnoses	NNPS	O	Diagnoses	conj_and	9	SENT_82	[p6l1435t2287r1761b2359],
31	for	IN	O	for	_	0	SENT_82	[p6l1791t2287r1883b2342],
32	Tardive	NNP	O	Tardive	nn	35	SENT_82	[p6l1909t2287r2148b2342],
33	Dyskinesia	NNP	O	Dyskinesia	nn	35	SENT_82	[p6l7t2367r358b2439],
34	(	NNP	O	(	nn	35	SENT_82	[p6l384t2367r689b2436],
35	Schooler	NNP	O	Schooler	prep_for	30	SENT_82	[p6l384t2367r689b2436],
36	and	CC	O	and	_	0	SENT_82	[p6l714t2367r825b2423],
37	Kane	NNP	PERSON	Kane	conj_and	9	SENT_82	[p6l851t2369r1014b2423],
38	1982	CD	DATE	1982	num	37	SENT_82	[p6l1048t2368r1239b2436],
39	)	CD	NUMBER	)	dep	37	SENT_82	[p6l1048t2368r1239b2436],
40	,	,	O	,	_	0	SENT_82	[p6l1048t2368r1239b2436],
41	subscale	NN	O	subscale	appos	39	SENT_82	[p6l1270t2367r1533b2423],
42	II	CD	NUMBER	ii	num	41	SENT_82	[p6l1559t2369r1610b2422],
43	from	IN	O	from	_	0	SENT_82	[p6l1635t2367r1787b2423],
44	EXtrapyra	NNP	O	EXtrapyra	prep_from	41	SENT_82	[p6l1811t2369r2146b2439],
45	—	CD	NUMBER	—	num	44	SENT_82	[p6l1811t2369r2146b2439],
46	midal	JJ	O	midal	amod	51	SENT_82	[p6l7t2448r185b2503],
47	Symptoms	NNS	O	symptom	nn	51	SENT_82	[p6l231t2449r563b2520],
48	Rating	NNP	O	Rating	nn	51	SENT_82	[p6l609t2448r817b2520],
49	Scale	NNP	O	Scale	nn	51	SENT_82	[p6l864t2448r1031b2504],
50	(	CD	NUMBER	(	num	51	SENT_82	[p6l1078t2448r1305b2517],
51	ESRS	NNP	O	ESRS	dep	41	SENT_82	[p6l1078t2448r1305b2517],
52	,	,	O	,	_	0	SENT_82	[p6l1078t2448r1305b2517],
53	Chouinard	NNP	PERSON	Chouinard	dep	55	SENT_82	[p6l1353t2448r1685b2504],
54	et	FW	O	et	nn	55	SENT_82	[p6l1729t2456r1784b2503],
55	al.	FW	O	al.	dep	5	SENT_82	[p6l1829t2448r1898b2503],
56	1980	CD	DATE	1980	num	57	SENT_82	[p6l1953t2448r2144b2516],
57	)	CD	NUMBER	)	dep	55	SENT_82	[p6l1953t2448r2144b2516],
58	.	.	O	.	_	0	SENT_82	[p6l1953t2448r2144b2516],

1	AIMS	NNS	O	aim	nsubjpass	3	SENT_83	[p6l7t2530r199b2585],
2	was	VBD	O	be	auxpass	3	SENT_83	[p6l238t2548r357b2585],
3	used	VBN	O	use	_	0	SENT_83	[p6l394t2530r538b2585],
4	for	IN	O	for	_	0	SENT_83	[p6l573t2530r665b2585],
5	assessment	NN	O	assessment	prep_for	3	SENT_83	[p6l700t2538r1050b2585],
6	of	IN	O	of	_	0	SENT_83	[p6l1085t2530r1153b2585],
7	the	DT	O	the	det	8	SENT_83	[p6l1183t2530r1277b2585],
8	presence	NN	O	presence	prep_of	5	SENT_83	[p6l1313t2547r1588b2602],
9	of	IN	O	of	_	0	SENT_83	[p6l1625t2530r1693b2585],
10	TD	NN	O	td	prep_of	8	SENT_83	[p6l1723t2531r1842b2585],
11	.	.	O	.	_	0	SENT_83	[p6l1723t2531r1842b2585],

1	Subjects	NNS	O	subject	nsubjpass	11	SENT_84	[p6l1884t2530r2146b2602],
2	with	IN	O	with	_	0	SENT_84	[p6l7t2611r146b2666],
3	an	DT	O	a	det	5	SENT_84	[p6l186t2628r257b2666],
4	AIMS	NNS	O	aim	nn	5	SENT_84	[p6l296t2611r488b2666],
5	score	NN	NUMBER	score	prep_with	1	SENT_84	[p6l534t2628r695b2666],
6	of	IN	O	of	_	0	SENT_84	[p6l736t2611r804b2666],
7	at	IN	O	at	quantmod	9	SENT_84	[p6l840t2619r894b2666],
8	least	JJS	O	least	mwe	7	SENT_84	[p6l932t2611r1076b2666],
9	4	CD	NUMBER	4	prep_of	5	SENT_84	[p6l1114t2611r1151b2665],
10	were	VBD	O	be	auxpass	11	SENT_84	[p6l1191t2628r1342b2666],
11	considered	VBN	O	consider	_	0	SENT_84	[p6l1383t2611r1723b2666],
12	as	IN	O	as	_	0	SENT_84	[p6l1763t2628r1823b2666],
13	currently	RB	DATE	currently	advmod	14	SENT_84	[p6l1865t2611r2148b2683],
14	suffering	VBG	O	suffer	prepc_as	11	SENT_84	[p6l9t2691r288b2763],
15	from	IN	O	from	_	0	SENT_84	[p6l337t2691r490b2747],
16	a	DT	O	a	det	17	SENT_84	[p6l539t2709r572b2747],
17	movement	NN	O	movement	prep_from	14	SENT_84	[p6l619t2700r951b2747],
18	disorder	NN	O	disorder	nn	20	SENT_84	[p6l1000t2691r1257b2747],
19	(	CD	NUMBER	(	num	20	SENT_84	[p6l1307t2692r1670b2763],
20	Armstrong	NNP	PERSON	Armstrong	dep	17	SENT_84	[p6l1307t2692r1670b2763],
21	et	FW	O	et	nn	22	SENT_84	[p6l1720t2700r1776b2747],
22	al.	FW	O	al.	dep	20	SENT_84	[p6l1825t2691r1893b2747],
23	1997	CD	DATE	1997	num	24	SENT_84	[p6l1953t2692r2144b2760],
24	)	CD	NUMBER	)	dobj	14	SENT_84	[p6l1953t2692r2144b2760],
25	.	.	O	.	_	0	SENT_84	[p6l1953t2692r2144b2760],

1	Research	NNP	O	Research	nn	2	SENT_85	[p6l7t2772r295b2828],
2	Diagnoses	NNPS	O	Diagnoses	nsubjpass	7	SENT_85	[p6l317t2772r643b2844],
3	for	IN	O	for	_	0	SENT_85	[p6l667t2772r759b2828],
4	Tardive	NNP	O	Tardive	nn	5	SENT_85	[p6l780t2772r1018b2828],
5	Dyskinesia	NNP	O	Dyskinesia	prep_for	2	SENT_85	[p6l1041t2772r1392b2844],
6	was	VBD	O	be	auxpass	7	SENT_85	[p6l1413t2790r1532b2828],
7	used	VBN	O	use	_	0	SENT_85	[p6l1556t2772r1700b2828],
8	for	IN	O	for	_	0	SENT_85	[p6l1722t2772r1814b2828],
9	the	DT	O	the	det	10	SENT_85	[p6l1835t2772r1929b2828],
10	evaluation	NN	O	evaluation	prep_for	7	SENT_85	[p6l1953t2772r2146b2828, p6l8t2853r163b2908],
11	of	IN	O	of	_	0	SENT_85	[p6l189t2853r257b2908],
12	the	DT	O	the	det	13	SENT_85	[p6l276t2853r370b2908],
13	presence	NN	O	presence	prep_of	10	SENT_85	[p6l395t2871r670b2925],
14	of	IN	O	of	_	0	SENT_85	[p6l697t2853r765b2908],
15	persistent	JJ	O	persistent	amod	16	SENT_85	[p6l784t2853r1087b2925],
16	TD	NN	O	td	prep_of	13	SENT_85	[p6l1111t2854r1230b2908],
17	.	.	O	.	_	0	SENT_85	[p6l1111t2854r1230b2908],

1	Subscale	NNP	O	Subscale	nn	2	SENT_86	[p6l1261t2853r1537b2909],
2	II	NNP	O	II	nsubjpass	6	SENT_86	[p6l1563t2855r1613b2908],
3	from	IN	O	from	_	0	SENT_86	[p6l1639t2853r1791b2908],
4	ESRS	NNP	ORGANIZATION	ESRS	prep_from	2	SENT_86	[p6l1815t2853r1998b2909],
5	was	VBD	O	be	auxpass	6	SENT_86	[p6l2027t2871r2146b2908],
6	used	VBN	O	use	_	0	SENT_86	[p6l6t2935r151b2990],
7	for	IN	O	for	_	0	SENT_86	[p6l197t2935r289b2990],
8	detection	NN	O	detection	prep_for	6	SENT_86	[p6l335t2935r623b2990],
9	of	IN	O	of	_	0	SENT_86	[p6l671t2935r739b2990],
10	parkinsonian	JJ	O	parkinsonian	amod	11	SENT_86	[p6l780t2935r1188b3007],
11	features	NNS	O	feature	prep_of	8	SENT_86	[p6l1235t2935r1499b2990],
12	.	.	O	.	_	0	SENT_86	[p6l1235t2935r1499b2990],

1	Parkinsonism	NNP	O	Parkinsonism	nsubjpass	3	SENT_87	[p6l1551t2935r1981b2990],
2	was	VBD	O	be	auxpass	3	SENT_87	[p6l2027t2952r2146b2990],
3	diagnosed	VBN	O	diagnose	_	0	SENT_87	[p6l8t3015r326b3087],
4	in	IN	O	in	_	0	SENT_87	[p6l352t3015r411b3070],
5	patients	NNS	O	patient	prep_in	3	SENT_87	[p6l436t3015r680b3087],
6	with	IN	O	with	_	0	SENT_87	[p6l708t3015r847b3071],
7	a	DT	O	a	det	9	SENT_87	[p6l874t3033r907b3071],
8	total	JJ	O	total	amod	9	SENT_87	[p6l932t3015r1071b3071],
9	score	NN	NUMBER	score	prep_with	5	SENT_87	[p6l1100t3033r1262b3071],
10	of	IN	O	of	_	0	SENT_87	[p6l1289t3015r1358b3071],
11	more	JJR	O	more	mwe	12	SENT_87	[p6l1378t3033r1538b3071],
12	than	IN	O	than	quantmod	13	SENT_87	[p6l1565t3016r1700b3071],
13	3	CD	NUMBER	3	prep_of	9	SENT_87	[p6l1728t3016r1779b3071],
14	.	.	O	.	_	0	SENT_87	[p6l1728t3016r1779b3071],

1	All	DT	O	all	det	2	SENT_88	[p6l1809t3015r1908b3070],
2	ratings	NNS	O	rating	nsubjpass	4	SENT_88	[p6l1933t3015r2146b3087],
3	were	VBD	O	be	auxpass	4	SENT_88	[p6l7t3114r158b3152],
4	performed	VBN	O	perform	dep	8	SENT_88	[p6l190t3096r519b3168],
5	by	IN	O	by	_	0	SENT_88	[p6l550t3096r628b3168],
6	experienced	JJ	O	experienced	amod	7	SENT_88	[p6l662t3096r1042b3168],
7	psychiatrists	NNS	O	psychiatrist	agent	4	SENT_88	[p6l1073t3096r1465b3168],
8	(	VBP	O	(	_	0	SENT_88	[p6l1503t3097r1724b3165],
9	Peeter	NNP	PERSON	Peeter	nn	11	SENT_88	[p6l1503t3097r1724b3165],
10	J	NNP	PERSON	J	nn	11	SENT_88	[p6l1754t3098r1784b3152],
11	aanson	NN	PERSON	aanson	dobj	8	SENT_88	[p6l1787t3114r2003b3152],
12	and	CC	O	and	_	0	SENT_88	[p6l2038t3096r2149b3152],
13	Siiri	NNP	O	Siiri	nn	14	SENT_88	[p6l9t3177r140b3233],
14	Véian	NNP	O	Véian	conj_and	11	SENT_88	[p6l167t3178r356b3246],
15	)	NN	O	)	nsubj	8	SENT_88	[p6l167t3178r356b3246],
16	who	WP	O	who	nsubj	18	SENT_88	[p6l385t3177r518b3233],
17	were	VBD	O	be	cop	18	SENT_88	[p6l546t3195r696b3232],
18	unaware	JJ	O	unaware	rcmod	15	SENT_88	[p6l723t3195r989b3232],
19	either	DT	O	either	dep	18	SENT_88	[p6l1017t3177r1195b3232],
20	of	IN	O	of	_	0	SENT_88	[p6l1221t3177r1289b3232],
21	the	DT	O	the	det	22	SENT_88	[p6l1310t3177r1404b3232],
22	dose	NN	O	dose	prep_of	18	SENT_88	[p6l1432t3177r1574b3232],
23	of	IN	O	of	_	0	SENT_88	[p6l1601t3177r1670b3232],
24	ZD	NN	O	zd	prep_of	22	SENT_88	[p6l1690t3179r1792b3232],
25	prescribed	VBN	O	prescribe	partmod	24	SENT_88	[p6l1820t3177r2149b3249],
26	or	CC	O	or	_	0	SENT_88	[p6l8t3276r72b3314],
27	the	DT	O	the	det	28	SENT_88	[p6l96t3259r190b3314],
28	genotype	NN	O	genotype	conj_or	15	SENT_88	[p6l217t3267r504b3331],
29	and	CC	O	and	_	0	SENT_88	[p6l531t3259r642b3314],
30	plasma	NN	O	plasma	nn	32	SENT_88	[p6l666t3259r890b3331],
31	zuclopenthixol	NN	O	zuclopenthixol	nn	32	SENT_88	[p6l915t3259r1383b3331],
32	concentrations	NNS	O	concentration	conj_and	28	SENT_88	[p6l1409t3259r1883b3314],
33	.	.	O	.	_	0	SENT_88	[p6l1409t3259r1883b3314],

1	Several	JJ	O	several	amod	2	SENT_89	[p6l1915t3259r2148b3314],
2	ratings	NNS	O	rating	nsubjpass	4	SENT_89	[p6l6t3340r218b3412],
3	were	VBD	O	be	auxpass	4	SENT_89	[p6l242t3357r393b3395],
4	performed	VBN	O	perform	_	0	SENT_89	[p6l414t3340r744b3412],
5	beforehand	RB	O	beforehand	advmod	4	SENT_89	[p6l763t3340r1119b3395],
6	to	TO	O	to	aux	7	SENT_89	[p6l1140t3348r1199b3395],
7	gather	VB	O	gather	xcomp	4	SENT_89	[p6l1222t3340r1419b3412],
8	inter-rater	JJ	O	inter-rater	amod	9	SENT_89	[p6l1439t3340r1753b3395],
9	reliability	NN	O	reliability	dobj	7	SENT_89	[p6l1772t3340r2090b3411],
10	.	.	O	.	_	0	SENT_89	[p6l1772t3340r2090b3411],

1	Blood	NN	O	blood	nn	2	SENT_90	[p6l7t3557r200b3613],
2	sampling	NN	O	sampling	_	0	SENT_90	[p6l225t3557r512b3629],

1	Drug	NN	O	drug	nn	2	SENT_91	[p7l7t52r168b123],
2	monitoring	NN	O	monitoring	nsubjpass	4	SENT_91	[p7l192t51r544b123],
3	was	VBD	O	be	auxpass	4	SENT_91	[p7l568t69r688b107],
4	based	VBN	O	base	_	0	SENT_91	[p7l713t51r894b106],
5	on	IN	O	on	_	0	SENT_91	[p7l917t69r994b106],
6	the	DT	O	the	det	9	SENT_91	[p7l1017t51r1112b106],
7	minimum	JJ	O	minimum	amod	9	SENT_91	[p7l1136t51r1445b106],
8	plasma	NN	O	plasma	nn	9	SENT_91	[p7l1466t51r1693b123],
9	concentration	NN	O	concentration	prep_on	4	SENT_91	[p7l1715t51r2148b106],
10	during	IN	O	during	_	0	SENT_91	[p7l8t133r210b205],
11	the	DT	O	the	det	13	SENT_91	[p7l234t133r328b188],
12	administration	NN	O	administration	nn	13	SENT_91	[p7l352t133r806b188],
13	interval	NN	O	interval	prep_during	4	SENT_91	[p7l828t133r1083b188],
14	.	.	O	.	_	0	SENT_91	[p7l828t133r1083b188],

1	Blood	NN	O	blood	nn	2	SENT_92	[p7l1109t133r1302b188],
2	samples	NNS	O	sample	nsubjpass	10	SENT_92	[p7l1326t133r1574b205],
3	for	IN	O	for	_	0	SENT_92	[p7l1598t133r1690b188],
4	determination	NN	O	determination	prep_for	2	SENT_92	[p7l1712t133r2148b188],
5	of	IN	O	of	_	0	SENT_92	[p7l8t214r76b269],
6	zuclopenthixol	NN	O	zuclopenthixol	nn	8	SENT_92	[p7l113t214r586b286],
7	plasma	NN	O	plasma	nn	8	SENT_92	[p7l626t214r853b285],
8	levels	NNS	O	level	prep_of	4	SENT_92	[p7l893t214r1076b269],
9	were	VBD	O	be	auxpass	10	SENT_92	[p7l1120t231r1272b269],
10	obtained	VBN	O	obtain	_	0	SENT_92	[p7l1315t214r1588b269],
11	on	IN	O	on	_	0	SENT_92	[p7l1630t231r1707b269],
12	week	NN	DURATION	week	nn	13	SENT_92	[p7l1749t214r1916b269],
13	o	NN	O	o	prep_on	10	SENT_92	[p7l1957t214r1993b269],
14	and	CC	O	and	_	0	SENT_92	[p7l2037t214r2149b269],
15	week	NN	DURATION	week	prep_on	10	SENT_92	[p7l7t295r175b350],
16	8	CD	NUMBER	8	num	15	SENT_92	[p7l218t295r269b360],
17	,	,	O	,	_	0	SENT_92	[p7l218t295r269b360],
18	just	RB	O	just	advmod	10	SENT_92	[p7l307t294r428b366],
19	before	IN	O	before	_	0	SENT_92	[p7l468t294r670b350],
20	the	DT	O	the	det	22	SENT_92	[p7l712t295r807b350],
21	next	JJ	O	next	amod	22	SENT_92	[p7l849t303r986b350],
22	injection	NN	O	injection	prep_before	10	SENT_92	[p7l1026t294r1305b366],
23	of	IN	O	of	_	0	SENT_92	[p7l1347t294r1416b350],
24	ZD	NNP	O	ZD	prep_of	22	SENT_92	[p7l1451t296r1573b360],
25	,	,	O	,	_	0	SENT_92	[p7l1451t296r1573b360],
26	into	IN	O	into	_	0	SENT_92	[p7l1617t294r1739b350],
27	heparinised	JJ	O	heparinised	amod	29	SENT_92	[p7l1781t294r2149b366],
28	Vacutainer	NNP	O	Vacutainer	nn	29	SENT_92	[p7l7t375r339b431],
29	tubes	NNS	O	tube	prep_into	10	SENT_92	[p7l369t375r552b431],
30	.	.	O	.	_	0	SENT_92	[p7l369t375r552b431],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_93	[p7l590t375r854b447],
2	were	VBD	O	be	auxpass	3	SENT_93	[p7l888t393r1040b431],
3	centrifuged	VBN	O	centrifuge	_	0	SENT_93	[p7l1073t375r1435b447],
4	for	IN	O	for	_	0	SENT_93	[p7l1467t375r1559b431],
5	10	CD	DURATION	10	num	6	SENT_93	[p7l1597t376r1666b431],
6	min	NN	DURATION	min	prep_for	3	SENT_93	[p7l1698t375r1820b430],
7	at	IN	O	at	_	0	SENT_93	[p7l1853t384r1908b431],
8	400	CD	NUMBER	400	num	9	SENT_93	[p7l1939t376r2056b431],
9	g	NN	O	g	prep_at	6	SENT_93	[p7l2087t393r2145b446],
10	;	:	O	;	_	0	SENT_93	[p7l2087t393r2145b446],
11	plasma	NN	O	plasma	nsubjpass	13	SENT_93	[p7l6t456r232b528],
12	was	VBD	O	be	auxpass	13	SENT_93	[p7l254t474r373b511],
13	separated	VBN	O	separate	parataxis	3	SENT_93	[p7l400t456r698b528],
14	and	CC	O	and	_	0	SENT_93	[p7l722t456r834b511],
15	kept	VBN	O	keep	conj_and	13	SENT_93	[p7l855t456r993b528],
16	frozen	JJ	O	frozen	amod	21	SENT_93	[p7l1014t456r1216b511],
17	at	IN	O	at	_	0	SENT_93	[p7l1240t464r1295b511],
18	—	CD	NUMBER	—	num	19	SENT_93	[p7l1315t456r1517b512],
19	20	CD	NUMBER	20	prep_at	16	SENT_93	[p7l1315t456r1517b512],
20	°	NN	O	°	nn	21	SENT_93	[p7l1315t456r1517b512],
21	C	NN	O	c	dobj	13	SENT_93	[p7l1315t456r1517b512],
22	until	IN	O	until	_	0	SENT_93	[p7l1541t456r1686b511],
23	the	DT	O	the	det	24	SENT_93	[p7l1709t456r1804b511],
24	analysis	NN	O	analysis	prep_until	13	SENT_93	[p7l1829t456r2098b528],
25	.	.	O	.	_	0	SENT_93	[p7l1829t456r2098b528],

1	Blood	NN	O	blood	nn	2	SENT_94	[p7l119t538r312b593],
2	samples	NNS	O	sample	nsubjpass	12	SENT_94	[p7l342t538r593b610],
3	for	IN	O	for	_	0	SENT_94	[p7l622t538r715b593],
4	the	DT	O	the	det	5	SENT_94	[p7l741t538r836b593],
5	determination	NN	O	determination	prep_for	2	SENT_94	[p7l865t538r1306b593],
6	of	IN	O	of	_	0	SENT_94	[p7l1335t538r1403b593],
7	the	DT	O	the	det	10	SENT_94	[p7l1425t538r1520b593],
8	C	NN	O	c	nn	10	SENT_94	[p7l1552t539r1602b594],
9	YPZD6	NN	O	ypzd6	nn	10	SENT_94	[p7l1606t538r1833b593],
10	genotype	NN	O	genotype	prep_of	5	SENT_94	[p7l1858t546r2148b610],
11	were	VBD	O	be	auxpass	12	SENT_94	[p7l7t636r159b674],
12	collected	VBN	O	collect	_	0	SENT_94	[p7l184t618r471b674],
13	at	IN	O	at	_	0	SENT_94	[p7l496t627r552b674],
14	week	NN	DURATION	week	nn	15	SENT_94	[p7l575t618r743b674],
15	o	NN	O	o	prep_at	12	SENT_94	[p7l765t619r802b674],
16	into	IN	O	into	_	0	SENT_94	[p7l827t618r948b674],
17	Vacutainer	NNP	O	Vacutainer	nn	18	SENT_94	[p7l973t618r1306b674],
18	tubes	NNS	O	tube	nsubj	19	SENT_94	[p7l1329t618r1493b674],
19	containing	VBG	O	contain	prepc_into	12	SENT_94	[p7l1520t618r1854b690],
20	ethylene	NN	O	ethylene	nn	21	SENT_94	[p7l1880t619r2148b690],
21	diamine	NN	O	diamine	nsubj	26	SENT_94	[p7l8t699r261b755],
22	tetraacetic	JJ	O	tetraacetic	amod	26	SENT_94	[p7l297t699r623b755],
23	acid	NN	O	acid	nn	26	SENT_94	[p7l661t699r791b755],
24	(	CD	NUMBER	(	num	26	SENT_94	[p7l829t700r1080b768],
25	EDTA	NN	O	edta	nn	26	SENT_94	[p7l829t700r1080b768],
26	)	NN	O	)	xcomp	19	SENT_94	[p7l829t700r1080b768],
27	and	CC	O	and	_	0	SENT_94	[p7l1120t699r1232b755],
28	kept	VBD	O	keep	conj_and	12	SENT_94	[p7l1266t699r1403b771],
29	frozen	VBN	O	freeze	dep	28	SENT_94	[p7l1438t699r1639b755],
30	at	IN	O	at	_	0	SENT_94	[p7l1676t708r1731b755],
31	—	CD	NUMBER	—	number	32	SENT_94	[p7l1764t700r1966b755],
32	20	CD	NUMBER	20	num	34	SENT_94	[p7l1764t700r1966b755],
33	°	NN	O	°	nn	34	SENT_94	[p7l1764t700r1966b755],
34	C	NN	O	c	prep_at	29	SENT_94	[p7l1764t700r1966b755],
35	until	IN	O	until	_	0	SENT_94	[p7l2003t699r2148b755],
36	determination	NN	O	determination	prep_until	29	SENT_94	[p7l8t780r449b835],
37	of	IN	O	of	_	0	SENT_94	[p7l472t780r541b835],
38	the	DT	O	the	det	39	SENT_94	[p7l558t780r653b835],
39	genotype	NN	O	genotype	prep_of	36	SENT_94	[p7l677t788r983b852],
40	.	.	O	.	_	0	SENT_94	[p7l677t788r983b852],

1	Determination	NN	O	determination	_	0	SENT_95	[p7l7t1001r466b1057],
2	of	IN	O	of	_	0	SENT_95	[p7l490t1001r559b1057],
3	zuclopenthixol	NN	O	zuclopenthixol	nn	5	SENT_95	[p7l577t1001r1049b1073],
4	plasma	NN	O	plasma	nn	5	SENT_95	[p7l1071t1001r1297b1073],
5	concentrations	NNS	O	concentration	prep_of	1	SENT_95	[p7l1319t1001r1781b1057],

1	Plasma	NN	O	plasma	nn	2	SENT_96	[p7l7t1153r233b1208],
2	concentrations	NNS	O	concentration	nsubjpass	6	SENT_96	[p7l258t1153r710b1208],
3	of	IN	O	of	_	0	SENT_96	[p7l738t1153r806b1208],
4	zuclopenthixol	NN	O	zuclopenthixol	prep_of	2	SENT_96	[p7l828t1153r1290b1225],
5	were	VBD	O	be	auxpass	6	SENT_96	[p7l1316t1170r1466b1208],
6	analysed	VBN	O	analyse	_	0	SENT_96	[p7l1494t1153r1765b1224],
7	using	VBG	O	use	xcomp	6	SENT_96	[p7l1790t1153r1958b1225],
8	highperformance	JJ	O	highperformance	amod	10	SENT_96	[p7l1984t1153r2146b1225, p7l6t1233r400b1305],
9	liquid	JJ	O	liquid	amod	10	SENT_96	[p7l446t1233r627b1305],
10	chromatography	NN	O	chromatography	dobj	7	SENT_96	[p7l673t1233r1193b1305],
11	.	.	O	.	_	0	SENT_96	[p7l673t1233r1193b1305],

1	A	DT	O	a	det	3	SENT_97	[p7l1242t1234r1298b1288],
2	1-ml	JJ	O	1-ml	amod	3	SENT_97	[p7l1350t1234r1489b1288],
3	sample	NN	O	sample	nsubjpass	38	SENT_97	[p7l1537t1233r1754b1305],
4	of	IN	O	of	_	0	SENT_97	[p7l1801t1233r1868b1289],
5	plasma	NN	O	plasma	prep_of	3	SENT_97	[p7l1907t1233r2145b1305],
6	,	,	O	,	_	0	SENT_97	[p7l1907t1233r2145b1305],
7	mixed	VBN	O	mix	partmod	3	SENT_97	[p7l7t1313r201b1368],
8	with	IN	O	with	_	0	SENT_97	[p7l237t1313r375b1369],
9	50	CD	NUMBER	50	num	10	SENT_97	[p7l412t1313r486b1369],
10	pl	NN	O	pl	prep_with	7	SENT_97	[p7l525t1313r582b1385],
11	internal	JJ	O	internal	amod	13	SENT_97	[p7l618t1313r855b1368],
12	standard	JJ	O	standard	amod	13	SENT_97	[p7l894t1313r1155b1368],
13	(	NN	O	(	dep	21	SENT_97	[p7l1193t1314r1310b1382],
14	0.7	CD	NUMBER	0.7	num	15	SENT_97	[p7l1193t1314r1310b1382],
15	umol-1-1	NN	O	umol-1-1	dep	13	SENT_97	[p7l1350t1310r1599b1385],
16	2.8	CD	NUMBER	2.8	num	17	SENT_97	[p7l1641t1313r2146b1385],
17	—	NN	O	—	dep	21	SENT_97	[p7l1641t1313r2146b1385],
18	dichloroper	NN	O	dichloroper	nn	21	SENT_97	[p7l1641t1313r2146b1385],
19	—	NN	O	—	nn	21	SENT_97	[p7l1641t1313r2146b1385],
20	phenazine	NN	O	phenazine	nn	21	SENT_97	[p7l6t1393r346b1465],
21	)	NN	O	)	dep	28	SENT_97	[p7l6t1393r346b1465],
22	and	CC	O	and	_	0	SENT_97	[p7l388t1393r498b1448],
23	0.5	CD	NUMBER	0.5	num	24	SENT_97	[p7l535t1393r628b1449],
24	ml	NN	O	ml	conj_and	21	SENT_97	[p7l669t1393r750b1448],
25	0.5	CD	NUMBER	0.5	num	28	SENT_97	[p7l788t1393r880b1449],
26	mol-1-1	NN	O	mol-1-1	nn	28	SENT_97	[p7l921t1390r1133b1448],
27	sodium	NN	O	sodium	nn	28	SENT_97	[p7l1178t1393r1405b1448],
28	hydroxide	NN	O	hydroxide	dep	35	SENT_97	[p7l1441t1393r1757b1465],
29	in	IN	O	in	_	0	SENT_97	[p7l1795t1393r1854b1448],
30	a	DT	O	a	det	33	SENT_97	[p7l1893t1411r1926b1448],
31	14	CD	NUMBER	14	num	33	SENT_97	[p7l1970t1393r2148b1448],
32	—	NN	O	—	nn	33	SENT_97	[p7l1970t1393r2148b1448],
33	ml	NN	O	ml	prep_in	28	SENT_97	[p7l1970t1393r2148b1448],
34	polypropylene	NN	O	polypropylene	nn	35	SENT_97	[p7l6t1475r457b1547],
35	tube	NN	O	tube	dep	10	SENT_97	[p7l481t1475r631b1540],
36	,	,	O	,	_	0	SENT_97	[p7l481t1475r631b1540],
37	was	VBD	O	be	auxpass	38	SENT_97	[p7l658t1492r776b1530],
38	extracted	VBN	O	extract	_	0	SENT_97	[p7l802t1475r1087b1530],
39	with	IN	O	with	_	0	SENT_97	[p7l1111t1475r1249b1530],
40	3	CD	NUMBER	3	num	41	SENT_97	[p7l1274t1475r1306b1530],
41	ml	NN	O	ml	nn	45	SENT_97	[p7l1334t1475r1415b1529],
42	3	CD	PERCENT	3	number	43	SENT_97	[p7l1441t1475r1538b1530],
43	%	NN	PERCENT	%	amod	45	SENT_97	[p7l1441t1475r1538b1530],
44	isoamyl	NN	O	isoamyl	nn	45	SENT_97	[p7l1566t1475r1812b1546],
45	alcohol	NN	O	alcohol	prep_with	38	SENT_97	[p7l1838t1475r2065b1530],
46	in	IN	O	in	_	0	SENT_97	[p7l2088t1475r2148b1529],
47	heptane	NN	O	heptane	prep_in	38	SENT_97	[p7l6t1556r264b1627],
48	.	.	O	.	_	0	SENT_97	[p7l6t1556r264b1627],

1	After	IN	O	after	_	0	SENT_98	[p7l294t1555r459b1611],
2	extraction	NN	O	extraction	prep_after	22	SENT_98	[p7l484t1555r794b1611],
3	by	IN	O	by	_	0	SENT_98	[p7l819t1555r896b1627],
4	rotation	NN	O	rotation	prep_by	2	SENT_98	[p7l922t1555r1164b1611],
5	for	IN	O	for	_	0	SENT_98	[p7l1190t1555r1281b1611],
6	10	CD	DURATION	10	num	7	SENT_98	[p7l1313t1556r1382b1611],
7	min	NN	DURATION	min	prep_for	4	SENT_98	[p7l1408t1555r1545b1621],
8	,	,	O	,	_	0	SENT_98	[p7l1408t1555r1545b1621],
9	and	CC	O	and	_	0	SENT_98	[p7l1576t1555r1686b1611],
10	centrifugation	NN	O	centrifugation	conj_and	4	SENT_98	[p7l1712t1555r2148b1627],
11	for	IN	O	for	_	0	SENT_98	[p7l7t1636r98b1692],
12	10	CD	DURATION	10	num	13	SENT_98	[p7l133t1637r201b1692],
13	min	NN	DURATION	min	prep_for	10	SENT_98	[p7l230t1636r350b1691],
14	at	IN	O	at	_	0	SENT_98	[p7l381t1645r435b1692],
15	3000	CD	NUMBER	3000	num	16	SENT_98	[p7l465t1637r617b1692],
16	g	NN	O	g	prep_at	13	SENT_98	[p7l646t1655r700b1707],
17	,	,	O	,	_	0	SENT_98	[p7l646t1655r700b1707],
18	the	DT	O	the	det	20	SENT_98	[p7l732t1636r825b1692],
19	water	NN	O	water	nn	20	SENT_98	[p7l855t1645r1028b1692],
20	phase	NN	O	phase	nsubjpass	22	SENT_98	[p7l1054t1636r1231b1708],
21	was	VBD	O	be	auxpass	22	SENT_98	[p7l1261t1654r1379b1692],
22	frozen	VBN	O	freeze	_	0	SENT_98	[p7l1410t1636r1608b1692],
23	in	IN	O	in	_	0	SENT_98	[p7l1637t1636r1695b1691],
24	ethanol/water	NN	O	ethanol/water	nn	25	SENT_98	[p7l1725t1636r2149b1692],
25	bath	NN	O	bath	prep_in	22	SENT_98	[p7l6t1717r140b1772],
26	at	IN	O	at	_	0	SENT_98	[p7l179t1725r233b1772],
27	—	CD	NUMBER	—	number	28	SENT_98	[p7l268t1717r485b1783],
28	30	CD	NUMBER	30	num	30	SENT_98	[p7l268t1717r485b1783],
29	°	NN	O	°	nn	30	SENT_98	[p7l268t1717r485b1783],
30	C	NN	O	c	prep_at	22	SENT_98	[p7l268t1717r485b1783],
31	,	,	O	,	_	0	SENT_98	[p7l268t1717r485b1783],
32	and	CC	O	and	_	0	SENT_98	[p7l527t1717r637b1772],
33	the	DT	O	the	det	35	SENT_98	[p7l674t1717r767b1772],
34	organic	JJ	O	organic	amod	35	SENT_98	[p7l806t1717r1035b1789],
35	phase	NN	O	phase	nsubjpass	37	SENT_98	[p7l1073t1717r1250b1789],
36	was	VBD	O	be	auxpass	37	SENT_98	[p7l1288t1735r1405b1772],
37	transferred	VBN	O	transfer	conj_and	22	SENT_98	[p7l1445t1717r1782b1772],
38	to	TO	O	to	_	0	SENT_98	[p7l1818t1725r1877b1772],
39	another	DT	O	another	det	41	SENT_98	[p7l1917t1717r2149b1772],
40	polypropylene	NN	O	polypropylene	nn	41	SENT_98	[p7l6t1798r457b1870],
41	tube	NN	O	tube	prep_to	37	SENT_98	[p7l500t1798r633b1853],
42	containing	VBG	O	contain	xcomp	37	SENT_98	[p7l677t1798r1004b1870],
43	100	CD	NUMBER	100	num	44	SENT_98	[p7l1056t1798r1163b1853],
44	pl	NN	O	pl	nsubj	48	SENT_98	[p7l1209t1798r1266b1870],
45	25	CD	NUMBER	25	num	48	SENT_98	[p7l1311t1798r1382b1853],
46	mmol-1-1	NN	O	mmol-1-1	nn	48	SENT_98	[p7l1429t1795r1702b1853],
47	formic	JJ	O	formic	amod	48	SENT_98	[p7l1750t1798r1955b1853],
48	acid	NN	O	acid	xcomp	42	SENT_98	[p7l2002t1798r2144b1853],
49	.	.	O	.	_	0	SENT_98	[p7l2002t1798r2144b1853],

1	After	IN	O	after	_	0	SENT_99	[p7l7t1878r172b1933],
2	extraction	NN	O	extraction	prep_after	16	SENT_99	[p7l196t1878r506b1933],
3	for	IN	O	for	_	0	SENT_99	[p7l532t1878r622b1933],
4	5	CD	DURATION	5	num	5	SENT_99	[p7l648t1877r680b1933],
5	min	NN	DURATION	min	prep_for	2	SENT_99	[p7l709t1878r830b1932],
6	and	CC	O	and	_	0	SENT_99	[p7l857t1878r967b1933],
7	centrifugation	NN	O	centrifugation	prep_after	16	SENT_99	[p7l993t1878r1429b1950],
8	for	IN	O	for	_	0	SENT_99	[p7l1454t1878r1545b1933],
9	5	CD	DURATION	5	num	10	SENT_99	[p7l1570t1878r1603b1933],
10	min	NN	DURATION	min	prep_for	7	SENT_99	[p7l1632t1878r1769b1943],
11	,	,	O	,	_	0	SENT_99	[p7l1632t1878r1769b1943],
12	the	DT	O	the	det	14	SENT_99	[p7l1797t1878r1890b1933],
13	organic	JJ	O	organic	amod	14	SENT_99	[p7l1918t1878r2147b1950],
14	phase	NN	O	phase	nsubjpass	16	SENT_99	[p7l6t1959r183b2030],
15	was	VBD	O	be	auxpass	16	SENT_99	[p7l206t1976r324b2014],
16	sucked	VBN	O	suck	_	0	SENT_99	[p7l351t1958r564b2014],
17	off	RP	O	off	prt	16	SENT_99	[p7l587t1958r690b2014],
18	.	.	O	.	_	0	SENT_99	[p7l587t1958r690b2014],

1	Heptane	JJ	O	heptane	amod	5	SENT_100	[p7l716t1960r975b2030],
2	(	NN	O	(	nn	5	SENT_100	[p7l1001t1958r1116b2027],
3	0.5	CD	NUMBER	0.5	num	5	SENT_100	[p7l1001t1958r1116b2027],
4	ml	NN	O	ml	nn	5	SENT_100	[p7l1142t1959r1247b2027],
5	)	NN	O	)	nsubjpass	7	SENT_100	[p7l1142t1959r1247b2027],
6	was	VBD	O	be	auxpass	7	SENT_100	[p7l1272t1976r1390b2014],
7	added	VBN	O	add	_	0	SENT_100	[p7l1416t1958r1600b2014],
8	and	CC	O	and	_	0	SENT_100	[p7l1624t1958r1734b2014],
9	the	DT	O	the	det	10	SENT_100	[p7l1756t1958r1849b2014],
10	tube	NN	O	tube	nsubjpass	12	SENT_100	[p7l1872t1958r2005b2014],
11	was	VBD	O	be	auxpass	12	SENT_100	[p7l2028t1976r2146b2014],
12	whirlrnixed	VBN	O	whirlrnix	conj_and	7	SENT_100	[p7l7t2039r367b2095],
13	for	IN	O	for	_	0	SENT_100	[p7l391t2039r481b2094],
14	10	CD	NUMBER	10	num	15	SENT_100	[p7l512t2039r580b2095],
15	s.	NN	O	s.	prep_for	12	SENT_100	[p7l608t2057r650b2094],
16	The	DT	O	the	det	18	SENT_100	[p7l678t2039r798b2094],
17	heptane	NN	O	heptane	nn	18	SENT_100	[p7l822t2039r1064b2111],
18	phase	NN	O	phase	nsubjpass	20	SENT_100	[p7l1088t2039r1265b2111],
19	was	VBD	O	be	auxpass	20	SENT_100	[p7l1291t2057r1408b2095],
20	sucked	VBN	O	suck	rcmod	15	SENT_100	[p7l1438t2039r1651b2094],
21	off	RP	O	off	prt	20	SENT_100	[p7l1676t2039r1768b2094],
22	completely	RB	O	completely	advmod	20	SENT_100	[p7l1788t2039r2145b2111],
23	,	,	O	,	_	0	SENT_100	[p7l1788t2039r2145b2111],
24	and	CC	O	and	_	0	SENT_100	[p7l8t2121r119b2176],
25	25	CD	NUMBER	25	num	26	SENT_100	[p7l164t2121r236b2176],
26	pl	NN	O	pl	nsubjpass	32	SENT_100	[p7l285t2121r343b2193],
27	of	IN	O	of	_	0	SENT_100	[p7l389t2121r457b2176],
28	the	DT	O	the	det	30	SENT_100	[p7l495t2121r589b2176],
29	acid	NN	O	acid	nn	30	SENT_100	[p7l636t2121r764b2176],
30	phase	NN	O	phase	prep_of	26	SENT_100	[p7l807t2121r983b2193],
31	was	VBD	O	be	auxpass	32	SENT_100	[p7l1029t2138r1147b2176],
32	injected	VBN	O	inject	conj_and	7	SENT_100	[p7l1193t2121r1440b2193],
33	onto	IN	O	onto	_	0	SENT_100	[p7l1484t2129r1620b2176],
34	a	DT	O	a	quantmod	35	SENT_100	[p7l1667t2139r1700b2176],
35	100	CD	NUMBER	100	num	36	SENT_100	[p7l1751t2121r2149b2176],
36	>	JJR	O	>	npadvmod	37	SENT_100	[p7l1751t2121r2149b2176],
37	<	JJR	O	<	prep_onto	32	SENT_100	[p7l1751t2121r2149b2176],
38	2.0	CD	NUMBER	2.0	num	40	SENT_100	[p7l1751t2121r2149b2176],
39	—	NN	O	—	nn	40	SENT_100	[p7l1751t2121r2149b2176],
40	mm	NN	O	mm	nn	44	SENT_100	[p7l1751t2121r2149b2176],
41	Phenomenex	NNP	PERSON	Phenomenex	nn	44	SENT_100	[p7l7t2202r409b2257],
42	Luna	NNP	PERSON	Luna	nn	44	SENT_100	[p7l432t2203r593b2257],
43	C18	NN	O	c18	nn	44	SENT_100	[p7l615t2202r740b2257],
44	column	NN	O	column	dep	32	SENT_100	[p7l767t2202r1000b2257],
45	with	IN	O	with	_	0	SENT_100	[p7l1022t2202r1160b2257],
46	3-pm	JJ	O	3-pm	amod	47	SENT_100	[p7l1184t2202r1347b2274],
47	particles	NNS	O	particle	prep_with	32	SENT_100	[p7l1367t2202r1647b2274],
48	.	.	O	.	_	0	SENT_100	[p7l1367t2202r1647b2274],

1	The	DT	O	the	det	2	SENT_101	[p7l1673t2202r1793b2257],
2	eluent	NN	O	eluent	nsubj	11	SENT_101	[p7l1816t2202r2006b2257],
3	was	VBD	O	be	aux	11	SENT_101	[p7l2028t2219r2146b2257],
4	a	DT	O	a	det	11	SENT_101	[p7l8t2299r41b2337],
5	40-mmol-1-1	JJ	O	40-mmol-1-1	amod	11	SENT_101	[p7l62t2278r432b2337],
6	phosphate	NN	O	phosphate	nn	11	SENT_101	[p7l458t2282r768b2353],
7	buffer	NN	O	buffer	nn	11	SENT_101	[p7l790t2281r977b2337],
8	(	CD	NUMBER	(	num	11	SENT_101	[p7l1000t2282r1116b2353],
9	pH	NN	O	ph	nn	11	SENT_101	[p7l1000t2282r1116b2353],
10	7.5	CD	NUMBER	7.5	num	11	SENT_101	[p7l1140t2281r1256b2350],
11	)	NN	O	)	_	0	SENT_101	[p7l1140t2281r1256b2350],
12	containing	VBG	O	contain	xcomp	11	SENT_101	[p7l1282t2282r1601b2353],
13	48	CD	PERCENT	48	number	14	SENT_101	[p7l1625t2282r1763b2337],
14	%	NN	PERCENT	%	amod	15	SENT_101	[p7l1625t2282r1763b2337],
15	acetonitrite	NN	O	acetonitrite	dobj	12	SENT_101	[p7l1790t2282r2144b2337],
16	.	.	O	.	_	0	SENT_101	[p7l1790t2282r2144b2337],

1	The	DT	O	the	det	3	SENT_102	[p7l7t2362r126b2418],
2	ﬂow	NN	O	ﬂow	nn	3	SENT_102	[p7l151t2362r292b2418],
3	rate	NN	O	rate	nsubj	6	SENT_102	[p7l315t2370r431b2418],
4	was	VBD	O	be	cop	6	SENT_102	[p7l455t2380r574b2418],
5	0.3	CD	NUMBER	0.3	num	6	SENT_102	[p7l600t2363r691b2418],
6	ml/min	NN	O	ml/min	_	0	SENT_102	[p7l719t2362r944b2418],
7	and	CC	O	and	_	0	SENT_102	[p7l969t2362r1079b2418],
8	the	DT	O	the	det	9	SENT_102	[p7l1102t2362r1196b2418],
9	temperature	NN	O	temperature	nsubj	11	SENT_102	[p7l1220t2371r1592b2434],
10	was	VBD	O	be	cop	11	SENT_102	[p7l1616t2380r1734b2418],
11	40	CD	NUMBER	40	conj_and	6	SENT_102	[p7l1759t2363r1935b2418],
12	°	CD	NUMBER	°	num	15	SENT_102	[p7l1759t2363r1935b2418],
13	C.	NNP	O	C.	nn	15	SENT_102	[p7l1759t2363r1935b2418],
14	Ultraviolet	NNP	O	Ultraviolet	nn	15	SENT_102	[p7l1963t2362r2146b2418, p7l7t2443r180b2498],
15	detection	NN	O	detection	nsubjpass	17	SENT_102	[p7l201t2443r479b2498],
16	was	VBD	O	be	auxpass	17	SENT_102	[p7l501t2461r617b2498],
17	carried	VBN	O	carry	rcmod	11	SENT_102	[p7l641t2443r852b2498],
18	out	RP	O	out	prt	17	SENT_102	[p7l873t2452r970b2498],
19	at	IN	O	at	_	0	SENT_102	[p7l992t2451r1046b2498],
20	a	DT	O	a	det	21	SENT_102	[p7l1068t2461r1100b2498],
21	wavelength	NN	O	wavelength	prep_at	17	SENT_102	[p7l1121t2443r1473b2515],
22	of	IN	O	of	_	0	SENT_102	[p7l1495t2443r1562b2498],
23	258	CD	NUMBER	258	num	24	SENT_102	[p7l1579t2443r1690b2499],
24	nm	NN	O	nm	prep_of	21	SENT_102	[p7l1714t2461r1826b2498],
25	.	.	O	.	_	0	SENT_102	[p7l1714t2461r1826b2498],

1	Retention	NN	O	retention	nn	2	SENT_103	[p7l1852t2443r2148b2498],
2	times	NNS	O	time	nsubj	5	SENT_103	[p7l7t2525r173b2580],
3	were	VBD	O	be	cop	5	SENT_103	[p7l207t2543r357b2580],
4	7.12	CD	DURATION	7.12	num	5	SENT_103	[p7l391t2525r524b2580],
5	min	NN	DURATION	min	_	0	SENT_103	[p7l558t2525r678b2579],
6	for	IN	O	for	_	0	SENT_103	[p7l711t2525r801b2580],
7	zuclopenthixol	NN	O	zuclopenthixol	prep_for	5	SENT_103	[p7l833t2525r1295b2597],
8	and	CC	O	and	_	0	SENT_103	[p7l1329t2525r1440b2580],
9	11.6	CD	DURATION	11.6	num	10	SENT_103	[p7l1479t2525r1603b2580],
10	min	NN	DURATION	min	conj_and	5	SENT_103	[p7l1636t2525r1757b2579],
11	for	IN	O	for	_	0	SENT_103	[p7l1789t2525r1880b2580],
12	intemal	JJ	O	intemal	amod	13	SENT_103	[p7l1911t2525r2148b2580],
13	standard	NN	O	standard	prep_for	10	SENT_103	[p7l9t2605r285b2660],
14	.	.	O	.	_	0	SENT_103	[p7l9t2605r285b2660],

1	Linear	JJ	O	linear	amod	3	SENT_104	[p7l315t2604r519b2660],
2	standard	JJ	O	standard	amod	3	SENT_104	[p7l546t2605r807b2660],
3	curves	NNS	O	curve	nsubjpass	11	SENT_104	[p7l833t2622r1032b2660],
4	with	IN	O	with	_	0	SENT_104	[p7l1060t2604r1197b2660],
5	correlation	NN	O	correlation	nn	6	SENT_104	[p7l1223t2604r1560b2660],
6	coefficients	NNS	O	coefficient	prep_with	3	SENT_104	[p7l1586t2604r1944b2660],
7	better	JJR	O	better	amod	6	SENT_104	[p7l1971t2604r2150b2660],
8	than	IN	O	than	_	0	SENT_104	[p7l7t2684r140b2740],
9	0.99	CD	NUMBER	0.99	prep_than	7	SENT_104	[p7l174t2685r307b2741],
10	were	VBD	O	be	auxpass	11	SENT_104	[p7l342t2702r492b2740],
11	obtained	VBN	O	obtain	_	0	SENT_104	[p7l527t2684r795b2740],
12	in	IN	O	in	_	0	SENT_104	[p7l828t2684r887b2739],
13	the	DT	O	the	det	16	SENT_104	[p7l921t2684r1014b2740],
14	range	NN	O	range	nn	16	SENT_104	[p7l1047t2702r1220b2756],
15	0-60	CD	NUMBER	0-60	num	16	SENT_104	[p7l1255t2684r1408b2740],
16	nmol-1-1	NN	O	nmol-1-1	prep_in	11	SENT_104	[p7l1443t2681r1713b2740],
17	.	.	O	.	_	0	SENT_104	[p7l1443t2681r1713b2740],

1	The	DT	O	the	det	2	SENT_105	[p7l1751t2684r1871b2740],
2	limit	NN	O	limit	nsubj	7	SENT_105	[p7l1905t2684r2052b2740],
3	of	IN	O	of	_	0	SENT_105	[p7l2085t2684r2153b2740],
4	detection	NN	O	detection	prep_of	2	SENT_105	[p7l8t2764r292b2819],
5	was	VBD	O	be	cop	7	SENT_105	[p7l314t2782r431b2820],
6	1.0	CD	NUMBER	1.0	num	7	SENT_105	[p7l463t2765r550b2820],
7	nmol-1-1	NN	O	nmol-1-1	_	0	SENT_105	[p7l572t2761r843b2819],
8	.	.	O	.	_	0	SENT_105	[p7l572t2761r843b2819],

1	A	DT	O	a	det	2	SENT_106	[p7l868t2765r924b2819],
2	coefficient	NN	O	coefficient	nsubjpass	13	SENT_106	[p7l946t2764r1277b2819],
3	of	IN	O	of	_	0	SENT_106	[p7l1298t2764r1366b2819],
4	Variation	NN	O	variation	nn	5	SENT_106	[p7l1383t2764r1659b2819],
5	(	NN	O	(	prep_of	2	SENT_106	[p7l1682t2764r1904b2832],
6	within	IN	O	within	_	0	SENT_106	[p7l1682t2764r1904b2832],
7	day	NN	DURATION	day	prep_within	5	SENT_106	[p7l1927t2764r2060b2836],
8	)	CD	NUMBER	)	num	7	SENT_106	[p7l1927t2764r2060b2836],
9	of	IN	O	of	_	0	SENT_106	[p7l2085t2764r2153b2819],
10	5.1	CD	PERCENT	5.1	num	11	SENT_106	[p7l8t2845r165b2900],
11	%	NN	PERCENT	%	prep_of	7	SENT_106	[p7l8t2845r165b2900],
12	was	VBD	O	be	auxpass	13	SENT_106	[p7l190t2863r308b2900],
13	obtained	VBN	O	obtain	_	0	SENT_106	[p7l332t2845r599b2900],
14	at	IN	O	at	_	0	SENT_106	[p7l621t2853r675b2900],
15	5.0	CD	NUMBER	5.0	num	16	SENT_106	[p7l696t2845r790b2900],
16	nmol-1-1	NN	O	nmol-1-1	prep_at	13	SENT_106	[p7l812t2842r1082b2900],
17	.	.	O	.	_	0	SENT_106	[p7l812t2842r1082b2900],

1	Genotyping	VBG	O	genotype	_	0	SENT_107	[p7l8t3058r381b3130],

1	Genomic	JJ	O	genomic	amod	2	SENT_108	[p7l8t3209r295b3265],
2	DNA	NN	O	dna	nsubjpass	4	SENT_108	[p7l321t3210r491b3265],
3	was	VBD	O	be	auxpass	4	SENT_108	[p7l515t3227r635b3265],
4	isolated	VBN	O	isolate	_	0	SENT_108	[p7l661t3209r908b3265],
5	from	IN	O	from	_	0	SENT_108	[p7l932t3209r1086b3265],
6	peripheral	JJ	O	peripheral	amod	7	SENT_108	[p7l1107t3209r1430b3281],
7	leukocytes	NNS	O	leukocyte	prep_from	4	SENT_108	[p7l1455t3209r1792b3281],
8	by	IN	O	by	_	0	SENT_108	[p7l1817t3209r1895b3281],
9	Qiagen	NNP	O	Qiagen	nn	10	SENT_108	[p7l1921t3209r2148b3281],
10	Blood	NNP	O	Blood	agent	4	SENT_108	[p7l7t3290r200b3346],
11	and	CC	O	and	_	0	SENT_108	[p7l226t3290r338b3346],
12	Cell	NN	O	cell	nn	14	SENT_108	[p7l363t3290r493b3346],
13	Culture	NN	O	culture	nn	14	SENT_108	[p7l519t3290r755b3346],
14	DNA	NN	O	dna	conj_and	10	SENT_108	[p7l780t3291r950b3346],
15	Kit	NN	O	kit	dep	14	SENT_108	[p7l976t3290r1076b3346],
16	(	CD	NUMBER	(	num	15	SENT_108	[p7l1102t3290r1372b3362],
17	Qiagen	NNP	ORGANIZATION	Qiagen	nn	21	SENT_108	[p7l1102t3290r1372b3362],
18	,	,	O	,	_	0	SENT_108	[p7l1102t3290r1372b3362],
19	Hilden	NNP	PERSON	Hilden	appos	21	SENT_108	[p7l1400t3290r1632b3356],
20	,	,	O	,	_	0	SENT_108	[p7l1400t3290r1632b3356],
21	Germany	NNP	LOCATION	Germany	dep	14	SENT_108	[p7l1661t3291r1997b3362],
22	)	CD	NUMBER	)	num	21	SENT_108	[p7l1661t3291r1997b3362],
23	.	.	O	.	_	0	SENT_108	[p7l1661t3291r1997b3362],

1	The	DT	O	the	det	4	SENT_109	[p7l2026t3290r2147b3346],
2	C	NN	O	c	nn	4	SENT_109	[p7l11t3373r60b3428],
3	YPZD6	NN	O	ypzd6	nn	4	SENT_109	[p7l65t3372r291b3427],
4	genotype	NN	O	genotype	nsubjpass	6	SENT_109	[p7l316t3380r605b3444],
5	was	VBD	O	be	auxpass	6	SENT_109	[p7l634t3390r753b3427],
6	determined	VBN	O	determine	_	0	SENT_109	[p7l783t3372r1140b3427],
7	in	IN	O	in	_	0	SENT_109	[p7l1167t3372r1227b3426],
8	leukocyte	NN	O	leukocyte	nn	9	SENT_109	[p7l1254t3372r1562b3444],
9	DNA	NN	MISC	dna	prep_in	6	SENT_109	[p7l1590t3372r1761b3427],
10	by	IN	O	by	_	0	SENT_109	[p7l1787t3372r1864b3444],
11	analysis	NN	O	analysis	agent	6	SENT_109	[p7l1894t3372r2146b3444],
12	of	IN	O	of	_	0	SENT_109	[p7l8t3452r76b3507],
13	the	DT	O	the	det	14	SENT_109	[p7l96t3452r191b3507],
14	two	CD	NUMBER	two	prep_of	11	SENT_109	[p7l216t3460r332b3507],
15	mutated	VBN	O	mutate	partmod	14	SENT_109	[p7l358t3452r614b3507],
16	alleles	NNS	O	allele	dobj	15	SENT_109	[p7l640t3452r858b3517],
17	,	,	O	,	_	0	SENT_109	[p7l640t3452r858b3517],
18	CYP2D6	NN	O	cyp2d6	appos	16	SENT_109	[p7l890t3451r1246b3508],
19	*	CD	NUMBER	*	number	23	SENT_109	[p7l890t3451r1246b3508],
20	3	CD	NUMBER	3	number	23	SENT_109	[p7l890t3451r1246b3508],
21	and	CC	O	and	_	0	SENT_109	[p7l1273t3452r1385b3507],
22	*	CD	NUMBER	*	dep	18	SENT_109	[p7l1419t3452r1504b3517],
23	4	CD	NUMBER	4	dep	18	SENT_109	[p7l1419t3452r1504b3517],
24	,	,	O	,	_	0	SENT_109	[p7l1419t3452r1504b3517],
25	by	IN	O	by	_	0	SENT_109	[p7l1531t3452r1609b3524],
26	means	NNS	O	means	_	0	SENT_109	[p7l1634t3469r1834b3507],
27	of	IN	O	of	_	0	SENT_109	[p7l1862t3452r1930b3507],
28	allelespecific	JJ	O	allelespecific	amod	34	SENT_109	[p7l1951t3452r2146b3507, p7l9t3532r252b3604],
29	polymerase	NN	O	polymerase	nn	34	SENT_109	[p7l282t3533r649b3604],
30	chain	NN	O	chain	nn	34	SENT_109	[p7l680t3532r850b3588],
31	reaction	NN	O	reaction	nn	34	SENT_109	[p7l879t3532r1136b3588],
32	(	CD	NUMBER	(	num	34	SENT_109	[p7l1168t3533r1365b3601],
33	PCR	NN	O	pcr	nn	34	SENT_109	[p7l1168t3533r1365b3601],
34	)	NN	O	)	prep_by_means_of	15	SENT_109	[p7l1168t3533r1365b3601],
35	according	VBG	O	accord	_	0	SENT_109	[p7l1399t3532r1709b3604],
36	to	TO	O	to	prepc_according_to	34	SENT_109	[p7l1740t3541r1799b3588],
37	Heim	NNP	PERSON	Heim	pobj	34	SENT_109	[p7l1830t3532r2006b3588],
38	and	CC	O	and	_	0	SENT_109	[p7l2037t3533r2149b3588],
39	Meyer	NNP	PERSON	Meyer	conj_and	37	SENT_109	[p7l6t3615r214b3685],
40	(	CD	NUMBER	(	num	39	SENT_109	[p7l266t3614r491b3682],
41	1990	CD	DATE	1990	num	42	SENT_109	[p7l266t3614r491b3682],
42	)	NN	O	)	dep	39	SENT_109	[p7l266t3614r491b3682],
43	.	.	O	.	_	0	SENT_109	[p7l266t3614r491b3682],

1	Alleles	NNS	O	allele	nsubjpass	18	SENT_110	[p7l546t3613r769b3669],
2	where	WRB	O	where	advmod	16	SENT_110	[p7l822t3613r1014b3669],
3	neither	CC	O	neither	preconj	7	SENT_110	[p7l1066t3613r1287b3669],
4	the	DT	O	the	det	7	SENT_110	[p7l1337t3613r1432b3669],
5	*	NN	O	*	nn	7	SENT_110	[p7l1493t3614r1586b3668],
6	3	CD	NUMBER	3	num	7	SENT_110	[p7l1493t3614r1586b3668],
7	—	NN	O	—	nsubjpass	16	SENT_110	[p7l1493t3614r1586b3668],
8	nor	CC	O	nor	_	0	SENT_110	[p7l1639t3631r1745b3669],
9	*	NN	O	*	nn	11	SENT_110	[p7l1804t3613r2147b3685],
10	4	CD	NUMBER	4	num	11	SENT_110	[p7l1804t3613r2147b3685],
11	—	NN	O	—	conj_nor	7	SENT_110	[p7l1804t3613r2147b3685],
12	specific	JJ	O	specific	amod	13	SENT_110	[p7l1804t3613r2147b3685],
13	mutations	NNS	O	mutation	dep	11	SENT_110	[p7l7t3693r318b3748],
14	could	MD	O	could	aux	16	SENT_110	[p7l363t3693r539b3748],
15	be	VB	O	be	auxpass	16	SENT_110	[p7l579t3693r653b3748],
16	identified	VBN	O	identify	rcmod	1	SENT_110	[p7l696t3693r1001b3748],
17	were	VBD	O	be	auxpass	18	SENT_110	[p7l1043t3711r1195b3749],
18	classified	VBN	O	classify	_	0	SENT_110	[p7l1239t3693r1539b3748],
19	as	IN	O	as	_	0	SENT_110	[p7l1583t3711r1643b3748],
20	the	DT	O	the	det	21	SENT_110	[p7l1688t3693r1783b3748],
21	functional	JJ	O	functional	prep_as	18	SENT_110	[p7l1826t3693r2148b3748],

1	C	NN	O	c	nn	3	SENT_111	[p8l11t20r60b75],
2	YPZD6	NN	O	ypzd6	nn	3	SENT_111	[p8l65t19r291b74],
3	*	NN	O	*	_	0	SENT_111	[p8l299t19r362b73],
4	1	CD	NUMBER	1	num	5	SENT_111	[p8l299t19r362b73],
5	alleles	NNS	O	allele	dep	3	SENT_111	[p8l392t19r609b74],
6	.	.	O	.	_	0	SENT_111	[p8l392t19r609b74],

1	Statistical	JJ	O	statistical	amod	2	SENT_112	[p8l9t233r321b288],
2	analysis	NN	O	analysis	_	0	SENT_112	[p8l345t233r597b305],

1	The	DT	O	the	det	5	SENT_113	[p8l7t384r128b440],
2	within	IN	O	within	advmod	5	SENT_113	[p8l167t384r720b440],
3	—	CD	NUMBER	—	num	4	SENT_113	[p8l167t384r720b440],
4	indiVidual	NN	O	individual	pobj	2	SENT_113	[p8l167t384r720b440],
5	differences	NNS	O	difference	nsubjpass	11	SENT_113	[p8l759t384r1109b440],
6	in	IN	O	in	_	0	SENT_113	[p8l1149t384r1209b439],
7	consecutive	JJ	O	consecutive	amod	9	SENT_113	[p8l1248t384r1622b440],
8	clinical	JJ	O	clinical	amod	9	SENT_113	[p8l1661t384r1894b440],
9	ratings	NNS	O	rating	prep_in	5	SENT_113	[p8l1932t384r2146b456],
10	were	VBD	O	be	auxpass	11	SENT_113	[p8l7t483r159b521],
11	compared	VBN	O	compare	_	0	SENT_113	[p8l184t465r497b537],
12	using	VBG	O	use	xcomp	11	SENT_113	[p8l519t465r690b537],
13	the	DT	O	the	det	15	SENT_113	[p8l714t465r809b520],
14	Friedman	NNP	O	Friedman	nn	15	SENT_113	[p8l832t465r1137b520],
15	analysis	NN	O	analysis	dobj	12	SENT_113	[p8l1162t465r1414b537],
16	of	IN	O	of	_	0	SENT_113	[p8l1441t465r1509b520],
17	Variance	NNP	O	Variance	prep_of	12	SENT_113	[p8l1527t465r1796b520],
18	(	CD	NUMBER	(	num	17	SENT_113	[p8l1822t465r2146b534],
19	ANOVA	NNP	ORGANIZATION	ANOVA	tmod	12	SENT_113	[p8l1822t465r2146b534],
20	)	CD	NUMBER	)	num	19	SENT_113	[p8l1822t465r2146b534],
21	69	CD	NUMBER	69	dep	19	SENT_113	[p8l2072t579r2147b635],

1	method	NN	O	method	nsubjpass	16	SENT_114	[p8l7t729r261b795],
2	,	,	O	,	_	0	SENT_114	[p8l7t729r261b795],
3	and	CC	O	and	_	0	SENT_114	[p8l291t729r403b784],
4	the	DT	O	the	det	8	SENT_114	[p8l426t729r521b784],
5	within	IN	O	within	advmod	8	SENT_114	[p8l547t729r1100b784],
6	—	CD	NUMBER	—	num	7	SENT_114	[p8l547t729r1100b784],
7	indiVidual	NN	O	individual	pobj	5	SENT_114	[p8l547t729r1100b784],
8	differences	NNS	O	difference	conj_and	1	SENT_114	[p8l1126t729r1475b784],
9	in	IN	O	in	_	0	SENT_114	[p8l1502t729r1561b784],
10	plasma	NN	O	plasma	nn	14	SENT_114	[p8l1585t729r1811b801],
11	zuclopen	NN	O	zuclopen	nn	14	SENT_114	[p8l1836t729r2146b801],
12	—	NN	O	—	nn	14	SENT_114	[p8l1836t729r2146b801],
13	thixol	NN	O	thixol	nn	14	SENT_114	[p8l7t811r191b866],
14	concentrations	NNS	O	concentration	prep_in	8	SENT_114	[p8l227t811r689b866],
15	were	VBD	O	be	auxpass	16	SENT_114	[p8l727t829r880b866],
16	compared	VBN	O	compare	_	0	SENT_114	[p8l916t811r1229b883],
17	using	VBG	O	use	xcomp	16	SENT_114	[p8l1263t811r1434b883],
18	t	NN	O	t	nn	20	SENT_114	[p8l1472t819r1657b866],
19	—	NN	O	—	nn	20	SENT_114	[p8l1472t819r1657b866],
20	tests	NNS	O	test	dobj	17	SENT_114	[p8l1472t819r1657b866],
21	for	IN	O	for	_	0	SENT_114	[p8l1695t811r1788b866],
22	dependent	JJ	O	dependent	amod	23	SENT_114	[p8l1823t811r2149b883],
23	samples	NNS	O	sample	prep_for	17	SENT_114	[p8l10t892r278b964],
24	.	.	O	.	_	0	SENT_114	[p8l10t892r278b964],

1	The	DT	O	the	det	3	SENT_115	[p8l321t892r443b947],
2	Kruskal-Wallis	NN	O	kruskal-walli	nn	3	SENT_115	[p8l484t892r961b947],
3	ANOVA	NNP	ORGANIZATION	ANOVA	nsubjpass	5	SENT_115	[p8l1002t892r1277b947],
4	was	VBD	O	be	auxpass	5	SENT_115	[p8l1317t909r1437b947],
5	used	VBN	O	use	_	0	SENT_115	[p8l1477t892r1622b947],
6	for	IN	O	for	_	0	SENT_115	[p8l1661t892r1754b947],
7	inter-group	JJ	O	inter-group	amod	8	SENT_115	[p8l1792t892r2147b964],
8	comparisons	NNS	O	comparison	prep_for	5	SENT_115	[p8l7t972r411b1044],
9	.	.	O	.	_	0	SENT_115	[p8l7t972r411b1044],

1	The	DT	O	the	det	2	SENT_116	[p8l437t972r556b1028],
2	relationship	NN	O	relationship	nsubjpass	15	SENT_116	[p8l578t972r941b1044],
3	between	IN	O	between	_	0	SENT_116	[p8l962t972r1220b1028],
4	the	DT	O	the	det	5	SENT_116	[p8l1241t972r1334b1028],
5	presence	NN	O	presence	prep_between	2	SENT_116	[p8l1355t990r1625b1044],
6	of	IN	O	of	_	0	SENT_116	[p8l1649t972r1716b1028],
7	parkinsonism	NN	O	parkinsonism	prep_of	5	SENT_116	[p8l1732t972r2149b1044],
8	or	CC	O	or	_	0	SENT_116	[p8l8t1071r73b1108],
9	TD	NN	O	td	prep_of	5	SENT_116	[p8l112t1054r214b1108],
10	and	CC	O	and	_	0	SENT_116	[p8l259t1053r371b1108],
11	the	DT	O	the	det	13	SENT_116	[p8l411t1053r506b1108],
12	demographic	JJ	O	demographic	amod	13	SENT_116	[p8l549t1053r961b1125],
13	Variables	NNP	O	Variables	prep_of	5	SENT_116	[p8l1004t1053r1289b1109],
14	was	VBD	O	be	auxpass	15	SENT_116	[p8l1332t1071r1452b1109],
15	evaluated	VBN	O	evaluate	_	0	SENT_116	[p8l1496t1053r1800b1108],
16	using	VBG	O	use	xcomp	15	SENT_116	[p8l1840t1053r2010b1125],
17	the	DT	O	the	det	20	SENT_116	[p8l2052t1053r2148b1108],
18	logistic	JJ	O	logistic	amod	20	SENT_116	[p8l7t1135r239b1207],
19	regression	NN	O	regression	nn	20	SENT_116	[p8l271t1135r599b1207],
20	method	NN	O	method	dobj	16	SENT_116	[p8l629t1135r883b1190],
21	.	.	O	.	_	0	SENT_116	[p8l629t1135r883b1190],

1	In	IN	O	in	_	0	SENT_117	[p8l919t1136r983b1189],
2	this	DT	O	this	det	3	SENT_117	[p8l1014t1135r1126b1190],
3	model	NN	O	model	prep_in	13	SENT_117	[p8l1159t1135r1356b1190],
4	the	DT	O	the	det	5	SENT_117	[p8l1388t1135r1483b1190],
5	presence	NN	O	presence	nsubj	13	SENT_117	[p8l1514t1153r1791b1207],
6	of	IN	O	of	_	0	SENT_117	[p8l1825t1135r1893b1190],
7	parkinsonism	NN	O	parkinsonism	prep_of	5	SENT_117	[p8l1918t1135r2146b1207, p8l10t1216r232b1271],
8	or	CC	O	or	_	0	SENT_117	[p8l264t1233r328b1271],
9	TD	NN	O	td	prep_of	5	SENT_117	[p8l359t1217r461b1270],
10	was	VBD	O	be	cop	13	SENT_117	[p8l495t1233r615b1271],
11	the	DT	O	the	det	13	SENT_117	[p8l648t1216r743b1271],
12	dependent	JJ	O	dependent	amod	13	SENT_117	[p8l776t1216r1103b1288],
13	Variable	NNP	O	Variable	_	0	SENT_117	[p8l1134t1216r1405b1271],
14	.	.	O	.	_	0	SENT_117	[p8l1134t1216r1405b1271],

1	Gender	NN	MISC	gender	nsubjpass	16	SENT_118	[p8l1443t1216r1688b1281],
2	,	,	O	,	_	0	SENT_118	[p8l1443t1216r1688b1281],
3	age	NN	O	age	conj_and	1	SENT_118	[p8l1724t1233r1848b1288],
4	,	,	O	,	_	0	SENT_118	[p8l1724t1233r1848b1288],
5	duration	NN	O	duration	nsubjpass	16	SENT_118	[p8l1884t1216r2148b1271],
6	of	IN	O	of	_	0	SENT_118	[p8l8t1296r76b1352],
7	illness	NN	O	illness	prep_of	5	SENT_118	[p8l98t1296r318b1362],
8	,	,	O	,	_	0	SENT_118	[p8l98t1296r318b1362],
9	plasma	NN	O	plasma	nn	11	SENT_118	[p8l347t1297r573b1368],
10	zuclopenthixol	NN	O	zuclopenthixol	nn	11	SENT_118	[p8l600t1296r1072b1368],
11	concentration	NN	O	concentration	conj_and	1	SENT_118	[p8l1100t1296r1533b1352],
12	and	CC	O	and	_	0	SENT_118	[p8l1561t1297r1673b1352],
13	CYPZD6	NN	O	cypzd6	nn	14	SENT_118	[p8l1704t1296r1984b1352],
14	genotype	NN	O	genotype	conj_and	1	SENT_118	[p8l2009t1314r2146b1368, p8l8t1386r181b1449],
15	were	VBD	O	be	auxpass	16	SENT_118	[p8l208t1395r360b1433],
16	included	VBN	O	include	_	0	SENT_118	[p8l387t1377r660b1433],
17	as	IN	O	as	_	0	SENT_118	[p8l687t1395r748b1433],
18	independent	JJ	O	independent	amod	19	SENT_118	[p8l775t1377r1165b1449],
19	Variables	NNP	O	Variables	prep_as	16	SENT_118	[p8l1190t1377r1492b1433],
20	.	.	O	.	_	0	SENT_118	[p8l1190t1377r1492b1433],

1	Multiple	JJ	O	multiple	amod	3	SENT_119	[p8l1522t1377r1795b1449],
2	regression	NN	O	regression	nn	3	SENT_119	[p8l1820t1377r2148b1449],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_119	[p8l8t1459r260b1531],
4	was	VBD	O	be	auxpass	5	SENT_119	[p8l289t1477r409b1514],
5	performed	VBN	O	perform	_	0	SENT_119	[p8l436t1459r768b1531],
6	to	TO	O	to	aux	7	SENT_119	[p8l794t1467r853b1514],
7	relate	VB	O	relate	xcomp	5	SENT_119	[p8l879t1459r1056b1514],
8	the	DT	O	the	det	10	SENT_119	[p8l1083t1459r1178b1514],
9	dose	NN	O	dose	nn	10	SENT_119	[p8l1205t1459r1674b1514],
10	—	NN	O	—	dobj	7	SENT_119	[p8l1205t1459r1674b1514],
11	corrected	VBN	O	correct	partmod	10	SENT_119	[p8l1205t1459r1674b1514],
12	plasma	NN	O	plasma	nn	18	SENT_119	[p8l1699t1459r1925b1531],
13	zuclo	NN	O	zuclo	nn	18	SENT_119	[p8l1951t1459r2146b1514],
14	—	NN	O	—	nn	18	SENT_119	[p8l1951t1459r2146b1514],
15	penthixol	NN	O	penthixol	nn	18	SENT_119	[p8l6t1540r307b1612],
16	(	CD	NUMBER	(	num	18	SENT_119	[p8l357t1540r537b1608],
17	C/D	NN	O	c/d	nn	18	SENT_119	[p8l357t1540r537b1608],
18	)	NN	O	)	nn	23	SENT_119	[p8l357t1540r537b1608],
19	concentrations	NNS	O	concentration	nn	20	SENT_119	[p8l588t1540r1050b1595],
20	(	NN	O	(	dep	18	SENT_119	[p8l1102t1540r1454b1612],
21	dependent	JJ	O	dependent	amod	22	SENT_119	[p8l1102t1540r1454b1612],
22	Variable	JJ	O	variable	amod	23	SENT_119	[p8l1501t1540r1781b1608],
23	)	NN	O	)	dobj	11	SENT_119	[p8l1501t1540r1781b1608],
24	with	IN	O	with	_	0	SENT_119	[p8l1832t1540r1972b1595],
25	age	NN	O	age	prep_with	11	SENT_119	[p8l2021t1557r2145b1612],
26	,	,	O	,	_	0	SENT_119	[p8l2021t1557r2145b1612],
27	gender	NN	O	gender	prep_with	11	SENT_119	[p8l8t1620r236b1692],
28	,	,	O	,	_	0	SENT_119	[p8l8t1620r236b1692],
29	presence	NN	O	presence	conj_or	25	SENT_119	[p8l262t1638r540b1692],
30	or	CC	O	or	_	0	SENT_119	[p8l565t1638r630b1676],
31	absence	NN	O	absence	conj_or	25	SENT_119	[p8l654t1620r903b1676],
32	of	IN	O	of	_	0	SENT_119	[p8l928t1620r997b1676],
33	smoking	NN	O	smoking	prep_of	25	SENT_119	[p8l1018t1620r1305b1692],
34	,	,	O	,	_	0	SENT_119	[p8l1018t1620r1305b1692],
35	duration	NN	O	duration	appos	25	SENT_119	[p8l1333t1620r1597b1676],
36	of	IN	O	of	_	0	SENT_119	[p8l1621t1620r1690b1676],
37	illness	NN	O	illness	prep_of	35	SENT_119	[p8l1709t1620r1928b1686],
38	,	,	O	,	_	0	SENT_119	[p8l1709t1620r1928b1686],
39	BPRS	NN	O	bpr	nn	40	SENT_119	[p8l1955t1621r2144b1676],
40	score	NN	NUMBER	score	appos	25	SENT_119	[p8l10t1719r173b1757],
41	and	CC	O	and	_	0	SENT_119	[p8l213t1701r325b1757],
42	CYPZD6	NN	O	cypzd6	nn	43	SENT_119	[p8l366t1701r646b1757],
43	genotype	NN	O	genotype	appos	25	SENT_119	[p8l682t1710r971b1773],
44	(	CD	NUMBER	(	num	47	SENT_119	[p8l1012t1701r1426b1773],
45	independent	JJ	O	independent	amod	47	SENT_119	[p8l1012t1701r1426b1773],
46	Variables	NNP	O	Variables	nn	47	SENT_119	[p8l1463t1701r1792b1770],
47	)	NN	O	)	dep	40	SENT_119	[p8l1463t1701r1792b1770],
48	.	.	O	.	_	0	SENT_119	[p8l1463t1701r1792b1770],

1	Statistical	JJ	O	statistical	amod	2	SENT_120	[p8l1836t1701r2148b1757],
2	significance	NN	O	significance	nsubjpass	7	SENT_120	[p8l10t1781r390b1853],
3	of	IN	O	of	_	0	SENT_120	[p8l415t1781r484b1836],
4	allele	NN	O	allele	nn	5	SENT_120	[p8l503t1781r672b1836],
5	frequencies	NNS	O	frequency	prep_of	2	SENT_120	[p8l696t1781r1060b1853],
6	was	VBD	O	be	auxpass	7	SENT_120	[p8l1085t1799r1205b1837],
7	assessed	VBN	O	assess	_	0	SENT_120	[p8l1231t1781r1499b1836],
8	using	VBG	O	use	xcomp	7	SENT_120	[p8l1521t1781r1691b1853],
9	the	DT	O	the	det	11	SENT_120	[p8l1715t1781r1809b1836],
10	X2	NN	O	x2	nn	11	SENT_120	[p8l1833t1778r1902b1852],
11	test	NN	O	test	dobj	8	SENT_120	[p8l1925t1789r2035b1836],
12	for	IN	O	for	_	0	SENT_120	[p8l2057t1781r2150b1836],
13	2x2	JJ	O	2x2	amod	14	SENT_120	[p8l8t1863r127b1917],
14	tables	NNS	O	table	prep_for	8	SENT_120	[p8l150t1863r351b1918],
15	.	.	O	.	_	0	SENT_120	[p8l150t1863r351b1918],

1	P	NN	O	p	nn	2	SENT_121	[p8l376t1865r425b1917],
2	Values	NNS	O	value	nsubjpass	8	SENT_121	[p8l447t1863r647b1918],
3	of	IN	O	of	_	0	SENT_121	[p8l673t1863r741b1918],
4	0.05	CD	NUMBER	0.05	prep_of	2	SENT_121	[p8l759t1863r892b1918],
5	or	CC	O	or	_	0	SENT_121	[p8l919t1881r984b1918],
6	less	JJR	O	less	prep_of	2	SENT_121	[p8l1006t1863r1121b1918],
7	were	VBD	O	be	auxpass	8	SENT_121	[p8l1146t1881r1298b1918],
8	considered	VBN	O	consider	_	0	SENT_121	[p8l1322t1863r1666b1918],
9	as	IN	O	as	_	0	SENT_121	[p8l1690t1881r1750b1918],
10	significant	JJ	O	significant	prep_as	8	SENT_121	[p8l1778t1863r2127b1935],
11	.	.	O	.	_	0	SENT_121	[p8l1778t1863r2127b1935],

1	Results	NNS	O	result	_	0	SENT_122	[p8l10t2118r305b2192],

1	Stability	NN	O	stability	_	0	SENT_123	[p8l9t2327r320b2410],
2	of	IN	O	of	_	0	SENT_123	[p8l349t2327r428b2391],
3	clinical	JJ	O	clinical	amod	4	SENT_123	[p8l450t2327r721b2391],
4	condition	NN	O	condition	prep_of	1	SENT_123	[p8l749t2327r1098b2391],
5	and	CC	O	and	_	0	SENT_123	[p8l1126t2327r1257b2391],
6	zuclopenthixol	NN	O	zuclopenthixol	nn	8	SENT_123	[p8l1283t2327r1834b2410],
7	plasma	NN	O	plasma	nn	8	SENT_123	[p8l1860t2327r2124b2410],
8	concentrations	NNS	O	concentration	prep_of	1	SENT_123	[p8l8t2425r546b2489],
9	throughout	IN	O	throughout	_	0	SENT_123	[p8l575t2425r983b2508],
10	the	DT	O	the	det	11	SENT_123	[p8l1008t2425r1119b2489],
11	study	NN	O	study	prep_throughout	1	SENT_123	[p8l1149t2425r1345b2508],

1	The	DT	O	the	det	3	SENT_124	[p8l7t2624r148b2688],
2	clinical	JJ	O	clinical	amod	3	SENT_124	[p8l190t2624r461b2688],
3	ratings	NNS	O	rating	nsubj	9	SENT_124	[p8l501t2624r751b2707],
4	of	IN	O	of	_	0	SENT_124	[p8l795t2624r874b2688],
5	the	DT	O	the	det	6	SENT_124	[p8l908t2624r1019b2688],
6	population	NN	O	population	prep_of	3	SENT_124	[p8l1059t2624r1457b2707],
7	studied	VBN	O	study	partmod	6	SENT_124	[p8l1500t2624r1764b2688],
8	remained	VBD	O	remain	cop	9	SENT_124	[p8l1802t2624r2149b2688],
9	stable	JJ	O	stable	_	0	SENT_124	[p8l10t2723r221b2787],
10	throughout	IN	O	throughout	_	0	SENT_124	[p8l268t2723r676b2806],
11	the	DT	O	the	det	14	SENT_124	[p8l721t2723r832b2787],
12	study	NN	O	study	nn	14	SENT_124	[p8l882t2723r1078b2806],
13	(	CD	NUMBER	(	num	14	SENT_124	[p8l1127t2722r1422b2802],
14	P	NN	O	p	prep_throughout	9	SENT_124	[p8l1127t2722r1422b2802],
15	=	JJ	O	=	amod	16	SENT_124	[p8l1127t2722r1422b2802],
16	O.	NNP	O	O.	tmod	9	SENT_124	[p8l1127t2722r1422b2802],
17	58	CD	NUMBER	58	num	16	SENT_124	[p8l1127t2722r1422b2802],
18	for	IN	O	for	_	0	SENT_124	[p8l1472t2723r1579b2787],
19	parkinsonism	NN	O	parkinsonism	prep_for	9	SENT_124	[p8l1623t2723r2144b2806],
20	,	,	O	,	_	0	SENT_124	[p8l1623t2723r2144b2806],
21	P	NN	O	p	dep	23	SENT_124	[p8l6t2822r275b2887],
22	=	JJ	O	=	amod	21	SENT_124	[p8l6t2822r275b2887],
23	O.	NNP	O	O.	ccomp	9	SENT_124	[p8l6t2822r275b2887],
24	36	CD	NUMBER	36	num	23	SENT_124	[p8l6t2822r275b2887],
25	for	IN	O	for	_	0	SENT_124	[p8l316t2822r424b2886],
26	TD	NN	O	td	prep_for	23	SENT_124	[p8l462t2824r602b2898],
27	,	,	O	,	_	0	SENT_124	[p8l462t2824r602b2898],
28	P	NN	O	p	dep	29	SENT_124	[p8l644t2823r913b2887],
29	=	JJ	O	=	ccomp	9	SENT_124	[p8l644t2823r913b2887],
30	0.39	CD	NUMBER	0.39	tmod	29	SENT_124	[p8l644t2823r913b2887],
31	for	IN	O	for	_	0	SENT_124	[p8l955t2822r1063b2886],
32	BPRS	JJ	O	bprs	amod	34	SENT_124	[p8l1101t2823r1321b2887],
33	score	NN	NUMBER	score	nn	34	SENT_124	[p8l1368t2823r1609b2901],
34	)	NN	O	)	prep_for	29	SENT_124	[p8l1368t2823r1609b2901],
35	.	.	O	.	_	0	SENT_124	[p8l1368t2823r1609b2901],

1	Neither	DT	O	neither	nsubj	2	SENT_125	[p8l1653t2822r1932b2886],
2	were	VBD	O	be	_	0	SENT_125	[p8l1970t2843r2147b2887],
3	there	EX	O	there	expl	6	SENT_125	[p8l7t2921r190b2985],
4	any	DT	O	any	det	6	SENT_125	[p8l241t2941r370b3004],
5	significant	JJ	O	significant	amod	6	SENT_125	[p8l422t2921r812b3004],
6	differences	NNS	O	difference	dep	2	SENT_125	[p8l860t2921r1268b2985],
7	in	IN	O	in	_	0	SENT_125	[p8l1318t2921r1388b2984],
8	the	DT	O	the	det	11	SENT_125	[p8l1436t2921r1547b2985],
9	zuclopenthixol	NN	O	zuclopenthixol	nn	11	SENT_125	[p8l1597t2921r2148b3004],
10	plasma	NN	O	plasma	nn	11	SENT_125	[p8l6t3020r270b3103],
11	concentrations	NNS	O	concentration	prep_in	6	SENT_125	[p8l330t3020r868b3084],
12	between	IN	O	between	_	0	SENT_125	[p8l930t3020r1239b3084],
13	week	NN	DURATION	week	nn	14	SENT_125	[p8l1300t3020r1495b3084],
14	o	NN	O	o	prep_between	11	SENT_125	[p8l1554t3021r1596b3084],
15	and	CC	O	and	_	0	SENT_125	[p8l1660t3020r1790b3084],
16	week	NN	DURATION	week	nn	19	SENT_125	[p8l1850t3020r2046b3084],
17	8	CD	NUMBER	8	num	19	SENT_125	[p8l2107t3021r2144b3084],
18	(	NN	O	(	nn	19	SENT_125	[p8l10t3119r358b3198],
19	P	NN	O	p	dep	23	SENT_125	[p8l10t3119r358b3198],
20	=	JJ	O	=	amod	19	SENT_125	[p8l10t3119r358b3198],
21	O.	NNP	O	O.	nn	23	SENT_125	[p8l10t3119r358b3198],
22	5l	NN	O	5l	nn	23	SENT_125	[p8l10t3119r358b3198],
23	)	NN	O	)	conj_and	6	SENT_125	[p8l10t3119r358b3198],
24	.	.	O	.	_	0	SENT_125	[p8l10t3119r358b3198],

1	Thus	RB	O	thus	advmod	18	SENT_126	[p8l411t3119r614b3195],
2	,	,	O	,	_	0	SENT_126	[p8l411t3119r614b3195],
3	the	DT	O	the	det	4	SENT_126	[p8l665t3119r776b3183],
4	results	NNS	O	result	nsubjpass	18	SENT_126	[p8l824t3119r1064b3183],
5	of	IN	O	of	_	0	SENT_126	[p8l1115t3119r1195b3183],
6	the	DT	O	the	det	8	SENT_126	[p8l1237t3119r1347b3183],
7	clinical	JJ	O	clinical	amod	8	SENT_126	[p8l1397t3119r1668b3183],
8	ratings	NNS	O	rating	prep_of	4	SENT_126	[p8l1715t3119r1966b3202],
9	and	CC	O	and	_	0	SENT_126	[p8l2018t3119r2148b3183],
10	zuclopenthixol	NN	O	zuclopenthixol	nn	12	SENT_126	[p8l8t3218r559b3301],
11	plasma	NN	O	plasma	nn	12	SENT_126	[p8l597t3218r860b3301],
12	concentrations	NNS	O	concentration	prep_of	4	SENT_126	[p8l898t3218r1437b3282],
13	from	IN	O	from	_	0	SENT_126	[p8l1478t3218r1657b3282],
14	the	DT	O	the	det	16	SENT_126	[p8l1695t3218r1805b3282],
15	baseline	NN	O	baseline	nn	16	SENT_126	[p8l1843t3218r2147b3282],
16	Visit	NN	O	visit	prep_from	12	SENT_126	[p8l7t3317r167b3381],
17	were	VBD	O	be	auxpass	18	SENT_126	[p8l192t3337r369b3381],
18	considered	VBN	O	consider	_	0	SENT_126	[p8l397t3317r799b3381],
19	appropriate	JJ	O	appropriate	acomp	18	SENT_126	[p8l827t3317r1246b3400],
20	for	IN	O	for	_	0	SENT_126	[p8l1274t3317r1381b3381],
21	further	JJ	O	further	amod	22	SENT_126	[p8l1406t3317r1659b3381],
22	analysis	NN	O	analysis	prep_for	18	SENT_126	[p8l1686t3317r2000b3400],
23	.	.	O	.	_	0	SENT_126	[p8l1686t3317r2000b3400],

1	C	NN	O	c	_	0	SENT_127	[p8l11t3560r70b3623],
2	YPZD6	NN	O	ypzd6	nn	3	SENT_127	[p8l74t3558r339b3622],
3	genotypes	NNS	O	genotype	dep	1	SENT_127	[p8l363t3568r735b3641],

1	Four	CD	NUMBER	four	num	2	SENT_128	[p9l7t67r185b129],
2	patients	NNS	O	patient	nsubjpass	8	SENT_128	[p9l293t65r586b148],
3	(	IN	O	(	_	0	SENT_128	[p9l702t66r882b144],
4	8	CD	PERCENT	8	num	5	SENT_128	[p9l702t66r882b144],
5	%	NN	PERCENT	%	prep_(	2	SENT_128	[p9l702t66r882b144],
6	)	CD	NUMBER	)	dep	5	SENT_128	[p9l702t66r882b144],
7	were	VBD	O	be	auxpass	8	SENT_128	[p9l996t86r1176b129],
8	genotyped	VBN	O	genotype	_	0	SENT_128	[p9l1289t65r1682b148],
9	as	IN	O	as	_	0	SENT_128	[p9l1794t86r1865b129],
10	PMS	NN	O	pm	nn	12	SENT_128	[p9l1978t67r2146b129],
11	(	CD	NUMBER	(	num	12	SENT_128	[p9l10t163r607b243],
12	CYP2D6	NN	O	cyp2d6	prep_as	8	SENT_128	[p9l10t163r607b243],
13	*	CD	NUMBER	*	number	14	SENT_128	[p9l10t163r607b243],
14	3	CD	NUMBER	3	dep	12	SENT_128	[p9l10t163r607b243],
15	/	:	O	/	punct	34	SENT_128	[p9l10t163r607b243],
16	*	CD	NUMBER	*	num	18	SENT_128	[p9l10t163r607b243],
17	4	CD	NUMBER	4	num	18	SENT_128	[p9l10t163r607b243],
18	)	NN	O	)	dep	24	SENT_128	[p9l10t163r607b243],
19	and	CC	O	and	_	0	SENT_128	[p9l669t163r800b227],
20	13	CD	PERCENT	13	num	21	SENT_128	[p9l865t164r942b228],
21	(	CD	PERCENT	(	conj_and	18	SENT_128	[p9l1007t163r1231b243],
22	25	CD	PERCENT	25	num	23	SENT_128	[p9l1007t163r1231b243],
23	%	NN	PERCENT	%	dep	24	SENT_128	[p9l1007t163r1231b243],
24	)	CD	NUMBER	)	dep	29	SENT_128	[p9l1007t163r1231b243],
25	as	IN	O	as	_	0	SENT_128	[p9l1293t184r1364b227],
26	heterozygous	JJ	O	heterozygous	amod	27	SENT_128	[p9l1422t164r1916b247],
27	EMS	NNP	O	EMS	prep_as	24	SENT_128	[p9l1975t165r2146b227],
28	(	CD	NUMBER	(	num	29	SENT_128	[p9l10t263r629b342],
29	CYP2D6	NN	O	cyp2d6	dep	30	SENT_128	[p9l10t263r629b342],
30	*	NN	O	*	dep	34	SENT_128	[p9l10t263r629b342],
31	1	CD	NUMBER	1	num	30	SENT_128	[p9l10t263r629b342],
32	/	:	O	/	punct	34	SENT_128	[p9l10t263r629b342],
33	*	CD	NUMBER	*	num	34	SENT_128	[p9l10t263r629b342],
34	4	CD	NUMBER	4	dep	14	SENT_128	[p9l10t263r629b342],
35	)	NN	O	)	dep	14	SENT_128	[p9l10t263r629b342],
36	.	.	O	.	_	0	SENT_128	[p9l10t263r629b342],

1	The	DT	O	the	det	4	SENT_129	[p9l677t263r818b327],
2	remaining	VBG	O	remain	amod	4	SENT_129	[p9l860t263r1236b346],
3	35	CD	PERCENT	35	number	4	SENT_129	[p9l1282t263r1366b327],
4	(	CD	PERCENT	(	_	0	SENT_129	[p9l1416t263r1640b342],
5	67	CD	PERCENT	67	num	6	SENT_129	[p9l1416t263r1640b342],
6	%	NN	PERCENT	%	dep	4	SENT_129	[p9l1416t263r1640b342],
7	)	CD	NUMBER	)	nsubj	13	SENT_129	[p9l1416t263r1640b342],
8	were	VBD	O	be	cop	13	SENT_129	[p9l1687t284r1864b327],
9	homozygous	JJ	O	homozygous	amod	13	SENT_129	[p9l1907t263r2145b327, p9l8t382r266b445],
10	EMS	NNP	O	EMS	dep	9	SENT_129	[p9l307t363r478b425],
11	(	CD	NUMBER	(	num	10	SENT_129	[p9l523t361r1141b441],
12	CYP2D6	NN	O	cyp2d6	nn	13	SENT_129	[p9l523t361r1141b441],
13	*	NN	O	*	rcmod	6	SENT_129	[p9l523t361r1141b441],
14	1	CD	NUMBER	1	dep	13	SENT_129	[p9l523t361r1141b441],
15	/	:	O	/	punct	17	SENT_129	[p9l523t361r1141b441],
16	*	CD	NUMBER	*	num	17	SENT_129	[p9l523t361r1141b441],
17	1	CD	NUMBER	1	dep	13	SENT_129	[p9l523t361r1141b441],
18	)	NN	O	)	dep	17	SENT_129	[p9l523t361r1141b441],
19	.	.	O	.	_	0	SENT_129	[p9l523t361r1141b441],

1	The	DT	O	the	det	3	SENT_130	[p9l1186t362r1327b425],
2	allele	NN	O	allele	nn	3	SENT_130	[p9l1369t361r1566b425],
3	frequencies	NNS	O	frequency	nsubj	14	SENT_130	[p9l1606t361r2032b445],
4	of	IN	O	of	_	0	SENT_130	[p9l2074t361r2154b425],
5	CYP2D6	NN	O	cyp2d6	prep_of	3	SENT_130	[p9l11t461r448b537],
6	*	CD	NUMBER	*	num	5	SENT_130	[p9l11t461r448b537],
7	I	PRP	O	I	dep	5	SENT_130	[p9l11t461r448b537],
8	,	,	O	,	_	0	SENT_130	[p9l11t461r448b537],
9	*	CD	NUMBER	*	number	10	SENT_130	[p9l506t462r584b525],
10	3	CD	NUMBER	3	appos	5	SENT_130	[p9l506t462r584b525],
11	and	CC	O	and	_	0	SENT_130	[p9l631t461r762b526],
12	*	CD	NUMBER	*	number	13	SENT_130	[p9l815t462r894b525],
13	4	CD	NUMBER	4	conj_and	10	SENT_130	[p9l815t462r894b525],
14	were	VBD	O	be	_	0	SENT_130	[p9l939t482r1116b526],
15	thus	RB	O	thus	advmod	14	SENT_130	[p9l1160t461r1311b526],
16	0.80	CD	NUMBER	0.80	tmod	14	SENT_130	[p9l1357t462r1537b537],
17	,	,	O	,	_	0	SENT_130	[p9l1357t462r1537b537],
18	0.04	CD	NUMBER	0.04	num	16	SENT_130	[p9l1585t462r1744b526],
19	and	CC	O	and	_	0	SENT_130	[p9l1790t461r1921b526],
20	0.16	CD	NUMBER	0.16	tmod	14	SENT_130	[p9l1965t461r2144b537],
21	,	,	O	,	_	0	SENT_130	[p9l1965t461r2144b537],
22	respectively	RB	O	respectively	advmod	14	SENT_130	[p9l6t560r468b643],
23	.	.	O	.	_	0	SENT_130	[p9l6t560r468b643],

1	Steady	JJ	O	steady	amod	3	SENT_131	[p9l9t802r460b885],
2	—	NN	O	—	nn	3	SENT_131	[p9l9t802r460b885],
3	state	NN	O	state	_	0	SENT_131	[p9l9t802r460b885],
4	plasma	NN	O	plasma	nn	5	SENT_131	[p9l486t802r750b885],
5	concentrations	NNS	O	concentration	dep	3	SENT_131	[p9l776t801r1315b865],
6	of	IN	O	of	_	0	SENT_131	[p9l1345t801r1424b865],
7	zuclopenthixol	NN	O	zuclopenthixol	nn	11	SENT_131	[p9l1446t801r1997b885],
8	and	CC	O	and	_	0	SENT_131	[p9l9t900r139b964],
9	C	NN	O	c	nn	11	SENT_131	[p9l170t902r228b965],
10	YPZD6	NN	O	ypzd6	nn	11	SENT_131	[p9l233t900r497b964],
11	genotype	NN	O	genotype	prep_of	5	SENT_131	[p9l521t909r858b983],

1	The	DT	O	the	det	2	SENT_132	[p9l7t1087r148b1151],
2	patients	NNS	O	patient	nsubj	3	SENT_132	[p9l176t1087r463b1170],
3	received	VBD	O	receive	_	0	SENT_132	[p9l492t1087r808b1151],
4	a	DT	O	a	det	5	SENT_132	[p9l837t1107r875b1151],
5	dose	NN	O	dose	dobj	3	SENT_132	[p9l903t1087r1069b1151],
6	of	IN	O	of	_	0	SENT_132	[p9l1099t1087r1179b1151],
7	ZD	NN	O	zd	prep_of	5	SENT_132	[p9l1200t1089r1320b1150],
8	ranging	VBG	O	range	partmod	7	SENT_132	[p9l1349t1087r1631b1170],
9	from	IN	O	from	_	0	SENT_132	[p9l1661t1087r1840b1151],
10	100	CD	NUMBER	100	num	11	SENT_132	[p9l1876t1087r2003b1151],
11	mg	NN	O	mg	prep_from	8	SENT_132	[p9l2032t1107r2147b1170],
12	to	TO	O	to	_	0	SENT_132	[p9l7t1196r76b1250],
13	400	CD	NUMBER	400	num	14	SENT_132	[p9l104t1187r240b1251],
14	mg	NN	O	mg	prep_to	8	SENT_132	[p9l269t1207r384b1269],
15	per	IN	O	per	_	0	SENT_132	[p9l411t1207r531b1269],
16	4	CD	DURATION	4	num	17	SENT_132	[p9l556t1187r599b1249],
17	weeks	NNS	NUMBER	week	prep_per	14	SENT_132	[p9l628t1186r876b1251],
18	.	.	O	.	_	0	SENT_132	[p9l628t1186r876b1251],

1	There	EX	O	there	expl	2	SENT_133	[p9l909t1186r1123b1250],
2	was	VBD	O	be	_	0	SENT_133	[p9l1151t1207r1291b1251],
3	no	DT	O	no	det	4	SENT_133	[p9l1320t1207r1409b1250],
4	difference	NN	O	difference	nsubj	2	SENT_133	[p9l1440t1186r1812b1250],
5	between	IN	O	between	_	0	SENT_133	[p9l1839t1186r2148b1251],
6	the	DT	O	the	det	9	SENT_133	[p9l7t1285r118b1349],
7	three	CD	NUMBER	three	num	9	SENT_133	[p9l165t1285r349b1349],
8	genotype	NN	O	genotype	nn	9	SENT_133	[p9l398t1295r735b1368],
9	groups	NNS	O	group	prep_between	4	SENT_133	[p9l784t1305r1032b1368],
10	with	IN	O	with	_	0	SENT_133	[p9l1082t1285r1245b1349],
11	respect	NN	O	respect	prep_with	9	SENT_133	[p9l1291t1294r1555b1368],
12	to	TO	O	to	_	0	SENT_133	[p9l1600t1295r1669b1349],
13	duration	NN	O	duration	prep_to	2	SENT_133	[p9l1718t1285r2026b1349],
14	of	IN	O	of	_	0	SENT_133	[p9l2075t1285r2154b1349],
15	treatment	NN	O	treatment	prep_of	13	SENT_133	[p9l7t1394r358b1448],
16	with	IN	O	with	_	0	SENT_133	[p9l404t1384r567b1449],
17	ZD	NN	O	zd	prep_with	2	SENT_133	[p9l613t1386r733b1447],
18	(	CD	NUMBER	(	number	19	SENT_133	[p9l784t1385r970b1464],
19	31.7	CD	DURATION	31.7	num	20	SENT_133	[p9l784t1385r970b1464],
20	months	NNS	NUMBER	month	npadvmod	17	SENT_133	[p9l1020t1384r1289b1448],
21	in	IN	O	in	_	0	SENT_133	[p9l1338t1384r1408b1447],
22	homozygous	JJ	O	homozygous	amod	23	SENT_133	[p9l1454t1384r1926b1467],
23	EMS	NN	O	em	prep_in	17	SENT_133	[p9l1975t1386r2146b1448],
24	and	CC	O	and	_	0	SENT_133	[p9l9t1483r139b1547],
25	heterozygous	JJ	O	heterozygous	amod	27	SENT_133	[p9l166t1483r659b1566],
26	EM	NN	O	em	nn	27	SENT_133	[p9l689t1485r825b1546],
27	groups	NNS	O	group	prep_in	17	SENT_133	[p9l855t1503r1102b1566],
28	and	CC	O	and	_	0	SENT_133	[p9l1135t1483r1265b1547],
29	32.2	CD	DURATION	32.2	num	30	SENT_133	[p9l1294t1483r1452b1547],
30	months	NNS	NUMBER	month	prep_with	2	SENT_133	[p9l1481t1483r1750b1547],
31	in	IN	O	in	_	0	SENT_133	[p9l1780t1483r1850b1546],
32	the	DT	O	the	det	34	SENT_133	[p9l1877t1483r1988b1547],
33	PM	NNP	O	PM	nn	34	SENT_133	[p9l2017t1485r2147b1546],
34	group	NN	O	group	prep_in	30	SENT_133	[p9l8t1603r244b1665],
35	;	:	O	;	_	0	SENT_133	[p9l8t1603r244b1665],
36	P	NN	O	p	dep	30	SENT_133	[p9l278t1583r552b1662],
37	=	JJ	O	=	amod	36	SENT_133	[p9l278t1583r552b1662],
38	O.	NNP	O	O.	nn	40	SENT_133	[p9l278t1583r552b1662],
39	9	CD	NUMBER	9	num	40	SENT_133	[p9l278t1583r552b1662],
40	)	NN	O	)	dep	36	SENT_133	[p9l278t1583r552b1662],
41	.	.	O	.	_	0	SENT_133	[p9l278t1583r552b1662],

1	Dose	NN	O	dose	nsubj	11	SENT_134	[p9l588t1584r776b1646],
2	of	IN	O	of	_	0	SENT_134	[p9l810t1582r889b1646],
3	ZD	NN	O	zd	prep_of	1	SENT_134	[p9l914t1584r1034b1645],
4	in	IN	O	in	_	0	SENT_134	[p9l1067t1582r1137b1645],
5	the	DT	O	the	det	8	SENT_134	[p9l1168t1582r1279b1646],
6	three	CD	NUMBER	three	num	8	SENT_134	[p9l1311t1582r1494b1646],
7	genotype	NN	O	genotype	nn	8	SENT_134	[p9l1527t1592r1865b1665],
8	groups	NNS	O	group	prep_in	3	SENT_134	[p9l1898t1603r2145b1665],
9	did	VBD	O	do	aux	11	SENT_134	[p9l8t1681r124b1745],
10	not	RB	O	not	neg	11	SENT_134	[p9l158t1690r275b1745],
11	differ	VB	O	differ	_	0	SENT_134	[p9l309t1681r513b1745],
12	significantly	RB	O	significantly	advmod	11	SENT_134	[p9l548t1681r1009b1764],
13	(	CD	NUMBER	(	number	14	SENT_134	[p9l1047t1681r1281b1760],
14	212.4	CD	NUMBER	212.4	num	16	SENT_134	[p9l1047t1681r1281b1760],
15	mg/4	NN	O	mg/4	nn	16	SENT_134	[p9l1316t1681r1504b1764],
16	weeks	NNS	DURATION	week	dobj	11	SENT_134	[p9l1540t1681r1767b1745],
17	in	IN	O	in	_	0	SENT_134	[p9l1804t1681r1873b1744],
18	homozygous	JJ	O	homozygous	amod	19	SENT_134	[p9l1907t1681r2145b1745, p9l8t1801r266b1863],
19	EMS	NNP	ORGANIZATION	EMS	prep_in	16	SENT_134	[p9l300t1782r493b1856],
20	,	,	O	,	_	0	SENT_134	[p9l300t1782r493b1856],
21	246	CD	NUMBER	246	num	23	SENT_134	[p9l530t1780r665b1845],
22	mg/4	NN	O	mg/4	nn	23	SENT_134	[p9l698t1781r886b1863],
23	weeks	NNS	DURATION	week	dobj	11	SENT_134	[p9l920t1780r1147b1845],
24	in	IN	O	in	_	0	SENT_134	[p9l1181t1780r1252b1843],
25	heterozygous	JJ	O	heterozygous	amod	26	SENT_134	[p9l1283t1780r1776b1863],
26	EMS	NN	ORGANIZATION	em	prep_in	23	SENT_134	[p9l1810t1782r1981b1844],
27	and	CC	O	and	_	0	SENT_134	[p9l2018t1780r2148b1844],
28	200	CD	NUMBER	200	num	30	SENT_134	[p9l8t1879r143b1943],
29	mg/4	NN	O	mg/4	nn	30	SENT_134	[p9l217t1879r405b1962],
30	weeks	NNS	DURATION	week	conj_and	16	SENT_134	[p9l480t1879r707b1943],
31	in	IN	O	in	_	0	SENT_134	[p9l783t1879r853b1942],
32	PMS	NN	O	pm	prep_in	30	SENT_134	[p9l926t1880r1116b1955],
33	;	:	O	;	_	0	SENT_134	[p9l926t1880r1116b1955],
34	Kruskal	NNP	PERSON	Kruskal	dep	30	SENT_134	[p9l1195t1879r1751b1943],
35	.	.	O	.	_	0	SENT_134	[p9l1195t1879r1751b1943],

1	—	NN	O	—	_	0	SENT_135	[p9l1195t1879r1751b1943],
2	.	.	O	.	_	0	SENT_135	[p9l1195t1879r1751b1943],

1	Wallis	NNP	PERSON	Wallis	nn	3	SENT_136	[p9l1195t1879r1751b1943],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_136	[p9l1827t1879r2148b1943],
3	P	NN	O	p	nsubj	4	SENT_136	[p9l6t1979r280b2058],
4	=	JJ	O	=	_	0	SENT_136	[p9l6t1979r280b2058],
5	0.2	CD	NUMBER	0.2	num	6	SENT_136	[p9l6t1979r280b2058],
6	)	NN	O	)	dobj	4	SENT_136	[p9l6t1979r280b2058],
7	.	.	O	.	_	0	SENT_136	[p9l6t1979r280b2058],

1	The	DT	O	the	det	5	SENT_137	[p9l312t1978r453b2042],
2	median	JJ	O	median	amod	5	SENT_137	[p9l480t1978r752b2042],
3	absolute	JJ	O	absolute	amod	5	SENT_137	[p9l780t1978r1086b2042],
4	plasma	NN	O	plasma	nn	5	SENT_137	[p9l1112t1978r1376b2061],
5	concentrations	NNS	O	concentration	nsubj	6	SENT_137	[p9l1402t1978r1941b2042],
6	were	VBD	O	be	_	0	SENT_137	[p9l1970t1999r2147b2043],
7	5.9	CD	NUMBER	5.9	num	10	SENT_137	[p9l8t2076r118b2142],
8	nmol/l	NN	O	nmol/l	nn	10	SENT_137	[p9l179t2077r420b2141],
9	(	NN	O	(	nn	10	SENT_137	[p9l481t2077r713b2160],
10	range	NN	O	range	dep	23	SENT_137	[p9l481t2077r713b2160],
11	2.1	CD	NUMBER	2.1	number	12	SENT_137	[p9l774t2077r1022b2141],
12	—	CD	NUMBER	—	dep	10	SENT_137	[p9l774t2077r1022b2141],
13	28	CD	NUMBER	28	num	15	SENT_137	[p9l774t2077r1022b2141],
14	nmol/1	NN	O	nmol/1	nn	15	SENT_137	[p9l1084t2077r1379b2156],
15	)	NN	O	)	dep	12	SENT_137	[p9l1084t2077r1379b2156],
16	;	:	O	;	_	0	SENT_137	[p9l1084t2077r1379b2156],
17	8.2	CD	NUMBER	8.2	num	19	SENT_137	[p9l1445t2077r1554b2141],
18	nmol/l	NN	O	nmol/l	nn	19	SENT_137	[p9l1613t2077r1854b2141],
19	(	NN	O	(	dep	12	SENT_137	[p9l1915t2078r2147b2160],
20	range	NN	O	range	dep	23	SENT_137	[p9l1915t2078r2147b2160],
21	5.6	CD	NUMBER	5.6	num	20	SENT_137	[p9l8t2176r330b2241],
22	—	CD	NUMBER	—	number	23	SENT_137	[p9l8t2176r330b2241],
23	36.4	CD	NUMBER	36.4	dep	6	SENT_137	[p9l8t2176r330b2241],
24	nmol/l	NN	O	nmol/l	nn	25	SENT_137	[p9l359t2176r629b2256],
25	)	NN	O	)	dep	23	SENT_137	[p9l359t2176r629b2256],
26	and	CC	O	and	_	0	SENT_137	[p9l661t2176r792b2240],
27	9.5	CD	NUMBER	9.5	num	30	SENT_137	[p9l821t2176r929b2241],
28	nmol/l	NN	O	nmol/l	nn	30	SENT_137	[p9l962t2176r1203b2241],
29	(	NN	O	(	nn	30	SENT_137	[p9l1234t2177r1466b2259],
30	range	NN	O	range	conj_and	23	SENT_137	[p9l1234t2177r1466b2259],
31	6.8	CD	NUMBER	6.8	number	32	SENT_137	[p9l1497t2176r1747b2241],
32	—	CD	NUMBER	—	dep	30	SENT_137	[p9l1497t2176r1747b2241],
33	16	CD	NUMBER	16	num	35	SENT_137	[p9l1497t2176r1747b2241],
34	nmol/l	NN	O	nmol/l	nn	35	SENT_137	[p9l1777t2176r2047b2256],
35	)	NN	O	)	dep	32	SENT_137	[p9l1777t2176r2047b2256],
36	in	IN	O	in	_	0	SENT_137	[p9l2078t2176r2148b2239],
37	homozygous	JJ	O	homozygous	amod	38	SENT_137	[p9l6t2275r478b2358],
38	EMS	NNP	ORGANIZATION	EMS	prep_in	6	SENT_137	[p9l515t2276r709b2351],
39	,	,	O	,	_	0	SENT_137	[p9l515t2276r709b2351],
40	heterozygous	JJ	O	heterozygous	amod	41	SENT_137	[p9l747t2275r1240b2358],
41	EMS	NNP	ORGANIZATION	EMS	prep_in	6	SENT_137	[p9l1278t2276r1449b2339],
42	and	CC	O	and	_	0	SENT_137	[p9l1489t2275r1619b2339],
43	PMS	NNP	O	PMS	prep_in	6	SENT_137	[p9l1654t2276r1842b2351],
44	,	,	O	,	_	0	SENT_137	[p9l1654t2276r1842b2351],
45	respectively	RB	O	respectively	advmod	6	SENT_137	[p9l1880t2295r2145b2358, p9l7t2374r230b2457],
46	.	.	O	.	_	0	SENT_137	[p9l1880t2295r2145b2358, p9l7t2374r230b2457],

1	Statistically	RB	O	statistically	advmod	2	SENT_138	[p9l293t2374r729b2457],
2	significant	JJ	O	significant	amod	3	SENT_138	[p9l789t2374r1178b2457],
3	differences	NNS	O	difference	nsubjpass	5	SENT_138	[p9l1234t2374r1641b2438],
4	were	VBD	O	be	auxpass	5	SENT_138	[p9l1699t2395r1877b2438],
5	found	VBN	O	find	_	0	SENT_138	[p9l1933t2374r2149b2438],
6	between	IN	O	between	_	0	SENT_138	[p9l6t2473r315b2537],
7	homozygous	JJ	O	homozygous	amod	8	SENT_138	[p9l392t2473r864b2556],
8	EMS	NN	O	em	prep_between	5	SENT_138	[p9l943t2474r1114b2537],
9	and	CC	O	and	_	0	SENT_138	[p9l1195t2473r1326b2537],
10	heterozygous	JJ	O	heterozygous	amod	13	SENT_138	[p9l1402t2473r1895b2556],
11	EMS	NNP	O	EMS	nn	13	SENT_138	[p9l1974t2474r2146b2537],
12	(	CD	NUMBER	(	num	13	SENT_138	[p9l10t2572r596b2652],
13	Kruskal-Wallis	NN	O	kruskal-walli	prep_between	5	SENT_138	[p9l10t2572r596b2652],
14	ANOVA	NNP	O	ANOVA	nn	15	SENT_138	[p9l666t2573r987b2637],
15	P	NN	O	p	dep	8	SENT_138	[p9l1053t2573r1353b2652],
16	=	JJ	O	=	advmod	8	SENT_138	[p9l1053t2573r1353b2652],
17	0.02	CD	NUMBER	0.02	num	18	SENT_138	[p9l1053t2573r1353b2652],
18	)	NN	O	)	dep	16	SENT_138	[p9l1053t2573r1353b2652],
19	and	CC	O	and	_	0	SENT_138	[p9l1426t2572r1557b2636],
20	also	RB	O	also	conj_and	16	SENT_138	[p9l1626t2572r1770b2636],
21	between	IN	O	between	_	0	SENT_138	[p9l1839t2572r2148b2637],
22	homozygous	JJ	O	homozygous	amod	23	SENT_138	[p9l6t2671r474b2754],
23	EMS	NNP	ORGANIZATION	EMS	prep_between	8	SENT_138	[p9l505t2672r675b2735],
24	and	CC	O	and	_	0	SENT_138	[p9l708t2671r837b2735],
25	PMS	NNP	O	PMS	nn	27	SENT_138	[p9l865t2672r1030b2735],
26	(	CD	NUMBER	(	num	27	SENT_138	[p9l1064t2671r1408b2750],
27	P	NN	O	p	conj_and	8	SENT_138	[p9l1064t2671r1408b2750],
28	=	JJ	O	=	amod	30	SENT_138	[p9l1064t2671r1408b2750],
29	0.03	CD	NUMBER	0.03	tmod	28	SENT_138	[p9l1064t2671r1408b2750],
30	)	NN	O	)	dep	27	SENT_138	[p9l1064t2671r1408b2750],
31	.	.	O	.	_	0	SENT_138	[p9l1064t2671r1408b2750],

1	The	DT	O	the	det	2	SENT_139	[p9l1442t2671r1582b2735],
2	concentrations	NNS	O	concentration	_	0	SENT_139	[p9l1613t2671r2146b2735],

1	0,16	CD	NUMBER	0,16	num	2	SENT_140	[p10l117t76r201b116],
2	p	NN	O	p	_	0	SENT_140	[p10l1335t52r1472b95],
3	=	JJ	O	=	amod	2	SENT_140	[p10l1335t52r1472b95],
4	0.03	CD	NUMBER	0.03	tmod	3	SENT_140	[p10l1335t52r1472b95],

1	p	NN	O	p	_	0	SENT_141	[p10l833t145r997b189],
2	=	JJ	O	=	amod	1	SENT_141	[p10l833t145r997b189],
3	0.014	CD	NUMBER	0.014	tmod	2	SENT_141	[p10l833t145r997b189],

1	_	NN	O	_	nn	4	SENT_142	[p10l12t441r35b451],
2	0,12	CD	NUMBER	0,12	num	4	SENT_142	[p10l117t405r201b447],
3	'	''	O	'	_	0	SENT_142	[p10l23t455r73b493],
4	o	NN	O	o	dep	13	SENT_142	[p10l23t455r73b493],
5	:	:	O	:	_	0	SENT_142	[p10l23t455r73b493],
6	E	NNP	O	E	dep	12	SENT_142	[p10l36t498r62b545],
7	'	POS	O	'	_	0	SENT_142	[p10l23t565r62b621],
8	2	CD	NUMBER	2	number	9	SENT_142	[p10l23t565r62b621],
9	0,10	CD	NUMBER	0,10	num	6	SENT_142	[p10l117t569r201b611],
10	8	CD	NUMBER	8	dep	6	SENT_142	[p10l36t626r64b687],
11	8	CD	NUMBER	8	dep	6	SENT_142	[p10l1180t631r1208b676],
12	C	NN	O	c	dep	13	SENT_142	[p10l36t695r62b716],
13	Q	NNP	O	Q	dep	22	SENT_142	[p10l26t734r64b779],
14	0,08	CD	NUMBER	0,08	num	17	SENT_142	[p10l117t734r201b775],
15	o	NN	O	o	nn	17	SENT_142	[p10l1661t745r1689b773],
16	O	NN	O	o	nn	17	SENT_142	[p10l26t780r64b813],
17	O	NN	O	o	dep	13	SENT_142	[p10l703t794r730b822],
18	o	NN	O	o	nn	20	SENT_142	[p10l1180t780r1208b808],
19	2	CD	NUMBER	2	num	20	SENT_142	[p10l26t839r64b895],
20	o	NN	O	o	dep	17	SENT_142	[p10l1180t853r1208b881],
21	£	CD	MONEY	£	num	22	SENT_142	[p10l26t902r64b938],
22	0,06	CD	MONEY	0,06	_	0	SENT_142	[p10l117t899r201b939],

1	§	NN	O	§	nn	6	SENT_143	[p10l36t942r71b1015],
2	o	NN	O	o	nn	6	SENT_143	[p10l703t975r730b1003],
3	o	NN	O	o	nn	6	SENT_143	[p10l1661t978r1689b1006],
4	o	NN	O	o	nn	6	SENT_143	[p10l36t1019r64b1044],
5	o	NN	O	o	nn	6	SENT_143	[p10l703t1008r730b1037],
6	o	NN	O	o	_	0	SENT_143	[p10l1180t1019r1208b1047],
7	7	CD	NUMBER	7	number	8	SENT_143	[p10l1624t1018r1728b1058],
8	‘	CD	NUMBER	‘	dep	6	SENT_143	[p10l26t1048r64b1079],
9	-9	CD	NUMBER	-9	dep	8	SENT_143	[p10l26t1048r64b1079],
10	004	CD	NUMBER	004	number	11	SENT_143	[p10l117t1063r201b1098],
11	9	CD	NUMBER	9	dep	6	SENT_143	[p10l703t1040r730b1091],
12	3	CD	NUMBER	3	num	13	SENT_143	[p10l36t1082r64b1129],
13	~	NN	O	~	dep	11	SENT_143	[p10l143t1092r149b1104],
14	.	.	O	.	_	0	SENT_143	[p10l1140t1065r1246b1158],

1	—	NN	O	—	_	0	SENT_144	[p10l1140t1065r1246b1158],
2	.	.	O	.	_	0	SENT_144	[p10l1140t1065r1246b1158],

1	§	NN	O	§	nn	2	SENT_145	[p10l1140t1065r1246b1158],
2	o	NN	O	o	_	0	SENT_145	[p10l1661t1124r1689b1151],

1	EM	NNP	O	EM	nn	3	SENT_146	[p10l514t1442r562b1473],
2	homozygous	JJ	O	homozygous	amod	3	SENT_146	[p10l583t1442r803b1482],
3	n	NN	O	n	_	0	SENT_146	[p10l821t1442r905b1474],
4	=	JJ	O	=	amod	12	SENT_146	[p10l821t1442r905b1474],
5	35	CD	NUMBER	35	num	6	SENT_146	[p10l821t1442r905b1474],
6	EM	NN	O	em	npadvmod	7	SENT_146	[p10l988t1442r1037b1473],
7	heterozygous	JJ	O	heterozygous	amod	12	SENT_146	[p10l1056t1442r1291b1482],
8	n	NN	O	n	nn	12	SENT_146	[p10l1310t1442r1394b1474],
9	=	JJ	O	=	amod	12	SENT_146	[p10l1310t1442r1394b1474],
10	13	CD	TIME	13	num	12	SENT_146	[p10l1310t1442r1394b1474],
11	PM	NN	TIME	pm	nn	12	SENT_146	[p10l1605t1442r1655b1473],
12	n	NN	O	n	dep	3	SENT_146	[p10l1675t1442r1739b1473],
13	=	JJ	O	=	amod	12	SENT_146	[p10l1675t1442r1739b1473],
14	4	CD	NUMBER	4	tmod	13	SENT_146	[p10l1675t1442r1739b1473],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_147	[p10l950t1524r1122b1559],
2	genotype	NN	O	genotype	_	0	SENT_147	[p10l1142t1527r1326b1569],

1	Fig	NN	O	fig	_	0	SENT_148	[p10l7t1656r135b1728],
2	.	.	O	.	_	0	SENT_148	[p10l7t1656r135b1728],

1	1	CD	NUMBER	1	_	0	SENT_149	[p10l163t1657r193b1712],
2	The	DT	O	the	det	4	SENT_149	[p10l239t1657r361b1712],
3	plasma	NN	O	plasma	nn	4	SENT_149	[p10l401t1657r627b1729],
4	concentration	NN	O	concentration	dep	1	SENT_149	[p10l668t1657r1362b1712],
5	—	CD	NUMBER	—	number	7	SENT_149	[p10l668t1657r1362b1712],
6	to	TO	O	to	dep	7	SENT_149	[p10l668t1657r1362b1712],
7	—	CD	NUMBER	—	dep	4	SENT_149	[p10l668t1657r1362b1712],
8	dose	NN	O	dose	nn	10	SENT_149	[p10l668t1657r1362b1712],
9	(	NN	O	(	nn	10	SENT_149	[p10l1406t1657r1586b1726],
10	C/D	NN	O	c/d	dep	7	SENT_149	[p10l1406t1657r1586b1726],
11	)	CD	NUMBER	)	num	12	SENT_149	[p10l1406t1657r1586b1726],
12	ratios	NNS	O	ratio	dep	1	SENT_149	[p10l1628t1657r1803b1712],
13	of	IN	O	of	_	0	SENT_149	[p10l1847t1657r1915b1712],
14	zuclo	NN	O	zuclo	nn	16	SENT_149	[p10l1952t1657r2146b1712],
15	—	NN	O	—	nn	16	SENT_149	[p10l1952t1657r2146b1712],
16	penthixol	NN	O	penthixol	prep_of	12	SENT_149	[p10l7t1737r308b1809],
17	in	IN	O	in	_	0	SENT_149	[p10l333t1737r393b1791],
18	relation	NN	O	relation	prep_in	16	SENT_149	[p10l418t1737r661b1792],
19	to	TO	O	to	_	0	SENT_149	[p10l687t1745r746b1792],
20	the	DT	O	the	det	23	SENT_149	[p10l773t1737r868b1792],
21	C	NN	O	c	nn	23	SENT_149	[p10l898t1738r948b1793],
22	YPZD6	NN	O	ypzd6	nn	23	SENT_149	[p10l952t1737r1178b1792],
23	genotype	NN	O	genotype	prep_to	18	SENT_149	[p10l1202t1745r1491b1809],
24	in	IN	O	in	_	0	SENT_149	[p10l1518t1737r1578b1791],
25	52	CD	NUMBER	52	num	27	SENT_149	[p10l1604t1737r1680b1792],
26	schizophrenic	JJ	O	schizophrenic	amod	27	SENT_149	[p10l1710t1737r2147b1809],
27	patients	NNS	O	patient	prep_in	23	SENT_149	[p10l7t1818r252b1890],
28	on	IN	O	on	_	0	SENT_149	[p10l283t1835r360b1873],
29	maintenance	NN	O	maintenance	nn	30	SENT_149	[p10l387t1818r788b1873],
30	treatment	NN	O	treatment	prep_on	27	SENT_149	[p10l816t1826r1117b1873],
31	with	IN	O	with	_	0	SENT_149	[p10l1143t1818r1284b1873],
32	zuclopenthixol	NN	O	zuclopenthixol	nn	33	SENT_149	[p10l1311t1818r1784b1890],
33	decanoate	NN	O	decanoate	prep_with	30	SENT_149	[p10l1812t1818r2145b1873],
34	.	.	O	.	_	0	SENT_149	[p10l1812t1818r2145b1873],

1	The	DT	O	the	det	2	SENT_150	[p10l8t1899r129b1954],
2	median	NN	O	median	nsubjpass	7	SENT_150	[p10l152t1898r385b1954],
3	in	IN	O	in	_	0	SENT_150	[p10l407t1898r467b1953],
4	each	DT	O	each	det	5	SENT_150	[p10l490t1899r634b1954],
5	group	NN	O	group	prep_in	2	SENT_150	[p10l658t1916r840b1970],
6	is	VBZ	O	be	auxpass	7	SENT_150	[p10l863t1898r912b1954],
7	indicated	VBN	O	indicate	dep	14	SENT_150	[p10l937t1898r1229b1954],
8	by	IN	O	by	_	0	SENT_150	[p10l1250t1899r1327b1970],
9	a	DT	O	a	det	11	SENT_150	[p10l1352t1916r1385b1954],
10	horizontal	JJ	O	horizontal	amod	11	SENT_150	[p10l1407t1898r1734b1960],
11	line	NN	O	line	agent	7	SENT_150	[p10l1758t1899r1872b1954],
12	did	VBD	O	do	aux	14	SENT_150	[p10l9t2128r125b2192],
13	not	RB	O	not	neg	14	SENT_150	[p10l168t2138r286b2192],
14	differ	VB	O	differ	_	0	SENT_150	[p10l330t2128r534b2192],
15	significantly	RB	O	significantly	advmod	14	SENT_150	[p10l579t2128r1040b2212],
16	between	IN	O	between	_	0	SENT_150	[p10l1084t2128r1393b2193],
17	heterozygous	JJ	O	heterozygous	amod	18	SENT_150	[p10l1436t2129r1929b2212],
18	EMS	NNP	ORGANIZATION	EMS	prep_between	14	SENT_150	[p10l1975t2130r2146b2192],
19	and	CC	O	and	_	0	SENT_150	[p10l9t2228r140b2292],
20	PMS	NNP	O	PMS	conj_and	18	SENT_150	[p10l166t2230r331b2292],
21	(	CD	NUMBER	(	num	22	SENT_150	[p10l363t2229r711b2307],
22	P	NN	O	p	nsubj	14	SENT_150	[p10l363t2229r711b2307],
23	=	JJ	O	=	amod	22	SENT_150	[p10l363t2229r711b2307],
24	0.09	CD	NUMBER	0.09	num	25	SENT_150	[p10l363t2229r711b2307],
25	)	NN	O	)	dep	23	SENT_150	[p10l363t2229r711b2307],
26	.	.	O	.	_	0	SENT_150	[p10l363t2229r711b2307],

1	Due	JJ	O	due	_	0	SENT_151	[p10l120t2328r272b2391],
2	to	TO	O	to	_	0	SENT_151	[p10l312t2336r381b2391],
3	individual	JJ	O	individual	amod	5	SENT_151	[p10l422t2326r798b2391],
4	dose	NN	O	dose	nn	5	SENT_151	[p10l839t2327r1006b2391],
5	Variation	NN	O	variation	prep_due_to	13	SENT_151	[p10l1047t2326r1396b2403],
6	,	,	O	,	_	0	SENT_151	[p10l1047t2326r1396b2403],
7	the	DT	O	the	det	9	SENT_151	[p10l1440t2327r1551b2391],
8	measured	VBN	O	measure	amod	9	SENT_151	[p10l1591t2326r1946b2391],
9	concentrations	NNS	O	concentration	nsubjpass	13	SENT_151	[p10l1987t2347r2146b2391, p10l8t2426r413b2490],
10	of	IN	O	of	_	0	SENT_151	[p10l477t2426r557b2490],
11	zuclopenthixol	NN	O	zuclopenthixol	prep_of	9	SENT_151	[p10l613t2426r1164b2509],
12	were	VBD	O	be	auxpass	13	SENT_151	[p10l1225t2447r1403b2490],
13	corrected	VBN	O	correct	_	0	SENT_151	[p10l1466t2426r1810b2490],
14	for	IN	O	for	_	0	SENT_151	[p10l1871t2426r1978b2490],
15	the	DT	O	the	det	16	SENT_151	[p10l2038t2426r2148b2490],
16	dose	NN	O	dose	prep_for	13	SENT_151	[p10l9t2525r195b2588],
17	.	.	O	.	_	0	SENT_151	[p10l9t2525r195b2588],

1	Ratios	NNS	O	ratio	nsubjpass	15	SENT_152	[p10l226t2524r460b2588],
2	between	IN	O	between	_	0	SENT_152	[p10l488t2524r797b2589],
3	steady	JJ	O	steady	amod	6	SENT_152	[p10l827t2525r1262b2608],
4	—	JJ	O	—	amod	6	SENT_152	[p10l827t2525r1262b2608],
5	state	NN	O	state	nn	6	SENT_152	[p10l827t2525r1262b2608],
6	concentration	NN	O	concentration	prep_between	1	SENT_152	[p10l1290t2524r1795b2588],
7	and	CC	O	and	_	0	SENT_152	[p10l1824t2525r1955b2588],
8	dose	NN	O	dose	prep_between	1	SENT_152	[p10l1982t2524r2148b2588],
9	of	IN	O	of	_	0	SENT_152	[p10l9t2624r89b2689],
10	ZD	NNP	O	ZD	prep_of	8	SENT_152	[p10l118t2626r238b2688],
11	per	IN	O	per	_	0	SENT_152	[p10l275t2645r394b2708],
12	4	CD	DURATION	4	num	13	SENT_152	[p10l429t2625r472b2688],
13	weeks	NNS	NUMBER	week	prep_per	10	SENT_152	[p10l509t2624r737b2689],
14	are	VBP	O	be	auxpass	15	SENT_152	[p10l777t2645r886b2689],
15	expressed	VBN	O	express	_	0	SENT_152	[p10l924t2624r1289b2708],
16	as	IN	O	as	_	0	SENT_152	[p10l1327t2645r1397b2689],
17	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	18	SENT_152	[p10l1436t2621r1965b2708],
18	—	NN	O	—	prep_as	15	SENT_152	[p10l1436t2621r1965b2708],
19	1	CD	NUMBER	1	dep	18	SENT_152	[p10l1436t2621r1965b2708],
20	.	.	O	.	_	0	SENT_152	[p10l1436t2621r1965b2708],

1	The	DT	O	the	det	2	SENT_153	[p10l2006t2624r2148b2689],
2	distributions	NNS	O	distribution	nsubjpass	20	SENT_153	[p10l9t2723r470b2788],
3	of	IN	O	of	_	0	SENT_153	[p10l505t2723r585b2788],
4	the	DT	O	the	det	5	SENT_153	[p10l610t2724r721b2788],
5	concentration	NN	O	concentration	prep_of	2	SENT_153	[p10l754t2724r1564b2788],
6	—	CD	NUMBER	—	num	5	SENT_153	[p10l754t2724r1564b2788],
7	to	TO	O	to	_	0	SENT_153	[p10l754t2724r1564b2788],
8	—	CD	NUMBER	—	num	13	SENT_153	[p10l754t2724r1564b2788],
9	dose	NN	O	dose	nn	13	SENT_153	[p10l754t2724r1564b2788],
10	(	NN	O	(	nn	13	SENT_153	[p10l1599t2724r1808b2803],
11	C/D	NN	O	c/d	nn	13	SENT_153	[p10l1599t2724r1808b2803],
12	)	CD	NUMBER	)	num	13	SENT_153	[p10l1599t2724r1808b2803],
13	ratios	NNS	O	ratio	prep_to	2	SENT_153	[p10l1842t2724r2045b2788],
14	in	IN	O	in	_	0	SENT_153	[p10l2079t2724r2149b2787],
15	the	DT	O	the	det	18	SENT_153	[p10l7t2823r118b2887],
16	three	CD	NUMBER	three	num	18	SENT_153	[p10l145t2823r329b2887],
17	genotype	NN	O	genotype	nn	18	SENT_153	[p10l357t2832r695b2906],
18	groups	NNS	O	group	prep_in	13	SENT_153	[p10l723t2843r970b2906],
19	are	VBP	O	be	auxpass	20	SENT_153	[p10l1001t2843r1110b2887],
20	shown	VBN	O	show	_	0	SENT_153	[p10l1140t2823r1378b2887],
21	in	IN	O	in	_	0	SENT_153	[p10l1404t2823r1474b2886],
22	Fig	NN	O	fig	prep_in	20	SENT_153	[p10l1500t2823r1640b2906],
23	.	.	O	.	_	0	SENT_153	[p10l1500t2823r1640b2906],

1	1	LS	NUMBER	1	_	0	SENT_154	[p10l1681t2824r1734b2887],
2	.	.	O	.	_	0	SENT_154	[p10l1681t2824r1734b2887],

1	The	DT	O	the	det	4	SENT_155	[p10l1766t2823r1907b2887],
2	median	JJ	O	median	amod	4	SENT_155	[p10l1934t2823r2146b2887, p10l10t2942r93b2986],
3	C/D	NN	O	c/d	nn	4	SENT_155	[p10l121t2922r270b2987],
4	ratios	NNS	O	ratio	nsubj	7	SENT_155	[p10l298t2922r499b2986],
5	of	IN	O	of	_	0	SENT_155	[p10l530t2922r610b2986],
6	zuclopenthixol	NN	O	zuclopenthixol	prep_of	4	SENT_155	[p10l632t2922r1177b3006],
7	were	VBD	O	be	_	0	SENT_155	[p10l1205t2942r1381b2987],
8	0.029	CD	NUMBER	0.029	num	10	SENT_155	[p10l1410t2922r1612b2987],
9	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	10	SENT_155	[p10l1642t2918r2143b3006],
10	—	NN	O	—	dep	17	SENT_155	[p10l1642t2918r2143b3006],
11	1	CD	NUMBER	1	num	12	SENT_155	[p10l1642t2918r2143b3006],
12	(	NN	O	(	dep	10	SENT_155	[p10l10t3023r243b3106],
13	range	NN	O	range	dep	17	SENT_155	[p10l10t3023r243b3106],
14	0.01-0	CD	NUMBER	0.01-0	num	13	SENT_155	[p10l306t3022r675b3087],
15	.14	CD	NUMBER	.14	num	17	SENT_155	[p10l306t3022r675b3087],
16	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	17	SENT_155	[p10l737t3019r1302b3106],
17	—	NN	O	—	dep	26	SENT_155	[p10l737t3019r1302b3106],
18	1	CD	NUMBER	1	num	19	SENT_155	[p10l737t3019r1302b3106],
19	)	NN	O	)	dep	17	SENT_155	[p10l737t3019r1302b3106],
20	;	:	O	;	_	0	SENT_155	[p10l737t3019r1302b3106],
21	0.038	CD	NUMBER	0.038	num	23	SENT_155	[p10l1369t3023r1572b3087],
22	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	23	SENT_155	[p10l1637t3019r2143b3106],
23	—	NN	O	—	dep	19	SENT_155	[p10l1637t3019r2143b3106],
24	1	CD	NUMBER	1	num	25	SENT_155	[p10l1637t3019r2143b3106],
25	(	NN	O	(	dep	23	SENT_155	[p10l10t3123r243b3206],
26	range	NN	O	range	dep	30	SENT_155	[p10l10t3123r243b3206],
27	0.02-0	CD	NUMBER	0.02-0	num	26	SENT_155	[p10l272t3122r640b3187],
28	.09	CD	NUMBER	.09	num	30	SENT_155	[p10l272t3122r640b3187],
29	nmol-l	JJ	O	nmol-l	amod	30	SENT_155	[p10l670t3118r1210b3206],
30	—	NN	O	—	dep	36	SENT_155	[p10l670t3118r1210b3206],
31	1	CD	NUMBER	1	num	34	SENT_155	[p10l670t3118r1210b3206],
32	~	NN	O	~	nn	34	SENT_155	[p10l670t3118r1210b3206],
33	mg	NN	O	mg	nn	34	SENT_155	[p10l670t3118r1210b3206],
34	—	NN	O	—	dep	30	SENT_155	[p10l670t3118r1210b3206],
35	1	CD	NUMBER	1	num	36	SENT_155	[p10l670t3118r1210b3206],
36	)	NN	O	)	dep	42	SENT_155	[p10l670t3118r1210b3206],
37	and	CC	O	and	_	0	SENT_155	[p10l1243t3122r1374b3186],
38	0.048	CD	NUMBER	0.048	num	40	SENT_155	[p10l1402t3122r1605b3187],
39	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	40	SENT_155	[p10l1637t3118r2143b3206],
40	—	NN	O	—	conj_and	36	SENT_155	[p10l1637t3118r2143b3206],
41	1	CD	NUMBER	1	num	42	SENT_155	[p10l1637t3118r2143b3206],
42	(	NN	O	(	dep	43	SENT_155	[p10l10t3223r243b3306],
43	range	NN	O	range	dep	47	SENT_155	[p10l10t3223r243b3306],
44	0.03-0	CD	NUMBER	0.03-0	num	43	SENT_155	[p10l295t3223r661b3287],
45	.08	CD	NUMBER	.08	num	47	SENT_155	[p10l295t3223r661b3287],
46	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	47	SENT_155	[p10l715t3219r1254b3306],
47	—	NN	O	—	dep	7	SENT_155	[p10l715t3219r1254b3306],
48	1	CD	NUMBER	1	num	49	SENT_155	[p10l715t3219r1254b3306],
49	)	NN	O	)	dep	47	SENT_155	[p10l715t3219r1254b3306],
50	in	IN	O	in	_	0	SENT_155	[p10l1308t3222r1378b3286],
51	homozygous	JJ	O	homozygous	amod	52	SENT_155	[p10l1427t3222r1899b3306],
52	EMS	NNP	ORGANIZATION	EMS	prep_in	7	SENT_155	[p10l1951t3224r2145b3299],
53	,	,	O	,	_	0	SENT_155	[p10l1951t3224r2145b3299],
54	heterozygous	JJ	O	heterozygous	amod	55	SENT_155	[p10l7t3322r500b3405],
55	EMS	NNP	ORGANIZATION	EMS	conj_and	52	SENT_155	[p10l551t3323r722b3385],
56	and	CC	O	and	_	0	SENT_155	[p10l775t3322r906b3385],
57	PMS	NNP	O	PMS	prep_in	7	SENT_155	[p10l954t3323r1142b3397],
58	,	,	O	,	_	0	SENT_155	[p10l954t3323r1142b3397],
59	respectively	RB	O	respectively	advmod	7	SENT_155	[p10l1193t3321r1656b3405],
60	.	.	O	.	_	0	SENT_155	[p10l1193t3321r1656b3405],

1	Statistically	RB	O	statistically	advmod	2	SENT_156	[p10l1712t3321r2148b3405],
2	significant	JJ	O	significant	amod	3	SENT_156	[p10l11t3421r401b3504],
3	differences	NNS	O	difference	nsubjpass	5	SENT_156	[p10l433t3421r841b3485],
4	were	VBD	O	be	auxpass	5	SENT_156	[p10l876t3441r1053b3485],
5	found	VBN	O	find	_	0	SENT_156	[p10l1087t3421r1302b3485],
6	between	IN	O	between	_	0	SENT_156	[p10l1333t3421r1642b3485],
7	homozygous	JJ	O	homozygous	dep	8	SENT_156	[p10l1674t3421r2146b3504],
8	EMS	NN	O	em	amod	13	SENT_156	[p10l7t3521r178b3583],
9	and	CC	O	and	_	0	SENT_156	[p10l234t3520r364b3583],
10	heterozygous	JJ	O	heterozygous	amod	13	SENT_156	[p10l414t3519r907b3603],
11	EMS	NNP	O	EMS	dep	8	SENT_156	[p10l961t3521r1132b3583],
12	(	CD	NUMBER	(	num	11	SENT_156	[p10l1188t3519r1774b3599],
13	KruSkal	NNP	PERSON	KruSkal	prep_between	5	SENT_156	[p10l1188t3519r1774b3599],
14	.	.	O	.	_	0	SENT_156	[p10l1188t3519r1774b3599],

1	—	NN	O	—	_	0	SENT_157	[p10l1188t3519r1774b3599],
2	.	.	O	.	_	0	SENT_157	[p10l1188t3519r1774b3599],

1	WalliS	NNP	O	WalliS	nn	3	SENT_158	[p10l1188t3519r1774b3599],
2	ANOVA	NNP	ORGANIZATION	ANOVA	nn	3	SENT_158	[p10l1828t3520r2149b3584],
3	P	NN	O	p	nsubj	4	SENT_158	[p10l6t3619r352b3698],
4	=	JJ	O	=	_	0	SENT_158	[p10l6t3619r352b3698],
5	0.0	CD	NUMBER	0.0	num	7	SENT_158	[p10l6t3619r352b3698],
6	l4	NN	O	l4	nn	7	SENT_158	[p10l6t3619r352b3698],
7	)	NN	O	)	dobj	4	SENT_158	[p10l6t3619r352b3698],
8	and	CC	O	and	_	0	SENT_158	[p10l394t3619r525b3683],
9	also	RB	O	also	dobj	4	SENT_158	[p10l563t3619r708b3683],
10	between	IN	O	between	_	0	SENT_158	[p10l745t3619r1054b3683],
11	homozygous	JJ	O	homozygous	amod	12	SENT_158	[p10l1090t3619r1562b3702],
12	EMS	NNP	ORGANIZATION	EMS	prep_between	9	SENT_158	[p10l1601t3621r1772b3683],
13	and	CC	O	and	_	0	SENT_158	[p10l1814t3619r1944b3683],
14	PMS	NNP	O	PMS	nn	16	SENT_158	[p10l1981t3621r2146b3683],
15	(	CD	NUMBER	(	num	16	SENT_158	[p10l10t3718r597b3797],
16	Kruskal-Wallis	NN	O	kruskal-walli	dobj	4	SENT_158	[p10l10t3718r597b3797],
17	ANOVA	NNP	O	ANOVA	nn	18	SENT_158	[p10l648t3719r969b3783],
18	P	NN	O	p	dep	16	SENT_158	[p10l1017t3719r1338b3798],
19	=	JJ	O	=	amod	21	SENT_158	[p10l1017t3719r1338b3798],
20	0.03	CD	NUMBER	0.03	tmod	19	SENT_158	[p10l1017t3719r1338b3798],
21	)	NN	O	)	dep	18	SENT_158	[p10l1017t3719r1338b3798],
22	.	.	O	.	_	0	SENT_158	[p10l1017t3719r1338b3798],

1	Differences	NNS	O	difference	_	0	SENT_159	[p10l1392t3718r1821b3782],
2	of	IN	O	of	_	0	SENT_159	[p10l1873t3718r1953b3782],
3	CH	NN	O	ch	prep_of	1	SENT_159	[p10l1997t3719r2147b3783],
4	)	CD	NUMBER	)	num	3	SENT_159	[p10l1997t3719r2147b3783],

1	ratios	NNS	O	ratio	nsubj	13	SENT_160	[p11l7t16r210b80],
2	between	IN	O	between	_	0	SENT_160	[p11l243t16r553b80],
3	the	DT	O	the	det	5	SENT_160	[p11l584t16r695b80],
4	heterozygous	JJ	O	heterozygous	amod	5	SENT_160	[p11l727t16r1220b99],
5	EMs	NNS	O	em	prep_between	1	SENT_160	[p11l1254t18r1424b80],
6	and	CC	O	and	_	0	SENT_160	[p11l1461t16r1591b80],
7	PMs	NNS	O	pm	prep_between	1	SENT_160	[p11l1622t18r1788b80],
8	were	VBD	O	be	cop	13	SENT_160	[p11l1822t36r1999b80],
9	not	RB	O	not	neg	13	SENT_160	[p11l2032t25r2150b80],
10	statistically	RB	O	statistically	advmod	11	SENT_160	[p11l11t115r431b198],
11	significant	JJ	O	significant	amod	13	SENT_160	[p11l461t115r851b198],
12	(	NN	O	(	nn	13	SENT_160	[p11l879t116r1180b195],
13	P	NN	O	p	_	0	SENT_160	[p11l879t116r1180b195],
14	=	JJ	O	=	amod	13	SENT_160	[p11l879t116r1180b195],
15	0.2	CD	NUMBER	0.2	num	16	SENT_160	[p11l879t116r1180b195],
16	)	NN	O	)	dep	14	SENT_160	[p11l879t116r1180b195],
17	.	.	O	.	_	0	SENT_160	[p11l879t116r1180b195],

1	Multiple	JJ	O	multiple	amod	3	SENT_161	[p11l120t214r431b297],
2	regression	NN	O	regression	nn	3	SENT_161	[p11l458t214r832b297],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_161	[p11l861t214r1149b297],
4	was	VBD	O	be	auxpass	5	SENT_161	[p11l1178t234r1316b278],
5	performed	VBN	O	perform	_	0	SENT_161	[p11l1344t214r1724b297],
6	to	TO	O	to	aux	7	SENT_161	[p11l1751t223r1818b278],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_161	[p11l1848t214r2148b278],
8	the	DT	O	the	det	9	SENT_161	[p11l8t313r118b377],
9	contribution	NN	O	contribution	dobj	7	SENT_161	[p11l182t313r635b377],
10	of	IN	O	of	_	0	SENT_161	[p11l699t313r778b377],
11	age	NN	O	age	nn	15	SENT_161	[p11l837t334r981b396],
12	,	,	O	,	_	0	SENT_161	[p11l837t334r981b396],
13	gender	NN	O	gender	dep	15	SENT_161	[p11l1048t313r1315b396],
14	,	,	O	,	_	0	SENT_161	[p11l1048t313r1315b396],
15	duration	NN	O	duration	prep_of	9	SENT_161	[p11l1382t313r1689b377],
16	of	IN	O	of	_	0	SENT_161	[p11l1753t313r1832b377],
17	illness	NN	O	illness	nn	20	SENT_161	[p11l1889t313r2145b389],
18	,	,	O	,	_	0	SENT_161	[p11l1889t313r2145b389],
19	CYPZD6	NN	O	cypzd6	prep_of	9	SENT_161	[p11l12t412r340b477],
20	genotype	NN	O	genotype	prep_of	9	SENT_161	[p11l376t421r714b495],
21	and	CC	O	and	_	0	SENT_161	[p11l755t412r886b476],
22	smoking	NN	O	smoking	conj_and	20	SENT_161	[p11l928t412r1242b495],
23	to	TO	O	to	_	0	SENT_161	[p11l1282t421r1351b476],
24	the	DT	O	the	det	26	SENT_161	[p11l1391t412r1502b476],
25	C/D	NN	O	c/d	nn	26	SENT_161	[p11l1543t412r1692b476],
26	ratio	NN	O	ratio	prep_to	7	SENT_161	[p11l1732t412r1921b476],
27	.	.	O	.	_	0	SENT_161	[p11l1732t412r1921b476],

1	Only	RB	O	only	advmod	7	SENT_162	[p11l1966t412r2148b495],
2	the	DT	O	the	det	6	SENT_162	[p11l8t511r119b575],
3	variable	JJ	O	variable	amod	6	SENT_162	[p11l195t511r496b576],
4	“	NN	O	“	nn	6	SENT_162	[p11l573t512r995b594],
5	genotype	NN	O	genotype	nn	6	SENT_162	[p11l573t512r995b594],
6	”	NN	O	”	nsubj	7	SENT_162	[p11l573t512r995b594],
7	remained	VBD	O	remain	_	0	SENT_162	[p11l1071t511r1420b575],
8	in	IN	O	in	_	0	SENT_162	[p11l1494t511r1565b574],
9	the	DT	O	the	det	12	SENT_162	[p11l1639t511r1751b575],
10	equation	NN	O	equation	nn	12	SENT_162	[p11l1828t511r2149b594],
11	(	CD	NUMBER	(	num	12	SENT_162	[p11l10t610r405b689],
12	P	NN	O	p	prep_in	7	SENT_162	[p11l10t610r405b689],
13	=	JJ	O	=	amod	12	SENT_162	[p11l10t610r405b689],
14	0.029	CD	NUMBER	0.029	num	15	SENT_162	[p11l10t610r405b689],
15	)	NN	O	)	dep	13	SENT_162	[p11l10t610r405b689],
16	.	.	O	.	_	0	SENT_162	[p11l10t610r405b689],

1	To	TO	O	to	aux	2	SENT_163	[p11l452t612r545b674],
2	evaluate	VB	O	evaluate	purpcl	32	SENT_163	[p11l588t610r896b674],
3	the	DT	O	the	det	5	SENT_163	[p11l937t610r1048b674],
4	demographic	JJ	O	demographic	amod	5	SENT_163	[p11l1092t610r1573b693],
5	characteristics	NNS	O	characteristic	dobj	2	SENT_163	[p11l1617t610r2146b674],
6	(	JJ	O	(	amod	7	SENT_163	[p11l10t710r186b792],
7	age	NN	O	age	dep	2	SENT_163	[p11l10t710r186b792],
8	,	,	O	,	_	0	SENT_163	[p11l10t710r186b792],
9	gender	NN	O	gender	appos	7	SENT_163	[p11l244t709r510b792],
10	,	,	O	,	_	0	SENT_163	[p11l244t709r510b792],
11	smoking	NN	O	smoking	nn	12	SENT_163	[p11l570t709r884b792],
12	habits	NNS	O	habit	appos	7	SENT_163	[p11l938t709r1179b785],
13	,	,	O	,	_	0	SENT_163	[p11l938t709r1179b785],
14	duration	NN	O	duration	appos	7	SENT_163	[p11l1237t709r1545b773],
15	of	IN	O	of	_	0	SENT_163	[p11l1600t709r1679b773],
16	illness	NN	O	illness	nn	20	SENT_163	[p11l1727t709r1961b773],
17	and	CC	O	and	_	0	SENT_163	[p11l2019t709r2149b773],
18	BPRS	NN	O	bpr	nn	20	SENT_163	[p11l8t808r225b872],
19	score	NN	NUMBER	score	nn	20	SENT_163	[p11l260t809r474b887],
20	)	NN	O	)	prep_of	14	SENT_163	[p11l260t809r474b887],
21	between	IN	O	between	_	0	SENT_163	[p11l503t808r806b872],
22	the	DT	O	the	det	25	SENT_163	[p11l833t808r942b872],
23	three	CD	NUMBER	three	num	25	SENT_163	[p11l969t808r1149b872],
24	genotype	NN	O	genotype	nn	25	SENT_163	[p11l1177t817r1508b891],
25	groups	NNS	O	group	prep_between	20	SENT_163	[p11l1537t828r1801b891],
26	,	,	O	,	_	0	SENT_163	[p11l1537t828r1801b891],
27	Kruskal	NNP	PERSON	Kruskal	nn	30	SENT_163	[p11l1833t808r2146b872],
28	—	NNP	O	—	nn	30	SENT_163	[p11l1833t808r2146b872],
29	Wallis	NNP	PERSON	Wallis	nn	30	SENT_163	[p11l8t906r240b970],
30	ANOVA	NNP	O	ANOVA	nsubjpass	32	SENT_163	[p11l296t907r617b970],
31	was	VBD	O	be	auxpass	32	SENT_163	[p11l672t927r811b970],
32	performed	VBN	O	perform	_	0	SENT_163	[p11l867t906r1272b989],
33	.	.	O	.	_	0	SENT_163	[p11l867t906r1272b989],

1	The	DT	O	the	det	3	SENT_164	[p11l1331t906r1473b970],
2	three	CD	NUMBER	three	num	3	SENT_164	[p11l1528t906r1711b970],
3	groups	NNS	O	group	nsubj	15	SENT_164	[p11l1767t927r2015b989],
4	of	IN	O	of	_	0	SENT_164	[p11l2073t906r2152b970],
5	patients	NNS	O	patient	prep_of	3	SENT_164	[p11l8t1004r316b1087],
6	,	,	O	,	_	0	SENT_164	[p11l8t1004r316b1087],
7	separated	VBN	O	separate	partmod	3	SENT_164	[p11l371t1004r718b1087],
8	according	VBG	O	accord	_	0	SENT_164	[p11l767t1003r1129b1087],
9	to	TO	O	to	prepc_according_to	7	SENT_164	[p11l1178t1013r1246b1067],
10	the	DT	O	the	det	11	SENT_164	[p11l1296t1004r1406b1067],
11	genotype	NN	O	genotype	pobj	7	SENT_164	[p11l1456t1013r1814b1087],
12	,	,	O	,	_	0	SENT_164	[p11l1456t1013r1814b1087],
13	did	VBD	O	do	aux	15	SENT_164	[p11l1867t1003r1983b1067],
14	not	RB	O	not	neg	15	SENT_164	[p11l2030t1013r2148b1067],
15	differ	VB	O	differ	_	0	SENT_164	[p11l10t1102r211b1166],
16	significantly	RB	O	significantly	advmod	17	SENT_164	[p11l242t1102r696b1185],
17	(	JJ	O	(	amod	19	SENT_164	[p11l728t1103r881b1185],
18	age	NN	O	age	nn	19	SENT_164	[p11l728t1103r881b1185],
19	P	NN	O	p	dobj	15	SENT_164	[p11l909t1103r1200b1178],
20	=	JJ	O	=	amod	19	SENT_164	[p11l909t1103r1200b1178],
21	O.	NNP	O	O.	dep	20	SENT_164	[p11l909t1103r1200b1178],
22	94	CD	NUMBER	94	num	21	SENT_164	[p11l909t1103r1200b1178],
23	;	:	O	;	_	0	SENT_164	[p11l909t1103r1200b1178],
24	gender	NN	O	gender	nn	25	SENT_164	[p11l1233t1102r1482b1185],
25	P	NN	O	p	dep	19	SENT_164	[p11l1508t1103r1798b1178],
26	=	JJ	O	=	amod	25	SENT_164	[p11l1508t1103r1798b1178],
27	O.	NNP	O	O.	dep	26	SENT_164	[p11l1508t1103r1798b1178],
28	74	CD	NUMBER	74	num	27	SENT_164	[p11l1508t1103r1798b1178],
29	;	:	O	;	_	0	SENT_164	[p11l1508t1103r1798b1178],
30	smoking	NN	O	smoking	nn	31	SENT_164	[p11l1835t1102r2145b1185],
31	P	NN	O	p	dep	19	SENT_164	[p11l7t1200r300b1276],
32	=	JJ	O	=	amod	31	SENT_164	[p11l7t1200r300b1276],
33	0	CD	NUMBER	0	tmod	32	SENT_164	[p11l7t1200r300b1276],
34	.	.	O	.	_	0	SENT_164	[p11l7t1200r300b1276],

1	l4	NN	O	l4	_	0	SENT_165	[p11l7t1200r300b1276],
2	;	:	O	;	_	0	SENT_165	[p11l7t1200r300b1276],
3	duration	NN	O	duration	dep	1	SENT_165	[p11l363t1199r670b1264],
4	of	IN	O	of	_	0	SENT_165	[p11l729t1199r809b1264],
5	illness	NN	O	illness	nn	6	SENT_165	[p11l860t1200r1094b1264],
6	P	NN	O	p	prep_of	3	SENT_165	[p11l1152t1200r1420b1264],
7	=	JJ	O	=	amod	6	SENT_165	[p11l1152t1200r1420b1264],
8	O.	NNP	O	O.	dep	7	SENT_165	[p11l1152t1200r1420b1264],
9	78	CD	NUMBER	78	num	8	SENT_165	[p11l1152t1200r1420b1264],
10	and	CC	O	and	_	0	SENT_165	[p11l1483t1200r1613b1264],
11	BPRS	JJ	ORGANIZATION	bprs	amod	13	SENT_165	[p11l1670t1200r1890b1264],
12	score	NN	NUMBER	score	nn	13	SENT_165	[p11l1956t1220r2146b1264],
13	P	NN	O	p	prep_of	3	SENT_165	[p11l7t1299r328b1377],
14	=	JJ	O	=	amod	16	SENT_165	[p11l7t1299r328b1377],
15	0.42	CD	NUMBER	0.42	tmod	14	SENT_165	[p11l7t1299r328b1377],
16	)	NN	O	)	dep	13	SENT_165	[p11l7t1299r328b1377],
17	.	.	O	.	_	0	SENT_165	[p11l7t1299r328b1377],

1	Smoking	NN	O	smoking	_	0	SENT_166	[p11l11t1535r341b1619],
2	and	CC	O	and	_	0	SENT_166	[p11l370t1536r501b1599],
3	plasma	NN	O	plasma	nn	5	SENT_166	[p11l525t1536r789b1619],
4	zuclopenthixol	NN	O	zuclopenthixol	nn	5	SENT_166	[p11l815t1535r1365b1619],
5	concentration	NN	O	concentration	conj_and	1	SENT_166	[p11l1392t1536r1897b1599],

1	Fifteen	CD	NUMBER	fifteen	nsubj	7	SENT_167	[p11l8t1713r271b1777],
2	of	IN	O	of	_	0	SENT_167	[p11l323t1713r402b1777],
3	the	DT	O	the	det	5	SENT_167	[p11l448t1713r558b1777],
4	52	CD	NUMBER	52	num	5	SENT_167	[p11l612t1713r699b1777],
5	patients	NNS	O	patient	prep_of	1	SENT_167	[p11l751t1713r1037b1796],
6	were	VBD	O	be	cop	7	SENT_167	[p11l1091t1734r1268b1777],
7	smokers	NNS	O	smoker	_	0	SENT_167	[p11l1324t1713r1647b1777],
8	.	.	O	.	_	0	SENT_167	[p11l1324t1713r1647b1777],

1	There	EX	O	there	expl	2	SENT_168	[p11l1703t1713r1917b1777],
2	were	VBD	O	be	_	0	SENT_168	[p11l1969t1734r2146b1777],
3	thirteen	CD	NUMBER	thirteen	num	4	SENT_168	[p11l8t1812r288b1875],
4	smokers	NNS	O	smoker	nsubj	2	SENT_168	[p11l317t1812r616b1875],
5	(	VBP	O	(	rcmod	4	SENT_168	[p11l647t1812r838b1891],
6	87	CD	PERCENT	87	num	7	SENT_168	[p11l647t1812r838b1891],
7	%	NN	PERCENT	%	nsubj	11	SENT_168	[p11l647t1812r838b1891],
8	of	IN	O	of	_	0	SENT_168	[p11l869t1811r949b1875],
9	all	DT	O	all	det	10	SENT_168	[p11l971t1812r1058b1875],
10	smokers	NNS	O	smoker	prep_of	7	SENT_168	[p11l1088t1812r1417b1891],
11	)	VBP	O	)	ccomp	5	SENT_168	[p11l1088t1812r1417b1891],
12	in	IN	O	in	_	0	SENT_168	[p11l1446t1811r1516b1875],
13	the	DT	O	the	det	16	SENT_168	[p11l1541t1812r1651b1875],
14	homozygous	JJ	O	homozygous	amod	16	SENT_168	[p11l1677t1812r2144b1895],
15	EM	NN	O	em	nn	16	SENT_168	[p11l8t1913r144b1974],
16	group	NN	O	group	prep_in	25	SENT_168	[p11l175t1931r387b1994],
17	and	CC	O	and	_	0	SENT_168	[p11l419t1911r549b1975],
18	two	CD	PERCENT	two	conj_and	16	SENT_168	[p11l577t1920r712b1975],
19	(	CD	PERCENT	(	num	21	SENT_168	[p11l745t1911r936b1990],
20	13	CD	PERCENT	13	num	21	SENT_168	[p11l745t1911r936b1990],
21	%	NN	PERCENT	%	nsubj	25	SENT_168	[p11l745t1911r936b1990],
22	of	IN	O	of	_	0	SENT_168	[p11l971t1911r1050b1975],
23	all	DT	O	all	det	24	SENT_168	[p11l1075t1911r1163b1975],
24	smokers	NNS	O	smoker	prep_of	21	SENT_168	[p11l1195t1911r1528b1990],
25	)	VBP	O	)	ccomp	11	SENT_168	[p11l1195t1911r1528b1990],
26	in	IN	O	in	_	0	SENT_168	[p11l1559t1911r1629b1974],
27	the	DT	O	the	det	30	SENT_168	[p11l1657t1911r1768b1975],
28	heterozygous	JJ	O	heterozygous	amod	30	SENT_168	[p11l1797t1911r2144b1994, p11l10t2030r180b2093],
29	EM	NN	O	em	nn	30	SENT_168	[p11l234t2011r370b2073],
30	group	NN	O	group	prep_in	25	SENT_168	[p11l424t2030r660b2093],
31	;	:	O	;	_	0	SENT_168	[p11l424t2030r660b2093],
32	all	DT	O	all	det	33	SENT_168	[p11l718t2010r807b2073],
33	PMs	NNS	O	pm	nsubj	37	SENT_168	[p11l859t2011r1025b2073],
34	were	VBD	O	be	cop	37	SENT_168	[p11l1080t2030r1257b2074],
35	non	JJ	O	non	amod	37	SENT_168	[p11l1310t2010r1808b2074],
36	—	NN	O	—	nn	37	SENT_168	[p11l1310t2010r1808b2074],
37	smokers	NNS	O	smoker	parataxis	2	SENT_168	[p11l1310t2010r1808b2074],
38	.	.	O	.	_	0	SENT_168	[p11l1310t2010r1808b2074],

1	Median	JJ	O	median	amod	4	SENT_169	[p11l1864t2010r2147b2073],
2	zuclopenthixol	NN	O	zuclopenthixol	nn	4	SENT_169	[p11l10t2109r560b2192],
3	C/D	NN	O	c/d	nn	4	SENT_169	[p11l601t2109r751b2173],
4	ratios	NNS	O	ratio	nsubj	15	SENT_169	[p11l792t2109r995b2173],
5	in	IN	O	in	_	0	SENT_169	[p11l1038t2109r1108b2172],
6	smokers	NNS	O	smoker	prep_in	4	SENT_169	[p11l1151t2109r1453b2173],
7	and	CC	O	and	_	0	SENT_169	[p11l1498t2109r1629b2173],
8	non	JJ	O	non	amod	10	SENT_169	[p11l1668t2109r2144b2173],
9	—	NN	O	—	nn	10	SENT_169	[p11l1668t2109r2144b2173],
10	smokers	NNS	O	smoker	prep_in	4	SENT_169	[p11l1668t2109r2144b2173],
11	were	VBD	O	be	cop	15	SENT_169	[p11l9t2228r183b2272],
12	0.029	CD	NUMBER	0.029	num	15	SENT_169	[p11l211t2208r412b2273],
13	nmol-1-1-mg-1	NN	O	nmol-1-1-mg-1	nn	15	SENT_169	[p11l441t2204r936b2290],
14	(	NN	O	(	nn	15	SENT_169	[p11l972t2208r1199b2290],
15	range	NN	O	range	_	0	SENT_169	[p11l972t2208r1199b2290],
16	0.01-0	CD	NUMBER	0.01-0	number	17	SENT_169	[p11l1227t2207r1587b2272],
17	.06	CD	NUMBER	.06	num	19	SENT_169	[p11l1227t2207r1587b2272],
18	nmol-l-1-mg-1	NN	O	nmol-l-1-mg-1	nn	19	SENT_169	[p11l1616t2204r2144b2290],
19	)	NN	O	)	dep	15	SENT_169	[p11l1616t2204r2144b2290],
20	and	CC	O	and	_	0	SENT_169	[p11l11t2307r140b2371],
21	0.037	CD	NUMBER	0.037	num	23	SENT_169	[p11l168t2308r369b2371],
22	nmol	NN	O	nmol	nn	23	SENT_169	[p11l400t2303r900b2390],
23	~	NN	O	~	conj_and	15	SENT_169	[p11l400t2303r900b2390],
24	l	NN	O	l	tmod	23	SENT_169	[p11l400t2303r900b2390],
25	—	CD	NUMBER	—	num	27	SENT_169	[p11l400t2303r900b2390],
26	1-mg	JJ	O	1-mg	amod	27	SENT_169	[p11l400t2303r900b2390],
27	—	NN	O	—	dep	34	SENT_169	[p11l400t2303r900b2390],
28	1	CD	NUMBER	1	num	29	SENT_169	[p11l400t2303r900b2390],
29	(	NN	O	(	dep	27	SENT_169	[p11l936t2308r1165b2390],
30	range	NN	O	range	dep	34	SENT_169	[p11l936t2308r1165b2390],
31	0.01-0	CD	NUMBER	0.01-0	num	30	SENT_169	[p11l1194t2307r1558b2371],
32	.14	CD	NUMBER	.14	num	34	SENT_169	[p11l1194t2307r1558b2371],
33	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	34	SENT_169	[p11l1587t2303r2143b2390],
34	—	NN	O	—	dep	49	SENT_169	[p11l1587t2303r2143b2390],
35	1	CD	NUMBER	1	num	36	SENT_169	[p11l1587t2303r2143b2390],
36	)	NN	O	)	dep	34	SENT_169	[p11l1587t2303r2143b2390],
37	,	,	O	,	_	0	SENT_169	[p11l1587t2303r2143b2390],
38	respectively	RB	O	respectively	advmod	34	SENT_169	[p11l8t2406r471b2489],
39	,	,	O	,	_	0	SENT_169	[p11l8t2406r471b2489],
40	with	IN	O	with	_	0	SENT_169	[p11l531t2406r694b2471],
41	a	DT	O	a	det	44	SENT_169	[p11l752t2427r790b2470],
42	statistically	RB	O	statistically	advmod	43	SENT_169	[p11l849t2406r1268b2489],
43	significant	JJ	O	significant	amod	44	SENT_169	[p11l1328t2406r1718b2489],
44	difference	NN	O	difference	prep_with	34	SENT_169	[p11l1774t2406r2146b2470],
45	(	CD	NUMBER	(	num	46	SENT_169	[p11l11t2505r384b2584],
46	P	NN	O	p	npadvmod	47	SENT_169	[p11l11t2505r384b2584],
47	=	JJ	O	=	amod	44	SENT_169	[p11l11t2505r384b2584],
48	0.049	CD	NUMBER	0.049	num	49	SENT_169	[p11l11t2505r384b2584],
49	)	NN	O	)	dep	15	SENT_169	[p11l11t2505r384b2584],
50	between	IN	O	between	_	0	SENT_169	[p11l434t2505r743b2569],
51	smokers	NNS	O	smoker	prep_between	49	SENT_169	[p11l794t2505r1096b2569],
52	and	CC	O	and	_	0	SENT_169	[p11l1149t2505r1279b2569],
53	non	JJ	O	non	amod	55	SENT_169	[p11l1326t2505r1823b2569],
54	—	NN	O	—	nn	55	SENT_169	[p11l1326t2505r1823b2569],
55	smokers	NNS	O	smoker	prep_between	49	SENT_169	[p11l1326t2505r1823b2569],
56	.	.	O	.	_	0	SENT_169	[p11l1326t2505r1823b2569],

1	Due	JJ	O	due	_	0	SENT_170	[p11l1876t2507r2028b2569],
2	to	TO	O	to	_	0	SENT_170	[p11l2076t2514r2145b2569],
3	the	DT	O	the	det	4	SENT_170	[p11l9t2604r119b2668],
4	overrepresentation	NN	O	overrepresentation	prep_due_to	16	SENT_170	[p11l171t2604r861b2687],
5	of	IN	O	of	_	0	SENT_170	[p11l912t2604r992b2668],
6	smokers	NNS	O	smoker	prep_of	4	SENT_170	[p11l1039t2604r1341b2668],
7	in	IN	O	in	_	0	SENT_170	[p11l1393t2604r1463b2667],
8	the	DT	O	the	det	11	SENT_170	[p11l1512t2604r1623b2668],
9	homozygous	JJ	O	homozygous	amod	11	SENT_170	[p11l1673t2604r2144b2687],
10	EM	NN	O	em	nn	11	SENT_170	[p11l8t2705r144b2766],
11	group	NN	O	group	prep_in	6	SENT_170	[p11l187t2723r420b2786],
12	,	,	O	,	_	0	SENT_170	[p11l187t2723r420b2786],
13	this	DT	O	this	det	14	SENT_170	[p11l464t2703r594b2767],
14	subgroup	NN	O	subgroup	nsubjpass	16	SENT_170	[p11l640t2703r979b2786],
15	was	VBD	O	be	auxpass	16	SENT_170	[p11l1022t2723r1161b2767],
16	analysed	VBN	O	analyse	_	0	SENT_170	[p11l1206t2703r1528b2786],
17	separately	RB	O	separately	advmod	16	SENT_170	[p11l1571t2703r1942b2786],
18	with	IN	O	with	_	0	SENT_170	[p11l1984t2703r2147b2767],
19	respect	NN	O	respect	prep_with	16	SENT_170	[p11l8t2812r272b2885],
20	to	TO	O	to	_	0	SENT_170	[p11l307t2812r375b2866],
21	the	DT	O	the	det	22	SENT_170	[p11l413t2802r524b2866],
22	effect	NN	O	effect	prep_to	16	SENT_170	[p11l562t2802r770b2866],
23	of	IN	O	of	_	0	SENT_170	[p11l807t2802r887b2866],
24	smoking	NN	O	smoking	prep_of	22	SENT_170	[p11l920t2802r1254b2885],
25	.	.	O	.	_	0	SENT_170	[p11l920t2802r1254b2885],

1	The	DT	O	the	det	5	SENT_171	[p11l1295t2802r1437b2866],
2	median	JJ	O	median	amod	5	SENT_171	[p11l1473t2802r1745b2866],
3	zuclopenthixol	NN	O	zuclopenthixol	nn	5	SENT_171	[p11l1783t2802r2144b2885, p11l8t2901r223b2965],
4	C/D	NN	O	c/d	nn	5	SENT_171	[p11l274t2901r423b2965],
5	ratios	NNS	O	ratio	nsubj	18	SENT_171	[p11l473t2901r676b2965],
6	of	IN	O	of	_	0	SENT_171	[p11l729t2901r809b2965],
7	smokers	NNS	O	smoker	prep_of	5	SENT_171	[p11l855t2901r1157b2965],
8	and	CC	O	and	_	0	SENT_171	[p11l1210t2901r1341b2965],
9	non	JJ	O	non	amod	11	SENT_171	[p11l1389t2901r1865b2965],
10	—	NN	O	—	nn	11	SENT_171	[p11l1389t2901r1865b2965],
11	smokers	NNS	O	smoker	prep_of	5	SENT_171	[p11l1389t2901r1865b2965],
12	in	IN	O	in	_	0	SENT_171	[p11l1917t2901r1986b2964],
13	the	DT	O	the	det	16	SENT_171	[p11l2035t2901r2146b2965],
14	homozygous	JJ	O	homozygous	amod	16	SENT_171	[p11l8t3000r479b3083],
15	EM	NN	O	em	nn	16	SENT_171	[p11l511t3002r648b3063],
16	group	NN	O	group	prep_in	11	SENT_171	[p11l680t3021r892b3083],
17	were	VBD	O	be	cop	18	SENT_171	[p11l924t3021r1101b3065],
18	0.029	CD	NUMBER	0.029	_	0	SENT_171	[p11l1133t3001r1337b3065],
19	nmol-1-1-mg-1	NN	O	nmol-1-1-mg-1	nn	25	SENT_171	[p11l1370t2997r1875b3083],
20	(	NN	O	(	nn	25	SENT_171	[p11l1914t3001r2146b3083],
21	range	NN	O	range	nn	25	SENT_171	[p11l1914t3001r2146b3083],
22	0.01-0	CD	NUMBER	0.01-0	num	25	SENT_171	[p11l9t3099r377b3163],
23	.06	CD	NUMBER	.06	num	25	SENT_171	[p11l9t3099r377b3163],
24	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	25	SENT_171	[p11l407t3095r946b3182],
25	—	NN	O	—	dep	18	SENT_171	[p11l407t3095r946b3182],
26	1	CD	NUMBER	1	num	27	SENT_171	[p11l407t3095r946b3182],
27	)	NN	O	)	dep	34	SENT_171	[p11l407t3095r946b3182],
28	and	CC	O	and	_	0	SENT_171	[p11l979t3099r1109b3163],
29	0.033	CD	NUMBER	0.033	num	31	SENT_171	[p11l1138t3099r1339b3163],
30	nmol-1-1-mg	JJ	O	nmol-1-1-mg	amod	31	SENT_171	[p11l1372t3095r1878b3182],
31	—	NN	O	—	dep	34	SENT_171	[p11l1372t3095r1878b3182],
32	1	CD	NUMBER	1	num	33	SENT_171	[p11l1372t3095r1878b3182],
33	(	NN	O	(	dep	34	SENT_171	[p11l1914t3100r2146b3182],
34	range	NN	O	range	dep	18	SENT_171	[p11l1914t3100r2146b3182],
35	0.01-0	CD	NUMBER	0.01-0	num	34	SENT_171	[p11l9t3199r378b3263],
36	.14	CD	NUMBER	.14	num	38	SENT_171	[p11l9t3199r378b3263],
37	nmol-1-1-mg-1	NN	O	nmol-1-1-mg-1	nn	38	SENT_171	[p11l429t3195r990b3281],
38	)	NN	O	)	dep	34	SENT_171	[p11l429t3195r990b3281],
39	,	,	O	,	_	0	SENT_171	[p11l429t3195r990b3281],
40	respectively	RB	O	respectively	advmod	18	SENT_171	[p11l1043t3198r1505b3281],
41	.	.	O	.	_	0	SENT_171	[p11l1043t3198r1505b3281],

1	This	DT	O	this	det	2	SENT_172	[p11l1560t3198r1720b3262],
2	difference	NN	O	difference	nsubj	18	SENT_172	[p11l1774t3198r2146b3262],
3	in	IN	O	in	_	0	SENT_172	[p11l9t3297r79b3360],
4	zuclopenthixol	NN	O	zuclopenthixol	nn	6	SENT_172	[p11l120t3297r670b3380],
5	C/D	NN	O	c/d	nn	6	SENT_172	[p11l712t3297r861b3361],
6	ratios	NNS	O	ratio	prep_in	2	SENT_172	[p11l903t3297r1106b3361],
7	between	IN	O	between	_	0	SENT_172	[p11l1148t3297r1456b3361],
8	homozygous	JJ	O	homozygous	amod	10	SENT_172	[p11l1496t3297r1967b3380],
9	EM	NN	O	em	nn	10	SENT_172	[p11l2010t3298r2146b3360],
10	smokers	NNS	O	smoker	prep_between	6	SENT_172	[p11l12t3396r311b3460],
11	and	CC	O	and	_	0	SENT_172	[p11l343t3396r473b3460],
12	non	JJ	O	non	amod	14	SENT_172	[p11l500t3396r972b3460],
13	—	NN	O	—	nn	14	SENT_172	[p11l500t3396r972b3460],
14	smokers	NNS	O	smoker	conj_and	10	SENT_172	[p11l500t3396r972b3460],
15	was	VBD	O	be	cop	18	SENT_172	[p11l1002t3417r1141b3461],
16	not	RB	O	not	neg	18	SENT_172	[p11l1171t3406r1288b3460],
17	statistically	RB	O	statistically	advmod	18	SENT_172	[p11l1317t3396r1731b3479],
18	significant	JJ	O	significant	_	0	SENT_172	[p11l1763t3396r2148b3479],
19	(	CD	NUMBER	(	nn	20	SENT_172	[p11l11t3495r597b3574],
20	Kruskal	NNP	PERSON	Kruskal	dep	18	SENT_172	[p11l11t3495r597b3574],
21	.	.	O	.	_	0	SENT_172	[p11l11t3495r597b3574],

1	—	NN	O	—	_	0	SENT_173	[p11l11t3495r597b3574],
2	.	.	O	.	_	0	SENT_173	[p11l11t3495r597b3574],

1	Wallis	NNP	PERSON	Wallis	nn	3	SENT_174	[p11l11t3495r597b3574],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_174	[p11l625t3495r946b3559],
3	P	NN	O	p	nsubj	4	SENT_174	[p11l971t3495r1291b3574],
4	=	JJ	O	=	_	0	SENT_174	[p11l971t3495r1291b3574],
5	0.36	CD	NUMBER	0.36	num	6	SENT_174	[p11l971t3495r1291b3574],
6	)	NN	O	)	dobj	4	SENT_174	[p11l971t3495r1291b3574],
7	.	.	O	.	_	0	SENT_174	[p11l971t3495r1291b3574],

1	C	NN	O	c	_	0	SENT_175	[p12l13t87r71b151],
2	YP2D6	NN	O	yp2d6	nn	3	SENT_175	[p12l76t86r340b150],
3	genotype	NN	O	genotype	dep	1	SENT_175	[p12l364t95r721b169],
4	,	,	O	,	_	0	SENT_175	[p12l364t95r721b169],
5	plasma	NN	O	plasma	nn	7	SENT_175	[p12l750t86r1014b169],
6	zuclopenthixol	NN	O	zuclopenthixol	nn	7	SENT_175	[p12l1040t86r1590b169],
7	concentrations	NNS	O	concentration	conj_and	3	SENT_175	[p12l9t184r548b248],
8	and	CC	O	and	_	0	SENT_175	[p12l578t184r709b248],
9	side	JJ	O	side	amod	10	SENT_175	[p12l738t184r881b248],
10	effects	NNS	O	effect	conj_and	3	SENT_175	[p12l909t184r1150b248],

1	The	DT	O	the	det	2	SENT_176	[p12l9t367r150b431],
2	prevalence	NN	O	prevalence	nsubjpass	8	SENT_176	[p12l186t367r588b450],
3	of	IN	O	of	_	0	SENT_176	[p12l627t367r707b431],
4	neurological	JJ	O	neurological	amod	6	SENT_176	[p12l737t367r1201b450],
5	side	JJ	O	side	amod	6	SENT_176	[p12l1241t367r1385b431],
6	effects	NNS	O	effect	prep_of	2	SENT_176	[p12l1423t367r1664b431],
7	is	VBZ	O	be	auxpass	8	SENT_176	[p12l1703t367r1761b431],
8	shown	VBN	O	show	_	0	SENT_176	[p12l1803t367r2041b431],
9	in	IN	O	in	_	0	SENT_176	[p12l2077t367r2147b430],
10	Table	NNP	O	Table	prep_in	8	SENT_176	[p12l9t466r211b529],
11	2	CD	NUMBER	2	num	10	SENT_176	[p12l245t466r306b530],
12	.	.	O	.	_	0	SENT_176	[p12l245t466r306b530],

1	Of	IN	O	of	_	0	SENT_177	[p12l346t465r445b530],
2	the	DT	O	the	det	4	SENT_177	[p12l472t466r582b529],
3	52	CD	NUMBER	52	num	4	SENT_177	[p12l617t465r705b530],
4	patients	NNS	O	patient	prep_of	12	SENT_177	[p12l738t466r1046b549],
5	,	,	O	,	_	0	SENT_177	[p12l738t466r1046b549],
6	11	CD	PERCENT	11	number	7	SENT_177	[p12l1091t466r1161b529],
7	(	CD	PERCENT	(	nsubj	12	SENT_177	[p12l1205t466r1428b545],
8	21	CD	PERCENT	21	num	9	SENT_177	[p12l1205t466r1428b545],
9	%	NN	PERCENT	%	dep	7	SENT_177	[p12l1205t466r1428b545],
10	)	CD	NUMBER	)	dep	7	SENT_177	[p12l1205t466r1428b545],
11	had	VBD	O	have	aux	12	SENT_177	[p12l1464t466r1597b529],
12	TD	VBN	O	td	_	0	SENT_177	[p12l1628t467r1748b529],
13	according	VBG	O	accord	_	0	SENT_177	[p12l1784t466r2146b549],
14	to	TO	O	to	prepc_according_to	12	SENT_177	[p12l9t575r77b629],
15	the	DT	O	the	det	17	SENT_177	[p12l107t565r218b629],
16	research	NN	O	research	nn	17	SENT_177	[p12l247t565r556b629],
17	criteria	NNS	O	criterion	pobj	12	SENT_177	[p12l585t565r848b629],
18	for	IN	O	for	_	0	SENT_177	[p12l876t565r983b629],
19	TD	NN	O	td	nn	21	SENT_177	[p12l1011t567r1130b628],
20	(	CD	NUMBER	(	num	21	SENT_177	[p12l1164t565r1522b644],
21	Schooler	NNP	O	Schooler	prep_for	17	SENT_177	[p12l1164t565r1522b644],
22	and	CC	O	and	_	0	SENT_177	[p12l1551t565r1682b629],
23	Kane	NNP	PERSON	Kane	conj_and	21	SENT_177	[p12l1711t567r1903b629],
24	1982	CD	DATE	1982	num	23	SENT_177	[p12l1941t566r2144b644],
25	)	CD	NUMBER	)	number	29	SENT_177	[p12l1941t566r2144b644],
26	and	CC	O	and	_	0	SENT_177	[p12l11t664r141b727],
27	32	CD	PERCENT	32	num	30	SENT_177	[p12l179t664r266b728],
28	(	CD	PERCENT	(	number	29	SENT_177	[p12l306t663r530b743],
29	62	CD	PERCENT	62	num	30	SENT_177	[p12l306t663r530b743],
30	%	NN	PERCENT	%	dep	23	SENT_177	[p12l306t663r530b743],
31	)	CD	NUMBER	)	nsubj	32	SENT_177	[p12l306t663r530b743],
32	had	VBD	O	have	rcmod	17	SENT_177	[p12l568t663r701b727],
33	parkinsonism	NN	O	parkinsonism	dobj	32	SENT_177	[p12l736t663r1238b747],
34	as	IN	O	as	_	0	SENT_177	[p12l1275t684r1345b727],
35	defined	VBN	O	define	conj_as	12	SENT_177	[p12l1385t663r1662b727],
36	by	IN	O	by	_	0	SENT_177	[p12l1696t664r1787b747],
37	Simpson	NNP	PERSON	Simpson	nn	40	SENT_177	[p12l1826t664r2147b747],
38	and	CC	O	and	_	0	SENT_177	[p12l11t763r141b827],
39	Angus	NNP	PERSON	Angus	conj_and	37	SENT_177	[p12l179t764r417b846],
40	criteria	NNS	O	criterion	prep_by	35	SENT_177	[p12l458t763r720b827],
41	(	CD	NUMBER	(	num	43	SENT_177	[p12l760t763r1022b842],
42	1970	CD	DATE	1970	num	43	SENT_177	[p12l760t763r1022b842],
43	)	NN	O	)	dobj	12	SENT_177	[p12l760t763r1022b842],
44	.	.	O	.	_	0	SENT_177	[p12l760t763r1022b842],

1	Nineteen	CD	NUMBER	nineteen	num	2	SENT_178	[p12l1064t763r1399b827],
2	patients	NNS	O	patient	nsubj	9	SENT_178	[p12l1435t763r1722b846],
3	(	IN	O	(	_	0	SENT_178	[p12l1765t763r1990b842],
4	37	CD	PERCENT	37	num	5	SENT_178	[p12l1765t763r1990b842],
5	%	NN	PERCENT	%	prep_(	2	SENT_178	[p12l1765t763r1990b842],
6	)	NN	O	)	dep	5	SENT_178	[p12l1765t763r1990b842],
7	did	VBD	O	do	aux	9	SENT_178	[p12l2032t763r2148b827],
8	not	RB	O	not	neg	9	SENT_178	[p12l9t871r126b925],
9	suffer	VB	O	suffer	_	0	SENT_178	[p12l161t861r373b925],
10	from	IN	O	from	_	0	SENT_178	[p12l404t861r583b925],
11	any	DT	O	any	det	13	SENT_178	[p12l616t882r746b945],
12	movement	NN	O	movement	nn	13	SENT_178	[p12l779t871r1170b926],
13	disorder	NN	O	disorder	prep_from	9	SENT_178	[p12l1203t861r1518b926],
14	.	.	O	.	_	0	SENT_178	[p12l1203t861r1518b926],

1	Co	NNP	O	Co	nn	3	SENT_179	[p12l1557t862r2038b926],
2	—	CD	NUMBER	—	num	3	SENT_179	[p12l1557t862r2038b926],
3	eXistence	NN	O	existence	nsubjpass	9	SENT_179	[p12l1557t862r2038b926],
4	of	IN	O	of	_	0	SENT_179	[p12l2073t861r2153b925],
5	TD	NN	O	td	prep_of	3	SENT_179	[p12l9t963r128b1024],
6	and	CC	O	and	_	0	SENT_179	[p12l163t961r294b1025],
7	parkinsonism	NN	O	parkinsonism	prep_of	3	SENT_179	[p12l323t961r825b1044],
8	was	VBD	O	be	auxpass	9	SENT_179	[p12l856t981r995b1025],
9	seen	VBN	O	see	_	0	SENT_179	[p12l1032t981r1192b1025],
10	in	IN	O	in	_	0	SENT_179	[p12l1224t961r1293b1024],
11	ten	CD	NUMBER	ten	num	12	SENT_179	[p12l1325t971r1437b1025],
12	patients	NNS	O	patient	prep_in	9	SENT_179	[p12l1467t961r1753b1044],
13	(	CD	PERCENT	(	number	14	SENT_179	[p12l1790t961r2037b1040],
14	19	CD	PERCENT	19	dep	15	SENT_179	[p12l1790t961r2037b1040],
15	%	NN	PERCENT	%	dep	12	SENT_179	[p12l1790t961r2037b1040],
16	)	CD	NUMBER	)	tmod	9	SENT_179	[p12l1790t961r2037b1040],
17	,	,	O	,	_	0	SENT_179	[p12l1790t961r2037b1040],
18	of	IN	O	of	_	0	SENT_179	[p12l2073t961r2153b1025],
19	whom	WP	O	whom	rel	27	SENT_179	[p12l9t1060r239b1124],
20	five	CD	PERCENT	five	dep	19	SENT_179	[p12l282t1059r423b1124],
21	(	CD	PERCENT	(	num	23	SENT_179	[p12l471t1059r695b1139],
22	50	CD	PERCENT	50	num	23	SENT_179	[p12l471t1059r695b1139],
23	%	NN	PERCENT	%	nsubj	27	SENT_179	[p12l471t1059r695b1139],
24	)	CD	NUMBER	)	dep	23	SENT_179	[p12l471t1059r695b1139],
25	were	VBD	O	be	cop	27	SENT_179	[p12l742t1080r919b1124],
26	homozygous	JJ	O	homozygous	amod	27	SENT_179	[p12l963t1060r1435b1143],
27	EMs	NNS	O	em	rcmod	16	SENT_179	[p12l1480t1061r1673b1136],
28	,	,	O	,	_	0	SENT_179	[p12l1480t1061r1673b1136],
29	four	CD	PERCENT	four	number	30	SENT_179	[p12l1721t1059r1875b1123],
30	(	CD	PERCENT	(	rcmod	16	SENT_179	[p12l1920t1060r2144b1139],
31	40	CD	PERCENT	40	num	32	SENT_179	[p12l1920t1060r2144b1139],
32	%	NN	PERCENT	%	dep	30	SENT_179	[p12l1920t1060r2144b1139],
33	)	CD	NUMBER	)	num	35	SENT_179	[p12l1920t1060r2144b1139],
34	heterozygous	JJ	O	heterozygous	amod	35	SENT_179	[p12l8t1159r500b1242],
35	EMs	NNS	O	em	dep	30	SENT_179	[p12l529t1161r699b1223],
36	and	CC	O	and	_	0	SENT_179	[p12l730t1159r861b1223],
37	one	CD	NUMBER	one	num	38	SENT_179	[p12l887t1179r1017b1223],
38	(	NN	O	(	rcmod	16	SENT_179	[p12l1047t1159r1271b1238],
39	10	CD	PERCENT	10	number	40	SENT_179	[p12l1047t1159r1271b1238],
40	%	NN	PERCENT	%	amod	38	SENT_179	[p12l1047t1159r1271b1238],
41	)	CD	NUMBER	)	num	42	SENT_179	[p12l1047t1159r1271b1238],
42	PM	NN	O	pm	dep	38	SENT_179	[p12l1300t1161r1450b1223],
43	.	.	O	.	_	0	SENT_179	[p12l1300t1161r1450b1223],

1	Patients	NNS	O	patient	nsubj	8	SENT_180	[p12l121t1257r411b1321],
2	with	IN	O	with	_	0	SENT_180	[p12l453t1258r615b1322],
3	parkinsonism	NN	O	parkinsonism	prep_with	1	SENT_180	[p12l653t1257r1155b1341],
4	or	CC	O	or	_	0	SENT_180	[p12l1193t1278r1269b1321],
5	TD	NN	O	td	conj_or	3	SENT_180	[p12l1306t1259r1425b1321],
6	were	VBD	O	be	cop	8	SENT_180	[p12l1466t1278r1643b1322],
7	significantly	RB	O	significantly	advmod	8	SENT_180	[p12l1686t1257r2146b1341],
8	older	JJR	O	older	_	0	SENT_180	[p12l10t1357r199b1421],
9	than	IN	O	than	mark	14	SENT_180	[p12l244t1357r402b1421],
10	patients	NNS	O	patient	nsubj	14	SENT_180	[p12l447t1357r733b1440],
11	without	IN	O	without	_	0	SENT_180	[p12l782t1357r1065b1421],
12	these	DT	O	these	det	13	SENT_180	[p12l1110t1357r1299b1421],
13	syndromes	NNS	O	syndrome	prep_without	10	SENT_180	[p12l1349t1357r1744b1440],
14	(	VBP	O	(	ccomp	8	SENT_180	[p12l1795t1357r2144b1436, p12l8t1456r240b1520],
15	KruskalWallis	NNP	O	KruskalWallis	nn	17	SENT_180	[p12l1795t1357r2144b1436, p12l8t1456r240b1520],
16	ANOVA	NNP	O	ANOVA	nn	17	SENT_180	[p12l296t1456r617b1520],
17	P	NN	O	p	dobj	14	SENT_180	[p12l670t1456r940b1520],
18	=	JJ	O	=	amod	17	SENT_180	[p12l670t1456r940b1520],
19	0.02	CD	NUMBER	0.02	tmod	18	SENT_180	[p12l670t1456r940b1520],
20	in	IN	O	in	_	0	SENT_180	[p12l995t1456r1065b1519],
21	case	NN	O	case	prep_in	17	SENT_180	[p12l1120t1476r1276b1519],
22	of	IN	O	of	_	0	SENT_180	[p12l1333t1455r1413b1519],
23	parkinsonism	NN	O	parkinsonism	prep_of	17	SENT_180	[p12l1460t1455r1962b1539],
24	and	CC	O	and	_	0	SENT_180	[p12l2017t1456r2147b1519],
25	P	NN	O	p	conj_and	23	SENT_180	[p12l7t1555r277b1619],
26	=	JJ	O	=	amod	17	SENT_180	[p12l7t1555r277b1619],
27	0.04	CD	NUMBER	0.04	tmod	26	SENT_180	[p12l7t1555r277b1619],
28	in	IN	O	in	_	0	SENT_180	[p12l314t1555r384b1618],
29	case	NN	O	case	_	0	SENT_180	[p12l421t1575r577b1619],
30	of	IN	O	of	_	0	SENT_180	[p12l615t1555r694b1619],
31	TD	NN	O	td	nn	32	SENT_180	[p12l724t1556r874b1634],
32	)	NN	O	)	prep_in_case_of	14	SENT_180	[p12l724t1556r874b1634],
33	but	CC	O	but	_	0	SENT_180	[p12l911t1555r1030b1619],
34	the	DT	O	the	det	35	SENT_180	[p12l1065t1555r1175b1619],
35	difference	NN	O	difference	nsubj	45	SENT_180	[p12l1213t1555r1585b1619],
36	in	IN	O	in	_	0	SENT_180	[p12l1622t1555r1692b1618],
37	duration	NN	O	duration	prep_in	35	SENT_180	[p12l1728t1555r2036b1619],
38	of	IN	O	of	_	0	SENT_180	[p12l2073t1555r2152b1619],
39	illness	NN	O	illness	prep_of	37	SENT_180	[p12l9t1654r242b1717],
40	between	IN	O	between	_	0	SENT_180	[p12l274t1654r583b1718],
41	these	DT	O	these	det	42	SENT_180	[p12l614t1654r802b1717],
42	groups	NNS	O	group	prep_between	39	SENT_180	[p12l835t1674r1082b1737],
43	was	VBD	O	be	cop	45	SENT_180	[p12l1115t1674r1254b1718],
44	not	RB	O	not	neg	45	SENT_180	[p12l1288t1663r1405b1717],
45	significant	JJ	O	significant	conj_but	8	SENT_180	[p12l1438t1653r1845b1737],
46	.	.	O	.	_	0	SENT_180	[p12l1438t1653r1845b1737],

1	Plasma	NN	O	plasma	nn	3	SENT_181	[p12l1880t1654r2148b1717],
2	zuclopenthixol	NN	O	zuclopenthixol	nn	3	SENT_181	[p12l10t1753r560b1836],
3	concentrations	NNS	O	concentration	nsubj	4	SENT_181	[p12l633t1753r1170b1817],
4	were	VBD	O	be	_	0	SENT_181	[p12l1245t1773r1422b1817],
5	not	RB	O	not	neg	4	SENT_181	[p12l1494t1762r1612b1817],
6	significantly	RB	O	significantly	advmod	4	SENT_181	[p12l1686t1753r2146b1836],

1	Table	NNP	O	Table	_	0	SENT_182	[p12l41t1912r128b1938],
2	2	CD	NUMBER	2	num	1	SENT_182	[p12l139t1911r157b1938],
3	Age	NNP	O	Age	dep	1	SENT_182	[p12l177t1912r247b1946],
4	,	,	O	,	_	0	SENT_182	[p12l177t1912r247b1946],
5	duration	NN	O	duration	appos	3	SENT_182	[p12l260t1912r384b1938],
6	of	IN	O	of	_	0	SENT_182	[p12l396t1912r428b1938],
7	illness	NN	O	illness	prep_of	5	SENT_182	[p12l40t1950r135b1976],
8	and	CC	O	and	_	0	SENT_182	[p12l148t1950r201b1976],
9	CYp2D6	NN	O	cyp2d6	nn	15	SENT_182	[p12l213t1950r346b1976],
10	genotype	NN	O	genotype	nn	15	SENT_182	[p12l356t1954r493b1984],
11	Tardive	NNP	O	Tardive	nn	15	SENT_182	[p12l1168t1938r1280b1964],
12	dyskinesia	NNP	O	dyskinesia	nn	15	SENT_182	[p12l1291t1938r1447b1972],
13	Parkinsonism	NNP	O	Parkinsonism	nn	15	SENT_182	[p12l1559t1938r1761b1964],
14	All	NNP	O	All	nn	15	SENT_182	[p12l1944t1938r1991b1964],
15	patients	NNS	O	patient	npadvmod	5	SENT_182	[p12l2000t1938r2114b1972],
16	in	IN	O	in	_	0	SENT_182	[p12l40t1988r69b2014],
17	relation	NN	O	relation	prep_in	15	SENT_182	[p12l79t1988r194b2014],
18	to	TO	O	to	_	0	SENT_182	[p12l205t1992r233b2014],
19	occurrence	NN	O	occurrence	prep_to	17	SENT_182	[p12l244t1996r409b2014],
20	of	IN	O	of	_	0	SENT_182	[p12l420t1988r453b2014],
21	movement	NN	O	movement	nn	22	SENT_182	[p12l40t2031r199b2053],
22	disorders	NNS	O	disorder	conj_and	7	SENT_182	[p12l210t2026r347b2053],
23	Yes	UH	O	yes	dep	22	SENT_182	[p12l1169t2015r1221b2041],
24	No	DT	O	no	dep	5	SENT_182	[p12l1373t2015r1418b2041],
25	Yes	UH	O	yes	dep	24	SENT_182	[p12l1560t2015r1612b2041],
26	No	DT	O	no	dep	1	SENT_182	[p12l1762t2015r1806b2041],

1	Patients	NNS	O	patient	dep	170	SENT_183	[p12l572t2092r687b2119],
2	(	CD	NUMBER	(	dep	170	SENT_183	[p12l699t2093r740b2125],
3	n	NN	O	n	dep	170	SENT_183	[p12l699t2093r740b2125],
4	)	CD	NUMBER	)	dep	170	SENT_183	[p12l699t2093r740b2125],
5	11	CD	NUMBER	11	dep	170	SENT_183	[p12l1172t2093r1200b2119],
6	41	CD	NUMBER	41	dep	170	SENT_183	[p12l1373t2092r1406b2119],
7	32	CD	NUMBER	32	dep	170	SENT_183	[p12l1561t2092r1595b2119],
8	20	CD	NUMBER	20	dep	170	SENT_183	[p12l1763t2092r1798b2119],
9	52	CD	NUMBER	52	dep	170	SENT_183	[p12l1945t2092r1980b2119],
10	Age	NNP	O	Age	dep	170	SENT_183	[p12l572t2131r633b2165],
11	[	CD	NUMBER	[	dep	170	SENT_183	[p12l645t2132r741b2165],
12	years	NNS	NUMBER	year	dep	170	SENT_183	[p12l645t2132r741b2165],
13	;	:	O	;	_	0	SENT_183	[p12l645t2132r741b2165],
14	mean	VB	O	mean	dep	170	SENT_183	[p12l753t2139r833b2157],
15	(	JJ	O	(	dep	170	SENT_183	[p12l844t2131r924b2164],
16	SD	NN	O	sd	dep	170	SENT_183	[p12l844t2131r924b2164],
17	)	NN	O	)	dep	170	SENT_183	[p12l844t2131r924b2164],
18	]	CD	NUMBER	]	dep	170	SENT_183	[p12l844t2131r924b2164],
19	50.3	CD	NUMBER	50.3	dep	170	SENT_183	[p12l1169t2131r1231b2158],
20	(	NN	O	(	dep	170	SENT_183	[p12l1244t2131r1348b2164],
21	13.8	CD	NUMBER	13.8	dep	170	SENT_183	[p12l1244t2131r1348b2164],
22	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1244t2131r1348b2164],
23	*	NN	O	*	dep	170	SENT_183	[p12l1244t2131r1348b2164],
24	41.9	CD	NUMBER	41.9	dep	170	SENT_183	[p12l1373t2131r1437b2158],
25	(	CD	NUMBER	(	dep	170	SENT_183	[p12l1449t2131r1534b2164],
26	11.1	CD	NUMBER	11.1	dep	170	SENT_183	[p12l1449t2131r1534b2164],
27	)	NN	O	)	dep	170	SENT_183	[p12l1449t2131r1534b2164],
28	47.8	CD	NUMBER	47.8	dep	170	SENT_183	[p12l1559t2131r1622b2158],
29	(	CD	NUMBER	(	dep	170	SENT_183	[p12l1635t2131r1739b2163],
30	10.0	CD	NUMBER	10.0	dep	170	SENT_183	[p12l1635t2131r1739b2163],
31	)	NN	O	)	dep	170	SENT_183	[p12l1635t2131r1739b2163],
32	*	CD	NUMBER	*	dep	170	SENT_183	[p12l1635t2131r1739b2163],
33	37.5	CD	NUMBER	37.5	dep	170	SENT_183	[p12l1763t2131r1824b2158],
34	(	NN	O	(	dep	170	SENT_183	[p12l1837t2131r1924b2164],
35	12.5	CD	NUMBER	12.5	dep	170	SENT_183	[p12l1837t2131r1924b2164],
36	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1837t2131r1924b2164],
37	43.7	CD	NUMBER	43.7	dep	170	SENT_183	[p12l1944t2131r2096b2164],
38	(	NN	O	(	dep	170	SENT_183	[p12l1944t2131r2096b2164],
39	12.1	CD	NUMBER	12.1	dep	170	SENT_183	[p12l1944t2131r2096b2164],
40	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1944t2131r2096b2164],
41	Duration	NN	O	duration	dep	170	SENT_183	[p12l572t2172r703b2198],
42	of	IN	O	of	dep	170	SENT_183	[p12l713t2172r746b2198],
43	illness	NN	O	illness	dep	170	SENT_183	[p12l753t2172r846b2198],
44	[	CD	NUMBER	[	dep	170	SENT_183	[p12l859t2173r955b2206],
45	years	NNS	NUMBER	year	dep	170	SENT_183	[p12l859t2173r955b2206],
46	;	:	O	;	_	0	SENT_183	[p12l859t2173r955b2206],
47	mean	VB	O	mean	dep	170	SENT_183	[p12l966t2180r1046b2198],
48	(	JJ	O	(	dep	170	SENT_183	[p12l1057t2172r1137b2204],
49	SD	NN	O	sd	dep	170	SENT_183	[p12l1057t2172r1137b2204],
50	)	NN	O	)	dep	170	SENT_183	[p12l1057t2172r1137b2204],
51	]	CD	NUMBER	]	dep	170	SENT_183	[p12l1057t2172r1137b2204],
52	14.7	CD	NUMBER	14.7	dep	170	SENT_183	[p12l1172t2172r1231b2198],
53	(	NN	O	(	dep	170	SENT_183	[p12l1244t2172r1312b2204],
54	4.6	CD	NUMBER	4.6	dep	170	SENT_183	[p12l1244t2172r1312b2204],
55	)	NN	O	)	dep	170	SENT_183	[p12l1244t2172r1312b2204],
56	15.6	CD	NUMBER	15.6	dep	170	SENT_183	[p12l1377t2172r1437b2199],
57	(	NN	O	(	dep	170	SENT_183	[p12l1449t2172r1535b2204],
58	10.2	CD	NUMBER	10.2	dep	170	SENT_183	[p12l1449t2172r1535b2204],
59	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1449t2172r1535b2204],
60	16.9	CD	NUMBER	16.9	dep	170	SENT_183	[p12l1563t2172r1623b2199],
61	(	CD	NUMBER	(	dep	170	SENT_183	[p12l1635t2172r1703b2204],
62	8.6	CD	NUMBER	8.6	dep	170	SENT_183	[p12l1635t2172r1703b2204],
63	)	NN	O	)	dep	170	SENT_183	[p12l1635t2172r1703b2204],
64	12.9	CD	NUMBER	12.9	dep	170	SENT_183	[p12l1766t2172r1825b2199],
65	(	NN	O	(	dep	170	SENT_183	[p12l1837t2172r1924b2204],
66	10.1	CD	NUMBER	10.1	dep	170	SENT_183	[p12l1837t2172r1924b2204],
67	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1837t2172r1924b2204],
68	15.4	CD	NUMBER	15.4	dep	170	SENT_183	[p12l1948t2172r2008b2199],
69	(	NN	O	(	dep	170	SENT_183	[p12l2019t2172r2087b2204],
70	9.3	CD	NUMBER	9.3	dep	170	SENT_183	[p12l2019t2172r2087b2204],
71	)	CD	NUMBER	)	dep	170	SENT_183	[p12l2019t2172r2087b2204],
72	Homozygous	JJ	O	homozygous	dep	170	SENT_183	[p12l572t2214r768b2247],
73	EMs	NNS	O	em	dep	170	SENT_183	[p12l779t2214r848b2239],
74	(	VBP	O	(	dep	170	SENT_183	[p12l860t2213r896b2245],
75	n	NN	O	n	dep	170	SENT_183	[p12l860t2213r896b2245],
76	,	,	O	,	_	0	SENT_183	[p12l860t2213r896b2245],
77	%	NN	O	%	dep	170	SENT_183	[p12l910t2213r949b2245],
78	)	CD	NUMBER	)	dep	170	SENT_183	[p12l910t2213r949b2245],
79	6	CD	NUMBER	6	dep	170	SENT_183	[p12l1188t2213r1204b2239],
80	(	NN	O	(	dep	170	SENT_183	[p12l1216t2213r1306b2245],
81	55	CD	PERCENT	55	dep	170	SENT_183	[p12l1216t2213r1306b2245],
82	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1216t2213r1306b2245],
83	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1216t2213r1306b2245],
84	29	CD	NUMBER	29	dep	170	SENT_183	[p12l1374t2213r1409b2240],
85	(	NN	O	(	dep	170	SENT_183	[p12l1421t2213r1511b2245],
86	71	CD	PERCENT	71	dep	170	SENT_183	[p12l1421t2213r1511b2245],
87	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1421t2213r1511b2245],
88	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1421t2213r1511b2245],
89	20	CD	NUMBER	20	dep	170	SENT_183	[p12l1560t2213r1596b2239],
90	(	NN	O	(	dep	170	SENT_183	[p12l1607t2213r1697b2245],
91	63	CD	PERCENT	63	dep	170	SENT_183	[p12l1607t2213r1697b2245],
92	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1607t2213r1697b2245],
93	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1607t2213r1697b2245],
94	15	CD	NUMBER	15	dep	170	SENT_183	[p12l1766t2213r1797b2239],
95	(	NN	O	(	dep	170	SENT_183	[p12l1809t2213r1899b2245],
96	75	CD	PERCENT	75	dep	170	SENT_183	[p12l1809t2213r1899b2245],
97	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1809t2213r1899b2245],
98	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1809t2213r1899b2245],
99	35	CD	NUMBER	35	dep	170	SENT_183	[p12l1945t2213r1979b2239],
100	(	NN	O	(	dep	170	SENT_183	[p12l1991t2213r2081b2245],
101	67	CD	PERCENT	67	dep	170	SENT_183	[p12l1991t2213r2081b2245],
102	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1991t2213r2081b2245],
103	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1991t2213r2081b2245],
104	_	NN	O	_	dep	170	SENT_183	[p12l396t2277r400b2281],
105	Heterozygous	JJ	O	heterozygous	dep	170	SENT_183	[p12l572t2252r776b2285],
106	EMs	NNS	O	em	dep	170	SENT_183	[p12l787t2252r856b2277],
107	(	VBP	O	(	dep	170	SENT_183	[p12l868t2251r904b2283],
108	n	NN	O	n	dep	170	SENT_183	[p12l868t2251r904b2283],
109	,	,	O	,	_	0	SENT_183	[p12l868t2251r904b2283],
110	%	NN	O	%	dep	170	SENT_183	[p12l917t2251r957b2283],
111	)	CD	NUMBER	)	dep	170	SENT_183	[p12l917t2251r957b2283],
112	4	CD	NUMBER	4	dep	170	SENT_183	[p12l1187t2251r1205b2277],
113	(	NN	O	(	dep	170	SENT_183	[p12l1216t2251r1306b2283],
114	36	CD	PERCENT	36	dep	170	SENT_183	[p12l1216t2251r1306b2283],
115	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1216t2251r1306b2283],
116	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1216t2251r1306b2283],
117	9	CD	NUMBER	9	dep	170	SENT_183	[p12l1392t2251r1409b2278],
118	(	NN	O	(	dep	170	SENT_183	[p12l1421t2251r1511b2283],
119	22	CD	PERCENT	22	dep	170	SENT_183	[p12l1421t2251r1511b2283],
120	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1421t2251r1511b2283],
121	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1421t2251r1511b2283],
122	8	CD	PERCENT	8	dep	170	SENT_183	[p12l1580t2251r1595b2277],
123	(	NN	PERCENT	(	dep	170	SENT_183	[p12l1607t2251r1697b2283],
124	25	CD	PERCENT	25	dep	170	SENT_183	[p12l1607t2251r1697b2283],
125	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1607t2251r1697b2283],
126	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1607t2251r1697b2283],
127	5	CD	NUMBER	5	dep	170	SENT_183	[p12l1781t2251r1797b2277],
128	(	NN	O	(	dep	170	SENT_183	[p12l1809t2251r1899b2283],
129	25	CD	PERCENT	25	dep	170	SENT_183	[p12l1809t2251r1899b2283],
130	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1809t2251r1899b2283],
131	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1809t2251r1899b2283],
132	13	CD	NUMBER	13	dep	170	SENT_183	[p12l1948t2251r1979b2277],
133	(	NN	O	(	dep	170	SENT_183	[p12l1992t2251r2081b2283],
134	25	CD	PERCENT	25	dep	170	SENT_183	[p12l1992t2251r2081b2283],
135	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1992t2251r2081b2283],
136	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1992t2251r2081b2283],
137	*	CD	NUMBER	*	dep	170	SENT_183	[p12l42t2277r178b2308],
138	P	NN	O	p	dep	170	SENT_183	[p12l42t2277r178b2308],
139	<	JJR	O	<	dep	170	SENT_183	[p12l42t2277r178b2308],
140	0-05	CD	NUMBER	0-05	dep	170	SENT_183	[p12l42t2277r178b2308],
141	;	:	O	;	_	0	SENT_183	[p12l42t2277r178b2308],
142	Kmskal-Wallis	NNP	O	Kmskal-Wallis	dep	170	SENT_183	[p12l191t2277r417b2304],
143	PMs	NNP	O	PMs	dep	170	SENT_183	[p12l572t2290r638b2316],
144	(	CD	NUMBER	(	dep	170	SENT_183	[p12l650t2290r687b2322],
145	n	NN	O	n	dep	170	SENT_183	[p12l650t2290r687b2322],
146	,	,	O	,	_	0	SENT_183	[p12l650t2290r687b2322],
147	%	NN	O	%	dep	170	SENT_183	[p12l700t2289r740b2322],
148	)	CD	PERCENT	)	dep	170	SENT_183	[p12l700t2289r740b2322],
149	1	CD	PERCENT	1	dep	170	SENT_183	[p12l1191t2290r1202b2315],
150	(	CD	PERCENT	(	dep	170	SENT_183	[p12l1216t2289r1287b2322],
151	9	CD	PERCENT	9	dep	170	SENT_183	[p12l1216t2289r1287b2322],
152	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1216t2289r1287b2322],
153	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1216t2289r1287b2322],
154	3	CD	NUMBER	3	dep	170	SENT_183	[p12l1393t2289r1408b2316],
155	(	NN	O	(	dep	170	SENT_183	[p12l1421t2289r1492b2322],
156	7	CD	PERCENT	7	dep	170	SENT_183	[p12l1421t2289r1492b2322],
157	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1421t2289r1492b2322],
158	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1421t2289r1492b2322],
159	4	CD	NUMBER	4	dep	170	SENT_183	[p12l1578t2289r1596b2315],
160	(	NN	O	(	dep	170	SENT_183	[p12l1607t2289r1697b2322],
161	12	CD	PERCENT	12	dep	170	SENT_183	[p12l1607t2289r1697b2322],
162	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1607t2289r1697b2322],
163	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1607t2289r1697b2322],
164	o	NN	O	o	dep	170	SENT_183	[p12l1781t2289r1798b2316],
165	4	CD	NUMBER	4	dep	170	SENT_183	[p12l1962t2289r1980b2315],
166	(	NN	O	(	dep	170	SENT_183	[p12l1992t2289r2063b2322],
167	8	CD	PERCENT	8	dep	170	SENT_183	[p12l1992t2289r2063b2322],
168	%	NN	PERCENT	%	dep	170	SENT_183	[p12l1992t2289r2063b2322],
169	)	CD	NUMBER	)	dep	170	SENT_183	[p12l1992t2289r2063b2322],
170	ANOVA	NNP	ORGANIZATION	ANOVA	_	0	SENT_183	[p12l40t2316r170b2342],

1	Table	NNP	O	Table	_	0	SENT_184	[p12l40t2488r128b2515],
2	3	CD	NUMBER	3	num	4	SENT_184	[p12l139t2488r156b2515],
3	Movement	NNP	O	Movement	nn	4	SENT_184	[p12l176t2489r340b2514],
4	disorders	NNS	O	disorder	dep	1	SENT_184	[p12l351t2488r487b2514],
5	.	.	O	.	_	0	SENT_184	[p12l766t2515r770b2519],

1	l	NN	O	l	_	0	SENT_185	[p12l1841t2523r1845b2528],
2	2	CD	NUMBER	2	num	3	SENT_185	[p12l1879t2513r1899b2531],
3	_	NN	O	_	dep	1	SENT_185	[p12l1879t2513r1899b2531],
4	in	IN	O	in	_	0	SENT_185	[p12l40t2527r68b2553],
5	relation	NN	O	relation	prep_in	3	SENT_185	[p12l78t2526r192b2553],
6	to	TO	O	to	_	0	SENT_185	[p12l202t2531r230b2553],
7	CYPZD6	NN	O	cypzd6	nn	8	SENT_185	[p12l243t2526r375b2553],
8	alleles	NNS	O	allele	prep_to	5	SENT_185	[p12l384t2527r478b2553],
9	Movement	NNP	O	Movement	nn	14	SENT_185	[p12l571t2515r734b2541],
10	disorder	NNP	O	disorder	nn	14	SENT_185	[p12l745t2515r868b2541],
11	Number	NNP	O	Number	nn	14	SENT_185	[p12l1016t2515r1140b2541],
12	(	JJ	O	(	amod	14	SENT_185	[p12l1151t2515r1324b2549],
13	frequency	NN	O	frequency	nn	14	SENT_185	[p12l1151t2515r1324b2549],
14	)	NN	O	)	dep	5	SENT_185	[p12l1151t2515r1324b2549],
15	of	IN	O	of	_	0	SENT_185	[p12l1336t2515r1368b2541],
16	alleles	NNS	O	allele	nn	18	SENT_185	[p12l1377t2515r1471b2541],
17	P	NN	O	p	nn	18	SENT_185	[p12l1723t2516r1746b2541],
18	value	NN	O	value	prep_of	14	SENT_185	[p12l1756t2515r1846b2546],
19	,	,	O	,	_	0	SENT_185	[p12l1756t2515r1846b2546],
20	x	NN	O	x	appos	5	SENT_185	[p12l1858t2521r1878b2548],
21	,	,	O	,	_	0	SENT_185	[p12l1895t2536r1900b2546],
22	OR	NN	O	or	appos	20	SENT_185	[p12l1913t2515r1964b2541],
23	(	CD	PERCENT	(	number	24	SENT_185	[p12l1976t2515r2054b2547],
24	95	CD	PERCENT	95	num	25	SENT_185	[p12l1976t2515r2054b2547],
25	%	NN	PERCENT	%	dep	22	SENT_185	[p12l1976t2515r2054b2547],
26	CI	NN	O	ci	nn	27	SENT_185	[p12l2067t2515r2114b2547],
27	)	NN	O	)	dep	1	SENT_185	[p12l2067t2515r2114b2547],

1	CYPZD6	NN	O	cypzd6	nn	2	SENT_186	[p12l1016t2585r1149b2612],
2	*	NN	O	*	_	0	SENT_186	[p12l1153t2585r1183b2611],
3	1	CD	NUMBER	1	num	4	SENT_186	[p12l1153t2585r1183b2611],
4	CYP2D6	NN	O	cyp2d6	dep	2	SENT_186	[p12l1326t2585r1567b2612],
5	*	CD	NUMBER	*	num	7	SENT_186	[p12l1326t2585r1567b2612],
6	3or	JJ	O	3or	amod	7	SENT_186	[p12l1326t2585r1567b2612],
7	*	NN	O	*	dep	4	SENT_186	[p12l1326t2585r1567b2612],
8	4	CD	NUMBER	4	dep	2	SENT_186	[p12l1326t2585r1567b2612],

1	Parkinsonism	NNP	O	Parkinsonism	_	0	SENT_187	[p12l571t2664r777b2690],
2	yes	RB	O	yes	advmod	3	SENT_187	[p12l788t2672r836b2698],
3	48	CD	NUMBER	48	dep	11	SENT_187	[p12l1014t2664r1050b2691],
4	(	CD	NUMBER	(	num	5	SENT_187	[p12l1063t2664r1151b2697],
5	0.75	CD	NUMBER	0.75	dep	3	SENT_187	[p12l1063t2664r1151b2697],
6	)	CD	NUMBER	)	number	7	SENT_187	[p12l1063t2664r1151b2697],
7	16	CD	NUMBER	16	dep	5	SENT_187	[p12l1328t2664r1361b2691],
8	(	NN	O	(	dep	11	SENT_187	[p12l1373t2664r1461b2696],
9	0.25	CD	NUMBER	0.25	num	8	SENT_187	[p12l1373t2664r1461b2696],
10	)	CD	NUMBER	)	num	11	SENT_187	[p12l1373t2664r1461b2696],
11	P	NN	O	p	dep	1	SENT_187	[p12l1723t2664r1842b2695],
12	=	JJ	O	=	dep	11	SENT_187	[p12l1723t2664r1842b2695],
13	0.12	CD	NUMBER	0.12	dep	12	SENT_187	[p12l1723t2664r1842b2695],
14	;	:	O	;	_	0	SENT_187	[p12l1723t2664r1842b2695],
15	x2	NN	O	x2	dep	1	SENT_187	[p12l1854t2662r1956b2698],
16	=	JJ	O	=	amod	15	SENT_187	[p12l1854t2662r1956b2698],
17	2.4	CD	NUMBER	2.4	tmod	16	SENT_187	[p12l1854t2662r1956b2698],

1	OR	NN	O	or	_	0	SENT_188	[p12l1724t2702r1775b2729],
2	2.3	CD	PERCENT	2.3	number	3	SENT_188	[p12l1786t2702r1830b2729],
3	(	CD	PERCENT	(	dep	1	SENT_188	[p12l1844t2702r1961b2735],
4	95	CD	PERCENT	95	num	6	SENT_188	[p12l1844t2702r1961b2735],
5	%	NN	PERCENT	%	nn	6	SENT_188	[p12l1844t2702r1961b2735],
6	CI	NN	O	ci	dep	3	SENT_188	[p12l1844t2702r1961b2735],
7	0.7-6	CD	NUMBER	0.7-6	num	9	SENT_188	[p12l1972t2702r2096b2735],
8	.9	CD	NUMBER	.9	num	9	SENT_188	[p12l1972t2702r2096b2735],
9	)	NN	O	)	dep	1	SENT_188	[p12l1972t2702r2096b2735],

1	Parkinsonism	NNP	O	Parkinsonism	_	0	SENT_189	[p12l571t2740r777b2766],
2	no	DT	O	no	quantmod	4	SENT_189	[p12l787t2748r824b2766],
3	35	CD	NUMBER	35	number	4	SENT_189	[p12l1015t2740r1050b2766],
4	(	CD	NUMBER	(	dep	1	SENT_189	[p12l1063t2740r1151b2772],
5	0.88	CD	NUMBER	0.88	num	6	SENT_189	[p12l1063t2740r1151b2772],
6	)	NN	O	)	dep	4	SENT_189	[p12l1063t2740r1151b2772],
7	5	CD	NUMBER	5	num	8	SENT_189	[p12l1344t2740r1360b2766],
8	(	NN	O	(	dep	1	SENT_189	[p12l1373t2740r1461b2772],
9	0.12	CD	NUMBER	0.12	dep	8	SENT_189	[p12l1373t2740r1461b2772],
10	)	CD	NUMBER	)	num	11	SENT_189	[p12l1373t2740r1461b2772],
11	TD	NN	O	td	dep	1	SENT_189	[p12l571t2778r620b2804],
12	yes	RB	O	yes	advmod	14	SENT_189	[p12l631t2786r680b2812],
13	16	CD	NUMBER	16	number	14	SENT_189	[p12l1018t2777r1051b2804],
14	(	CD	NUMBER	(	dep	11	SENT_189	[p12l1063t2777r1151b2810],
15	0.73	CD	NUMBER	0.73	num	16	SENT_189	[p12l1063t2777r1151b2810],
16	)	NN	O	)	dep	1	SENT_189	[p12l1063t2777r1151b2810],
17	6	CD	NUMBER	6	num	18	SENT_189	[p12l1344t2777r1361b2804],
18	(	NN	O	(	dep	16	SENT_189	[p12l1373t2777r1461b2810],
19	0.27	CD	NUMBER	0.27	num	20	SENT_189	[p12l1373t2777r1461b2810],
20	)	CD	NUMBER	)	rcmod	18	SENT_189	[p12l1373t2777r1461b2810],
21	$	$	MONEY	$	dep	20	SENT_189	[p12l1723t2776r1961b2848],
22	5	CD	MONEY	5	number	21	SENT_189	[p12l1723t2776r1961b2848],
23	:	:	O	:	_	0	SENT_189	[p12l1723t2776r1961b2848],
24	/	:	O	/	punct	30	SENT_189	[p12l1723t2776r1961b2848],
25	(	CD	NUMBER	(	number	26	SENT_189	[p12l1723t2776r1961b2848],
26	0691	CD	DATE	0691	num	27	SENT_189	[p12l1723t2776r1961b2848],
27	o	NN	O	o	dep	30	SENT_189	[p12l1972t2815r1989b2842],
28	54	CD	NUMBER	54	number	29	SENT_189	[p12l2001t2815r2056b2842],
29	9	CD	NUMBER	9	amod	27	SENT_189	[p12l2067t2815r2096b2848],
30	)	NN	O	)	dep	18	SENT_189	[p12l2067t2815r2096b2848],
31	.	.	O	.	_	0	SENT_189	[p12l1806t2837r1811b2842],

1	o	NN	O	o	_	0	SENT_190	[p12l1909t2827r1922b2842],
2	.	.	O	.	_	0	SENT_190	[p12l1993t2837r1997b2842],

1	.	.	O	.	_	0	SENT_191	[p12l2059t2837r2064b2842],

1	TD	NNP	O	TD	_	0	SENT_192	[p12l571t2854r620b2879],
2	no	DT	O	no	det	4	SENT_192	[p12l631t2861r668b2880],
3	67	CD	NUMBER	67	num	4	SENT_192	[p12l1015t2853r1050b2880],
4	(	NN	O	(	dep	1	SENT_192	[p12l1063t2853r1151b2886],
5	0.82	CD	NUMBER	0.82	dep	4	SENT_192	[p12l1063t2853r1151b2886],
6	)	CD	NUMBER	)	number	7	SENT_192	[p12l1063t2853r1151b2886],
7	15	CD	NUMBER	15	num	8	SENT_192	[p12l1328t2853r1360b2880],
8	(	NN	O	(	dep	5	SENT_192	[p12l1373t2853r1461b2886],
9	0.18	CD	NUMBER	0.18	num	10	SENT_192	[p12l1373t2853r1461b2886],
10	)	NN	O	)	dep	1	SENT_192	[p12l1373t2853r1461b2886],

1	different	JJ	O	different	conj_and	1	SENT_193	[p12l8t3065r326b3129],
2	between	IN	O	between	_	0	SENT_193	[p12l388t3065r697b3129],
3	patients	NNS	O	patient	prep_between	1	SENT_193	[p12l761t3065r1048b3148],
4	with	IN	O	with	_	0	SENT_193	[p12l1115t3065r1279b3129],
5	and	CC	O	and	_	0	SENT_193	[p12l1345t3065r1475b3129],
6	without	IN	O	without	_	0	SENT_193	[p12l1540t3065r1823b3129],
7	TD	NN	O	td	prep_without	1	SENT_193	[p12l1887t3067r2006b3128],
8	or	CC	O	or	_	0	SENT_193	[p12l2074t3086r2150b3129],
9	parkinsonism	NN	O	parkinsonism	nn	11	SENT_193	[p12l6t3164r508b3247],
10	(	CD	NUMBER	(	num	11	SENT_193	[p12l598t3164r1184b3243],
11	Kruskal	NNP	PERSON	Kruskal	prep_without	1	SENT_193	[p12l598t3164r1184b3243],
12	.	.	O	.	_	0	SENT_193	[p12l598t3164r1184b3243],

1	—	NN	O	—	_	0	SENT_194	[p12l598t3164r1184b3243],
2	.	.	O	.	_	0	SENT_194	[p12l598t3164r1184b3243],

1	Wallis	NNP	PERSON	Wallis	nn	3	SENT_195	[p12l598t3164r1184b3243],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_195	[p12l1274t3164r1596b3228],
3	P	NN	O	p	nsubj	4	SENT_195	[p12l1682t3163r1952b3228],
4	=	JJ	O	=	_	0	SENT_195	[p12l1682t3163r1952b3228],
5	0.56	CD	NUMBER	0.56	dobj	4	SENT_195	[p12l1682t3163r1952b3228],
6	for	IN	O	for	_	0	SENT_195	[p12l2042t3164r2150b3228],
7	parkinsonism	NN	O	parkinsonism	prep_for	5	SENT_195	[p12l6t3263r508b3346],
8	and	CC	O	and	_	0	SENT_195	[p12l535t3263r666b3327],
9	P	NN	O	p	prep_for	5	SENT_195	[p12l690t3264r957b3327],
10	=	JJ	O	=	amod	5	SENT_195	[p12l690t3264r957b3327],
11	0.73	CD	NUMBER	0.73	tmod	10	SENT_195	[p12l690t3264r957b3327],
12	for	IN	O	for	_	0	SENT_195	[p12l988t3263r1096b3327],
13	TD	NN	O	td	nn	14	SENT_195	[p12l1121t3264r1291b3342],
14	)	NN	O	)	prep_for	4	SENT_195	[p12l1121t3264r1291b3342],
15	.	.	O	.	_	0	SENT_195	[p12l1121t3264r1291b3342],

1	There	EX	O	there	expl	2	SENT_196	[p12l119t3362r333b3426],
2	was	VBD	O	be	_	0	SENT_196	[p12l372t3382r511b3426],
3	a	DT	O	a	det	4	SENT_196	[p12l552t3382r591b3426],
4	tendency	NN	O	tendency	nsubj	2	SENT_196	[p12l626t3362r960b3445],
5	for	IN	O	for	_	0	SENT_196	[p12l998t3362r1105b3426],
6	heterozygous	JJ	O	heterozygous	amod	7	SENT_196	[p12l1140t3362r1634b3445],
7	EM	NN	O	em	prep_for	4	SENT_196	[p12l1673t3363r1809b3425],
8	and	CC	O	and	_	0	SENT_196	[p12l1849t3362r1980b3426],
9	PM	NN	O	pm	nn	10	SENT_196	[p12l2016t3363r2147b3425],
10	patients	NNS	O	patient	prep_for	4	SENT_196	[p12l6t3461r293b3544],
11	to	TO	O	to	aux	12	SENT_196	[p12l323t3470r392b3525],
12	have	VB	O	have	infmod	4	SENT_196	[p12l421t3461r594b3525],
13	more	RBR	O	more	advmod	14	SENT_196	[p12l623t3482r811b3525],
14	severe	JJ	O	severe	amod	15	SENT_196	[p12l844t3482r1076b3525],
15	parkinsonism	NN	O	parkinsonism	dobj	12	SENT_196	[p12l1103t3461r1606b3544],
16	than	IN	O	than	_	0	SENT_196	[p12l1633t3461r1791b3525],
17	homozygous	JJ	O	homozygous	amod	18	SENT_196	[p12l1818t3461r2145b3544, p12l8t3580r178b3643],
18	EMs	NNS	O	em	prep_than	12	SENT_196	[p12l225t3561r419b3636],
19	,	,	O	,	_	0	SENT_196	[p12l225t3561r419b3636],
20	but	CC	O	but	_	0	SENT_196	[p12l467t3560r586b3624],
21	this	DT	O	this	det	22	SENT_196	[p12l630t3560r760b3624],
22	difference	NN	O	difference	nsubj	25	SENT_196	[p12l809t3560r1182b3624],
23	did	VBD	O	do	aux	25	SENT_196	[p12l1229t3560r1345b3624],
24	not	RB	O	not	neg	25	SENT_196	[p12l1390t3569r1508b3624],
25	reach	VB	O	reach	conj_but	2	SENT_196	[p12l1551t3560r1751b3624],
26	statistical	JJ	O	statistical	amod	27	SENT_196	[p12l1800t3560r2148b3624],
27	significance	NN	O	significance	dobj	25	SENT_196	[p12l10t3659r455b3742],
28	(	CD	NUMBER	(	num	29	SENT_196	[p12l485t3659r1071b3738],
29	Kruskal	NNP	PERSON	Kruskal	dep	27	SENT_196	[p12l485t3659r1071b3738],
30	.	.	O	.	_	0	SENT_196	[p12l485t3659r1071b3738],

1	—	NN	O	—	_	0	SENT_197	[p12l485t3659r1071b3738],
2	.	.	O	.	_	0	SENT_197	[p12l485t3659r1071b3738],

1	Wallis	NNP	PERSON	Wallis	nn	3	SENT_198	[p12l485t3659r1071b3738],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_198	[p12l1100t3660r1421b3723],
3	P	NN	O	p	nsubj	4	SENT_198	[p12l1445t3659r1813b3738],
4	=	JJ	O	=	_	0	SENT_198	[p12l1445t3659r1813b3738],
5	0.067	CD	NUMBER	0.067	num	6	SENT_198	[p12l1445t3659r1813b3738],
6	)	NN	O	)	dobj	4	SENT_198	[p12l1445t3659r1813b3738],
7	.	.	O	.	_	0	SENT_198	[p12l1445t3659r1813b3738],

1	Logistic	JJ	O	logistic	amod	3	SENT_199	[p12l1844t3659r2146b3742],
2	regression	NN	O	regression	nn	3	SENT_199	[p13l6t15r388b98],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_199	[p13l418t15r712b98],
4	was	VBD	O	be	auxpass	5	SENT_199	[p13l743t35r883b79],
5	performed	VBN	O	perform	_	0	SENT_199	[p13l912t15r1300b98],
6	where	WRB	O	where	advmod	14	SENT_199	[p13l1328t15r1552b79],
7	the	DT	O	the	det	8	SENT_199	[p13l1581t15r1692b79],
8	presence	NN	O	presence	nsubj	14	SENT_199	[p13l1719t35r2044b98],
9	of	IN	O	of	_	0	SENT_199	[p13l2074t15r2154b79],
10	TD	NN	O	td	prep_of	8	SENT_199	[p13l7t116r126b177],
11	was	VBD	O	be	cop	14	SENT_199	[p13l157t135r296b178],
12	the	DT	O	the	det	14	SENT_199	[p13l327t114r438b178],
13	dependent	JJ	O	dependent	amod	14	SENT_199	[p13l467t114r848b197],
14	variable	NN	O	variable	advcl	5	SENT_199	[p13l875t114r1173b178],
15	and	CC	O	and	_	0	SENT_199	[p13l1203t114r1334b178],
16	age	NN	O	age	conj_and	14	SENT_199	[p13l1364t135r1508b197],
17	,	,	O	,	_	0	SENT_199	[p13l1364t135r1508b197],
18	gender	NN	O	gender	conj_and	14	SENT_199	[p13l1541t114r1807b197],
19	,	,	O	,	_	0	SENT_199	[p13l1541t114r1807b197],
20	duration	NN	O	duration	conj_and	14	SENT_199	[p13l1840t114r2148b178],
21	of	IN	O	of	_	0	SENT_199	[p13l8t213r88b277],
22	illness	NN	O	illness	prep_of	20	SENT_199	[p13l153t213r409b289],
23	,	,	O	,	_	0	SENT_199	[p13l153t213r409b289],
24	plasma	NN	O	plasma	nn	26	SENT_199	[p13l483t213r747b296],
25	zuclopenthixol	NN	O	zuclopenthixol	nn	26	SENT_199	[p13l817t213r1368b296],
26	concentration	NN	O	concentration	conj_and	14	SENT_199	[p13l1440t213r1945b277],
27	and	CC	O	and	_	0	SENT_199	[p13l2018t213r2148b277],
28	CYPZD6	NN	O	cypzd6	nn	29	SENT_199	[p13l11t312r339b377],
29	genotype	NN	O	genotype	conj_and	14	SENT_199	[p13l377t322r715b395],
30	were	VBD	O	be	cop	32	SENT_199	[p13l757t333r935b376],
31	independent	JJ	O	independent	amod	32	SENT_199	[p13l976t312r1431b395],
32	variables	NNS	O	variable	rcmod	29	SENT_199	[p13l1471t312r1824b376],
33	.	.	O	.	_	0	SENT_199	[p13l1471t312r1824b376],

1	Neither	DT	O	neither	det	4	SENT_200	[p13l1870t312r2149b376],
2	C	NN	O	c	nn	4	SENT_200	[p13l11t412r69b475],
3	YPZD6	NN	O	ypzd6	nn	4	SENT_200	[p13l74t410r339b474],
4	genotype	NN	O	genotype	nsubj	13	SENT_200	[p13l367t420r725b494],
5	,	,	O	,	_	0	SENT_200	[p13l367t420r725b494],
6	duration	NN	O	duration	appos	4	SENT_200	[p13l761t410r1069b474],
7	of	IN	O	of	_	0	SENT_200	[p13l1100t410r1180b474],
8	illness	NN	O	illness	prep_of	6	SENT_200	[p13l1205t410r1439b474],
9	nor	CC	O	nor	_	0	SENT_200	[p13l1472t431r1596b474],
10	plasma	NN	O	plasma	nn	12	SENT_200	[p13l1624t411r1888b494],
11	zuclopenthixol	NN	O	zuclopenthixol	nn	12	SENT_200	[p13l1918t410r2145b474, p13l6t510r357b593],
12	concentration	NN	O	concentration	prep_of	6	SENT_200	[p13l405t510r910b574],
13	contributed	VBD	O	contribute	_	0	SENT_200	[p13l957t510r1380b574],
14	to	TO	O	to	_	0	SENT_200	[p13l1426t520r1495b574],
15	the	DT	O	the	det	16	SENT_200	[p13l1543t510r1654b574],
16	presence	NN	O	presence	prep_to	13	SENT_200	[p13l1701t531r2025b593],
17	of	IN	O	of	_	0	SENT_200	[p13l2074t510r2154b574],
18	TD	NN	O	td	prep_of	16	SENT_200	[p13l7t610r147b673],
19	.	.	O	.	_	0	SENT_200	[p13l7t610r147b673],

1	Similarly	RB	O	similarly	advmod	25	SENT_201	[p13l195t608r551b692],
2	,	,	O	,	_	0	SENT_201	[p13l195t608r551b692],
3	when	WRB	O	when	advmod	11	SENT_201	[p13l595t609r794b673],
4	the	DT	O	the	det	5	SENT_201	[p13l834t609r945b672],
5	presence	NN	O	presence	nsubj	11	SENT_201	[p13l985t629r1309b692],
6	of	IN	O	of	_	0	SENT_201	[p13l1351t608r1431b672],
7	parkinsonism	NN	O	parkinsonism	prep_of	5	SENT_201	[p13l1464t608r1966b692],
8	was	VBD	O	be	cop	11	SENT_201	[p13l2006t629r2146b673],
9	the	DT	O	the	det	11	SENT_201	[p13l7t708r118b772],
10	dependent	JJ	O	dependent	amod	11	SENT_201	[p13l150t708r531b791],
11	variable	NN	O	variable	advcl	25	SENT_201	[p13l561t708r879b784],
12	,	,	O	,	_	0	SENT_201	[p13l561t708r879b784],
13	neither	CC	O	neither	dep	11	SENT_201	[p13l913t708r1172b772],
14	C	NN	O	c	nn	16	SENT_201	[p13l1205t710r1264b773],
15	YPZD6	NN	O	ypzd6	nn	16	SENT_201	[p13l1269t708r1533b772],
16	genotype	NN	O	genotype	conj	11	SENT_201	[p13l1561t717r1919b791],
17	,	,	O	,	_	0	SENT_201	[p13l1561t717r1919b791],
18	duration	NN	O	duration	nsubj	25	SENT_201	[p13l1954t708r2145b772, p13l7t806r150b870],
19	of	IN	O	of	_	0	SENT_201	[p13l192t806r272b870],
20	illness	NN	O	illness	prep_of	18	SENT_201	[p13l306t806r541b870],
21	nor	CC	O	nor	_	0	SENT_201	[p13l584t827r707b870],
22	plasma	NN	O	plasma	nn	24	SENT_201	[p13l745t807r1009b890],
23	zuclopenthixol	NN	O	zuclopenthixol	nn	24	SENT_201	[p13l1050t806r1601b890],
24	concentration	NN	O	concentration	prep_of	18	SENT_201	[p13l1643t806r2148b870],
25	contributed	VBD	O	contribute	_	0	SENT_201	[p13l8t906r430b970],
26	to	TO	O	to	_	0	SENT_201	[p13l475t916r544b970],
27	the	DT	O	the	det	28	SENT_201	[p13l591t906r701b970],
28	presence	NN	O	presence	prep_to	25	SENT_201	[p13l747t927r1071b989],
29	of	IN	O	of	_	0	SENT_201	[p13l1119t906r1198b970],
30	parkinsonism	NN	O	parkinsonism	prep_of	28	SENT_201	[p13l1237t906r1757b989],
31	.	.	O	.	_	0	SENT_201	[p13l1237t906r1757b989],

1	Age	NN	O	age	nsubjpass	3	SENT_202	[p13l1808t907r1959b989],
2	was	VBD	O	be	auxpass	3	SENT_202	[p13l2006t927r2146b970],
3	defined	VBN	O	define	_	0	SENT_202	[p13l8t1004r285b1068],
4	as	IN	O	as	_	0	SENT_202	[p13l323t1025r393b1068],
5	a	DT	O	a	det	7	SENT_202	[p13l434t1025r473b1068],
6	risk	NN	O	risk	nn	7	SENT_202	[p13l507t1004r648b1068],
7	factor	NN	O	factor	prep_as	3	SENT_202	[p13l682t1004r899b1068],
8	for	IN	O	for	_	0	SENT_202	[p13l934t1004r1041b1068],
9	parkinsonism	NN	O	parkinsonism	nn	11	SENT_202	[p13l1076t1004r1578b1088],
10	(	CD	NUMBER	(	num	11	SENT_202	[p13l1617t1005r1981b1084],
11	P	NN	O	p	prep_for	7	SENT_202	[p13l1617t1005r1981b1084],
12	=	JJ	O	=	amod	11	SENT_202	[p13l1617t1005r1981b1084],
13	0.008	CD	NUMBER	0.008	tmod	12	SENT_202	[p13l1617t1005r1981b1084],
14	,	,	O	,	_	0	SENT_202	[p13l1617t1005r1981b1084],
15	OR	NN	O	or	dep	22	SENT_202	[p13l2023t1005r2149b1069],
16	1.08	CD	PERCENT	1.08	num	18	SENT_202	[p13l16t1105r164b1169],
17	95	CD	PERCENT	95	num	18	SENT_202	[p13l227t1104r486b1169],
18	%	NN	PERCENT	%	dep	15	SENT_202	[p13l227t1104r486b1169],
19	CI	NN	O	ci	dep	22	SENT_202	[p13l227t1104r486b1169],
20	1.03-1	CD	NUMBER	1.03-1	num	19	SENT_202	[p13l553t1104r944b1183],
21	.16	CD	NUMBER	.16	num	22	SENT_202	[p13l553t1104r944b1183],
22	)	NN	O	)	dep	26	SENT_202	[p13l553t1104r944b1183],
23	and	CC	O	and	_	0	SENT_202	[p13l1007t1104r1137b1168],
24	TD	NN	O	td	dep	26	SENT_202	[p13l1195t1106r1313b1167],
25	(	CD	NUMBER	(	num	26	SENT_202	[p13l1376t1104r1741b1183],
26	P	NN	O	p	dep	34	SENT_202	[p13l1376t1104r1741b1183],
27	=	JJ	O	=	amod	28	SENT_202	[p13l1376t1104r1741b1183],
28	0.016	CD	NUMBER	0.016	dep	26	SENT_202	[p13l1376t1104r1741b1183],
29	,	,	O	,	_	0	SENT_202	[p13l1376t1104r1741b1183],
30	OR	NN	O	or	appos	28	SENT_202	[p13l1805t1105r1930b1169],
31	1.09	CD	PERCENT	1.09	number	32	SENT_202	[p13l1996t1105r2146b1169],
32	95	CD	PERCENT	95	num	33	SENT_202	[p13l8t1202r268b1268],
33	%	NN	PERCENT	%	dep	30	SENT_202	[p13l8t1202r268b1268],
34	CI	NN	O	ci	dep	37	SENT_202	[p13l8t1202r268b1268],
35	1.02-1	CD	NUMBER	1.02-1	num	34	SENT_202	[p13l303t1203r715b1282],
36	.19	CD	NUMBER	.19	num	37	SENT_202	[p13l303t1203r715b1282],
37	)	NN	O	)	dep	7	SENT_202	[p13l303t1203r715b1282],
38	.	.	O	.	_	0	SENT_202	[p13l303t1203r715b1282],

1	Comparison	NN	O	comparison	nsubj	15	SENT_203	[p13l120t1302r573b1385],
2	of	IN	O	of	_	0	SENT_203	[p13l605t1302r685b1366],
3	C	NN	O	c	nn	6	SENT_203	[p13l716t1304r774b1367],
4	YPZD6	NN	O	ypzd6	nn	6	SENT_203	[p13l779t1302r1043b1366],
5	allele	NN	O	allele	nn	6	SENT_203	[p13l1073t1302r1271b1366],
6	frequencies	NNS	O	frequency	prep_of	1	SENT_203	[p13l1303t1302r1729b1385],
7	in	IN	O	in	_	0	SENT_203	[p13l1763t1302r1833b1365],
8	relation	NN	O	relation	prep_in	6	SENT_203	[p13l1864t1302r2148b1366],
9	to	TO	O	to	_	0	SENT_203	[p13l7t1410r75b1464],
10	the	DT	O	the	det	11	SENT_203	[p13l105t1401r214b1464],
11	presence	NN	O	presence	prep_to	8	SENT_203	[p13l242t1421r563b1484],
12	of	IN	O	of	_	0	SENT_203	[p13l593t1400r673b1464],
13	side	JJ	O	side	amod	14	SENT_203	[p13l698t1400r841b1464],
14	effects	NNS	O	effect	prep_of	11	SENT_203	[p13l870t1400r1109b1464],
15	revealed	VBD	O	reveal	_	0	SENT_203	[p13l1139t1400r1451b1465],
16	that	IN	O	that	complm	22	SENT_203	[p13l1478t1401r1615b1464],
17	the	DT	O	the	det	18	SENT_203	[p13l1642t1401r1752b1464],
18	frequency	NN	O	frequency	nsubj	22	SENT_203	[p13l1781t1400r2147b1484],
19	of	IN	O	of	_	0	SENT_203	[p13l8t1500r87b1564],
20	mutated	VBN	O	mutate	amod	21	SENT_203	[p13l108t1500r401b1564],
21	alleles	NNS	O	allele	prep_of	18	SENT_203	[p13l429t1500r655b1564],
22	tended	VBD	O	tend	ccomp	15	SENT_203	[p13l684t1500r927b1564],
23	to	TO	O	to	aux	25	SENT_203	[p13l953t1509r1020b1564],
24	be	VB	O	be	cop	25	SENT_203	[p13l1047t1500r1133b1564],
25	higher	JJR	O	higher	xcomp	22	SENT_203	[p13l1159t1500r1393b1583],
26	in	IN	O	in	_	0	SENT_203	[p13l1418t1500r1487b1563],
27	patients	NNS	O	patient	prep_in	25	SENT_203	[p13l1513t1500r1793b1583],
28	suffering	VBG	O	suffer	partmod	27	SENT_203	[p13l1826t1500r2147b1583],
29	from	IN	O	from	_	0	SENT_203	[p13l7t1598r187b1662],
30	movement	NN	O	movement	nn	31	SENT_203	[p13l243t1608r635b1663],
31	disorders	NNS	O	disorder	prep_from	28	SENT_203	[p13l693t1599r1029b1662],
32	than	IN	O	than	advmod	25	SENT_203	[p13l1089t1599r1247b1662],
33	among	IN	O	among	_	0	SENT_203	[p13l1307t1619r1554b1682],
34	those	DT	O	those	prep_among	32	SENT_203	[p13l1613t1599r1807b1662],
35	without	IN	O	without	_	0	SENT_203	[p13l1866t1598r2149b1663],
36	but	CC	O	but	cc	41	SENT_203	[p13l6t1698r125b1762],
37	this	DT	O	this	det	38	SENT_203	[p13l164t1698r294b1762],
38	difference	NN	O	difference	nsubj	41	SENT_203	[p13l338t1698r711b1762],
39	did	VBD	O	do	aux	41	SENT_203	[p13l754t1698r870b1762],
40	not	RB	O	not	neg	41	SENT_203	[p13l910t1708r1028b1762],
41	reach	VB	O	reach	prepc_without	34	SENT_203	[p13l1066t1698r1267b1762],
42	statistical	JJ	O	statistical	amod	43	SENT_203	[p13l1311t1698r1658b1762],
43	significance	NN	O	significance	nsubj	47	SENT_203	[p13l1702t1698r2147b1781],
44	(	CD	NUMBER	(	num	47	SENT_203	[p13l10t1797r241b1876],
45	Table	NNP	O	Table	nn	47	SENT_203	[p13l10t1797r241b1876],
46	3	CD	NUMBER	3	num	47	SENT_203	[p13l270t1797r361b1876],
47	)	NN	O	)	xcomp	41	SENT_203	[p13l270t1797r361b1876],
48	.	.	O	.	_	0	SENT_203	[p13l270t1797r361b1876],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_204	[p13l8t2034r487b2098],
2	medication	NN	O	medication	_	0	SENT_204	[p13l512t2034r924b2098],

1	The	DT	O	the	det	4	SENT_205	[p13l7t2233r148b2297],
2	anticholinergic	JJ	O	anticholinergic	amod	4	SENT_205	[p13l182t2233r734b2316],
3	drug	NN	O	drug	nn	4	SENT_205	[p13l769t2233r935b2316],
4	trihexyphenidyl	NN	O	trihexyphenidyl	nsubj	13	SENT_205	[p13l967t2233r1555b2316],
5	up	IN	O	up	advmod	4	SENT_205	[p13l1586t2253r1676b2316],
6	to	TO	O	to	_	0	SENT_205	[p13l1708t2243r1777b2297],
7	8	CD	NUMBER	8	num	8	SENT_205	[p13l1813t2233r1849b2297],
8	mg	NN	O	mg	prep_to	5	SENT_205	[p13l1884t2253r1999b2316],
9	per	IN	O	per	_	0	SENT_205	[p13l2030t2253r2149b2316],
10	day	NN	DURATION	day	prep_per	8	SENT_205	[p13l8t2331r138b2415],
11	did	VBD	O	do	aux	13	SENT_205	[p13l166t2331r282b2395],
12	not	RB	O	not	neg	13	SENT_205	[p13l308t2341r426b2395],
13	inﬂuence	VB	O	inﬂuence	_	0	SENT_205	[p13l451t2331r795b2395],
14	the	DT	O	the	det	16	SENT_205	[p13l822t2332r933b2395],
15	plasma	NN	O	plasma	nn	16	SENT_205	[p13l959t2331r1223b2415],
16	concentrations	NNS	O	concentration	nsubj	20	SENT_205	[p13l1249t2332r1787b2395],
17	of	IN	O	of	_	0	SENT_205	[p13l1817t2331r1897b2395],
18	zuclopenthixol	NN	O	zuclopenthixol	prep_of	16	SENT_205	[p13l1918t2332r2145b2395, p13l6t2431r356b2514],
19	(	CD	NUMBER	(	num	18	SENT_205	[p13l394t2431r980b2510],
20	Kruskal	NNP	PERSON	Kruskal	xcomp	13	SENT_205	[p13l394t2431r980b2510],
21	.	.	O	.	_	0	SENT_205	[p13l394t2431r980b2510],

1	—	NN	O	—	_	0	SENT_206	[p13l394t2431r980b2510],
2	.	.	O	.	_	0	SENT_206	[p13l394t2431r980b2510],

1	Wallis	NNP	PERSON	Wallis	nn	3	SENT_207	[p13l394t2431r980b2510],
2	ANOVA	NNP	O	ANOVA	nn	3	SENT_207	[p13l1017t2431r1338b2495],
3	P	NN	O	p	nsubj	4	SENT_207	[p13l1370t2431r1691b2510],
4	=	JJ	O	=	_	0	SENT_207	[p13l1370t2431r1691b2510],
5	0.64	CD	NUMBER	0.64	num	6	SENT_207	[p13l1370t2431r1691b2510],
6	)	NN	O	)	dobj	4	SENT_207	[p13l1370t2431r1691b2510],
7	.	.	O	.	_	0	SENT_207	[p13l1370t2431r1691b2510],

1	Of	IN	O	of	_	0	SENT_208	[p13l1732t2431r1832b2495],
2	patients	NNS	O	patient	prep_of	12	SENT_208	[p13l1859t2431r2146b2514],
3	with	IN	O	with	_	0	SENT_208	[p13l7t2530r171b2595],
4	parkinsonism	NN	O	parkinsonism	prep_with	2	SENT_208	[p13l203t2530r724b2613],
5	,	,	O	,	_	0	SENT_208	[p13l203t2530r724b2613],
6	17	CD	PERCENT	17	number	7	SENT_208	[p13l770t2531r848b2594],
7	(	CD	PERCENT	(	amod	10	SENT_208	[p13l889t2530r1113b2609],
8	53	CD	PERCENT	53	num	9	SENT_208	[p13l889t2530r1113b2609],
9	%	NN	PERCENT	%	dep	7	SENT_208	[p13l889t2530r1113b2609],
10	)	NN	O	)	nsubj	12	SENT_208	[p13l889t2530r1113b2609],
11	did	VBD	O	do	aux	12	SENT_208	[p13l1151t2530r1267b2594],
12	receive	VB	O	receive	_	0	SENT_208	[p13l1298t2530r1566b2595],
13	the	DT	O	the	det	15	SENT_208	[p13l1600t2530r1711b2594],
14	anticholinergic	JJ	O	anticholinergic	amod	15	SENT_208	[p13l1748t2530r2145b2594, p13l8t2629r188b2712],
15	agent	NN	O	agent	dobj	12	SENT_208	[p13l237t2639r453b2712],
16	.	.	O	.	_	0	SENT_208	[p13l237t2639r453b2712],

1	Eight	CD	PERCENT	eight	nsubj	23	SENT_209	[p13l504t2629r705b2712],
2	(	CD	PERCENT	(	num	4	SENT_209	[p13l753t2629r978b2708],
3	73	CD	PERCENT	73	num	4	SENT_209	[p13l753t2629r978b2708],
4	%	NN	PERCENT	%	dep	1	SENT_209	[p13l753t2629r978b2708],
5	)	CD	NUMBER	)	dep	1	SENT_209	[p13l753t2629r978b2708],
6	of	IN	O	of	_	0	SENT_209	[p13l1028t2629r1108b2693],
7	the	DT	O	the	det	8	SENT_209	[p13l1147t2629r1258b2693],
8	patients	NNS	O	patient	prep_of	5	SENT_209	[p13l1304t2629r1591b2712],
9	with	IN	O	with	_	0	SENT_209	[p13l1640t2629r1803b2693],
10	TD	NN	O	td	prep_with	8	SENT_209	[p13l1849t2631r1968b2692],
11	and	CC	O	and	_	0	SENT_209	[p13l2018t2629r2149b2693],
12	eight	CD	PERCENT	eight	number	13	SENT_209	[p13l8t2728r192b2811],
13	(	CD	PERCENT	(	prep_of	5	SENT_209	[p13l247t2729r471b2808],
14	40	CD	PERCENT	40	num	15	SENT_209	[p13l247t2729r471b2808],
15	%	NN	PERCENT	%	dep	13	SENT_209	[p13l247t2729r471b2808],
16	)	CD	NUMBER	)	dep	13	SENT_209	[p13l247t2729r471b2808],
17	without	IN	O	without	_	0	SENT_209	[p13l527t2728r811b2792],
18	any	DT	O	any	det	19	SENT_209	[p13l864t2749r993b2811],
19	signs	NNS	O	sign	prep_without	16	SENT_209	[p13l1050t2728r1233b2811],
20	of	IN	O	of	_	0	SENT_209	[p13l1290t2728r1370b2792],
21	parkinsonism	NN	O	parkinsonism	prep_of	19	SENT_209	[p13l1415t2728r1918b2811],
22	were	VBD	O	be	aux	23	SENT_209	[p13l1970t2749r2147b2793],
23	receiving	VBG	O	receive	_	0	SENT_209	[p13l6t2827r350b2910],
24	anticholinergic	JJ	O	anticholinergic	amod	25	SENT_209	[p13l394t2827r946b2910],
25	treatment	NN	O	treatment	dobj	23	SENT_209	[p13l988t2836r1357b2891],
26	.	.	O	.	_	0	SENT_209	[p13l988t2836r1357b2891],

1	There	EX	O	there	expl	2	SENT_210	[p13l1402t2827r1616b2891],
2	was	VBD	O	be	_	0	SENT_210	[p13l1657t2847r1796b2891],
3	a	DT	O	a	det	9	SENT_210	[p13l1840t2847r1879b2891],
4	strong	JJ	O	strong	amod	9	SENT_210	[p13l1921t2836r2147b2910],
5	tendency	NN	O	tendency	nn	9	SENT_210	[p13l7t2926r340b3009],
6	(	CD	NUMBER	(	num	9	SENT_210	[p13l381t2926r967b3006],
7	Kruskal-Wallis	NN	O	kruskal-walli	nn	9	SENT_210	[p13l381t2926r967b3006],
8	ANOVA	NNP	O	ANOVA	nn	9	SENT_210	[p13l1006t2927r1327b2991],
9	P	NN	O	p	nsubj	2	SENT_210	[p13l1362t2927r1630b2991],
10	=	JJ	O	=	advmod	15	SENT_210	[p13l1362t2927r1630b2991],
11	0.07	CD	NUMBER	0.07	dep	10	SENT_210	[p13l1362t2927r1630b2991],
12	that	IN	O	that	dep	15	SENT_210	[p13l1670t2926r1809b2990],
13	anticholinergic	JJ	O	anticholinergic	amod	14	SENT_210	[p13l1847t2926r2145b2990, p13l7t3025r286b3108],
14	medication	NN	O	medication	nsubj	15	SENT_210	[p13l358t3025r770b3089],
15	reduced	VBD	O	reduce	dep	2	SENT_210	[p13l839t3025r1133b3089],
16	the	DT	O	the	det	18	SENT_210	[p13l1202t3025r1313b3089],
17	parkinsonian	JJ	O	parkinsonian	amod	18	SENT_210	[p13l1382t3025r1863b3108],
18	rating	NN	O	rating	iobj	15	SENT_210	[p13l1931t3025r2147b3108],
19	scores	NNS	O	score	dobj	15	SENT_210	[p13l10t3145r256b3188],
20	.	.	O	.	_	0	SENT_210	[p13l10t3145r256b3188],

1	No	DT	O	no	det	2	SENT_211	[p13l294t3126r404b3188],
2	differences	NNS	O	difference	dep	10	SENT_211	[p13l440t3124r847b3188],
3	in	IN	O	in	_	0	SENT_211	[p13l882t3124r953b3187],
4	the	DT	O	the	det	6	SENT_211	[p13l986t3124r1097b3188],
5	plasma	NN	O	plasma	nn	6	SENT_211	[p13l1129t3124r1394b3207],
6	levels	NNS	O	level	prep_in	2	SENT_211	[p13l1426t3124r1638b3188],
7	of	IN	O	of	_	0	SENT_211	[p13l1675t3124r1755b3188],
8	zuclopenthixol	NN	O	zuclopenthixol	prep_of	2	SENT_211	[p13l1783t3124r2145b3207, p13l7t3223r222b3287],
9	were	VBD	O	be	auxpass	10	SENT_211	[p13l274t3243r451b3287],
10	found	VBN	O	find	conj_and	10	SENT_211	[p13l504t3223r719b3287],
11	between	IN	O	between	_	0	SENT_211	[p13l768t3223r1077b3287],
12	patients	NNS	O	patient	prep_between	10	SENT_211	[p13l1127t3223r1414b3306],
13	with	IN	O	with	_	0	SENT_211	[p13l1468t3223r1631b3287],
14	and	CC	O	and	_	0	SENT_211	[p13l1684t3223r1815b3287],
15	without	IN	O	without	_	0	SENT_211	[p13l1866t3223r2149b3287],
16	concomitant	JJ	O	concomitant	amod	18	SENT_211	[p13l8t3322r467b3386],
17	benzodiazepine	NN	O	benzodiazepine	nn	18	SENT_211	[p13l491t3322r1069b3405],
18	medication	NN	O	medication	prep_without	10	SENT_211	[p13l1096t3322r1508b3386],
19	(	CD	NUMBER	(	num	20	SENT_211	[p13l1537t3323r1864b3402],
20	P	NN	O	p	npadvmod	21	SENT_211	[p13l1537t3323r1864b3402],
21	=	JJ	O	=	amod	18	SENT_211	[p13l1537t3323r1864b3402],
22	0.48	CD	NUMBER	0.48	num	23	SENT_211	[p13l1537t3323r1864b3402],
23	)	NN	O	)	nsubjpass	10	SENT_211	[p13l1537t3323r1864b3402],

1	Discussion	NN	O	discussion	_	0	SENT_212	[p13l10t3588r439b3662],

1	Higher	JJR	O	higher	nsubj	22	SENT_213	[p14l7t74r258b157],
2	absolute	JJ	O	absolute	amod	1	SENT_213	[p14l287t74r583b138],
3	and	CC	O	and	_	0	SENT_213	[p14l614t74r742b138],
4	dose	NN	O	dose	nn	5	SENT_213	[p14l770t74r1299b138],
5	—	NN	O	—	nsubj	22	SENT_213	[p14l770t74r1299b138],
6	corrected	VBN	O	correct	partmod	5	SENT_213	[p14l770t74r1299b138],
7	zuclopenthixol	NN	O	zuclopenthixol	nn	10	SENT_213	[p14l1328t74r1860b157],
8	steadystate	NN	O	steadystate	nn	10	SENT_213	[p14l1892t74r2145b157, p14l10t182r175b236],
9	plasma	NN	O	plasma	nn	10	SENT_213	[p14l224t172r488b255],
10	concentrations	NNS	O	concentration	dobj	6	SENT_213	[p14l538t172r1076b236],
11	in	IN	O	in	_	0	SENT_213	[p14l1128t172r1198b235],
12	heterozygous	JJ	O	heterozygous	amod	13	SENT_213	[p14l1247t172r1741b255],
13	EMS	NN	ORGANIZATION	em	prep_in	10	SENT_213	[p14l1793t174r1964b236],
14	and	CC	O	and	_	0	SENT_213	[p14l2018t172r2149b236],
15	PMs	NNS	O	pm	conj_and	13	SENT_213	[p14l7t273r172b335],
16	than	IN	O	than	prep	6	SENT_213	[p14l218t271r376b335],
17	in	IN	O	in	pcomp	16	SENT_213	[p14l418t271r489b334],
18	homozygous	JJ	O	homozygous	amod	20	SENT_213	[p14l531t271r1003b354],
19	EM	NN	O	em	nn	20	SENT_213	[p14l1047t273r1184b334],
20	patients	NNS	O	patient	pobj	17	SENT_213	[p14l1226t271r1513b354],
21	was	VBD	O	be	cop	22	SENT_213	[p14l1559t292r1698b335],
22	one	CD	NUMBER	one	_	0	SENT_213	[p14l1745t292r1875b335],
23	of	IN	O	of	_	0	SENT_213	[p14l1920t271r1999b335],
24	the	DT	O	the	det	26	SENT_213	[p14l2036t271r2147b335],
25	main	JJ	O	main	amod	26	SENT_213	[p14l7t370r191b434],
26	findings	NNS	O	finding	prep_of	22	SENT_213	[p14l219t370r520b453],
27	of	IN	O	of	_	0	SENT_213	[p14l552t370r632b434],
28	the	DT	O	the	det	31	SENT_213	[p14l654t370r765b434],
29	study	NN	O	study	nn	31	SENT_213	[p14l797t370r993b453],
30	(	CD	NUMBER	(	num	31	SENT_213	[p14l1025t370r1193b453],
31	Fig	NN	O	fig	prep_of	26	SENT_213	[p14l1025t370r1193b453],
32	.	.	O	.	_	0	SENT_213	[p14l1025t370r1193b453],

1	1	CD	NUMBER	1	_	0	SENT_214	[p14l1236t370r1321b449],
2	)	NN	O	)	dep	1	SENT_214	[p14l1236t370r1321b449],
3	.	.	O	.	_	0	SENT_214	[p14l1236t370r1321b449],

1	No	DT	O	no	det	3	SENT_215	[p14l1353t371r1463b434],
2	significant	JJ	O	significant	amod	3	SENT_215	[p14l1496t370r1886b453],
3	differences	NNS	O	difference	nsubjpass	5	SENT_215	[p14l1914t370r2145b434, p14l8t490r209b533],
4	were	VBD	O	be	auxpass	5	SENT_215	[p14l260t490r438b533],
5	found	VBN	O	find	_	0	SENT_215	[p14l487t469r703b533],
6	between	IN	O	between	_	0	SENT_215	[p14l749t469r1059b533],
7	heterozygous	JJ	O	heterozygous	amod	8	SENT_215	[p14l1106t469r1599b552],
8	EM	NN	O	em	prep_between	5	SENT_215	[p14l1650t471r1786b532],
9	and	CC	O	and	_	0	SENT_215	[p14l1838t469r1968b533],
10	PM	NN	O	pm	nn	11	SENT_215	[p14l2016t471r2147b532],
11	groups	NNS	O	group	prep_between	5	SENT_215	[p14l8t588r277b651],
12	.	.	O	.	_	0	SENT_215	[p14l8t588r277b651],

1	This	DT	O	this	nsubj	2	SENT_216	[p14l322t568r483b632],
2	suggests	VBZ	O	suggest	_	0	SENT_216	[p14l528t577r836b651],
3	that	IN	O	that	complm	12	SENT_216	[p14l879t568r1018b632],
4	a	DT	O	a	det	6	SENT_216	[p14l1059t588r1097b632],
5	significant	JJ	O	significant	amod	6	SENT_216	[p14l1139t568r1529b651],
6	decrease	NN	O	decrease	nsubj	12	SENT_216	[p14l1568t568r1885b632],
7	in	IN	O	in	_	0	SENT_216	[p14l1926t568r1996b631],
8	the	DT	O	the	det	9	SENT_216	[p14l2036t568r2147b632],
9	metabolism	NN	O	metabolism	prep_in	6	SENT_216	[p14l7t667r441b731],
10	of	IN	O	of	_	0	SENT_216	[p14l477t667r557b731],
11	zuclopenthixol	NN	O	zuclopenthixol	prep_of	9	SENT_216	[p14l588t667r1139b750],
12	occurs	VBZ	O	occur	ccomp	2	SENT_216	[p14l1177t688r1414b731],
13	in	IN	O	in	_	0	SENT_216	[p14l1453t667r1523b730],
14	patients	NNS	O	patient	prep_in	12	SENT_216	[p14l1558t667r1845b750],
15	with	IN	O	with	_	0	SENT_216	[p14l1884t667r2047b731],
16	at	IN	O	at	quantmod	18	SENT_216	[p14l2085t677r2149b731],
17	least	JJS	O	least	mwe	16	SENT_216	[p14l7t766r177b830],
18	one	CD	NUMBER	one	num	19	SENT_216	[p14l213t786r343b830],
19	CYP2D6	NN	O	cyp2d6	prep_with	14	SENT_216	[p14l383t766r1178b849],
20	—	CD	NUMBER	—	dobj	12	SENT_216	[p14l383t766r1178b849],
21	inactivating	VBG	O	inactivate	partmod	20	SENT_216	[p14l383t766r1178b849],
22	mutation	NN	O	mutation	dobj	21	SENT_216	[p14l1215t766r1563b830],
23	.	.	O	.	_	0	SENT_216	[p14l1215t766r1563b830],

1	CYPZD6	NN	O	cypzd6	nsubj	2	SENT_217	[p14l1604t766r1940b830],
2	is	VBZ	O	be	_	0	SENT_217	[p14l1978t766r2035b830],
3	of	IN	O	of	_	0	SENT_217	[p14l2074t766r2154b830],
4	high	JJ	O	high	amod	6	SENT_217	[p14l6t865r475b948],
5	—	NN	O	—	nn	6	SENT_217	[p14l6t865r475b948],
6	affinity	NN	O	affinity	prep_of	2	SENT_217	[p14l6t865r475b948],
7	and	CC	O	and	_	0	SENT_217	[p14l518t865r649b929],
8	low	JJ	O	low	amod	11	SENT_217	[p14l689t865r1167b948],
9	—	NN	O	—	nn	11	SENT_217	[p14l689t865r1167b948],
10	capacity	NN	O	capacity	nn	11	SENT_217	[p14l689t865r1167b948],
11	character	NN	O	character	prep_of	2	SENT_217	[p14l1210t865r1565b941],
12	,	,	O	,	_	0	SENT_217	[p14l1210t865r1565b941],
13	and	CC	O	and	_	0	SENT_217	[p14l1611t865r1742b929],
14	saturation	NN	O	saturation	nsubj	19	SENT_217	[p14l1786t865r2148b929],
15	of	IN	O	of	_	0	SENT_217	[p14l8t964r87b1028],
16	the	DT	O	the	det	17	SENT_217	[p14l107t964r217b1028],
17	isozyme	NN	O	isozyme	prep_of	14	SENT_217	[p14l244t964r548b1047],
18	may	MD	O	may	aux	19	SENT_217	[p14l575t984r731b1047],
19	occur	VB	O	occur	conj_and	2	SENT_217	[p14l759t984r962b1028],
20	in	IN	O	in	_	0	SENT_217	[p14l986t964r1056b1027],
21	EMs	NNS	O	em	prep_in	19	SENT_217	[p14l1082t965r1252b1028],
22	during	IN	O	during	_	0	SENT_217	[p14l1281t964r1517b1047],
23	repeated	VBN	O	repeat	amod	24	SENT_217	[p14l1543t964r1856b1047],
24	dosing	NN	O	dosing	prep_during	19	SENT_217	[p14l1882t964r2144b1047],
25	,	,	O	,	_	0	SENT_217	[p14l1882t964r2144b1047],
26	decreasing	VBG	O	decrease	partmod	24	SENT_217	[p14l8t1063r402b1146],
27	the	DT	O	the	det	29	SENT_217	[p14l443t1063r554b1127],
28	quantitative	JJ	O	quantitative	amod	29	SENT_217	[p14l595t1063r1032b1146],
29	differences	NNS	O	difference	dobj	26	SENT_217	[p14l1073t1063r1480b1127],
30	in	IN	O	in	_	0	SENT_217	[p14l1522t1063r1592b1126],
31	the	DT	O	the	det	33	SENT_217	[p14l1631t1063r1742b1127],
32	metabolic	JJ	O	metabolic	amod	33	SENT_217	[p14l1782t1063r2146b1127],
33	capacity	NN	O	capacity	prep_in	29	SENT_217	[p14l8t1162r314b1245],
34	between	IN	O	between	_	0	SENT_217	[p14l348t1162r657b1226],
35	EMs	NNS	O	em	prep_between	33	SENT_217	[p14l690t1163r862b1226],
36	and	CC	O	and	_	0	SENT_217	[p14l900t1162r1030b1226],
37	PMs	NNS	O	pm	prep_between	33	SENT_217	[p14l1063t1163r1250b1226],
38	.	.	O	.	_	0	SENT_217	[p14l1063t1163r1250b1226],

1	It	PRP	O	it	nsubj	2	SENT_218	[p14l1289t1163r1345b1226],
2	is	VBZ	O	be	_	0	SENT_218	[p14l1377t1162r1435b1226],
3	of	IN	O	of	_	0	SENT_218	[p14l1472t1162r1552b1226],
4	interest	NN	O	interest	prep_of	2	SENT_218	[p14l1580t1162r1853b1226],
5	to	TO	O	to	aux	6	SENT_218	[p14l1886t1171r1955b1226],
6	note	VB	O	note	xcomp	2	SENT_218	[p14l1990t1171r2147b1226],
7	that	IN	O	that	complm	15	SENT_218	[p14l7t1261r144b1325],
8	differences	NNS	O	difference	nsubj	15	SENT_218	[p14l172t1261r575b1325],
9	in	IN	O	in	_	0	SENT_218	[p14l606t1261r676b1324],
10	zuclopenthixol	NN	O	zuclopenthixol	nn	11	SENT_218	[p14l704t1261r1250b1344],
11	concentrations	NNS	O	concentration	prep_in	8	SENT_218	[p14l1279t1261r1812b1325],
12	between	IN	O	between	_	0	SENT_218	[p14l1842t1261r2148b1325],
13	genotypes	NNS	O	genotype	prep_between	11	SENT_218	[p14l8t1369r380b1443],
14	were	VBD	O	be	cop	15	SENT_218	[p14l415t1380r593b1424],
15	apparent	JJ	O	apparent	ccomp	6	SENT_218	[p14l628t1369r946b1443],
16	during	IN	O	during	_	0	SENT_218	[p14l979t1360r1217b1443],
17	treatment	NN	O	treatment	prep_during	15	SENT_218	[p14l1251t1369r1603b1423],
18	with	IN	O	with	_	0	SENT_218	[p14l1635t1359r1798b1424],
19	an	DT	O	a	det	22	SENT_218	[p14l1832t1380r1916b1423],
20	intramuscular	JJ	O	intramuscular	amod	22	SENT_218	[p14l1948t1359r2145b1423, p14l7t1459r348b1523],
21	depot	NN	O	depot	nn	22	SENT_218	[p14l375t1459r580b1542],
22	preparation	NN	O	preparation	prep_with	15	SENT_218	[p14l605t1459r1047b1542],
23	.	.	O	.	_	0	SENT_218	[p14l605t1459r1047b1542],

1	The	DT	O	the	det	3	SENT_219	[p14l1080t1459r1221b1523],
2	previous	JJ	O	previous	amod	3	SENT_219	[p14l1249t1459r1566b1542],
3	documentation	NN	O	documentation	nsubjpass	13	SENT_219	[p14l1597t1459r2148b1523],
4	for	IN	O	for	_	0	SENT_219	[p14l7t1557r115b1621],
5	the	DT	O	the	det	6	SENT_219	[p14l158t1557r268b1621],
6	role	NN	O	role	prep_for	3	SENT_219	[p14l313t1558r456b1621],
7	of	IN	O	of	_	0	SENT_219	[p14l502t1557r582b1621],
8	CYPZD6	NN	O	cypzd6	prep_of	6	SENT_219	[p14l622t1557r958b1622],
9	in	IN	O	in	_	0	SENT_219	[p14l1004t1557r1074b1621],
10	zuclopenthixol	NN	O	zuclopenthixol	nn	11	SENT_219	[p14l1119t1557r1670b1641],
11	metabolism	NN	O	metabolism	prep_in	8	SENT_219	[p14l1715t1557r2149b1621],
12	was	VBD	O	be	auxpass	13	SENT_219	[p14l7t1678r147b1721],
13	derived	VBN	O	derive	_	0	SENT_219	[p14l177t1657r453b1721],
14	from	IN	O	from	_	0	SENT_219	[p14l479t1657r658b1721],
15	a	DT	O	a	det	16	SENT_219	[p14l685t1678r724b1721],
16	study	NN	O	study	prep_from	13	SENT_219	[p14l752t1657r947b1740],
17	using	VBG	O	use	partmod	16	SENT_219	[p14l974t1657r1173b1740],
18	single	JJ	O	single	amod	20	SENT_219	[p14l1204t1657r1420b1740],
19	oral	JJ	O	oral	amod	20	SENT_219	[p14l1448t1657r1590b1721],
20	doses	NNS	O	dose	nsubj	21	SENT_219	[p14l1617t1657r1819b1721],
21	(	VBP	O	(	ccomp	17	SENT_219	[p14l1850t1657r2056b1736],
22	Dahl	NNP	PERSON	Dahl	nsubj	24	SENT_219	[p14l1850t1657r2056b1736],
23	et	FW	O	et	nn	24	SENT_219	[p14l2084t1667r2149b1721],
24	al.	FW	O	al.	xcomp	21	SENT_219	[p14l9t1755r90b1820],
25	1991	CD	DATE	1991	num	26	SENT_219	[p14l135t1756r338b1835],
26	)	NN	O	)	dep	24	SENT_219	[p14l135t1756r338b1835],
27	and	CC	O	and	_	0	SENT_219	[p14l374t1756r505b1819],
28	from	IN	O	from	_	0	SENT_219	[p14l536t1755r715b1819],
29	patients	NNS	O	patient	dep	35	SENT_219	[p14l744t1755r1031b1839],
30	on	IN	O	on	_	0	SENT_219	[p14l1065t1776r1155b1819],
31	continuous	JJ	O	continuous	amod	33	SENT_219	[p14l1187t1756r1591b1819],
32	oral	JJ	O	oral	amod	33	SENT_219	[p14l1625t1756r1766b1819],
33	treatment	NN	O	treatment	prep_on	29	SENT_219	[p14l1798t1765r2149b1819],
34	(	CD	NUMBER	(	dep	35	SENT_219	[p14l10t1855r289b1938],
35	Jerling	NNP	O	Jerling	dep	39	SENT_219	[p14l10t1855r289b1938],
36	et	FW	O	et	nn	37	SENT_219	[p14l337t1864r403b1919],
37	al.	FW	O	al.	dep	35	SENT_219	[p14l450t1855r532b1919],
38	1996	CD	DATE	1996	num	39	SENT_219	[p14l593t1855r817b1934],
39	)	CD	NUMBER	)	dep	13	SENT_219	[p14l593t1855r817b1934],
40	.	.	O	.	_	0	SENT_219	[p14l593t1855r817b1934],

1	During	IN	O	during	_	0	SENT_220	[p14l869t1855r1129b1938],
2	depot	NN	O	depot	nn	3	SENT_220	[p14l1178t1855r1383b1938],
3	administration	NN	O	administration	prep_during	15	SENT_220	[p14l1431t1855r1986b1931],
4	,	,	O	,	_	0	SENT_220	[p14l1431t1855r1986b1931],
5	the	DT	O	the	det	9	SENT_220	[p14l2036t1855r2147b1919],
6	first	JJ	ORDINAL	first	amod	9	SENT_220	[p14l7t1953r345b2037],
7	—	NN	O	—	nn	9	SENT_220	[p14l7t1953r345b2037],
8	pass	NN	O	pass	nn	9	SENT_220	[p14l7t1953r345b2037],
9	metabolism	NN	O	metabolism	nsubjpass	15	SENT_220	[p14l376t1954r810b2017],
10	in	IN	O	in	_	0	SENT_220	[p14l838t1953r908b2017],
11	gut	NN	O	gut	prep_in	9	SENT_220	[p14l938t1963r1055b2037],
12	and	CC	O	and	_	0	SENT_220	[p14l1085t1954r1215b2017],
13	liver	NN	O	liver	prep_in	9	SENT_220	[p14l1244t1954r1414b2018],
14	is	VBZ	O	be	auxpass	15	SENT_220	[p14l1441t1954r1499b2017],
15	avoided	VBN	O	avoid	_	0	SENT_220	[p14l1532t1953r1843b2029],
16	,	,	O	,	_	0	SENT_220	[p14l1532t1953r1843b2029],
17	and	CC	O	and	_	0	SENT_220	[p14l1877t1954r2008b2017],
18	the	DT	O	the	det	19	SENT_220	[p14l2036t1953r2147b2017],
19	pharmacokinetics	NNS	O	pharmacokinetic	nsubjpass	22	SENT_220	[p14l6t2053r660b2136],
20	might	MD	O	might	aux	22	SENT_220	[p14l699t2053r916b2136],
21	be	VB	O	be	auxpass	22	SENT_220	[p14l950t2053r1035b2117],
22	expected	VBN	O	expect	conj_and	15	SENT_220	[p14l1074t2053r1402b2136],
23	to	TO	O	to	aux	24	SENT_220	[p14l1438t2063r1507b2117],
24	show	VB	O	show	xcomp	22	SENT_220	[p14l1548t2053r1738b2117],
25	less	JJR	O	less	amod	27	SENT_220	[p14l1776t2053r1911b2117],
26	interindividual	JJ	O	interindividual	amod	27	SENT_220	[p14l1950t2053r2145b2117, p14l7t2152r383b2216],
27	variations	NNS	O	variation	dobj	24	SENT_220	[p14l440t2151r804b2216],
28	than	IN	O	than	prep	24	SENT_220	[p14l863t2152r1021b2215],
29	during	IN	O	during	pcomp	28	SENT_220	[p14l1079t2151r1317b2235],
30	oral	JJ	O	oral	amod	31	SENT_220	[p14l1377t2152r1518b2215],
31	treatment	NN	O	treatment	pobj	29	SENT_220	[p14l1575t2161r1944b2216],
32	.	.	O	.	_	0	SENT_220	[p14l1575t2161r1944b2216],

1	The	DT	O	the	det	2	SENT_221	[p14l2006t2151r2147b2215],
2	difference	NN	O	difference	nsubj	22	SENT_221	[p14l8t2251r381b2315],
3	in	IN	O	in	_	0	SENT_221	[p14l446t2251r516b2314],
4	the	DT	O	the	det	7	SENT_221	[p14l581t2251r691b2315],
5	median	JJ	O	median	amod	7	SENT_221	[p14l757t2251r1029b2315],
6	concentrations	NNS	O	concentration	nn	7	SENT_221	[p14l1094t2251r1633b2315],
7	(	NN	O	(	prep_in	2	SENT_221	[p14l1703t2251r1864b2330],
8	and	CC	O	and	_	0	SENT_221	[p14l1703t2251r1864b2330],
9	C/Ds	NN	O	c/ds	nn	10	SENT_221	[p14l1929t2252r2145b2330],
10	)	NN	O	)	conj_and	7	SENT_221	[p14l1929t2252r2145b2330],
11	between	IN	O	between	_	0	SENT_221	[p14l6t2350r315b2414],
12	PM	NNP	O	PM	prep_between	7	SENT_221	[p14l367t2351r498b2413],
13	and	CC	O	and	_	0	SENT_221	[p14l552t2349r683b2413],
14	homozygous	JJ	O	homozygous	amod	15	SENT_221	[p14l733t2350r1205b2433],
15	EM	NN	O	em	conj_and	7	SENT_221	[p14l1259t2351r1395b2413],
16	in	IN	O	in	_	0	SENT_221	[p14l1448t2349r1518b2413],
17	this	DT	O	this	det	18	SENT_221	[p14l1570t2349r1700b2413],
18	study	NN	O	study	prep_in	15	SENT_221	[p14l1757t2350r1953b2433],
19	was	VBD	O	be	cop	22	SENT_221	[p14l2006t2370r2146b2414],
20	1.6	CD	NUMBER	1.6	number	21	SENT_221	[p14l16t2449r323b2525],
21	—	CD	NUMBER	—	dep	22	SENT_221	[p14l16t2449r323b2525],
22	fold	NN	O	fold	_	0	SENT_221	[p14l16t2449r323b2525],
23	,	,	O	,	_	0	SENT_221	[p14l16t2449r323b2525],
24	similar	JJ	O	similar	dep	22	SENT_221	[p14l371t2449r626b2513],
25	to	TO	O	to	prep	24	SENT_221	[p14l667t2458r735b2513],
26	that	DT	O	that	tmod	22	SENT_221	[p14l779t2449r918b2513],
27	found	VBN	O	find	partmod	26	SENT_221	[p14l959t2449r1174b2513],
28	by	IN	O	by	_	0	SENT_221	[p14l1214t2449r1305b2532],
29	Jerling	NNP	PERSON	Jerling	agent	27	SENT_221	[p14l1347t2449r1598b2532],
30	et	FW	O	et	nn	32	SENT_221	[p14l1642t2459r1707b2513],
31	al.	FW	O	al.	nn	32	SENT_221	[p14l1750t2449r1831b2513],
32	(	FW	O	(	dobj	27	SENT_221	[p14l1881t2449r2143b2528],
33	1996	CD	DATE	1996	num	34	SENT_221	[p14l1881t2449r2143b2528],
34	)	CD	NUMBER	)	dep	26	SENT_221	[p14l1881t2449r2143b2528],
35	.	.	O	.	_	0	SENT_221	[p14l1881t2449r2143b2528],

1	The	DT	O	the	det	2	SENT_222	[p14l7t2548r148b2611],
2	results	NNS	O	result	nsubj	8	SENT_222	[p14l180t2548r420b2611],
3	of	IN	O	of	_	0	SENT_222	[p14l456t2547r536b2611],
4	the	DT	O	the	det	6	SENT_222	[p14l562t2548r673b2611],
5	present	JJ	DATE	present	amod	6	SENT_222	[p14l705t2557r974b2631],
6	study	NN	O	study	prep_of	2	SENT_222	[p14l1008t2548r1204b2631],
7	thus	RB	O	thus	advmod	8	SENT_222	[p14l1237t2548r1387b2611],
8	indicate	VBP	O	indicate	_	0	SENT_222	[p14l1422t2547r1714b2611],
9	a	DT	O	a	det	12	SENT_222	[p14l1750t2568r1787b2611],
10	quantitatively	RB	O	quantitatively	advmod	11	SENT_222	[p14l1819t2547r2145b2631, p14l7t2647r216b2730],
11	important	JJ	O	important	amod	12	SENT_222	[p14l262t2647r624b2730],
12	role	NN	O	role	dobj	8	SENT_222	[p14l667t2647r810b2711],
13	of	IN	O	of	_	0	SENT_222	[p14l856t2647r937b2711],
14	CYPZD6	NN	O	cypzd6	prep_of	12	SENT_222	[p14l977t2647r1312b2711],
15	also	RB	O	also	advmod	8	SENT_222	[p14l1361t2647r1506b2711],
16	in	IN	O	in	_	0	SENT_222	[p14l1552t2647r1622b2710],
17	the	DT	O	the	det	19	SENT_222	[p14l1667t2647r1778b2711],
18	systemic	JJ	O	systemic	amod	19	SENT_222	[p14l1827t2647r2146b2730],
19	elimination	NN	O	elimination	prep_in	8	SENT_222	[p14l8t2745r430b2809],
20	of	IN	O	of	_	0	SENT_222	[p14l461t2745r540b2809],
21	zuclopenthixol	NN	O	zuclopenthixol	prep_of	19	SENT_222	[p14l565t2745r1135b2829],
22	.	.	O	.	_	0	SENT_222	[p14l565t2745r1135b2829],

1	It	PRP	O	it	nsubj	2	SENT_223	[p14l1169t2747r1225b2809],
2	is	VBZ	O	be	_	0	SENT_223	[p14l1253t2746r1311b2809],
3	to	TO	O	to	aux	5	SENT_223	[p14l1343t2755r1411b2809],
4	be	VB	O	be	auxpass	5	SENT_223	[p14l1441t2746r1527b2809],
5	pointed	VBN	O	point	xcomp	2	SENT_223	[p14l1556t2746r1835b2829],
6	out	RP	O	out	prt	5	SENT_223	[p14l1866t2755r1982b2809],
7	that	IN	O	that	complm	9	SENT_223	[p14l2010t2746r2149b2809],
8	there	EX	O	there	expl	9	SENT_223	[p14l7t2845r190b2909],
9	was	VBD	O	be	ccomp	5	SENT_223	[p14l243t2865r382b2909],
10	a	DT	O	a	det	13	SENT_223	[p14l438t2865r476b2909],
11	marked	JJ	O	marked	amod	13	SENT_223	[p14l526t2845r803b2909],
12	inter	NN	O	inter	nn	13	SENT_223	[p14l854t2845r1430b2909],
13	—	NN	O	—	nsubj	9	SENT_223	[p14l854t2845r1430b2909],
14	individual	JJ	O	individual	amod	15	SENT_223	[p14l854t2845r1430b2909],
15	variability	NN	O	variability	nsubj	26	SENT_223	[p14l1482t2845r1863b2928],
16	in	IN	O	in	_	0	SENT_223	[p14l1915t2845r1985b2908],
17	the	DT	O	the	det	18	SENT_223	[p14l2037t2845r2147b2909],
18	CD	NNP	O	CD	prep_in	15	SENT_223	[p14l8t2944r157b3008],
19	also	RB	O	also	advmod	18	SENT_223	[p14l213t2944r357b3007],
20	within	IN	O	within	_	0	SENT_223	[p14l410t2943r646b3008],
21	each	DT	O	each	det	23	SENT_223	[p14l698t2944r865b3007],
22	genotype	NN	O	genotype	nn	23	SENT_223	[p14l917t2953r1254b3027],
23	group	NN	O	group	prep_within	18	SENT_223	[p14l1308t2964r1520b3027],
24	and	CC	O	and	_	0	SENT_223	[p14l1575t2944r1705b3007],
25	significant	JJ	O	significant	conj_and	23	SENT_223	[p14l1759t2943r2149b3027],
26	overlap	VBP	O	overlap	rcmod	13	SENT_223	[p14l8t3043r283b3126],
27	between	IN	O	between	_	0	SENT_223	[p14l334t3043r643b3107],
28	the	DT	O	the	det	29	SENT_223	[p14l695t3043r806b3107],
29	genotype	NN	O	genotype	prep_between	26	SENT_223	[p14l858t3053r1196b3126],
30	groups	NNS	O	group	nsubj	31	SENT_223	[p14l1249t3063r1497b3126],
31	(	VBP	O	(	rcmod	29	SENT_223	[p14l1553t3043r1722b3126],
32	Fig	NN	O	fig	dobj	31	SENT_223	[p14l1553t3043r1722b3126],
33	.	.	O	.	_	0	SENT_223	[p14l1553t3043r1722b3126],

1	1	CD	NUMBER	1	_	0	SENT_224	[p14l1787t3044r1871b3122],
2	)	NN	O	)	dep	1	SENT_224	[p14l1787t3044r1871b3122],
3	.	.	O	.	_	0	SENT_224	[p14l1787t3044r1871b3122],

1	These	DT	O	these	det	2	SENT_225	[p14l1928t3043r2147b3107],
2	data	NNS	O	datum	nsubj	4	SENT_225	[p14l8t3141r161b3205],
3	are	VBP	O	be	cop	4	SENT_225	[p14l189t3162r298b3205],
4	similar	JJ	O	similar	_	0	SENT_225	[p14l329t3141r584b3205],
5	to	TO	O	to	_	0	SENT_225	[p14l610t3151r679b3205],
6	those	DT	O	those	prep_to	4	SENT_225	[p14l708t3142r902b3205],
7	reported	VBN	O	report	partmod	6	SENT_225	[p14l929t3142r1239b3225],
8	for	IN	O	for	_	0	SENT_225	[p14l1266t3141r1373b3205],
9	other	JJ	O	other	amod	10	SENT_225	[p14l1401t3142r1590b3205],
10	antipsychotics	NNS	O	antipsychotic	prep_for	7	SENT_225	[p14l1618t3141r2146b3225],
11	including	VBG	O	include	_	0	SENT_225	[p14l7t3241r356b3324],
12	risperidone	NN	O	risperidone	nn	14	SENT_225	[p14l382t3241r800b3324],
13	(	CD	NUMBER	(	num	14	SENT_225	[p14l830t3241r1118b3320],
14	Scordo	NNP	O	Scordo	prep_including	10	SENT_225	[p14l830t3241r1118b3320],
15	et	FW	O	et	nn	16	SENT_225	[p14l1147t3250r1212b3305],
16	al.	FW	O	al.	dep	14	SENT_225	[p14l1239t3241r1321b3305],
17	1999	CD	DATE	1999	num	18	SENT_225	[p14l1361t3241r1585b3320],
18	)	CD	NUMBER	)	dep	16	SENT_225	[p14l1361t3241r1585b3320],
19	.	.	O	.	_	0	SENT_225	[p14l1361t3241r1585b3320],

1	Interestingly	RB	O	interestingly	advmod	4	SENT_226	[p14l119t3339r602b3423],
2	,	,	O	,	_	0	SENT_226	[p14l119t3339r602b3423],
3	there	EX	O	there	expl	4	SENT_226	[p14l633t3340r817b3403],
4	were	VBD	O	be	_	0	SENT_226	[p14l845t3360r1022b3404],
5	no	DT	O	no	det	6	SENT_226	[p14l1050t3360r1139b3403],
6	differences	NNS	O	difference	nsubj	4	SENT_226	[p14l1169t3339r1576b3403],
7	in	IN	O	in	_	0	SENT_226	[p14l1605t3339r1676b3403],
8	the	DT	O	the	det	9	SENT_226	[p14l1702t3340r1813b3403],
9	doses	NNS	O	dose	prep_in	6	SENT_226	[p14l1842t3340r2043b3403],
10	of	IN	O	of	_	0	SENT_226	[p14l2074t3339r2154b3403],
11	zuclopenthixol	NN	O	zuclopenthixol	nn	12	SENT_226	[p14l8t3439r559b3522],
12	decanoate	NN	O	decanoate	prep_of	9	SENT_226	[p14l597t3439r966b3503],
13	between	IN	O	between	_	0	SENT_226	[p14l1002t3439r1311b3503],
14	the	DT	O	the	det	16	SENT_226	[p14l1348t3439r1459b3503],
15	genotype	NN	O	genotype	nn	16	SENT_226	[p14l1498t3448r1835b3522],
16	groups	NNS	O	group	prep_between	9	SENT_226	[p14l1874t3459r2144b3522],
17	,	,	O	,	_	0	SENT_226	[p14l1874t3459r2144b3522],
18	indicating	VBG	O	indicate	partmod	9	SENT_226	[p14l7t3537r377b3621],
19	that	IN	O	that	complm	24	SENT_226	[p14l408t3537r547b3601],
20	the	DT	O	the	det	21	SENT_226	[p14l576t3538r686b3601],
21	clinicians	NNS	O	clinician	nsubj	24	SENT_226	[p14l718t3537r1070b3601],
22	had	VBD	O	have	aux	24	SENT_226	[p14l1102t3537r1235b3601],
23	not	RB	O	not	neg	24	SENT_226	[p14l1265t3547r1383b3601],
24	adjusted	VBN	O	adjust	ccomp	18	SENT_226	[p14l1413t3537r1720b3621],
25	the	DT	O	the	det	26	SENT_226	[p14l1750t3538r1861b3601],
26	dosage	NN	O	dosage	dobj	24	SENT_226	[p14l1892t3538r2147b3621],
27	because	IN	O	because	_	0	SENT_226	[p14l6t3637r299b3701],
28	of	IN	O	of	_	0	SENT_226	[p14l332t3637r412b3701],
29	possibly	RB	O	possibly	advmod	32	SENT_226	[p14l436t3637r745b3720],
30	increased	VBN	O	increase	amod	32	SENT_226	[p14l777t3637r1128b3701],
31	side	JJ	O	side	amod	32	SENT_226	[p14l1162t3637r1306b3701],
32	effects	NNS	O	effect	prep_because_of	24	SENT_226	[p14l1338t3637r1580b3701],
33	in	IN	O	in	_	0	SENT_226	[p14l1614t3637r1684b3700],
34	PM	NNP	O	PM	prep_in	9	SENT_226	[p14l1715t3639r1865b3701],
35	.	.	O	.	_	0	SENT_226	[p14l1715t3639r1865b3701],

1	Therapeutic	JJ	O	therapeutic	amod	3	SENT_227	[p14l1902t3637r2145b3701, p14l6t3736r231b3819],
2	drug	NN	O	drug	nn	3	SENT_227	[p14l288t3736r454b3819],
3	monitoring	NN	O	monitoring	nsubj	9	SENT_227	[p14l510t3736r921b3819],
4	of	IN	O	of	_	0	SENT_227	[p14l978t3736r1058b3800],
5	antipsychotic	JJ	O	antipsychotic	amod	6	SENT_227	[p14l1109t3736r1600b3819],
6	drugs	NNS	O	drug	prep_of	3	SENT_227	[p14l1658t3736r1860b3819],
7	is	VBZ	O	be	cop	9	SENT_227	[p14l1916t3736r1974b3800],
8	not	RB	O	not	neg	9	SENT_227	[p14l2031t3746r2149b3800],
9	available	JJ	O	available	_	0	SENT_227	[p15l9t15r341b79],
10	in	IN	O	in	_	0	SENT_227	[p15l384t15r454b78],
11	Estonia	NNP	LOCATION	Estonia	prep_in	9	SENT_227	[p15l495t15r793b91],
12	,	,	O	,	_	0	SENT_227	[p15l495t15r793b91],
13	excluding	VBG	O	exclude	_	0	SENT_227	[p15l840t15r1203b98],
14	the	DT	O	the	det	15	SENT_227	[p15l1247t15r1358b79],
15	use	NN	O	use	prep_excluding	9	SENT_227	[p15l1400t35r1521b79],
16	of	IN	O	of	_	0	SENT_227	[p15l1566t15r1646b79],
17	this	DT	O	this	det	18	SENT_227	[p15l1682t15r1812b79],
18	tool	NN	O	tool	prep_of	15	SENT_227	[p15l1856t15r1999b79],
19	for	IN	O	for	_	0	SENT_227	[p15l2042t15r2149b79],
20	dose	NN	O	dose	nn	21	SENT_227	[p15l8t114r174b178],
21	titration	NN	O	titration	prep_for	18	SENT_227	[p15l228t114r541b178],
22	.	.	O	.	_	0	SENT_227	[p15l228t114r541b178],

1	The	DT	O	the	det	3	SENT_228	[p15l599t114r741b178],
2	common	JJ	O	common	amod	3	SENT_228	[p15l795t135r1118b178],
3	use	NN	O	use	nsubj	12	SENT_228	[p15l1170t135r1292b178],
4	of	IN	O	of	_	0	SENT_228	[p15l1347t114r1427b178],
5	a	DT	O	a	det	8	SENT_228	[p15l1477t135r1515b178],
6	4-week	JJ	DURATION	4-week	amod	8	SENT_228	[p15l1566t114r1840b179],
7	dosage	NN	O	dosage	nn	8	SENT_228	[p15l1892t114r2147b197],
8	interval	NN	O	interval	prep_of	3	SENT_228	[p15l7t213r289b277],
9	is	VBZ	O	be	cop	12	SENT_228	[p15l321t213r379b277],
10	not	RB	O	not	neg	12	SENT_228	[p15l413t222r530b277],
11	optimal	JJ	O	optimal	amod	12	SENT_228	[p15l562t213r843b296],
12	due	JJ	O	due	_	0	SENT_228	[p15l876t213r1006b277],
13	to	TO	O	to	_	0	SENT_228	[p15l1039t223r1107b277],
14	the	DT	O	the	det	19	SENT_228	[p15l1140t213r1251b277],
15	short	JJ	O	short	amod	19	SENT_228	[p15l1286t213r1468b277],
16	apparent	JJ	O	apparent	amod	19	SENT_228	[p15l1501t223r1819b296],
17	half	NN	O	half	nn	19	SENT_228	[p15l1849t213r2147b277],
18	—	JJ	O	—	amod	19	SENT_228	[p15l1849t213r2147b277],
19	life	NN	O	life	prep_to	12	SENT_228	[p15l1849t213r2147b277],
20	of	IN	O	of	prep	19	SENT_228	[p15l8t312r88b376],
21	zuclopenthixol	NN	O	zuclopenthixol	dep	27	SENT_228	[p15l118t312r669b395],
22	in	IN	O	in	_	0	SENT_228	[p15l704t312r774b375],
23	the	DT	O	the	det	24	SENT_228	[p15l809t312r920b376],
24	compound	NN	O	compound	prep_in	21	SENT_228	[p15l956t312r1346b395],
25	viscoleo	NN	O	viscoleo	dep	27	SENT_228	[p15l1381t312r1688b377],
26	(	CD	NUMBER	(	num	25	SENT_228	[p15l1727t312r2049b392],
27	Poulsen	NNP	PERSON	Poulsen	dep	31	SENT_228	[p15l1727t312r2049b392],
28	et	FW	O	et	nn	29	SENT_228	[p15l2084t322r2149b376],
29	al.	FW	O	al.	dep	27	SENT_228	[p15l9t411r90b475],
30	1994	CD	DATE	1994	num	31	SENT_228	[p15l135t411r360b490],
31	)	CD	NUMBER	)	dep	20	SENT_228	[p15l135t411r360b490],
32	.	.	O	.	_	0	SENT_228	[p15l135t411r360b490],

1	However	RB	O	however	advmod	6	SENT_229	[p15l396t413r751b487],
2	,	,	O	,	_	0	SENT_229	[p15l396t413r751b487],
3	this	DT	O	this	nsubj	6	SENT_229	[p15l785t411r916b475],
4	was	VBD	O	be	cop	6	SENT_229	[p15l950t431r1089b475],
5	common	JJ	O	common	amod	6	SENT_229	[p15l1123t431r1445b475],
6	routine	NN	O	routine	_	0	SENT_229	[p15l1475t411r1737b475],
7	in	IN	O	in	_	0	SENT_229	[p15l1770t411r1839b474],
8	Estonia	NNP	LOCATION	Estonia	prep_in	6	SENT_229	[p15l1870t411r2149b475],
9	at	IN	O	at	_	0	SENT_229	[p15l9t520r73b574],
10	the	DT	O	the	det	11	SENT_229	[p15l98t510r209b574],
11	time	NN	O	time	prep_at	6	SENT_229	[p15l236t510r398b574],
12	of	IN	O	of	_	0	SENT_229	[p15l427t510r506b574],
13	the	DT	O	the	det	14	SENT_229	[p15l526t510r637b574],
14	study	NN	O	study	prep_of	11	SENT_229	[p15l667t510r876b593],
15	.	.	O	.	_	0	SENT_229	[p15l667t510r876b593],

1	It	PRP	O	it	nsubjpass	4	SENT_230	[p15l119t611r175b673],
2	is	VBZ	O	be	auxpass	4	SENT_230	[p15l204t609r262b673],
3	well	RB	O	well	advmod	4	SENT_230	[p15l296t609r453b673],
4	established	VBN	O	establish	_	0	SENT_230	[p15l485t609r898b673],
5	that	IN	O	that	complm	8	SENT_230	[p15l928t609r1067b673],
6	smoking	NN	O	smoking	nsubj	8	SENT_230	[p15l1100t609r1414b692],
7	can	MD	O	can	aux	8	SENT_230	[p15l1447t629r1573b673],
8	inﬂuence	VB	O	inﬂuence	ccomp	4	SENT_230	[p15l1603t609r1948b673],
9	drug	NN	O	drug	nn	10	SENT_230	[p15l1981t609r2147b692],
10	disposition	NN	O	disposition	dobj	8	SENT_230	[p15l8t708r410b791],
11	in	IN	O	in	_	0	SENT_230	[p15l437t708r507b771],
12	humans	NNS	O	human	prep_in	8	SENT_230	[p15l533t708r839b784],
13	,	,	O	,	_	0	SENT_230	[p15l533t708r839b784],
14	mainly	RB	O	mainly	advmod	27	SENT_230	[p15l870t708r1123b791],
15	due	JJ	O	due	_	0	SENT_230	[p15l1153t708r1282b772],
16	to	TO	O	to	_	0	SENT_230	[p15l1310t718r1379b772],
17	induction	NN	O	induction	prep_due_to	27	SENT_230	[p15l1407t708r1754b772],
18	of	IN	O	of	_	0	SENT_230	[p15l1782t708r1862b772],
19	hepatic	JJ	O	hepatic	amod	21	SENT_230	[p15l1883t708r2146b791],
20	isozyme	NN	O	isozyme	nn	21	SENT_230	[p15l7t807r314b890],
21	CYP1A2	NN	O	cyp1a2	prep_of	17	SENT_230	[p15l343t807r679b871],
22	but	CC	O	but	dep	23	SENT_230	[p15l705t807r824b871],
23	probably	RB	O	probably	dep	27	SENT_230	[p15l849t807r1178b890],
24	also	RB	O	also	dep	23	SENT_230	[p15l1208t807r1352b871],
25	other	JJ	O	other	amod	27	SENT_230	[p15l1381t807r1571b871],
26	CYP	NN	O	cyp	nn	27	SENT_230	[p15l1597t807r1774b871],
27	enzymes	NNS	O	enzyme	appos	12	SENT_230	[p15l1802t827r2143b890],
28	.	.	O	.	_	0	SENT_230	[p15l1802t827r2143b890],

1	Reviewing	VBG	O	review	partmod	24	SENT_231	[p15l7t906r407b989],
2	data	NNS	O	datum	dobj	1	SENT_231	[p15l472t906r626b970],
3	about	IN	O	about	_	0	SENT_231	[p15l689t906r893b970],
4	the	DT	O	the	det	5	SENT_231	[p15l955t906r1066b970],
5	inﬂuence	NN	O	inﬂuence	prep_about	1	SENT_231	[p15l1129t906r1474b970],
6	of	IN	O	of	_	0	SENT_231	[p15l1539t906r1618b970],
7	smoking	NN	O	smoking	prep_of	5	SENT_231	[p15l1679t906r1993b989],
8	on	IN	O	on	_	0	SENT_231	[p15l2059t927r2148b970],
9	plasma	NN	O	plasma	nn	10	SENT_231	[p15l6t1005r270b1088],
10	concentrations	NNS	O	concentration	prep_on	1	SENT_231	[p15l321t1005r860b1069],
11	of	IN	O	of	_	0	SENT_231	[p15l915t1005r995b1069],
12	a	DT	O	a	det	13	SENT_231	[p15l1043t1025r1081b1069],
13	number	NN	O	number	prep_of	10	SENT_231	[p15l1132t1005r1415b1069],
14	of	IN	O	of	_	0	SENT_231	[p15l1467t1005r1547b1069],
15	antipsychotics	NNS	O	antipsychotic	prep_of	13	SENT_231	[p15l1595t1005r2144b1088],
16	,	,	O	,	_	0	SENT_231	[p15l1595t1005r2144b1088],
17	ZumBrunnen	NN	O	zumbrunnen	nn	20	SENT_231	[p15l6t1106r501b1168],
18	and	CC	O	and	_	0	SENT_231	[p15l535t1104r666b1168],
19	J	NN	O	j	nn	20	SENT_231	[p15l697t1106r731b1169],
20	ann	NN	O	ann	nsubj	24	SENT_231	[p15l736t1125r866b1168],
21	(	CD	NUMBER	(	num	23	SENT_231	[p15l901t1105r1141b1184],
22	1998	CD	DATE	1998	num	23	SENT_231	[p15l901t1105r1141b1184],
23	)	NN	O	)	dep	20	SENT_231	[p15l901t1105r1141b1184],
24	concluded	VBD	O	conclude	_	0	SENT_231	[p15l1177t1104r1558b1168],
25	that	IN	O	that	complm	34	SENT_231	[p15l1589t1104r1728b1168],
26	the	DT	O	the	det	27	SENT_231	[p15l1759t1104r1870b1168],
27	effects	NNS	O	effect	nsubj	34	SENT_231	[p15l1904t1104r2146b1168],
28	of	IN	O	of	_	0	SENT_231	[p15l16t1377r95b1441],
29	smoking	NN	O	smoking	prep_of	27	SENT_231	[p15l127t1377r439b1460],
30	on	IN	O	on	_	0	SENT_231	[p15l475t1398r565b1441],
31	antipsychotic	JJ	O	antipsychotic	amod	33	SENT_231	[p15l600t1377r1090b1460],
32	drug	NN	O	drug	nn	33	SENT_231	[p15l1126t1377r1291b1460],
33	disposition	NN	O	disposition	prep_on	29	SENT_231	[p15l1328t1377r1732b1460],
34	tend	VBP	O	tend	ccomp	24	SENT_231	[p15l1766t1377r1924b1441],
35	to	TO	O	to	aux	37	SENT_231	[p15l1957t1387r2025b1441],
36	be	VB	O	be	cop	37	SENT_231	[p15l2059t1377r2145b1441],
37	consistent	JJ	O	consistent	xcomp	34	SENT_231	[p15l16t1475r404b1551],
38	,	,	O	,	_	0	SENT_231	[p15l16t1475r404b1551],
39	with	IN	O	with	_	0	SENT_231	[p15l439t1475r602b1540],
40	smokers	NNS	O	smoker	prep_with	37	SENT_231	[p15l636t1476r937b1539],
41	having	VBG	O	have	partmod	40	SENT_231	[p15l970t1475r1220b1559],
42	lower	JJR	O	lower	dep	43	SENT_231	[p15l1253t1475r1463b1540],
43	plasma	NN	O	plasma	amod	45	SENT_231	[p15l1491t1476r1754b1559],
44	drug	NN	O	drug	nn	45	SENT_231	[p15l1785t1476r1951b1559],
45	concentrations	NNS	O	concentration	dobj	41	SENT_231	[p15l1984t1496r2143b1539, p15l16t1575r439b1639],
46	.	.	O	.	_	0	SENT_231	[p15l1984t1496r2143b1539, p15l16t1575r439b1639],

1	Our	PRP$	O	we	poss	2	SENT_232	[p15l480t1576r622b1639],
2	finding	NN	O	finding	nsubjpass	17	SENT_232	[p15l656t1575r920b1658],
3	of	IN	O	of	_	0	SENT_232	[p15l958t1575r1037b1639],
4	lower	JJR	O	lower	amod	6	SENT_232	[p15l1067t1575r1277b1639],
5	plasma	NN	O	plasma	nn	6	SENT_232	[p15l1310t1575r1572b1658],
6	concentrations	NNS	O	concentration	prep_of	2	SENT_232	[p15l1607t1575r2143b1639],
7	of	IN	O	of	_	0	SENT_232	[p15l16t1673r95b1737],
8	zuclopenthixol	NN	O	zuclopenthixol	prep_of	6	SENT_232	[p15l143t1674r691b1757],
9	in	IN	O	in	_	0	SENT_232	[p15l744t1674r814b1737],
10	smokers	NNS	O	smoker	prep_in	8	SENT_232	[p15l869t1673r1170b1737],
11	than	IN	O	than	prep	10	SENT_232	[p15l1225t1674r1383b1737],
12	in	IN	O	in	pcomp	11	SENT_232	[p15l1435t1674r1504b1737],
13	non	JJ	O	non	amod	15	SENT_232	[p15l1557t1674r2031b1737],
14	—	NN	O	—	nn	15	SENT_232	[p15l1557t1674r2031b1737],
15	smokers	NNS	O	smoker	pobj	12	SENT_232	[p15l1557t1674r2031b1737],
16	is	VBZ	O	be	auxpass	17	SENT_232	[p15l2086t1674r2143b1737],
17	confounded	VBN	O	confound	_	0	SENT_232	[p15l16t1773r451b1837],
18	by	IN	O	by	_	0	SENT_232	[p15l484t1773r574b1856],
19	the	DT	O	the	det	20	SENT_232	[p15l610t1773r720b1837],
20	overrepresentation	NN	O	overrepresentation	agent	17	SENT_232	[p15l757t1773r1445b1856],
21	of	IN	O	of	_	0	SENT_232	[p15l1481t1773r1560b1837],
22	smokers	NNS	O	smoker	prep_of	20	SENT_232	[p15l1592t1773r1893b1837],
23	in	IN	O	in	_	0	SENT_232	[p15l1930t1773r2000b1836],
24	the	DT	O	the	det	27	SENT_232	[p15l2034t1773r2145b1837],
25	homozygous	JJ	O	homozygous	amod	27	SENT_232	[p15l14t1871r484b1955],
26	EM	NN	O	em	nn	27	SENT_232	[p15l512t1873r648b1935],
27	group	NN	O	group	prep_in	22	SENT_232	[p15l677t1892r908b1955],
28	.	.	O	.	_	0	SENT_232	[p15l677t1892r908b1955],

1	However	RB	O	however	advmod	22	SENT_233	[p15l939t1873r1292b1947],
2	,	,	O	,	_	0	SENT_233	[p15l939t1873r1292b1947],
3	the	DT	O	the	det	4	SENT_233	[p15l1322t1872r1433b1935],
4	finding	NN	O	finding	nsubj	22	SENT_233	[p15l1460t1871r1725b1955],
5	that	IN	O	that	complm	20	SENT_233	[p15l1752t1872r1891b1935],
6	zuclopenthixol	NN	O	zuclopenthixol	nn	8	SENT_233	[p15l1917t1872r2143b1935, p15l14t1971r363b2054],
7	plasma	NN	O	plasma	nn	8	SENT_233	[p15l413t1971r675b2054],
8	concentrations	NNS	O	concentration	nsubj	20	SENT_233	[p15l725t1971r1261b2035],
9	of	IN	O	of	_	0	SENT_233	[p15l1315t1971r1395b2035],
10	smokers	NNS	O	smoker	prep_of	8	SENT_233	[p15l1443t1971r1744b2035],
11	and	CC	O	and	_	0	SENT_233	[p15l1798t1971r1928b2035],
12	nonsmokers	NNS	O	nonsmoker	conj_and	10	SENT_233	[p15l1978t1991r2143b2035, p15l18t2070r319b2133],
13	within	IN	O	within	_	0	SENT_233	[p15l350t2069r584b2134],
14	the	DT	O	the	det	17	SENT_233	[p15l612t2070r722b2133],
15	homozygous	JJ	O	homozygous	amod	17	SENT_233	[p15l750t2069r1220b2153],
16	EM	NN	O	em	nn	17	SENT_233	[p15l1250t2071r1385b2133],
17	group	NN	O	group	prep_within	10	SENT_233	[p15l1415t2090r1626b2153],
18	did	VBD	O	do	aux	20	SENT_233	[p15l1656t2069r1772b2133],
19	not	RB	O	not	neg	20	SENT_233	[p15l1799t2079r1917b2133],
20	differ	VB	O	differ	dep	4	SENT_233	[p15l1944t2069r2147b2133],
21	significantly	RB	O	significantly	advmod	20	SENT_233	[p15l18t2169r477b2252],
22	is	VBZ	O	be	_	0	SENT_233	[p15l513t2169r570b2233],
23	of	IN	O	of	_	0	SENT_233	[p15l609t2169r689b2233],
24	interest	NN	O	interest	prep_of	22	SENT_233	[p15l718t2169r1008b2233],
25	.	.	O	.	_	0	SENT_233	[p15l718t2169r1008b2233],

1	More	RBR	O	more	advmod	2	SENT_234	[p15l1048t2171r1246b2233],
2	prospective	JJ	O	prospective	amod	3	SENT_234	[p15l1281t2169r1707b2252],
3	studies	NNS	O	study	nsubjpass	5	SENT_234	[p15l1747t2169r1997b2233],
4	are	VBP	O	be	auxpass	5	SENT_234	[p15l2037t2189r2145b2233],
5	needed	VBN	O	need	_	0	SENT_234	[p15l15t2268r276b2331],
6	to	TO	O	to	aux	7	SENT_234	[p15l324t2277r392b2331],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_234	[p15l443t2268r749b2332],
8	the	DT	O	the	det	9	SENT_234	[p15l798t2268r908b2331],
9	impact	NN	O	impact	dobj	7	SENT_234	[p15l958t2267r1209b2351],
10	of	IN	O	of	_	0	SENT_234	[p15l1258t2267r1337b2331],
11	smoking	NN	O	smoking	prep_of	9	SENT_234	[p15l1384t2268r1696b2351],
12	on	IN	O	on	_	0	SENT_234	[p15l1748t2288r1837b2331],
13	plasma	NN	O	plasma	nn	15	SENT_234	[p15l1884t2268r2147b2351],
14	zuclopenthixol	NN	O	zuclopenthixol	nn	15	SENT_234	[p15l16t2367r558b2450],
15	concentrations	NNS	O	concentration	prep_on	7	SENT_234	[p15l588t2367r1118b2431],
16	in	IN	O	in	_	0	SENT_234	[p15l1148t2367r1218b2430],
17	different	JJ	O	different	amod	20	SENT_234	[p15l1247t2367r1559b2431],
18	CYPZD6	NN	O	cypzd6	nn	20	SENT_234	[p15l1591t2367r1914b2432],
19	genotype	NN	O	genotype	nn	20	SENT_234	[p15l1940t2387r2143b2450, p15l15t2475r171b2548],
20	groups	NNS	O	group	prep_in	15	SENT_234	[p15l199t2485r466b2548],
21	.	.	O	.	_	0	SENT_234	[p15l199t2485r466b2548],

1	The	DT	O	the	det	3	SENT_235	[p15l127t2564r267b2628],
2	allele	NN	O	allele	nn	3	SENT_235	[p15l315t2564r511b2628],
3	frequencies	NNS	O	frequency	dep	16	SENT_235	[p15l557t2564r979b2647],
4	of	IN	O	of	_	0	SENT_235	[p15l1027t2564r1107b2628],
5	CYPZD6	NN	O	cypzd6	prep_of	3	SENT_235	[p15l1150t2564r1476b2629],
6	*	CD	NUMBER	*	number	10	SENT_235	[p15l1485t2564r1563b2628],
7	3	CD	NUMBER	3	number	10	SENT_235	[p15l1485t2564r1563b2628],
8	and	CC	O	and	_	0	SENT_235	[p15l1612t2564r1742b2628],
9	*	CD	NUMBER	*	conj_and	10	SENT_235	[p15l1796t2564r1875b2627],
10	4	CD	NUMBER	4	dep	3	SENT_235	[p15l1796t2564r1875b2627],
11	in	IN	O	in	_	0	SENT_235	[p15l1921t2564r1990b2627],
12	the	DT	O	the	det	13	SENT_235	[p15l2034t2564r2145b2628],
13	patients	NNS	O	patient	prep_in	10	SENT_235	[p15l14t2663r299b2746],
14	studied	VBN	O	study	partmod	10	SENT_235	[p15l340t2662r603b2727],
15	were	VBD	O	be	cop	16	SENT_235	[p15l637t2683r813b2727],
16	similar	JJ	O	similar	_	0	SENT_235	[p15l852t2662r1105b2726],
17	to	TO	O	to	_	0	SENT_235	[p15l1139t2672r1207b2726],
18	those	DT	O	those	prep_to	16	SENT_235	[p15l1243t2663r1435b2726],
19	found	VBN	O	find	partmod	18	SENT_235	[p15l1471t2662r1685b2726],
20	in	IN	O	in	_	0	SENT_235	[p15l1719t2662r1789b2726],
21	Estonian	JJ	MISC	estonian	amod	25	SENT_235	[p15l1823t2662r2146b2726],
22	and	CC	O	and	_	0	SENT_235	[p15l17t2762r147b2826],
23	Russian	JJ	LOCATION	russian	amod	25	SENT_235	[p15l209t2762r501b2826],
24	healthy	JJ	O	healthy	amod	25	SENT_235	[p15l562t2762r833b2845],
25	subjects	NNS	O	subject	prep_in	19	SENT_235	[p15l900t2762r1191b2845],
26	(	JJ	O	(	amod	27	SENT_235	[p15l1259t2762r1598b2841],
27	Marandi	NNP	PERSON	Marandi	tmod	19	SENT_235	[p15l1259t2762r1598b2841],
28	et	FW	O	et	nn	29	SENT_235	[p15l1663t2772r1727b2826],
29	al.	FW	O	al.	dep	27	SENT_235	[p15l1791t2762r1872b2826],
30	1996	CD	DATE	1996	nsubj	16	SENT_235	[p15l1948t2762r2142b2838],
31	,	,	DATE	,	_	0	SENT_235	[p15l1948t2762r2142b2838],
32	1997	CD	DATE	1997	num	33	SENT_235	[p15l24t2862r247b2940],
33	)	NN	O	)	appos	30	SENT_235	[p15l24t2862r247b2940],
34	.	.	O	.	_	0	SENT_235	[p15l24t2862r247b2940],

1	As	IN	O	as	mark	10	SENT_236	[p15l321t2862r419b2925],
2	other	JJ	O	other	amod	5	SENT_236	[p15l492t2861r680b2925],
3	rare	JJ	O	rare	amod	5	SENT_236	[p15l746t2882r889b2925],
4	inactivating	VBG	O	inactivate	amod	5	SENT_236	[p15l958t2861r1393b2944],
5	mutations	NNS	O	mutation	nsubjpass	10	SENT_236	[p15l1463t2861r1825b2925],
6	in	IN	O	in	_	0	SENT_236	[p15l1896t2861r1966b2924],
7	the	DT	O	the	det	8	SENT_236	[p15l2035t2861r2145b2925],
8	CYPZD6	NN	O	cypzd6	prep_in	5	SENT_236	[p15l19t2960r345b3025],
9	are	VBP	O	be	auxpass	10	SENT_236	[p15l394t2980r503b3024],
10	missed	VBN	O	miss	advcl	24	SENT_236	[p15l554t2960r810b3024],
11	by	IN	O	by	_	0	SENT_236	[p15l858t2960r949b3043],
12	the	DT	O	the	det	14	SENT_236	[p15l1000t2960r1111b3024],
13	genotyping	NN	O	genotyping	nn	14	SENT_236	[p15l1164t2960r1576b3043],
14	method	NN	O	method	agent	10	SENT_236	[p15l1628t2960r1904b3024],
15	used	VBN	O	use	partmod	14	SENT_236	[p15l1954t2960r2142b3036],
16	,	,	O	,	_	0	SENT_236	[p15l1954t2960r2142b3036],
17	some	DT	O	some	nsubjpass	24	SENT_236	[p15l18t3080r207b3123],
18	of	IN	O	of	_	0	SENT_236	[p15l268t3059r347b3123],
19	the	DT	O	the	det	20	SENT_236	[p15l400t3059r510b3123],
20	patients	NNS	O	patient	prep_of	17	SENT_236	[p15l568t3059r854b3142],
21	could	MD	O	could	aux	24	SENT_236	[p15l915t3059r1119b3123],
22	have	VB	O	have	aux	24	SENT_236	[p15l1176t3059r1349b3124],
23	been	VBN	O	be	auxpass	24	SENT_236	[p15l1407t3059r1581b3123],
24	misclassified	VBN	O	misclassify	_	0	SENT_236	[p15l1639t3059r2141b3123],
25	.	.	O	.	_	0	SENT_236	[p15l1639t3059r2141b3123],

1	Especially	RB	O	especially	advmod	35	SENT_237	[p15l14t3158r413b3241],
2	,	,	O	,	_	0	SENT_237	[p15l14t3158r413b3241],
3	as	IN	O	as	_	0	SENT_237	[p15l454t3178r524b3222],
4	the	DT	O	the	det	6	SENT_237	[p15l561t3158r672b3222],
5	CYPZD6	NN	O	cypzd6	nn	6	SENT_237	[p15l712t3158r1037b3223],
6	*	NN	O	*	prep_as	18	SENT_237	[p15l1047t3159r1127b3222],
7	5	CD	NUMBER	5	num	8	SENT_237	[p15l1047t3159r1127b3222],
8	allele	NN	O	allele	nsubjpass	18	SENT_237	[p15l1164t3158r1360b3222],
9	with	IN	O	with	_	0	SENT_237	[p15l1396t3158r1559b3222],
10	deletion	NN	O	deletion	prep_with	8	SENT_237	[p15l1594t3158r1890b3222],
11	of	IN	O	of	_	0	SENT_237	[p15l1926t3158r2006b3222],
12	the	DT	O	the	det	15	SENT_237	[p15l2034t3158r2145b3222],
13	active	JJ	O	active	amod	15	SENT_237	[p15l17t3257r234b3321],
14	CYPZD6	NN	O	cypzd6	nn	15	SENT_237	[p15l269t3257r595b3322],
15	gene	NN	O	gene	prep_of	10	SENT_237	[p15l623t3278r794b3340],
16	was	VBD	O	be	auxpass	18	SENT_237	[p15l825t3278r964b3321],
17	not	RB	O	not	neg	18	SENT_237	[p15l996t3267r1114b3321],
18	analysed	VBN	O	analyse	parataxis	35	SENT_237	[p15l1145t3257r1485b3340],
19	,	,	O	,	_	0	SENT_237	[p15l1145t3257r1485b3340],
20	some	DT	O	some	nsubj	35	SENT_237	[p15l1522t3278r1711b3321],
21	of	IN	O	of	_	0	SENT_237	[p15l1743t3257r1823b3321],
22	the	DT	O	the	det	23	SENT_237	[p15l1847t3257r1957b3321],
23	subjects	NNS	O	subject	prep_of	20	SENT_237	[p15l1991t3257r2143b3321, p15l7t3356r180b3439],
24	classified	VBN	O	classify	partmod	23	SENT_237	[p15l215t3356r564b3420],
25	as	IN	O	as	mark	30	SENT_237	[p15l596t3376r666b3420],
26	homozygous	JJ	O	homozygous	nsubj	30	SENT_237	[p15l699t3356r1168b3439],
27	for	IN	O	for	_	0	SENT_237	[p15l1202t3356r1309b3420],
28	*	NN	O	*	prep_for	26	SENT_237	[p15l1349t3357r1421b3419],
29	1	CD	NUMBER	1	num	28	SENT_237	[p15l1349t3357r1421b3419],
30	might	MD	O	might	advcl	24	SENT_237	[p15l1460t3356r1675b3439],
31	in	IN	O	in	_	0	SENT_237	[p15l1705t3356r1774b3419],
32	fact	NN	O	fact	prep_in	30	SENT_237	[p15l1805t3356r1943b3420],
33	have	VBP	O	have	aux	35	SENT_237	[p15l1972t3356r2145b3420],
34	been	VBN	O	be	cop	35	SENT_237	[p15l14t3455r188b3519],
35	heterozygous	JJ	O	heterozygous	_	0	SENT_237	[p15l230t3455r721b3538],
36	for	IN	O	for	_	0	SENT_237	[p15l766t3455r873b3519],
37	*	CD	NUMBER	*	number	38	SENT_237	[p15l925t3456r998b3518],
38	1	CD	NUMBER	1	prep_for	35	SENT_237	[p15l925t3456r998b3518],
39	and	CC	O	and	_	0	SENT_237	[p15l1050t3455r1180b3519],
40	*	CD	NUMBER	*	number	41	SENT_237	[p15l1233t3457r1331b3519],
41	5	CD	NUMBER	5	prep_for	35	SENT_237	[p15l1233t3457r1331b3519],
42	.	.	O	.	_	0	SENT_237	[p15l1233t3457r1331b3519],

1	We	PRP	O	we	nsubj	4	SENT_238	[p15l1378t3457r1497b3519],
2	have	VBP	O	have	aux	4	SENT_238	[p15l1540t3455r1712b3520],
3	previously	RB	DATE	previously	advmod	4	SENT_238	[p15l1755t3455r2145b3538],
4	shown	VBN	O	show	_	0	SENT_238	[p15l18t3554r254b3618],
5	that	IN	O	that	complm	6	SENT_238	[p15l297t3554r435b3618],
6	genotyping	VBG	O	genotype	ccomp	4	SENT_238	[p15l478t3554r891b3637],
7	for	IN	O	for	_	0	SENT_238	[p15l936t3554r1043b3618],
8	CYPZD6	NN	O	cypzd6	prep_for	6	SENT_238	[p15l1089t3554r1414b3619],
9	*	CD	NUMBER	*	number	13	SENT_238	[p15l1424t3554r1502b3618],
10	3	CD	NUMBER	3	number	13	SENT_238	[p15l1424t3554r1502b3618],
11	and	CC	O	and	_	0	SENT_238	[p15l1549t3554r1679b3618],
12	*	CD	NUMBER	*	conj_and	13	SENT_238	[p15l1732t3554r1811b3617],
13	4	CD	NUMBER	4	dobj	6	SENT_238	[p15l1732t3554r1811b3617],
14	allowed	VBN	O	allow	partmod	13	SENT_238	[p15l1856t3554r2146b3618],
15	prediction	NN	O	prediction	dobj	14	SENT_238	[p15l14t3653r389b3736],
16	of	IN	O	of	_	0	SENT_238	[p15l432t3653r512b3717],
17	the	DT	O	the	det	19	SENT_238	[p15l547t3653r658b3717],
18	PM	NN	O	pm	nn	19	SENT_238	[p15l700t3655r830b3716],
19	phenotype	NN	O	phenotype	prep_of	15	SENT_238	[p15l872t3653r1256b3736],
20	with	IN	O	with	_	0	SENT_238	[p15l1299t3653r1461b3717],
21	high	JJ	O	high	amod	22	SENT_238	[p15l1502t3653r1665b3736],
22	accuracy	NN	O	accuracy	prep_with	14	SENT_238	[p15l1709t3674r2033b3736],
23	in	IN	O	in	_	0	SENT_238	[p15l2076t3653r2146b3716],
24	the	DT	O	the	det	26	SENT_238	[p16l15t15r125b79],
25	Estonian	JJ	MISC	estonian	amod	26	SENT_238	[p16l159t15r482b79],
26	population	NN	O	population	prep_in	14	SENT_238	[p16l515t15r911b98],
27	(	CD	NUMBER	(	num	28	SENT_238	[p16l948t15r1287b94],
28	Marandi	NNP	PERSON	Marandi	dep	26	SENT_238	[p16l948t15r1287b94],
29	et	FW	O	et	nn	30	SENT_238	[p16l1322t24r1387b79],
30	al.	FW	O	al.	dep	6	SENT_238	[p16l1421t15r1502b79],
31	1996	CD	DATE	1996	num	32	SENT_238	[p16l1550t15r1777b94],
32	)	NN	O	)	dep	30	SENT_238	[p16l1550t15r1777b94],
33	;	:	O	;	_	0	SENT_238	[p16l1550t15r1777b94],
34	while	IN	O	while	mark	49	SENT_238	[p16l1816t15r2038b91],
35	,	,	O	,	_	0	SENT_238	[p16l1816t15r2038b91],
36	in	IN	O	in	_	0	SENT_238	[p16l2076t15r2146b78],
37	a	DT	O	a	det	40	SENT_238	[p16l17t135r55b178],
38	Russian	JJ	LOCATION	russian	amod	40	SENT_238	[p16l86t114r378b178],
39	population	NN	O	population	nn	40	SENT_238	[p16l409t114r805b197],
40	living	NN	O	living	prep_in	49	SENT_238	[p16l838t114r1051b197],
41	in	IN	O	in	_	0	SENT_238	[p16l1085t114r1155b177],
42	Estonia	NNP	LOCATION	Estonia	prep_in	40	SENT_238	[p16l1187t114r1483b190],
43	,	,	O	,	_	0	SENT_238	[p16l1187t114r1483b190],
44	some	DT	O	some	det	47	SENT_238	[p16l1523t135r1712b178],
45	phenotypically	RB	O	phenotypically	advmod	46	SENT_238	[p16l1744t114r2143b197, p16l16t213r192b296],
46	PM	JJ	O	pm	amod	47	SENT_238	[p16l238t215r368b276],
47	subjects	NNS	O	subject	nsubjpass	49	SENT_238	[p16l417t213r708b296],
48	were	VBD	O	be	auxpass	49	SENT_238	[p16l756t233r933b277],
49	classified	VBN	O	classify	advcl	4	SENT_238	[p16l979t213r1328b277],
50	as	IN	O	as	mark	60	SENT_238	[p16l1374t233r1444b277],
51	EM	NN	O	em	dep	56	SENT_238	[p16l1491t215r1627b276],
52	by	IN	O	by	_	0	SENT_238	[p16l1672t213r1762b296],
53	genotype	NN	O	genotype	prep_by	51	SENT_238	[p16l1809t223r2145b296],
54	analysis	NN	O	analysis	dep	56	SENT_238	[p16l17t312r304b395],
55	(	CD	NUMBER	(	num	54	SENT_238	[p16l335t312r668b391],
56	Marandi	NNP	PERSON	Marandi	dep	60	SENT_238	[p16l335t312r668b391],
57	et	FW	O	et	nn	58	SENT_238	[p16l696t322r760b376],
58	al.	FW	O	al.	dep	56	SENT_238	[p16l786t312r866b376],
59	1997	CD	DATE	1997	num	60	SENT_238	[p16l906t313r1124b392],
60	)	CD	NUMBER	)	advcl	49	SENT_238	[p16l906t313r1124b392],
61	.	.	O	.	_	0	SENT_238	[p16l906t313r1124b392],

1	Analysis	NN	O	analysis	nsubj	11	SENT_239	[p16l1155t312r1469b395],
2	of	IN	O	of	_	0	SENT_239	[p16l1499t312r1577b376],
3	the	DT	O	the	det	5	SENT_239	[p16l1597t312r1706b376],
4	C	NN	O	c	nn	5	SENT_239	[p16l1737t314r1795b377],
5	YPZD6	NN	O	ypzd6	prep_of	1	SENT_239	[p16l1799t312r2058b376],
6	*	CD	NUMBER	*	number	7	SENT_239	[p16l2067t312r2149b376],
7	6	CD	NUMBER	6	num	8	SENT_239	[p16l2067t312r2149b376],
8	allele	NN	O	allele	dep	5	SENT_239	[p16l17t411r213b475],
9	did	VBD	O	do	aux	11	SENT_239	[p16l277t411r393b475],
10	not	RB	O	not	neg	11	SENT_239	[p16l454t420r572b475],
11	explain	VB	O	explain	_	0	SENT_239	[p16l634t411r904b494],
12	this	DT	O	this	det	14	SENT_239	[p16l966t411r1095b475],
13	discrepancy	NN	O	discrepancy	nn	14	SENT_239	[p16l1161t411r1600b494],
14	(	NN	O	(	nsubj	15	SENT_239	[p16l1666t411r2146b494],
15	unpublished	JJ	O	unpublished	ccomp	11	SENT_239	[p16l1666t411r2146b494],
16	data	NNS	O	datum	iobj	15	SENT_239	[p16l16t510r217b590],
17	)	NN	O	)	dobj	15	SENT_239	[p16l16t510r217b590],
18	.	.	O	.	_	0	SENT_239	[p16l16t510r217b590],

1	Whether	IN	O	whether	complm	8	SENT_240	[p16l261t510r580b574],
2	this	DT	O	this	det	3	SENT_240	[p16l619t510r748b574],
3	discordance	NN	O	discordance	nsubj	8	SENT_240	[p16l792t510r1231b574],
4	in	IN	O	in	_	0	SENT_240	[p16l1272t510r1342b573],
5	the	DT	O	the	det	7	SENT_240	[p16l1382t510r1492b574],
6	Russian	JJ	LOCATION	russian	amod	7	SENT_240	[p16l1533t510r1825b574],
7	population	NN	O	population	prep_in	3	SENT_240	[p16l1863t510r2143b593, p16l15t609r157b673],
8	was	VBD	O	be	csubj	15	SENT_240	[p16l213t629r352b673],
9	of	IN	O	of	_	0	SENT_240	[p16l410t609r490b673],
10	genetic	JJ	O	genetic	amod	13	SENT_240	[p16l540t609r803b692],
11	or	CC	O	or	_	0	SENT_240	[p16l861t629r936b673],
12	environmental	JJ	O	environmental	amod	13	SENT_240	[p16l991t609r1524b673],
13	origin	NN	O	origin	prep_of	8	SENT_240	[p16l1581t609r1799b692],
14	remains	VBZ	O	remain	cop	15	SENT_240	[p16l1853t609r2143b673],
15	unknown	JJ	O	unknown	_	0	SENT_240	[p16l14t708r376b772],
16	.	.	O	.	_	0	SENT_240	[p16l14t708r376b772],

1	The	DT	O	the	det	2	SENT_241	[p16l127t807r267b871],
2	finding	NN	O	finding	nsubj	18	SENT_241	[p16l301t807r566b890],
3	that	IN	O	that	complm	8	SENT_241	[p16l599t807r738b871],
4	age	NN	O	age	nsubj	8	SENT_241	[p16l771t827r895b890],
5	is	VBZ	O	be	cop	8	SENT_241	[p16l929t807r986b871],
6	a	DT	O	a	det	8	SENT_241	[p16l1023t827r1061b871],
7	risk	NN	O	risk	nn	8	SENT_241	[p16l1091t807r1231b871],
8	factor	NN	O	factor	dep	2	SENT_241	[p16l1262t807r1478b871],
9	for	IN	O	for	_	0	SENT_241	[p16l1509t807r1617b871],
10	parkinsonism	NN	O	parkinsonism	prep_for	8	SENT_241	[p16l1647t807r2147b890],
11	is	VBZ	O	be	cop	18	SENT_241	[p16l15t906r72b970],
12	in	IN	O	in	_	0	SENT_241	[p16l120t906r191b969],
13	accordance	NN	O	accordance	_	0	SENT_241	[p16l239t906r651b970],
14	with	IN	O	with	_	0	SENT_241	[p16l699t906r861b971],
15	previous	JJ	O	previous	amod	16	SENT_241	[p16l906t906r1222b989],
16	evidence	NN	O	evidence	prep_in_accordance_with	18	SENT_241	[p16l1271t906r1597b970],
17	(	CD	NUMBER	(	num	18	SENT_241	[p16l1648t907r2146b989],
18	Morgenstern	NNP	PERSON	Morgenstern	_	0	SENT_241	[p16l1648t907r2146b989],
19	and	CC	O	and	_	0	SENT_241	[p16l17t1005r144b1069],
20	Glazer	NNP	PERSON	Glazer	conj_and	18	SENT_241	[p16l169t1005r407b1069],
21	1993	CD	DATE	1993	num	20	SENT_241	[p16l438t1005r628b1081],
22	;	:	O	;	_	0	SENT_241	[p16l438t1005r628b1081],
23	Miller	NNP	PERSON	Miller	dep	18	SENT_241	[p16l656t1005r880b1069],
24	et	FW	O	et	nn	25	SENT_241	[p16l903t1014r967b1069],
25	al.	FW	O	al.	dep	23	SENT_241	[p16l992t1005r1070b1069],
26	1995	CD	DATE	1995	num	27	SENT_241	[p16l1107t1004r1324b1084],
27	)	NN	O	)	dep	23	SENT_241	[p16l1107t1004r1324b1084],
28	.	.	O	.	_	0	SENT_241	[p16l1107t1004r1324b1084],

1	Also	RB	O	also	advmod	13	SENT_242	[p16l1353t1005r1540b1081],
2	,	,	O	,	_	0	SENT_242	[p16l1353t1005r1540b1081],
3	the	DT	O	the	det	6	SENT_242	[p16l1567t1005r1674b1069],
4	co	NN	O	co	nn	6	SENT_242	[p16l1700t1005r2145b1069],
5	—	CD	NUMBER	—	num	6	SENT_242	[p16l1700t1005r2145b1069],
6	eXistence	NN	O	existence	nsubjpass	13	SENT_242	[p16l1700t1005r2145b1069],
7	of	IN	O	of	_	0	SENT_242	[p16l16t1104r95b1168],
8	parkinsonism	NN	O	parkinsonism	prep_of	6	SENT_242	[p16l134t1104r634b1187],
9	and	CC	O	and	_	0	SENT_242	[p16l680t1104r809b1168],
10	TD	NN	O	td	prep_of	6	SENT_242	[p16l854t1106r973b1167],
11	has	VBZ	O	have	aux	13	SENT_242	[p16l1019t1104r1139b1168],
12	been	VBN	O	be	auxpass	13	SENT_242	[p16l1185t1104r1359b1168],
13	reported	VBN	O	report	_	0	SENT_242	[p16l1402t1104r1711b1187],
14	previously	RB	DATE	previously	advmod	15	SENT_242	[p16l1755t1104r2145b1187],
15	(	CD	NUMBER	(	dobj	13	SENT_242	[p16l18t1203r466b1282],
16	Richardson	NNP	PERSON	Richardson	dep	15	SENT_242	[p16l18t1203r466b1282],
17	and	CC	O	and	_	0	SENT_242	[p16l510t1203r640b1267],
18	Craig	NNP	PERSON	Craig	conj_and	15	SENT_242	[p16l682t1203r883b1286],
19	1982	CD	DATE	1982	num	18	SENT_242	[p16l935t1203r1159b1282],
20	)	CD	NUMBER	)	dep	18	SENT_242	[p16l935t1203r1159b1282],
21	.	.	O	.	_	0	SENT_242	[p16l935t1203r1159b1282],

1	In	IN	O	in	_	0	SENT_243	[p16l1205t1204r1280b1266],
2	our	PRP$	O	we	poss	3	SENT_243	[p16l1323t1223r1444b1267],
3	study	NN	O	study	prep_in	7	SENT_243	[p16l1487t1203r1682b1286],
4	we	PRP	O	we	nsubj	7	SENT_243	[p16l1725t1223r1829b1267],
5	did	VBD	O	do	aux	7	SENT_243	[p16l1873t1203r1988b1267],
6	not	RB	O	not	neg	7	SENT_243	[p16l2029t1212r2147b1267],
7	find	VB	O	find	_	0	SENT_243	[p16l15t1302r163b1366],
8	a	DT	O	a	det	10	SENT_243	[p16l200t1323r238b1366],
9	contributory	JJ	O	contributory	amod	10	SENT_243	[p16l274t1302r729b1385],
10	role	NN	O	role	dobj	7	SENT_243	[p16l765t1302r908b1366],
11	of	IN	O	of	_	0	SENT_243	[p16l946t1302r1025b1366],
12	the	DT	O	the	det	13	SENT_243	[p16l1056t1302r1166b1366],
13	duration	NN	O	duration	prep_of	10	SENT_243	[p16l1204t1302r1510b1366],
14	of	IN	O	of	_	0	SENT_243	[p16l1547t1302r1627b1366],
15	illness	NN	O	illness	prep_of	13	SENT_243	[p16l1657t1302r1890b1366],
16	to	TO	O	to	_	0	SENT_243	[p16l1929t1312r1997b1366],
17	the	DT	O	the	det	18	SENT_243	[p16l2035t1302r2145b1366],
18	frequency	NN	O	frequency	prep_to	7	SENT_243	[p16l15t1401r383b1484],
19	of	IN	O	of	_	0	SENT_243	[p16l411t1401r490b1465],
20	parkinsonism	NN	O	parkinsonism	prep_of	18	SENT_243	[p16l510t1401r1009b1484],
21	or	CC	O	or	_	0	SENT_243	[p16l1036t1421r1111b1465],
22	TD	NN	O	td	conj_or	20	SENT_243	[p16l1135t1402r1274b1465],
23	.	.	O	.	_	0	SENT_243	[p16l1135t1402r1274b1465],

1	There	EX	O	there	expl	2	SENT_244	[p16l127t1500r338b1564],
2	was	VBD	O	be	_	0	SENT_244	[p16l365t1521r503b1564],
3	a	DT	O	a	det	7	SENT_244	[p16l534t1521r572b1564],
4	non	JJ	O	non	amod	7	SENT_244	[p16l597t1500r1152b1583],
5	—	NN	O	—	nn	7	SENT_244	[p16l597t1500r1152b1583],
6	significant	JJ	O	significant	amod	7	SENT_244	[p16l597t1500r1152b1583],
7	trend	NN	O	trend	nsubj	2	SENT_244	[p16l1177t1500r1365b1564],
8	for	IN	O	for	_	0	SENT_244	[p16l1391t1500r1497b1564],
9	subjects	NNS	O	subject	prep_for	7	SENT_244	[p16l1525t1500r1813b1583],
10	carrying	VBG	O	carry	partmod	9	SENT_244	[p16l1842t1500r2144b1583],
11	at	IN	O	at	quantmod	13	SENT_244	[p16l17t1608r81b1663],
12	least	JJS	O	least	mwe	11	SENT_244	[p16l110t1599r278b1663],
13	one	CD	NUMBER	one	dobj	10	SENT_244	[p16l308t1619r438b1663],
14	mutated	VBN	O	mutate	partmod	13	SENT_244	[p16l469t1599r765b1663],
15	CYPZD6	NN	O	cypzd6	nn	16	SENT_244	[p16l800t1598r1125b1663],
16	allele	NN	O	allele	dobj	14	SENT_244	[p16l1153t1599r1350b1663],
17	to	TO	O	to	aux	18	SENT_244	[p16l1380t1608r1449b1663],
18	have	VB	O	have	xcomp	14	SENT_244	[p16l1480t1599r1652b1663],
19	an	DT	O	a	det	21	SENT_244	[p16l1685t1619r1768b1663],
20	increased	VBN	O	increase	amod	21	SENT_244	[p16l1797t1599r2146b1663],
21	risk	NN	O	risk	dobj	18	SENT_244	[p16l14t1698r154b1762],
22	of	IN	O	of	_	0	SENT_244	[p16l181t1698r261b1762],
23	movement	NN	O	movement	nn	24	SENT_244	[p16l283t1708r673b1762],
24	disorders	NNS	O	disorder	prep_of	21	SENT_244	[p16l702t1698r1057b1762],
25	.	.	O	.	_	0	SENT_244	[p16l702t1698r1057b1762],

1	This	DT	O	this	det	2	SENT_245	[p16l1090t1698r1250b1762],
2	finding	NN	O	finding	nsubj	3	SENT_245	[p16l1281t1698r1546b1781],
3	is	VBZ	O	be	dep	9	SENT_245	[p16l1575t1698r1632b1762],
4	in	IN	O	in	_	0	SENT_245	[p16l1663t1698r1733b1761],
5	agreement	NN	O	agreement	prep_in	3	SENT_245	[p16l1763t1707r2147b1781],
6	with	IN	O	with	_	0	SENT_245	[p16l15t1797r176b1861],
7	previous	JJ	O	previous	amod	8	SENT_245	[p16l202t1797r515b1880],
8	studies	NNS	O	study	prep_with	5	SENT_245	[p16l548t1797r796b1861],
9	(	VBP	O	(	_	0	SENT_245	[p16l828t1797r1282b1876],
10	Andreassen	NNP	PERSON	Andreassen	dobj	9	SENT_245	[p16l828t1797r1282b1876],
11	et	FW	O	et	nn	12	SENT_245	[p16l1310t1806r1374b1861],
12	al.	FW	O	al.	nsubj	9	SENT_245	[p16l1403t1797r1483b1861],
13	1997	CD	DATE	1997	dep	12	SENT_245	[p16l1524t1797r1718b1873],
14	;	:	O	;	_	0	SENT_245	[p16l1524t1797r1718b1873],
15	Armstrong	NNP	ORGANIZATION	Armstrong	dep	12	SENT_245	[p16l1750t1797r2144b1880],
16	et	FW	O	et	nn	17	SENT_245	[p16l16t1906r80b1960],
17	al.	FW	O	al.	nsubj	39	SENT_245	[p16l107t1896r187b1960],
18	1997	CD	DATE	1997	num	19	SENT_245	[p16l227t1897r425b1975],
19	)	NN	O	)	dep	17	SENT_245	[p16l227t1897r425b1975],
20	and	CC	O	and	_	0	SENT_245	[p16l457t1896r585b1960],
21	suggests	VBZ	O	suggest	dep	17	SENT_245	[p16l615t1906r914b1979],
22	that	IN	O	that	complm	31	SENT_245	[p16l944t1896r1079b1960],
23	genetically	RB	O	genetically	advmod	24	SENT_245	[p16l1106t1896r1500b1979],
24	impaired	JJ	O	impaired	amod	25	SENT_245	[p16l1527t1896r1849b1979],
25	activity	NN	O	activity	nsubj	31	SENT_245	[p16l1878t1896r2145b1979],
26	of	IN	O	of	_	0	SENT_245	[p16l16t1995r95b2059],
27	CYP2D6	NN	O	cyp2d6	prep_of	25	SENT_245	[p16l136t1995r470b2059],
28	may	MD	O	may	aux	31	SENT_245	[p16l516t2015r673b2078],
29	be	VB	O	be	cop	31	SENT_245	[p16l717t1995r803b2059],
30	a	DT	O	a	det	31	SENT_245	[p16l850t2015r888b2059],
31	cofactor	NN	O	cofactor	ccomp	21	SENT_245	[p16l933t1995r1235b2059],
32	in	IN	O	in	_	0	SENT_245	[p16l1278t1995r1348b2058],
33	the	DT	O	the	det	34	SENT_245	[p16l1393t1995r1503b2059],
34	development	NN	O	development	prep_in	31	SENT_245	[p16l1550t1995r2027b2078],
35	of	IN	O	of	_	0	SENT_245	[p16l2072t1995r2151b2059],
36	antipsychotic	JJ	O	antipsychotic	amod	38	SENT_245	[p16l17t2094r506b2177],
37	drug	NN	O	drug	nn	38	SENT_245	[p16l549t2094r1041b2177],
38	—	NN	O	—	prep_of	34	SENT_245	[p16l549t2094r1041b2177],
39	induced	VBD	O	induce	rcmod	15	SENT_245	[p16l549t2094r1041b2177],
40	parkinsonism	NN	O	parkinsonism	dobj	39	SENT_245	[p16l1080t2094r1598b2177],
41	.	.	O	.	_	0	SENT_245	[p16l1080t2094r1598b2177],

1	Tendency	NN	O	tendency	nsubj	14	SENT_246	[p16l1643t2094r1999b2177],
2	for	IN	O	for	_	0	SENT_246	[p16l2040t2094r2147b2158],
3	PM	NNP	O	PM	prep_for	1	SENT_246	[p16l15t2194r145b2256],
4	and	CC	O	and	_	0	SENT_246	[p16l182t2193r313b2257],
5	heterozygous	JJ	O	heterozygous	amod	7	SENT_246	[p16l346t2193r837b2276],
6	EM	NN	O	em	nn	7	SENT_246	[p16l874t2194r1009b2256],
7	subjects	NNS	O	subject	prep_for	1	SENT_246	[p16l1048t2193r1339b2276],
8	to	TO	O	to	aux	9	SENT_246	[p16l1376t2202r1445b2257],
9	have	VB	O	have	infmod	1	SENT_246	[p16l1480t2193r1653b2257],
10	more	RBR	O	more	advmod	11	SENT_246	[p16l1688t2213r1875b2257],
11	severe	JJ	O	severe	amod	13	SENT_246	[p16l1914t2213r2145b2257],
12	movement	NN	O	movement	nn	13	SENT_246	[p16l15t2302r405b2356],
13	disorders	NNS	O	disorder	dobj	9	SENT_246	[p16l442t2292r777b2356],
14	is	VBZ	O	be	_	0	SENT_246	[p16l817t2292r874b2356],
15	in	IN	O	in	_	0	SENT_246	[p16l914t2292r984b2355],
16	accordance	NN	O	accordance	_	0	SENT_246	[p16l1023t2292r1435b2356],
17	with	IN	O	with	_	0	SENT_246	[p16l1474t2292r1636b2356],
18	Arthur	NNP	PERSON	Arthur	prep_in_accordance_with	14	SENT_246	[p16l1673t2292r1920b2356],
19	et	FW	O	et	nn	20	SENT_246	[p16l1957t2302r2021b2356],
20	al.	FW	O	al.	dep	18	SENT_246	[p16l2059t2292r2141b2356],
21	.	.	O	.	_	0	SENT_246	[p16l2059t2292r2141b2356],

1	(	RB	O	(	advmod	2	SENT_247	[p16l18t2390r282b2470],
2	1995	CD	DATE	1995	nsubj	24	SENT_247	[p16l18t2390r282b2470],
3	)	NN	O	)	dep	2	SENT_247	[p16l18t2390r282b2470],
4	;	:	O	;	_	0	SENT_247	[p16l18t2390r282b2470],
5	Andreassen	NNP	PERSON	Andreassen	dep	8	SENT_247	[p16l312t2391r742b2455],
6	et	FW	O	et	nn	8	SENT_247	[p16l769t2400r834b2455],
7	al.	FW	O	al.	nn	8	SENT_247	[p16l861t2391r942b2455],
8	(	FW	O	(	dep	2	SENT_247	[p16l976t2391r1240b2470],
9	1997	CD	DATE	1997	num	10	SENT_247	[p16l976t2391r1240b2470],
10	)	NN	O	)	dep	2	SENT_247	[p16l976t2391r1240b2470],
11	;	:	O	;	_	0	SENT_247	[p16l976t2391r1240b2470],
12	Armstrong	NNP	PERSON	Armstrong	dep	15	SENT_247	[p16l1270t2391r1668b2474],
13	et	FW	O	et	nn	15	SENT_247	[p16l1697t2400r1762b2455],
14	al.	FW	O	al.	nn	15	SENT_247	[p16l1789t2391r1870b2455],
15	(	FW	O	(	dep	2	SENT_247	[p16l1904t2391r2143b2470],
16	1997	CD	DATE	1997	num	17	SENT_247	[p16l1904t2391r2143b2470],
17	)	NN	O	)	dep	2	SENT_247	[p16l1904t2391r2143b2470],
18	and	CC	O	and	_	0	SENT_247	[p16l17t2490r147b2554],
19	Kapitany	NNP	PERSON	Kapitany	nsubj	24	SENT_247	[p16l197t2490r532b2573],
20	et	FW	O	et	dep	19	SENT_247	[p16l583t2499r648b2554],
21	al.	FW	O	al.	nn	22	SENT_247	[p16l699t2490r780b2554],
22	(	FW	O	(	dep	2	SENT_247	[p16l837t2491r1099b2569],
23	1998	CD	DATE	1998	num	24	SENT_247	[p16l837t2491r1099b2569],
24	)	CD	NUMBER	)	_	0	SENT_247	[p16l837t2491r1099b2569],
25	,	,	O	,	_	0	SENT_247	[p16l837t2491r1099b2569],
26	who	WP	O	who	nsubj	27	SENT_247	[p16l1152t2490r1307b2554],
27	found	VBD	O	find	rcmod	24	SENT_247	[p16l1358t2490r1572b2554],
28	a	DT	O	a	det	29	SENT_247	[p16l1623t2511r1661b2554],
29	relationship	NN	O	relationship	dobj	27	SENT_247	[p16l1708t2490r2144b2573],
30	between	IN	O	between	_	0	SENT_247	[p16l14t2588r322b2653],
31	the	DT	O	the	det	32	SENT_247	[p16l362t2589r471b2652],
32	degree	NN	O	degree	prep_between	29	SENT_247	[p16l514t2589r757b2672],
33	of	IN	O	of	_	0	SENT_247	[p16l798t2588r878b2652],
34	impairment	NN	O	impairment	prep_of	32	SENT_247	[p16l912t2589r1339b2672],
35	of	IN	O	of	_	0	SENT_247	[p16l1379t2588r1458b2652],
36	CYPZD6	NN	O	cypzd6	nn	37	SENT_247	[p16l1493t2588r1828b2653],
37	activity	NN	O	activity	prep_of	34	SENT_247	[p16l1871t2589r2145b2672],
38	and	CC	O	and	dep	39	SENT_247	[p16l17t2688r147b2752],
39	severity	NN	O	severity	dep	24	SENT_247	[p16l176t2688r463b2771],
40	of	IN	O	of	_	0	SENT_247	[p16l492t2688r571b2752],
41	neurological	JJ	O	neurological	amod	43	SENT_247	[p16l591t2688r1053b2771],
42	side	JJ	O	side	amod	43	SENT_247	[p16l1082t2688r1225b2752],
43	effects	NNS	O	effect	prep_of	39	SENT_247	[p16l1253t2688r1514b2752],
44	.	.	O	.	_	0	SENT_247	[p16l1253t2688r1514b2752],

1	The	DT	O	the	det	2	SENT_248	[p16l127t2786r267b2850],
2	effects	NNS	O	effect	nsubjpass	14	SENT_248	[p16l329t2786r570b2850],
3	of	IN	O	of	_	0	SENT_248	[p16l634t2786r713b2850],
4	trihexyphenidyl	NN	O	trihexyphenidyl	nn	5	SENT_248	[p16l767t2787r1353b2870],
5	medication	NN	O	medication	prep_of	2	SENT_248	[p16l1414t2786r1824b2850],
6	on	IN	O	on	_	0	SENT_248	[p16l1885t2807r1975b2850],
7	the	DT	O	the	det	8	SENT_248	[p16l2034t2787r2145b2850],
8	disposition	NN	O	disposition	prep_on	5	SENT_248	[p16l16t2886r421b2969],
9	of	IN	O	of	_	0	SENT_248	[p16l469t2886r548b2950],
10	zuclopenthixol	NN	O	zuclopenthixol	prep_of	8	SENT_248	[p16l590t2886r1139b2969],
11	are	VBP	O	be	auxpass	14	SENT_248	[p16l1188t2907r1296b2950],
12	not	RB	O	not	neg	14	SENT_248	[p16l1344t2896r1461b2950],
13	well	RB	O	well	advmod	14	SENT_248	[p16l1507t2886r1664b2950],
14	established	VBN	O	establish	_	0	SENT_248	[p16l1712t2886r2141b2950],
15	.	.	O	.	_	0	SENT_248	[p16l1712t2886r2141b2950],

1	Our	PRP$	O	we	poss	2	SENT_249	[p16l16t2985r158b3049],
2	results	NNS	O	result	nsubj	17	SENT_249	[p16l201t2985r440b3048],
3	suggesting	VBG	O	suggest	partmod	2	SENT_249	[p16l492t2984r882b3068],
4	that	IN	O	that	complm	9	SENT_249	[p16l929t2985r1067b3048],
5	the	DT	O	the	det	6	SENT_249	[p16l1111t2985r1222b3048],
6	anticholinergic	JJ	O	anticholinergic	nsubj	9	SENT_249	[p16l1270t2984r1820b3068],
7	did	VBD	O	do	aux	9	SENT_249	[p16l1868t2984r1984b3048],
8	not	RB	O	not	neg	9	SENT_249	[p16l2029t2994r2147b3048],
9	inﬂuence	VB	O	inﬂuence	ccomp	3	SENT_249	[p16l15t3084r358b3148],
10	the	DT	O	the	det	13	SENT_249	[p16l410t3084r520b3148],
11	average	JJ	O	average	amod	13	SENT_249	[p16l575t3105r859b3167],
12	plasma	NN	O	plasma	nn	13	SENT_249	[p16l910t3084r1173b3167],
13	concentrations	NNS	O	concentration	dobj	9	SENT_249	[p16l1225t3084r1761b3148],
14	of	IN	O	of	_	0	SENT_249	[p16l1816t3084r1896b3148],
15	depot	NN	O	depot	nn	16	SENT_249	[p16l1943t3084r2147b3167],
16	zuclopenthixol	NN	O	zuclopenthixol	prep_of	13	SENT_249	[p16l16t3183r564b3266],
17	are	VBP	O	be	dep	23	SENT_249	[p16l625t3203r734b3246],
18	in	IN	O	in	_	0	SENT_249	[p16l793t3183r863b3246],
19	accordance	NN	O	accordance	_	0	SENT_249	[p16l924t3183r1336b3246],
20	with	IN	O	with	_	0	SENT_249	[p16l1396t3182r1559b3247],
21	previous	JJ	O	previous	amod	22	SENT_249	[p16l1616t3182r1932b3266],
22	data	NNS	O	datum	prep_in_accordance_with	17	SENT_249	[p16l1994t3183r2147b3246],
23	(	VBP	O	(	_	0	SENT_249	[p16l18t3283r538b3361],
24	ZumBrunnen	NN	O	zumbrunnen	nn	27	SENT_249	[p16l18t3283r538b3361],
25	and	CC	O	and	_	0	SENT_249	[p16l584t3282r714b3346],
26	J	NN	O	j	nn	27	SENT_249	[p16l757t3284r791b3346],
27	ann	NN	O	ann	dobj	23	SENT_249	[p16l796t3303r925b3346],
28	1998	CD	DATE	1998	num	29	SENT_249	[p16l978t3283r1202b3361],
29	)	NN	O	)	nsubj	23	SENT_249	[p16l978t3283r1202b3361],
30	.	.	O	.	_	0	SENT_249	[p16l978t3283r1202b3361],

1	However	RB	O	however	advmod	10	SENT_250	[p16l1251t3284r1604b3358],
2	,	,	O	,	_	0	SENT_250	[p16l1251t3284r1604b3358],
3	regardless	RB	O	regardless	_	0	SENT_250	[p16l1651t3282r2024b3365],
4	of	IN	O	of	_	0	SENT_250	[p16l2072t3282r2151b3346],
5	this	DT	O	this	det	6	SENT_250	[p16l15t3381r145b3444],
6	finding	NN	O	finding	prep_regardless_of	10	SENT_250	[p16l174t3380r459b3464],
7	,	,	O	,	_	0	SENT_250	[p16l174t3380r459b3464],
8	anticholinergics	NNS	O	anticholinergic	nsubjpass	10	SENT_250	[p16l492t3380r1077b3464],
9	are	VBP	O	be	auxpass	10	SENT_250	[p16l1108t3401r1217b3444],
10	indicated	VBN	O	indicate	_	0	SENT_250	[p16l1244t3380r1583b3444],
11	for	IN	O	for	_	0	SENT_250	[p16l1610t3380r1716b3444],
12	only	RB	O	only	advmod	14	SENT_250	[p16l1743t3381r1903b3464],
13	shortterm	JJ	O	shortterm	amod	14	SENT_250	[p16l1934t3381r2143b3444, p16l8t3490r177b3544],
14	treatment	NN	O	treatment	prep_for	10	SENT_250	[p16l208t3490r559b3544],
15	of	IN	O	of	_	0	SENT_250	[p16l591t3480r671b3544],
16	parkinsonian	JJ	O	parkinsonian	amod	18	SENT_250	[p16l696t3480r1177b3563],
17	side	JJ	O	side	amod	18	SENT_250	[p16l1212t3480r1356b3544],
18	effects	NNS	O	effect	prep_of	14	SENT_250	[p16l1390t3480r1632b3544],
19	because	IN	O	because	mark	22	SENT_250	[p16l1665t3480r1958b3544],
20	they	PRP	O	they	nsubj	22	SENT_250	[p16l1990t3480r2148b3563],
21	can	MD	O	can	aux	22	SENT_250	[p16l8t3599r135b3643],
22	induce	VB	O	induce	advcl	10	SENT_250	[p16l200t3579r445b3643],
23	delirium	NN	O	delirium	nn	26	SENT_250	[p16l512t3579r826b3643],
24	or	CC	O	or	_	0	SENT_250	[p16l891t3599r967b3643],
25	memory	NN	O	memory	nn	26	SENT_250	[p16l1031t3599r1338b3662],
26	deficits	NNS	O	deficit	dobj	22	SENT_250	[p16l1405t3579r1674b3643],
27	and	CC	O	and	_	0	SENT_250	[p16l1743t3579r1874b3643],
28	abuse	NN	O	abuse	nn	30	SENT_250	[p16l1941t3579r2148b3643],
29	(	CD	NUMBER	(	num	30	SENT_250	[p16l10t3678r556b3757],
30	Fleischhacker	NNP	PERSON	Fleischhacker	conj_and	26	SENT_250	[p16l10t3678r556b3757],
31	and	CC	O	and	_	0	SENT_250	[p16l615t3678r745b3742],
32	Hummer	NNP	DATE	Hummer	conj_and	26	SENT_250	[p16l803t3680r1133b3742],
33	1997	CD	DATE	1997	num	32	SENT_250	[p16l1198t3679r1423b3757],
34	)	CD	NUMBER	)	dep	32	SENT_250	[p16l1198t3679r1423b3757],
35	.	.	O	.	_	0	SENT_250	[p16l1198t3679r1423b3757],

1	The	DT	O	the	det	2	SENT_251	[p16l1486t3678r1627b3742],
2	finding	NN	O	finding	_	0	SENT_251	[p16l1686t3678r1952b3761],
3	that	IN	O	that	dep	2	SENT_251	[p16l2011t3678r2150b3742],

1	40	CD	PERCENT	40	num	2	SENT_252	[p17l7t15r171b79],
2	%	NN	PERCENT	%	nsubj	7	SENT_252	[p17l7t15r171b79],
3	of	IN	O	of	_	0	SENT_252	[p17l205t15r285b79],
4	the	DT	O	the	det	5	SENT_252	[p17l307t15r418b79],
5	patients	NNS	O	patient	prep_of	2	SENT_252	[p17l446t15r733b98],
6	not	RB	O	not	neg	7	SENT_252	[p17l764t24r882b79],
7	having	VBG	O	have	_	0	SENT_252	[p17l908t15r1158b98],
8	parkinsonism	NN	O	parkinsonism	dobj	7	SENT_252	[p17l1187t15r1690b98],
9	and	CC	O	and	_	0	SENT_252	[p17l1719t15r1849b79],
10	73	CD	PERCENT	73	num	11	SENT_252	[p17l1878t15r2041b79],
11	%	NN	PERCENT	%	nsubj	18	SENT_252	[p17l1878t15r2041b79],
12	of	IN	O	of	_	0	SENT_252	[p17l2075t15r2154b79],
13	patients	NNS	O	patient	prep_of	11	SENT_252	[p17l7t114r293b197],
14	that	WDT	O	that	nsubj	16	SENT_252	[p17l338t114r477b178],
15	had	VBD	O	have	aux	16	SENT_252	[p17l517t114r651b178],
16	TD	VBN	O	td	rcmod	13	SENT_252	[p17l693t116r812b177],
17	were	VBD	O	be	aux	18	SENT_252	[p17l857t135r1034b178],
18	receiving	VBG	O	receive	conj_and	7	SENT_252	[p17l1076t114r1421b197],
19	an	DT	O	a	det	21	SENT_252	[p17l1467t135r1550b178],
20	anticholinergic	JJ	O	anticholinergic	amod	21	SENT_252	[p17l1595t114r2147b197],
21	drug	NN	O	drug	dobj	18	SENT_252	[p17l9t213r175b296],
22	is	VBZ	O	be	cop	23	SENT_252	[p17l205t213r262b277],
23	alarming	JJ	O	alarming	rcmod	21	SENT_252	[p17l295t213r640b296],
24	.	.	O	.	_	0	SENT_252	[p17l295t213r640b296],

1	Use	NN	O	use	nsubjpass	9	SENT_253	[p17l674t214r816b277],
2	of	IN	O	of	_	0	SENT_253	[p17l846t213r926b277],
3	anticholinergics	NNS	O	anticholinergic	prep_of	1	SENT_253	[p17l951t213r1539b296],
4	in	IN	O	in	_	0	SENT_253	[p17l1570t213r1640b276],
5	patients	NNS	O	patient	prep_in	3	SENT_253	[p17l1667t213r1954b296],
6	with	IN	O	with	_	0	SENT_253	[p17l1986t213r2149b277],
7	TD	NN	O	td	prep_with	5	SENT_253	[p17l8t314r127b375],
8	is	VBZ	O	be	auxpass	9	SENT_253	[p17l184t312r242b376],
9	known	VBN	O	know	_	0	SENT_253	[p17l299t312r551b376],
10	to	TO	O	to	aux	11	SENT_253	[p17l606t321r674b376],
11	contribute	VB	O	contribute	xcomp	9	SENT_253	[p17l732t312r1107b376],
12	to	TO	O	to	_	0	SENT_253	[p17l1163t321r1231b376],
13	the	DT	O	the	det	14	SENT_253	[p17l1288t312r1399b376],
14	worsening	NN	O	worsening	prep_to	11	SENT_253	[p17l1455t312r1840b395],
15	of	IN	O	of	_	0	SENT_253	[p17l1898t312r1978b376],
16	TD	NN	O	td	nn	18	SENT_253	[p17l2027t314r2147b375],
17	(	CD	NUMBER	(	num	18	SENT_253	[p17l10t411r452b490],
18	Muscettola	NNP	O	Muscettola	prep_of	14	SENT_253	[p17l10t411r452b490],
19	et	FW	O	et	nn	20	SENT_253	[p17l483t420r548b475],
20	al.	FW	O	al.	dep	18	SENT_253	[p17l579t411r660b475],
21	1993	CD	DATE	1993	num	22	SENT_253	[p17l705t411r908b490],
22	)	NN	O	)	dep	20	SENT_253	[p17l705t411r908b490],
23	and	CC	O	and	_	0	SENT_253	[p17l944t411r1075b475],
24	is	VBZ	O	be	auxpass	26	SENT_253	[p17l1105t411r1162b475],
25	thus	RB	O	thus	advmod	26	SENT_253	[p17l1195t411r1346b475],
26	contraindicated	VBN	O	contraindicate	conj_and	9	SENT_253	[p17l1380t411r1971b475],
27	.	.	O	.	_	0	SENT_253	[p17l1380t411r1971b475],

1	Our	PRP$	O	we	poss	2	SENT_254	[p17l2008t411r2150b475],
2	findings	NNS	O	finding	nsubj	4	SENT_254	[p17l8t510r309b593],
3	thus	RB	O	thus	advmod	4	SENT_254	[p17l356t510r506b574],
4	demonstrate	VBP	O	demonstrate	_	0	SENT_254	[p17l555t510r1006b574],
5	that	IN	O	that	complm	31	SENT_254	[p17l1052t510r1210b586],
6	,	,	O	,	_	0	SENT_254	[p17l1052t510r1210b586],
7	in	IN	O	in	_	0	SENT_254	[p17l1258t510r1328b573],
8	routine	JJ	O	routine	amod	10	SENT_254	[p17l1372t510r1634b574],
9	maintenance	NN	O	maintenance	nn	10	SENT_254	[p17l1680t510r2148b574],
10	therapy	NN	O	therapy	prep_in	31	SENT_254	[p17l7t609r284b692],
11	with	IN	O	with	_	0	SENT_254	[p17l312t609r475b673],
12	antipsychotics	NNS	O	antipsychotic	prep_with	10	SENT_254	[p17l504t609r1054b692],
13	,	,	O	,	_	0	SENT_254	[p17l504t609r1054b692],
14	careful	JJ	O	careful	amod	15	SENT_254	[p17l1084t609r1340b673],
15	assessment	NN	O	assessment	nsubj	31	SENT_254	[p17l1369t618r1780b673],
16	of	IN	O	of	_	0	SENT_254	[p17l1807t609r1887b673],
17	neurological	JJ	O	neurological	amod	19	SENT_254	[p17l1908t629r2146b673, p17l8t708r259b791],
18	side	JJ	O	side	amod	19	SENT_254	[p17l289t708r433b772],
19	effects	NNS	O	effect	prep_of	15	SENT_254	[p17l461t708r703b772],
20	and	CC	O	and	_	0	SENT_254	[p17l734t708r865b772],
21	re	VB	O	re	dep	27	SENT_254	[p17l889t708r1381b772],
22	—	JJ	O	—	amod	23	SENT_254	[p17l889t708r1381b772],
23	evaluation	NN	O	evaluation	dobj	21	SENT_254	[p17l889t708r1381b772],
24	of	IN	O	of	_	0	SENT_254	[p17l1408t708r1488b772],
25	the	DT	O	the	det	26	SENT_254	[p17l1509t708r1620b772],
26	need	NN	O	need	prep_of	23	SENT_254	[p17l1647t708r1821b772],
27	for	IN	O	for	conj_and	19	SENT_254	[p17l1847t708r1955b772],
28	anticholinergic	JJ	O	anticholinergic	amod	29	SENT_254	[p17l1982t708r2146b772, p17l8t807r422b890],
29	medication	NN	O	medication	pobj	27	SENT_254	[p17l450t807r862b871],
30	are	VBP	O	be	cop	31	SENT_254	[p17l890t827r999b871],
31	essential	JJ	O	essential	ccomp	4	SENT_254	[p17l1026t807r1364b871],
32	.	.	O	.	_	0	SENT_254	[p17l1026t807r1364b871],

1	In	IN	O	in	_	0	SENT_255	[p17l120t908r195b969],
2	conclusion	NN	O	conclusion	prep_in	7	SENT_255	[p17l231t906r651b982],
3	,	,	O	,	_	0	SENT_255	[p17l231t906r651b982],
4	the	DT	O	the	det	6	SENT_255	[p17l689t906r800b970],
5	present	JJ	DATE	present	amod	6	SENT_255	[p17l835t916r1104b989],
6	study	NN	O	study	nsubj	7	SENT_255	[p17l1141t906r1336b989],
7	demonstrates	VBZ	O	demonstrate	_	0	SENT_255	[p17l1373t906r1859b970],
8	for	IN	O	for	_	0	SENT_255	[p17l1896t906r2004b970],
9	the	DT	O	the	det	11	SENT_255	[p17l2037t906r2148b970],
10	first	JJ	ORDINAL	first	amod	11	SENT_255	[p17l8t1004r157b1068],
11	time	NN	O	time	prep_for	7	SENT_255	[p17l183t1005r346b1068],
12	the	DT	O	the	det	13	SENT_255	[p17l374t1005r485b1068],
13	relationship	NN	O	relationship	dep	11	SENT_255	[p17l512t1004r950b1088],
14	between	IN	O	between	_	0	SENT_255	[p17l978t1005r1287b1069],
15	the	DT	O	the	det	18	SENT_255	[p17l1314t1005r1425b1068],
16	C	NN	O	c	nn	18	SENT_255	[p17l1458t1006r1516b1069],
17	YPZD6	NN	O	ypzd6	nn	18	SENT_255	[p17l1521t1004r1785b1068],
18	genotype	NN	O	genotype	prep_between	13	SENT_255	[p17l1811t1014r2148b1088],
19	and	CC	O	and	_	0	SENT_255	[p17l9t1104r140b1168],
20	the	DT	O	the	det	25	SENT_255	[p17l199t1104r309b1168],
21	steady	JJ	O	steady	amod	25	SENT_255	[p17l373t1104r807b1187],
22	—	NN	O	—	nn	25	SENT_255	[p17l373t1104r807b1187],
23	state	NN	O	state	nn	25	SENT_255	[p17l373t1104r807b1187],
24	plasma	NN	O	plasma	nn	25	SENT_255	[p17l866t1104r1130b1187],
25	levels	NNS	O	level	prep_for	7	SENT_255	[p17l1188t1104r1401b1168],
26	of	IN	O	of	_	0	SENT_255	[p17l1463t1104r1543b1168],
27	zuclopenthixol	NN	O	zuclopenthixol	prep_of	25	SENT_255	[p17l1597t1104r2148b1187],
28	when	WRB	O	when	advmod	29	SENT_255	[p17l8t1203r207b1267],
29	administered	VBN	O	administer	advcl	7	SENT_255	[p17l250t1203r728b1266],
30	as	IN	O	as	_	0	SENT_255	[p17l770t1223r841b1266],
31	depot	NN	O	depot	nn	32	SENT_255	[p17l885t1203r1090b1286],
32	formulation	NN	O	formulation	prep_as	29	SENT_255	[p17l1129t1202r1586b1267],
33	.	.	O	.	_	0	SENT_255	[p17l1129t1202r1586b1267],

1	The	DT	O	the	det	2	SENT_256	[p17l1632t1203r1773b1266],
2	tendency	NN	O	tendency	nsubj	16	SENT_256	[p17l1814t1203r2148b1286],
3	for	IN	O	for	_	0	SENT_256	[p17l8t1302r115b1366],
4	an	DT	O	a	det	6	SENT_256	[p17l141t1323r224b1366],
5	increased	VBN	O	increase	amod	6	SENT_256	[p17l250t1302r597b1366],
6	risk	NN	O	risk	prep_for	2	SENT_256	[p17l621t1302r760b1366],
7	for	IN	O	for	_	0	SENT_256	[p17l784t1302r891b1366],
8	parkinsonism	NN	O	parkinsonism	prep_for	6	SENT_256	[p17l914t1302r1412b1385],
9	in	IN	O	in	_	0	SENT_256	[p17l1437t1302r1506b1365],
10	patients	NNS	O	patient	prep_in	8	SENT_256	[p17l1531t1302r1815b1385],
11	carrying	VBG	O	carry	partmod	10	SENT_256	[p17l1844t1302r2147b1385],
12	mutated	VBN	O	mutate	dep	11	SENT_256	[p17l8t1401r306b1464],
13	C	NN	O	c	nn	15	SENT_256	[p17l345t1402r403b1465],
14	YPZD6	NN	O	ypzd6	nn	15	SENT_256	[p17l408t1400r672b1464],
15	genes	NNS	O	gene	dobj	12	SENT_256	[p17l704t1421r910b1484],
16	is	VBZ	O	be	_	0	SENT_256	[p17l947t1400r1004b1464],
17	in	IN	O	in	_	0	SENT_256	[p17l1041t1400r1111b1464],
18	line	NN	O	line	prep_in	16	SENT_256	[p17l1145t1401r1282b1464],
19	with	IN	O	with	_	0	SENT_256	[p17l1317t1401r1481b1465],
20	previous	JJ	O	previous	amod	21	SENT_256	[p17l1514t1400r1831b1484],
21	studies	NNS	O	study	prep_with	18	SENT_256	[p17l1871t1400r2144b1465],
22	.	.	O	.	_	0	SENT_256	[p17l1871t1400r2144b1465],

1	Larger	JJR	O	larger	amod	2	SENT_257	[p17l7t1502r253b1583],
2	studies	NNS	O	study	nsubj	11	SENT_257	[p17l301t1500r552b1564],
3	with	IN	O	with	_	0	SENT_257	[p17l601t1500r764b1564],
4	careful	JJ	O	careful	amod	8	SENT_257	[p17l810t1500r1066b1564],
5	side	NN	O	side	nn	8	SENT_257	[p17l1115t1500r1503b1564],
6	—	NN	O	—	nn	8	SENT_257	[p17l1115t1500r1503b1564],
7	effect	NN	O	effect	nn	8	SENT_257	[p17l1115t1500r1503b1564],
8	registration	NN	O	registration	prep_with	2	SENT_257	[p17l1547t1500r1971b1583],
9	and	CC	O	and	_	0	SENT_257	[p17l2019t1500r2150b1564],
10	assessment	NN	O	assessment	conj_and	8	SENT_257	[p17l10t1608r421b1663],
11	are	VBP	O	be	_	0	SENT_257	[p17l452t1619r581b1674],
12	,	,	O	,	_	0	SENT_257	[p17l452t1619r581b1674],
13	however	RB	O	however	advmod	11	SENT_257	[p17l614t1599r949b1674],
14	,	,	O	,	_	0	SENT_257	[p17l614t1599r949b1674],
15	required	VBN	O	require	dep	11	SENT_257	[p17l982t1598r1292b1682],
16	to	TO	O	to	aux	18	SENT_257	[p17l1321t1608r1390b1662],
17	fully	RB	O	fully	advmod	18	SENT_257	[p17l1422t1598r1595b1682],
18	establish	VB	O	establish	xcomp	15	SENT_257	[p17l1626t1599r1951b1662],
19	such	PDT	O	such	predet	21	SENT_257	[p17l1984t1598r2149b1662],
20	a	DT	O	a	det	21	SENT_257	[p17l9t1719r47b1762],
21	relationship	NN	O	relationship	dobj	18	SENT_257	[p17l71t1698r530b1781],
22	.	.	O	.	_	0	SENT_257	[p17l71t1698r530b1781],

1	Acknowledgements	NNS	O	acknowledgement	nsubjpass	5	SENT_258	[p17l7t1886r665b1958],
2	The	DT	O	the	det	3	SENT_258	[p17l709t1887r830b1942],
3	study	NN	O	study	dep	1	SENT_258	[p17l868t1887r1036b1958],
4	was	VBD	O	be	auxpass	5	SENT_258	[p17l1072t1904r1191b1942],
5	supported	VBN	O	support	_	0	SENT_258	[p17l1231t1887r1541b1959],
6	by	IN	O	by	_	0	SENT_258	[p17l1575t1887r1653b1959],
7	The	DT	ORGANIZATION	the	det	11	SENT_258	[p17l1688t1887r1809b1942],
8	European	NNP	O	European	nn	11	SENT_258	[p17l1845t1888r2149b1959],
9	Union	NNP	O	Union	nn	11	SENT_258	[p17l7t1967r200b2023],
10	Project-Inco-Copemicus	NNP	O	Project-Inco-Copemicus	nn	11	SENT_258	[p17l226t1967r982b2039],
11	ERBIC15CT980340	NNP	O	ERBIC15CT980340	agent	5	SENT_258	[p17l1009t1967r1663b2033],
12	,	,	O	,	_	0	SENT_258	[p17l1009t1967r1663b2033],
13	the	DT	O	the	det	16	SENT_258	[p17l1692t1968r1784b2023],
14	Karolinska	NNP	ORGANIZATION	Karolinska	nn	16	SENT_258	[p17l1812t1967r2150b2023],
15	International	NNP	ORGANIZATION	International	nn	16	SENT_258	[p17l7t2048r414b2103],
16	Research	NNP	ORGANIZATION	Research	appos	11	SENT_258	[p17l461t2048r752b2103],
17	and	CC	ORGANIZATION	and	_	0	SENT_258	[p17l800t2048r912b2103],
18	Training	NNP	ORGANIZATION	Training	nn	19	SENT_258	[p17l958t2048r1227b2120],
19	Programme	NNP	ORGANIZATION	Programme	conj_and	16	SENT_258	[p17l1275t2050r1662b2120],
20	,	,	O	,	_	0	SENT_258	[p17l1275t2050r1662b2120],
21	The	DT	O	the	det	25	SENT_258	[p17l1712t2048r1833b2103],
22	Swedish	NNP	O	Swedish	nn	25	SENT_258	[p17l1883t2048r2149b2104],
23	Medical	NNP	ORGANIZATION	Medical	nn	25	SENT_258	[p17l7t2130r267b2185],
24	Research	NNP	ORGANIZATION	Research	nn	25	SENT_258	[p17l291t2130r582b2185],
25	Council	NNP	ORGANIZATION	Council	appos	11	SENT_258	[p17l606t2130r856b2186],
26	(	CD	NUMBER	(	number	27	SENT_258	[p17l883t2130r1109b2198],
27	3902	CD	NUMBER	3902	num	28	SENT_258	[p17l883t2130r1109b2198],
28	)	NN	O	)	dep	25	SENT_258	[p17l883t2130r1109b2198],
29	,	,	O	,	_	0	SENT_258	[p17l883t2130r1109b2198],
30	the	DT	O	the	det	35	SENT_258	[p17l1135t2130r1230b2185],
31	Estonian	JJ	ORGANIZATION	estonian	amod	35	SENT_258	[p17l1254t2130r1532b2185],
32	Scientific	NNP	ORGANIZATION	Scientific	nn	35	SENT_258	[p17l1558t2130r1859b2186],
33	Foundation	NNP	ORGANIZATION	Foundation	nn	35	SENT_258	[p17l1884t2130r2146b2185, p17l7t2210r130b2265],
34	(	CD	NUMBER	(	num	35	SENT_258	[p17l159t2210r346b2282],
35	grant	NN	O	grant	dep	11	SENT_258	[p17l159t2210r346b2282],
36	no.	RB	O	no.	amod	38	SENT_258	[p17l371t2227r465b2265],
37	3053	CD	NUMBER	3053	tmod	36	SENT_258	[p17l497t2210r677b2278],
38	)	NN	O	)	dep	11	SENT_258	[p17l497t2210r677b2278],
39	and	CC	O	and	_	0	SENT_258	[p17l707t2210r820b2265],
40	the	DT	O	the	det	42	SENT_258	[p17l845t2210r940b2265],
41	State	NNP	ORGANIZATION	State	nn	42	SENT_258	[p17l969t2210r1124b2265],
42	Agency	NNP	ORGANIZATION	Agency	conj_and	11	SENT_258	[p17l1150t2210r1396b2282],
43	of	IN	ORGANIZATION	of	_	0	SENT_258	[p17l1424t2210r1493b2265],
44	Medicines	NNP	ORGANIZATION	Medicines	nn	46	SENT_258	[p17l1513t2210r1862b2275],
45	,	,	O	,	_	0	SENT_258	[p17l1513t2210r1862b2275],
46	Estonia	NNP	LOCATION	Estonia	prep_of	42	SENT_258	[p17l1890t2210r2145b2265],
47	.	.	O	.	_	0	SENT_258	[p17l1890t2210r2145b2265],

1	The	DT	O	the	det	2	SENT_259	[p17l7t2290r129b2345],
2	authors	NNS	O	author	nsubj	3	SENT_259	[p17l175t2290r404b2345],
3	thank	VBP	O	thank	_	0	SENT_259	[p17l450t2290r627b2345],
4	Lilleba	NNP	PERSON	Lilleba	nn	5	SENT_259	[p17l668t2289r894b2345],
5	Bohman	NNP	PERSON	Bohman	dobj	3	SENT_259	[p17l937t2289r1205b2345],
6	and	CC	O	and	_	0	SENT_259	[p17l1250t2290r1362b2345],
7	Ulla	NNP	PERSON	Ulla	nn	8	SENT_259	[p17l1405t2290r1541b2345],
8	Pettersson	NNP	PERSON	Pettersson	conj_and	5	SENT_259	[p17l1584t2291r1911b2345],
9	at	IN	O	at	_	0	SENT_259	[p17l1956t2298r2011b2345],
10	the	DT	O	the	det	11	SENT_259	[p17l2053t2290r2148b2345],
11	Department	NNP	ORGANIZATION	Department	prep_at	3	SENT_259	[p17l7t2372r384b2442],
12	of	IN	ORGANIZATION	of	_	0	SENT_259	[p17l449t2370r518b2426],
13	Clinical	JJ	ORGANIZATION	clinical	amod	14	SENT_259	[p17l579t2370r829b2426],
14	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	11	SENT_259	[p17l895t2370r1366b2442],
15	,	,	O	,	_	0	SENT_259	[p17l895t2370r1366b2442],
16	Huddinge	NNP	ORGANIZATION	Huddinge	nn	18	SENT_259	[p17l1435t2370r1747b2442],
17	University	NNP	ORGANIZATION	University	nn	18	SENT_259	[p17l1813t2370r2148b2442],
18	Hospital	NNP	ORGANIZATION	Hospital	appos	14	SENT_259	[p17l8t2451r293b2523],
19	,	,	O	,	_	0	SENT_259	[p17l8t2451r293b2523],
20	for	IN	O	for	_	0	SENT_259	[p17l321t2451r413b2506],
21	skilful	JJ	O	skilful	amod	23	SENT_259	[p17l439t2451r638b2506],
22	technical	JJ	O	technical	amod	23	SENT_259	[p17l663t2451r949b2506],
23	assistance	NN	O	assistance	prep_for	3	SENT_259	[p17l976t2451r1291b2506],
24	with	IN	O	with	_	0	SENT_259	[p17l1317t2451r1457b2507],
25	the	DT	O	the	det	26	SENT_259	[p17l1481t2451r1575b2506],
26	analysis	NN	O	analysis	prep_with	23	SENT_259	[p17l1602t2451r1854b2523],
27	of	IN	O	of	_	0	SENT_259	[p17l1882t2451r1950b2506],
28	genotypes	NNS	O	genotype	prep_of	26	SENT_259	[p17l1970t2469r2146b2523, p17l7t2541r190b2605],
29	.	.	O	.	_	0	SENT_259	[p17l1970t2469r2146b2523, p17l7t2541r190b2605],

1	We	PRP	O	we	nsubj	3	SENT_260	[p17l234t2534r336b2588],
2	also	RB	O	also	advmod	3	SENT_260	[p17l379t2533r503b2588],
3	thank	VBP	O	thank	_	0	SENT_260	[p17l544t2533r722b2588],
4	Prof.	NNP	O	Prof.	nn	6	SENT_260	[p17l760t2533r911b2588],
5	Lembit	NNP	PERSON	Lembit	nn	6	SENT_260	[p17l955t2533r1186b2588],
6	Rago	NNP	PERSON	Rago	dobj	3	SENT_260	[p17l1225t2534r1408b2605],
7	,	,	O	,	_	0	SENT_260	[p17l1225t2534r1408b2605],
8	Prof.	NNP	O	Prof.	nn	10	SENT_260	[p17l1452t2533r1603b2588],
9	Folke	NNP	PERSON	Folke	nn	10	SENT_260	[p17l1647t2533r1827b2588],
10	Sjoqvist	NNP	PERSON	Sjoqvist	dobj	3	SENT_260	[p17l1870t2533r2146b2605],
11	,	,	O	,	_	0	SENT_260	[p17l1870t2533r2146b2605],
12	Dr.	NNP	O	Dr.	nn	14	SENT_260	[p17l7t2615r100b2669],
13	Holger	NNP	PERSON	Holger	nn	14	SENT_260	[p17l128t2614r347b2685],
14	Arthur	NNP	PERSON	Arthur	conj_and	6	SENT_260	[p17l369t2614r591b2679],
15	,	,	O	,	_	0	SENT_260	[p17l369t2614r591b2679],
16	Dr.	NNP	O	Dr.	nn	18	SENT_260	[p17l618t2615r710b2669],
17	Aavo	NNP	PERSON	Aavo	nn	18	SENT_260	[p17l738t2614r906b2669],
18	Lang	NNP	PERSON	Lang	conj_and	6	SENT_260	[p17l930t2615r1090b2685],
19	and	CC	O	and	_	0	SENT_260	[p17l1116t2614r1227b2669],
20	Dr.	NNP	O	Dr.	nn	22	SENT_260	[p17l1250t2615r1343b2669],
21	Ann	NNP	PERSON	Ann	nn	22	SENT_260	[p17l1370t2614r1505b2668],
22	Veiken	NNP	PERSON	Veiken	dobj	3	SENT_260	[p17l1528t2613r1746b2669],
23	for	IN	O	for	_	0	SENT_260	[p17l1769t2613r1861b2669],
24	valuable	JJ	O	valuable	amod	25	SENT_260	[p17l1883t2614r2148b2669],
25	discussions	NNS	O	discussion	prep_for	3	SENT_260	[p17l8t2693r386b2749],
26	.	.	O	.	_	0	SENT_260	[p17l8t2693r386b2749],

1	References	NNS	O	reference	_	0	SENT_261	[p17l11t2931r460b3006],

1	Alvan	NNP	PERSON	Alvan	nn	2	SENT_262	[p17l7t3119r201b3174],
2	G	NNP	PERSON	G	_	0	SENT_262	[p17l230t3119r301b3184],
3	,	,	O	,	_	0	SENT_262	[p17l230t3119r301b3184],
4	Bechtel	NNP	ORGANIZATION	Bechtel	nn	5	SENT_262	[p17l332t3119r574b3174],
5	P	NN	ORGANIZATION	p	appos	2	SENT_262	[p17l602t3120r652b3184],
6	,	,	O	,	_	0	SENT_262	[p17l602t3120r652b3184],
7	Iselius	NNP	O	Iselius	nn	8	SENT_262	[p17l683t3119r888b3174],
8	L	NNP	O	L	appos	2	SENT_262	[p17l918t3120r982b3184],
9	,	,	O	,	_	0	SENT_262	[p17l918t3120r982b3184],
10	Gundert-Remy	NNP	O	Gundert-Remy	nn	12	SENT_262	[p17l1014t3119r1489b3191],
11	U	NNP	O	U	nn	12	SENT_262	[p17l1518t3120r1573b3174],
12	(	NNP	O	(	appos	2	SENT_262	[p17l1604t3119r1810b3187],
13	1990	CD	DATE	1990	dep	12	SENT_262	[p17l1604t3119r1810b3187],
14	)	CD	NUMBER	)	num	16	SENT_262	[p17l1604t3119r1810b3187],
15	Hydroxylation	NN	O	hydroxylation	nn	16	SENT_262	[p17l1840t3119r2146b3191, p17l132t3199r312b3255],
16	polymorphisms	NNS	O	polymorphism	dep	2	SENT_262	[p17l357t3199r851b3271],
17	of	IN	O	of	_	0	SENT_262	[p17l901t3199r969b3255],
18	debrisoquine	NN	O	debrisoquine	prep_of	16	SENT_262	[p17l1011t3199r1421b3271],
19	and	CC	O	and	_	0	SENT_262	[p17l1470t3199r1581b3255],
20	mephenytoin	NN	O	mephenytoin	conj_and	18	SENT_262	[p17l1627t3199r2042b3271],
21	in	IN	O	in	_	0	SENT_262	[p17l2089t3199r2149b3254],
22	European	JJ	LOCATION	european	amod	23	SENT_262	[p17l132t3282r436b3352],
23	populations	NNS	O	population	prep_in	16	SENT_262	[p17l457t3280r846b3352],
24	.	.	O	.	_	0	SENT_262	[p17l457t3280r846b3352],

1	Eur	NNP	O	Eur	nn	4	SENT_263	[p17l872t3282r987b3336],
2	J	NNP	O	J	nn	4	SENT_263	[p17l1007t3282r1037b3336],
3	Clin	NNP	O	Clin	nn	4	SENT_263	[p17l1061t3280r1195b3336],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_263	[p17l1217t3280r1557b3336],
5	39:533	CD	NUMBER	39:533	dep	4	SENT_263	[p17l1582t3280r1956b3336],
6	—	CD	NUMBER	—	number	7	SENT_263	[p17l1582t3280r1956b3336],
7	537	CD	NUMBER	537	dep	5	SENT_263	[p17l1582t3280r1956b3336],

1	Andreassen	NNP	PERSON	Andreassen	nn	2	SENT_264	[p17l7t3361r378b3416],
2	OA	NNP	O	OA	dep	16	SENT_264	[p17l413t3361r542b3426],
3	,	,	O	,	_	0	SENT_264	[p17l413t3361r542b3426],
4	MacEwan	NNP	PERSON	MacEwan	nn	5	SENT_264	[p17l578t3363r899b3416],
5	T	NN	O	t	appos	2	SENT_264	[p17l933t3363r991b3426],
6	,	,	O	,	_	0	SENT_264	[p17l933t3363r991b3426],
7	Gulbrandsen	NNP	ORGANIZATION	Gulbrandsen	nn	8	SENT_264	[p17l1029t3361r1434b3416],
8	AK	NNP	ORGANIZATION	AK	appos	2	SENT_264	[p17l1467t3362r1597b3426],
9	,	,	O	,	_	0	SENT_264	[p17l1467t3362r1597b3426],
10	McCreadie	NNP	PERSON	McCreadie	nn	11	SENT_264	[p17l1634t3361r1986b3416],
11	RG	NNP	O	RG	appos	2	SENT_264	[p17l2020t3361r2146b3426],
12	,	,	O	,	_	0	SENT_264	[p17l2020t3361r2146b3426],
13	Steen	NNP	PERSON	Steen	nn	14	SENT_264	[p17l134t3442r308b3498],
14	VM	NNP	O	VM	appos	2	SENT_264	[p17l349t3443r475b3497],
15	(	CD	NUMBER	(	num	16	SENT_264	[p17l520t3442r726b3510],
16	1997	CD	DATE	1997	_	0	SENT_264	[p17l520t3442r726b3510],
17	)	CD	NUMBER	)	num	22	SENT_264	[p17l520t3442r726b3510],
18	Non	NNP	O	Non	nn	22	SENT_264	[p17l770t3442r1257b3497],
19	—	CD	NUMBER	—	num	22	SENT_264	[p17l770t3442r1257b3497],
20	functional	JJ	O	functional	amod	22	SENT_264	[p17l770t3442r1257b3497],
21	CYPZD6	NN	O	cypzd6	nn	22	SENT_264	[p17l1300t3442r1588b3498],
22	alleles	NNS	O	allele	dep	16	SENT_264	[p17l1633t3442r1832b3497],
23	and	CC	O	and	_	0	SENT_264	[p17l1877t3442r1990b3497],
24	risk	NN	O	risk	dep	16	SENT_264	[p17l2030t3442r2150b3497],
25	for	IN	O	for	_	0	SENT_264	[p17l132t3523r225b3578],
26	neuroleptic-induced	JJ	O	neuroleptic-induced	amod	28	SENT_264	[p17l255t3523r893b3595],
27	movement	NN	O	movement	nn	28	SENT_264	[p17l925t3531r1261b3578],
28	disorders	NNS	O	disorder	prep_for	22	SENT_264	[p17l1292t3523r1581b3578],
29	in	IN	O	in	_	0	SENT_264	[p17l1615t3523r1675b3577],
30	schizophrenic	JJ	O	schizophrenic	amod	31	SENT_264	[p17l1710t3523r2147b3595],
31	patients	NNS	O	patient	prep_in	16	SENT_264	[p17l131t3603r395b3675],
32	.	.	O	.	_	0	SENT_264	[p17l131t3603r395b3675],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_265	[p17l422t3603r1107b3675],
2	131	CD	NUMBER	131	num	1	SENT_265	[p17l1138t3604r1265b3659],
3	:	:	O	:	_	0	SENT_265	[p17l1138t3604r1265b3659],
4	174-179	CD	NUMBER	174-179	dep	1	SENT_265	[p17l1280t3604r1548b3660],

1	Armstrong	NNP	O	Armstrong	nn	2	SENT_266	[p17l7t3685r350b3756],
2	M	NNP	O	M	_	0	SENT_266	[p17l394t3686r480b3750],
3	,	,	O	,	_	0	SENT_266	[p17l394t3686r480b3750],
4	Daly	NNP	PERSON	Daly	nn	5	SENT_266	[p17l526t3684r678b3756],
5	AK	NNP	PERSON	AK	appos	2	SENT_266	[p17l722t3685r852b3750],
6	,	,	O	,	_	0	SENT_266	[p17l722t3685r852b3750],
7	Blennerhassett	NNP	PERSON	Blennerhassett	nn	8	SENT_266	[p17l898t3684r1368b3739],
8	R	NNP	PERSON	R	appos	2	SENT_266	[p17l1410t3686r1478b3750],
9	,	,	O	,	_	0	SENT_266	[p17l1410t3686r1478b3750],
10	Ferrier	NNP	PERSON	Ferrier	nn	11	SENT_266	[p17l1524t3684r1742b3739],
11	N	NNP	O	N	appos	2	SENT_266	[p17l1782t3686r1855b3750],
12	,	,	O	,	_	0	SENT_266	[p17l1782t3686r1855b3750],
13	Idle	NNP	O	Idle	nn	14	SENT_266	[p17l1902t3684r2023b3739],
14	JR	NNP	O	JR	appos	2	SENT_266	[p17l2066t3686r2150b3740],

1	(	RB	O	(	advmod	7	SENT_267	[p18l135t12r341b80],
2	1997	CD	DATE	1997	num	3	SENT_267	[p18l135t12r341b80],
3	)	CD	NUMBER	)	nsubj	7	SENT_267	[p18l135t12r341b80],
4	Antipsychotic	JJ	O	antipsychotic	amod	6	SENT_267	[p18l392t12r838b84],
5	drug	NN	O	drug	nn	6	SENT_267	[p18l890t12r1314b84],
6	—	NN	O	—	dep	3	SENT_267	[p18l890t12r1314b84],
7	induced	VBD	O	induce	_	0	SENT_267	[p18l890t12r1314b84],
8	movement	NN	O	movement	nn	9	SENT_267	[p18l1363t20r1699b67],
9	disorders	NNS	O	disorder	dobj	7	SENT_267	[p18l1749t12r2037b67],
10	in	IN	O	in	_	0	SENT_267	[p18l2088t12r2149b66],
11	schizophrenics	NNS	O	schizophrenic	prep_in	7	SENT_267	[p18l135t93r593b165],
12	in	IN	O	in	_	0	SENT_267	[p18l617t93r676b147],
13	relation	NN	O	relation	prep_in	11	SENT_267	[p18l697t93r935b148],
14	to	TO	O	to	_	0	SENT_267	[p18l956t101r1014b148],
15	CYP2D6	NN	O	cyp2d6	nn	16	SENT_267	[p18l1038t93r1322b148],
16	genotype	NN	O	genotype	prep_to	7	SENT_267	[p18l1346t101r1645b165],
17	.	.	O	.	_	0	SENT_267	[p18l1346t101r1645b165],

1	Br	NN	O	br	nn	2	SENT_268	[p18l1671t94r1749b147],
2	J	NN	O	j	_	0	SENT_268	[p18l1769t94r1798b148],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_268	[p18l1820t93r2148b165],
4	170:23	CD	NUMBER	170:23	num	3	SENT_268	[p18l140t172r470b228],
5	—	CD	NUMBER	—	number	6	SENT_268	[p18l140t172r470b228],
6	26	CD	NUMBER	26	dep	3	SENT_268	[p18l140t172r470b228],

1	Arthur	NNP	PERSON	Arthur	nn	2	SENT_269	[p18l7t253r220b309],
2	H	NNP	PERSON	H	_	0	SENT_269	[p18l258t255r330b319],
3	,	,	O	,	_	0	SENT_269	[p18l258t255r330b319],
4	Dahl	NNP	PERSON	Dahl	nn	5	SENT_269	[p18l373t253r525b309],
5	ML	NNP	O	ML	appos	2	SENT_269	[p18l565t255r699b319],
6	,	,	O	,	_	0	SENT_269	[p18l565t255r699b319],
7	Siwers	NNP	O	Siwers	nn	8	SENT_269	[p18l744t253r955b309],
8	B	NNP	O	B	appos	2	SENT_269	[p18l996t255r1064b319],
9	,	,	O	,	_	0	SENT_269	[p18l996t255r1064b319],
10	Sjoqvist	NNP	O	Sjoqvist	nn	11	SENT_269	[p18l1109t253r1368b325],
11	F	NN	O	f	appos	2	SENT_269	[p18l1406t255r1449b308],
12	(	CD	NUMBER	(	num	13	SENT_269	[p18l1490t253r1696b322],
13	1995	CD	DATE	1995	dep	11	SENT_269	[p18l1490t253r1696b322],
14	)	CD	NUMBER	)	num	17	SENT_269	[p18l1490t253r1696b322],
15	Polymorphic	JJ	O	polymorphic	amod	17	SENT_269	[p18l1738t253r2148b325],
16	drug	NN	O	drug	nn	17	SENT_269	[p18l133t334r275b406],
17	metabolism	NN	O	metabolism	dep	2	SENT_269	[p18l304t334r676b389],
18	in	IN	O	in	_	0	SENT_269	[p18l703t334r763b389],
19	schizophrenic	JJ	O	schizophrenic	amod	20	SENT_269	[p18l793t334r1231b406],
20	patients	NNS	O	patient	prep_in	17	SENT_269	[p18l1260t334r1506b406],
21	with	IN	O	with	_	0	SENT_269	[p18l1536t334r1676b390],
22	tardive	JJ	O	tardive	amod	25	SENT_269	[p18l1703t334r1923b390],
23	dyski	NN	O	dyskus	nn	25	SENT_269	[p18l1952t334r2147b406],
24	—	NN	O	—	nn	25	SENT_269	[p18l1952t334r2147b406],
25	nesia	NN	O	nesium	prep_with	20	SENT_269	[p18l132t416r310b471],
26	.	.	O	.	_	0	SENT_269	[p18l132t416r310b471],

1	J	NNP	O	J	nn	3	SENT_270	[p18l336t417r366b471],
2	Clin	NNP	O	Clin	nn	3	SENT_270	[p18l389t416r524b471],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_270	[p18l546t416r1112b488],
4	15:211	CD	NUMBER	15:211	num	5	SENT_270	[p18l1143t416r1511b471],
5	-216	CD	NUMBER	-216	dep	3	SENT_270	[p18l1143t416r1511b471],

1	Bertilsson	NN	PERSON	bertilsson	nn	2	SENT_271	[p18l7t496r330b552],
2	L	NN	PERSON	l	dep	11	SENT_271	[p18l386t498r449b562],
3	,	,	O	,	_	0	SENT_271	[p18l386t498r449b562],
4	Dahl	NNP	PERSON	Dahl	nn	11	SENT_271	[p18l509t497r662b552],
5	ML	NNP	O	ML	nn	11	SENT_271	[p18l718t498r835b551],
6	(	CD	NUMBER	(	num	11	SENT_271	[p18l894t496r1100b565],
7	1996	CD	DATE	1996	num	11	SENT_271	[p18l894t496r1100b565],
8	)	CD	NUMBER	)	num	11	SENT_271	[p18l894t496r1100b565],
9	Polymorphic	JJ	O	polymorphic	amod	11	SENT_271	[p18l1159t496r1568b568],
10	drug	NN	O	drug	nn	11	SENT_271	[p18l1627t497r1769b568],
11	oxidation	NN	O	oxidation	_	0	SENT_271	[p18l1828t496r2144b552],
12	:	:	O	:	_	0	SENT_271	[p18l1828t496r2144b552],
13	relevance	NN	O	relevance	parataxis	11	SENT_271	[p18l131t577r436b633],
14	to	TO	O	to	dep	13	SENT_271	[p18l460t585r519b633],
15	the	DT	O	the	det	16	SENT_271	[p18l543t577r638b633],
16	treatment	NN	O	treatment	pobj	14	SENT_271	[p18l662t585r963b633],
17	of	IN	O	of	_	0	SENT_271	[p18l986t577r1055b633],
18	psychiatric	JJ	O	psychiatric	amod	19	SENT_271	[p18l1072t577r1421b649],
19	disorders	NNS	O	disorder	prep_of	16	SENT_271	[p18l1446t577r1753b633],
20	.	.	O	.	_	0	SENT_271	[p18l1446t577r1753b633],

1	CNS	NNS	O	cn	nn	2	SENT_272	[p18l1781t578r1929b633],
2	Drugs	NNS	O	drug	_	0	SENT_272	[p18l1956t579r2147b649],
3	3:200	CD	NUMBER	3:200	num	4	SENT_272	[p18l134t657r468b713],
4	—	NN	O	—	dep	2	SENT_272	[p18l134t657r468b713],
5	223	CD	NUMBER	223	dep	2	SENT_272	[p18l134t657r468b713],

1	Broly	RB	O	broly	advmod	2	SENT_273	[p18l7t739r187b811],
2	F	NN	O	f	_	0	SENT_273	[p18l218t740r272b804],
3	,	,	O	,	_	0	SENT_273	[p18l218t740r272b804],
4	Gaedigk	NNP	O	Gaedigk	nn	5	SENT_273	[p18l308t739r577b811],
5	A	NNP	O	A	appos	2	SENT_273	[p18l606t739r679b804],
6	,	,	O	,	_	0	SENT_273	[p18l606t739r679b804],
7	Heim	NNP	PERSON	Heim	nn	8	SENT_273	[p18l714t739r889b794],
8	M	NNP	O	M	appos	2	SENT_273	[p18l919t740r1005b804],
9	,	,	O	,	_	0	SENT_273	[p18l919t740r1005b804],
10	Eichelbaum	NNP	PERSON	Eichelbaum	nn	11	SENT_273	[p18l1040t739r1421b794],
11	M	NNP	O	M	appos	2	SENT_273	[p18l1451t740r1537b805],
12	,	,	O	,	_	0	SENT_273	[p18l1451t740r1537b805],
13	Morike	NNP	PERSON	Morike	nn	14	SENT_273	[p18l1571t739r1804b794],
14	K	NNP	PERSON	K	appos	2	SENT_273	[p18l1837t740r1908b805],
15	,	,	O	,	_	0	SENT_273	[p18l1837t740r1908b805],
16	Meyer	NNP	ORGANIZATION	Meyer	nn	17	SENT_273	[p18l1943t740r2151b811],
17	UA	NNP	ORGANIZATION	UA	appos	2	SENT_273	[p18l132t820r245b875],
18	(	CD	NUMBER	(	num	17	SENT_273	[p18l301t820r507b888],
19	1991	CD	DATE	1991	number	20	SENT_273	[p18l301t820r507b888],
20	)	CD	NUMBER	)	num	23	SENT_273	[p18l301t820r507b888],
21	Debrisoquine/sparteine	NN	O	debrisoquine/sparteine	nn	23	SENT_273	[p18l563t820r1303b892],
22	hydroxylation	NN	O	hydroxylation	nn	23	SENT_273	[p18l1357t820r1805b892],
23	genotype	NN	O	genotype	dep	17	SENT_273	[p18l1859t828r2149b892],
24	and	CC	O	and	_	0	SENT_273	[p18l134t900r246b956],
25	phenotype	NN	O	phenotype	conj_and	23	SENT_273	[p18l277t900r625b972],
26	:	:	O	:	_	0	SENT_273	[p18l277t900r625b972],
27	analysis	NN	O	analysis	dep	2	SENT_273	[p18l665t900r917b972],
28	of	IN	O	of	_	0	SENT_273	[p18l953t900r1021b956],
29	common	JJ	O	common	amod	30	SENT_273	[p18l1049t918r1326b956],
30	mutations	NNS	O	mutation	prep_of	27	SENT_273	[p18l1358t900r1670b956],
31	and	CC	O	and	_	0	SENT_273	[p18l1706t900r1818b956],
32	alleles	NNS	O	allele	prep_of	27	SENT_273	[p18l1851t900r2050b956],
33	of	IN	O	of	_	0	SENT_273	[p18l2086t900r2154b956],
34	CYP2D6	NN	O	cyp2d6	prep_of	30	SENT_273	[p18l133t981r421b1037],
35	in	IN	O	in	_	0	SENT_273	[p18l476t981r536b1036],
36	a	DT	O	a	det	38	SENT_273	[p18l592t999r625b1036],
37	European	JJ	MISC	european	amod	38	SENT_273	[p18l677t983r982b1053],
38	population	NN	O	population	prep_in	34	SENT_273	[p18l1035t981r1392b1053],
39	.	.	O	.	_	0	SENT_273	[p18l1035t981r1392b1053],

1	DNA	NN	O	dna	nn	2	SENT_274	[p18l1450t982r1620b1036],
2	Cell	NN	O	cell	_	0	SENT_274	[p18l1675t981r1805b1037],
3	Biol	NNP	O	Biol	dep	2	SENT_274	[p18l1859t981r1995b1036],
4	10	CD	NUMBER	10	num	3	SENT_274	[p18l2057t982r2144b1037],
5	:	:	O	:	_	0	SENT_274	[p18l2057t982r2144b1037],
6	545-558	CD	NUMBER	545-558	dep	3	SENT_274	[p18l133t1061r406b1116],

1	Burnett	NNP	ORGANIZATION	Burnett	nn	2	SENT_275	[p18l7t1144r244b1198],
2	PL	NNP	ORGANIZATION	PL	_	0	SENT_275	[p18l277t1144r384b1208],
3	,	,	O	,	_	0	SENT_275	[p18l277t1144r384b1208],
4	Galletly	NNP	PERSON	Galletly	nn	5	SENT_275	[p18l423t1143r674b1214],
5	CA	NNP	O	CA	appos	2	SENT_275	[p18l710t1143r833b1208],
6	,	,	O	,	_	0	SENT_275	[p18l710t1143r833b1208],
7	Moyle	NNP	PERSON	Moyle	nn	8	SENT_275	[p18l870t1143r1075b1215],
8	RJ	NN	O	rj	appos	2	SENT_275	[p18l1109t1144r1208b1208],
9	,	,	O	,	_	0	SENT_275	[p18l1109t1144r1208b1208],
10	Clark	NNP	PERSON	Clark	nn	11	SENT_275	[p18l1246t1143r1421b1198],
11	CR	NN	PERSON	cr	appos	2	SENT_275	[p18l1454t1143r1557b1198],
12	(	CD	NUMBER	(	num	13	SENT_275	[p18l1594t1143r1798b1211],
13	1993	CD	DATE	1993	dep	11	SENT_275	[p18l1594t1143r1798b1211],
14	)	CD	NUMBER	)	num	17	SENT_275	[p18l1594t1143r1798b1211],
15	Low-dose	JJ	O	low-dose	amod	17	SENT_275	[p18l1834t1143r2148b1198],
16	depot	NN	O	depot	nn	17	SENT_275	[p18l133t1224r307b1295],
17	medication	NN	O	medication	dep	2	SENT_275	[p18l328t1223r677b1279],
18	in	IN	O	in	_	0	SENT_275	[p18l699t1223r759b1278],
19	schizophrenia	NN	O	schizophrenia	prep_in	17	SENT_275	[p18l783t1223r1233b1295],
20	.	.	O	.	_	0	SENT_275	[p18l783t1223r1233b1295],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_276	[p18l1261t1223r1579b1295],
2	Bull	NNP	O	Bull	_	0	SENT_276	[p18l1600t1224r1734b1279],
3	19	CD	NUMBER	19	num	2	SENT_276	[p18l1764t1224r1849b1280],
4	:	:	O	:	_	0	SENT_276	[p18l1764t1224r1849b1280],
5	155-164	CD	NUMBER	155-164	num	7	SENT_276	[p18l1865t1223r2131b1279],
6	Chouinard	NNP	O	Chouinard	nn	7	SENT_276	[p18l8t1304r343b1360],
7	G	NNP	O	G	dep	2	SENT_276	[p18l383t1305r453b1370],
8	,	,	O	,	_	0	SENT_276	[p18l383t1305r453b1370],
9	Ross	NNP	PERSON	Ross	appos	7	SENT_276	[p18l495t1304r1013b1360],
10	.	.	O	.	_	0	SENT_276	[p18l495t1304r1013b1360],

1	—	NN	O	—	_	0	SENT_277	[p18l495t1304r1013b1360],
2	.	.	O	.	_	0	SENT_277	[p18l495t1304r1013b1360],

1	Chouinard	NNP	PERSON	Chouinard	nn	2	SENT_278	[p18l495t1304r1013b1360],
2	A	NNP	O	A	_	0	SENT_278	[p18l1051t1305r1123b1370],
3	,	,	O	,	_	0	SENT_278	[p18l1051t1305r1123b1370],
4	Annable	NNP	PERSON	Annable	nn	5	SENT_278	[p18l1164t1304r1433b1360],
5	L	NNP	PERSON	L	appos	2	SENT_278	[p18l1471t1306r1535b1370],
6	,	,	O	,	_	0	SENT_278	[p18l1471t1306r1535b1370],
7	Jones	NNP	PERSON	Jones	nn	8	SENT_278	[p18l1577t1306r1750b1360],
8	BD	NNP	O	BD	appos	2	SENT_278	[p18l1791t1306r1898b1359],
9	(	CD	NUMBER	(	num	11	SENT_278	[p18l1940t1305r2146b1373],
10	1980	CD	DATE	1980	num	11	SENT_278	[p18l1940t1305r2146b1373],
11	)	NN	O	)	dep	8	SENT_278	[p18l1940t1305r2146b1373],

1	Extrapyramidal	JJ	O	extrapyramidal	amod	2	SENT_279	[p18l131t1385r627b1457],
2	symptom	NN	O	symptom	_	0	SENT_279	[p18l653t1393r946b1457],
3	rating	NN	O	rating	nn	4	SENT_279	[p18l967t1385r1151b1457],
4	scale	NN	O	scale	dep	2	SENT_279	[p18l1177t1385r1348b1440],
5	.	.	O	.	_	0	SENT_279	[p18l1177t1385r1348b1440],

1	Can	MD	O	can	_	0	SENT_280	[p18l1376t1385r1501b1441],
2	J	NNP	O	J	nn	3	SENT_280	[p18l1523t1387r1552b1441],
3	Neurosci	NNP	O	Neurosci	nsubj	1	SENT_280	[p18l1575t1385r1861b1440],
4	8:233	CD	NUMBER	8:233	dep	3	SENT_280	[p18l1887t1386r2060b1441],

1	Dahl	NNP	PERSON	Dahl	nn	2	SENT_281	[p18l7t1467r160b1522],
2	ML	NNP	O	ML	nsubj	7	SENT_281	[p18l187t1468r322b1533],
3	,	,	O	,	_	0	SENT_281	[p18l187t1468r322b1533],
4	Ekqvist	NNP	O	Ekqvist	nn	5	SENT_281	[p18l351t1467r595b1539],
5	B	NNP	O	B	appos	2	SENT_281	[p18l621t1468r689b1533],
6	,	,	O	,	_	0	SENT_281	[p18l621t1468r689b1533],
7	Widen	VB	O	widen	_	0	SENT_281	[p18l718t1467r926b1522],
8	J	NN	O	j	nn	11	SENT_281	[p18l953t1468r1000b1532],
9	,	,	O	,	_	0	SENT_281	[p18l953t1468r1000b1532],
10	Bertilsson	NN	O	bertilsson	dep	11	SENT_281	[p18l1029t1467r1352b1522],
11	L	NN	O	l	nsubj	13	SENT_281	[p18l1378t1468r1425b1521],
12	(	CD	NUMBER	(	num	13	SENT_281	[p18l1455t1467r1661b1535],
13	1991	CD	DATE	1991	ccomp	7	SENT_281	[p18l1455t1467r1661b1535],
14	)	CD	NUMBER	)	num	15	SENT_281	[p18l1455t1467r1661b1535],
15	Disposition	NNP	O	Disposition	dobj	13	SENT_281	[p18l1690t1467r2057b1539],
16	of	IN	O	of	_	0	SENT_281	[p18l2085t1467r2154b1522],
17	the	DT	O	the	det	20	SENT_281	[p18l132t1547r224b1603],
18	neuroleptic	JJ	O	neuroleptic	amod	20	SENT_281	[p18l245t1547r585b1619],
19	zuclopenthixol	NN	O	zuclopenthixol	nn	20	SENT_281	[p18l608t1547r1060b1619],
20	cosegregates	NNS	O	cosegregate	prep_of	15	SENT_281	[p18l1081t1556r1467b1619],
21	with	IN	O	with	_	0	SENT_281	[p18l1490t1547r1626b1603],
22	the	DT	O	the	det	24	SENT_281	[p18l1645t1548r1737b1603],
23	polymorphic	JJ	O	polymorphic	amod	24	SENT_281	[p18l1757t1547r2147b1619],
24	hydroxylation	NN	O	hydroxylation	prep_with	13	SENT_281	[p18l131t1628r569b1700],
25	of	IN	O	of	_	0	SENT_281	[p18l594t1628r662b1684],
26	debrisoquine	NN	O	debrisoquine	prep_of	24	SENT_281	[p18l681t1628r1082b1700],
27	in	IN	O	in	_	0	SENT_281	[p18l1107t1628r1166b1683],
28	humans	NNS	O	human	prep_in	26	SENT_281	[p18l1190t1628r1447b1684],
29	.	.	O	.	_	0	SENT_281	[p18l1190t1628r1447b1684],

1	Acta	NNP	O	Acta	nn	3	SENT_282	[p18l1475t1629r1623b1684],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_282	[p18l1645t1628r1937b1700],
3	Scand	NNP	O	Scand	_	0	SENT_282	[p18l1961t1628r2149b1684],
4	84:99	CD	NUMBER	84:99	number	5	SENT_282	[p18l135t1708r471b1764],
5	—	CD	NUMBER	—	dep	3	SENT_282	[p18l135t1708r471b1764],
6	102	CD	NUMBER	102	dep	5	SENT_282	[p18l135t1708r471b1764],

1	Dahl	NNP	PERSON	Dahl	nn	2	SENT_283	[p18l7t1789r159b1844],
2	ML	NNP	O	ML	_	0	SENT_283	[p18l210t1791r345b1855],
3	,	,	O	,	_	0	SENT_283	[p18l210t1791r345b1855],
4	Johansson	NNP	PERSON	Johansson	appos	2	SENT_283	[p18l398t1789r725b1845],
5	1	CD	NUMBER	1	num	4	SENT_283	[p18l775t1791r816b1855],
6	,	,	O	,	_	0	SENT_283	[p18l775t1791r816b1855],
7	Palmertz	NNP	O	Palmertz	nn	8	SENT_283	[p18l870t1789r1152b1844],
8	MP	NNP	O	MP	appos	2	SENT_283	[p18l1202t1791r1324b1855],
9	,	,	O	,	_	0	SENT_283	[p18l1202t1791r1324b1855],
10	Ingelman	NNP	O	Ingelman	appos	2	SENT_283	[p18l1377t1789r2008b1861],
11	.	.	O	.	_	0	SENT_283	[p18l1377t1789r2008b1861],

1	—	NN	O	—	_	0	SENT_284	[p18l1377t1789r2008b1861],
2	.	.	O	.	_	0	SENT_284	[p18l1377t1789r2008b1861],

1	Sundberg	NNP	PERSON	Sundberg	nn	5	SENT_285	[p18l1377t1789r2008b1861],
2	M	NNP	O	M	nn	5	SENT_285	[p18l2059t1791r2145b1855],
3	,	,	O	,	_	0	SENT_285	[p18l2059t1791r2145b1855],
4	Sjoqvist	NNP	O	Sjoqvist	appos	5	SENT_285	[p18l133t1871r393b1943],
5	F	NN	O	f	_	0	SENT_285	[p18l427t1872r470b1925],
6	(	CD	NUMBER	(	num	5	SENT_285	[p18l508t1871r714b1939],
7	1992	CD	DATE	1992	num	9	SENT_285	[p18l508t1871r714b1939],
8	)	CD	NUMBER	)	num	9	SENT_285	[p18l508t1871r714b1939],
9	Analysis	NN	O	analysis	dep	5	SENT_285	[p18l753t1871r1028b1943],
10	of	IN	O	of	_	0	SENT_285	[p18l1067t1871r1136b1926],
11	the	DT	O	the	det	13	SENT_285	[p18l1167t1871r1262b1926],
12	CYP2D6	NN	O	cyp2d6	nn	13	SENT_285	[p18l1299t1871r1588b1926],
13	gene	NN	O	gene	prep_of	9	SENT_285	[p18l1626t1888r1773b1943],
14	in	IN	O	in	_	0	SENT_285	[p18l1809t1871r1869b1925],
15	relation	NN	O	relation	prep_in	13	SENT_285	[p18l1905t1871r2148b1926],
16	to	TO	O	to	_	0	SENT_285	[p18l131t1960r190b2007],
17	debrisoquin	NN	O	debrisoquin	nn	20	SENT_285	[p18l231t1952r606b2024],
18	and	CC	O	and	_	0	SENT_285	[p18l646t1952r758b2007],
19	desipramine	NN	O	desipramine	nn	20	SENT_285	[p18l797t1952r1184b2024],
20	hydroxylation	NN	O	hydroxylation	prep_to	15	SENT_285	[p18l1223t1952r1670b2024],
21	in	IN	O	in	_	0	SENT_285	[p18l1709t1952r1769b2006],
22	a	DT	O	a	det	24	SENT_285	[p18l1809t1969r1842b2007],
23	Swedish	JJ	MISC	swedish	amod	24	SENT_285	[p18l1882t1952r2148b2007],
24	population	NN	O	population	prep_in	5	SENT_285	[p18l130t2032r487b2104],
25	.	.	O	.	_	0	SENT_285	[p18l130t2032r487b2104],

1	Clin	NNP	O	Clin	nn	3	SENT_286	[p18l515t2032r650b2088],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_286	[p18l672t2032r1011b2088],
3	Ther	NNP	O	Ther	_	0	SENT_286	[p18l1034t2032r1184b2088],
4	51:12	CD	NUMBER	51:12	num	5	SENT_286	[p18l1207t2032r1502b2088],
5	-17	CD	NUMBER	-17	dep	3	SENT_286	[p18l1207t2032r1502b2088],

1	Dahl	NNP	PERSON	Dahl	nn	2	SENT_287	[p18l7t2113r159b2168],
2	ML	NNP	O	ML	_	0	SENT_287	[p18l212t2115r347b2179],
3	,	,	O	,	_	0	SENT_287	[p18l212t2115r347b2179],
4	Johansson	NNP	PERSON	Johansson	appos	2	SENT_287	[p18l403t2113r730b2169],
5	1	CD	NUMBER	1	num	4	SENT_287	[p18l782t2115r824b2179],
6	,	,	O	,	_	0	SENT_287	[p18l782t2115r824b2179],
7	Bertilsson	NN	PERSON	bertilsson	nn	8	SENT_287	[p18l880t2113r1203b2168],
8	L	NN	PERSON	l	appos	2	SENT_287	[p18l1255t2115r1319b2179],
9	,	,	O	,	_	0	SENT_287	[p18l1255t2115r1319b2179],
10	Ingelman	NNP	O	Ingelman	appos	2	SENT_287	[p18l1375t2113r2005b2185],
11	.	.	O	.	_	0	SENT_287	[p18l1375t2113r2005b2185],

1	—	NN	O	—	_	0	SENT_288	[p18l1375t2113r2005b2185],
2	.	.	O	.	_	0	SENT_288	[p18l1375t2113r2005b2185],

1	Sundberg	NNP	PERSON	Sundberg	nn	5	SENT_289	[p18l1375t2113r2005b2185],
2	M	NNP	O	M	nn	5	SENT_289	[p18l2059t2115r2145b2179],
3	,	,	O	,	_	0	SENT_289	[p18l2059t2115r2145b2179],
4	Sjoqvist	NNP	O	Sjoqvist	appos	5	SENT_289	[p18l133t2195r393b2267],
5	F	NN	O	f	_	0	SENT_289	[p18l419t2196r462b2249],
6	(	CD	NUMBER	(	num	5	SENT_289	[p18l492t2195r697b2263],
7	1995	CD	DATE	1995	num	10	SENT_289	[p18l492t2195r697b2263],
8	)	NN	O	)	nn	10	SENT_289	[p18l492t2195r697b2263],
9	Ultrarapid	NN	O	ultrarapid	nn	10	SENT_289	[p18l728t2195r1055b2267],
10	hydroxylation	NN	O	hydroxylation	dep	5	SENT_289	[p18l1082t2195r1530b2267],
11	of	IN	O	of	_	0	SENT_289	[p18l1558t2195r1627b2250],
12	debrisoquine	NN	O	debrisoquine	prep_of	10	SENT_289	[p18l1650t2195r2059b2267],
13	in	IN	O	in	_	0	SENT_289	[p18l2088t2195r2148b2249],
14	a	DT	O	a	det	16	SENT_289	[p18l133t2293r166b2331],
15	Swedish	JJ	MISC	swedish	amod	16	SENT_289	[p18l191t2276r458b2331],
16	population	NN	O	population	prep_in	12	SENT_289	[p18l480t2276r837b2348],
17	.	.	O	.	_	0	SENT_289	[p18l480t2276r837b2348],

1	Analysis	NN	O	analysis	_	0	SENT_290	[p18l866t2276r1141b2347],
2	of	IN	O	of	_	0	SENT_290	[p18l1168t2276r1237b2331],
3	the	DT	O	the	det	6	SENT_290	[p18l1256t2276r1351b2331],
4	molecular	JJ	O	molecular	amod	6	SENT_290	[p18l1375t2276r1694b2331],
5	genetic	JJ	O	genetic	amod	6	SENT_290	[p18l1718t2276r1944b2348],
6	basis	NN	O	basis	prep_of	1	SENT_290	[p18l1969t2276r2144b2331],
7	.	.	O	.	_	0	SENT_290	[p18l1969t2276r2144b2331],

1	JPET	NN	O	jpet	_	0	SENT_291	[p18l131t2357r302b2411],
2	274:515	CD	NUMBER	274:515	num	3	SENT_291	[p18l326t2355r744b2411],
3	—	NN	O	—	dep	1	SENT_291	[p18l326t2355r744b2411],
4	520	CD	NUMBER	520	dep	1	SENT_291	[p18l326t2355r744b2411],

1	Fleischhacker	NNP	PERSON	Fleischhacker	nn	2	SENT_292	[p18l6t2436r450b2492],
2	WW	NNP	O	WW	nsubj	6	SENT_292	[p18l476t2438r635b2502],
3	,	,	O	,	_	0	SENT_292	[p18l476t2438r635b2502],
4	Hummer	NNP	O	Hummer	nn	5	SENT_292	[p18l665t2438r948b2492],
5	M	NNP	O	M	nsubj	6	SENT_292	[p18l974t2438r1042b2491],
6	(	VBD	O	(	_	0	SENT_292	[p18l1073t2437r1279b2505],
7	1997	CD	DATE	1997	dobj	6	SENT_292	[p18l1073t2437r1279b2505],
8	)	CD	NUMBER	)	num	10	SENT_292	[p18l1073t2437r1279b2505],
9	Drug	NN	O	drug	nn	10	SENT_292	[p18l1310t2438r1470b2508],
10	treatment	NN	O	treatment	dep	7	SENT_292	[p18l1499t2444r1800b2492],
11	of	IN	O	of	_	0	SENT_292	[p18l1828t2436r1897b2492],
12	schizophrenia	NN	O	schizophrenia	prep_of	10	SENT_292	[p18l1922t2436r2146b2492, p18l130t2517r370b2589],
13	in	IN	O	in	_	0	SENT_292	[p18l398t2517r459b2572],
14	the	DT	DATE	the	det	15	SENT_292	[p18l488t2517r583b2572],
15	1990s	CD	DATE	1990s	prep_in	12	SENT_292	[p18l621t2517r819b2573],
16	:	:	O	:	_	0	SENT_292	[p18l621t2517r819b2573],
17	achievements	NNS	O	achievement	dep	7	SENT_292	[p18l856t2517r1285b2572],
18	and	CC	O	and	_	0	SENT_292	[p18l1318t2517r1430b2572],
19	future	JJ	DATE	future	amod	20	SENT_292	[p18l1460t2517r1647b2572],
20	possibilities	NNS	O	possibility	dep	7	SENT_292	[p18l1677t2517r2056b2589],
21	in	IN	O	in	_	0	SENT_292	[p18l2088t2517r2148b2572],
22	optimising	VBG	O	optimise	amod	23	SENT_292	[p18l132t2598r470b2670],
23	outcomes	NNS	O	outcome	prep_in	6	SENT_292	[p18l495t2606r814b2653],
24	.	.	O	.	_	0	SENT_292	[p18l495t2606r814b2653],

1	Drugs	NNS	O	drug	_	0	SENT_293	[p18l840t2599r1032b2670],
2	532915-929	CD	NUMBER	532915-929	dep	1	SENT_293	[p18l1058t2597r1434b2654],

1	Gerlach	NNP	PERSON	Gerlach	nn	2	SENT_294	[p18l8t2678r258b2734],
2	J	NNP	PERSON	J	nsubj	3	SENT_294	[p18l317t2680r346b2734],
3	(	VBD	O	(	_	0	SENT_294	[p18l409t2678r615b2747],
4	1995	CD	DATE	1995	num	7	SENT_294	[p18l409t2678r615b2747],
5	)	CD	NUMBER	)	num	7	SENT_294	[p18l409t2678r615b2747],
6	Depot	NNP	O	Depot	nn	7	SENT_294	[p18l678t2680r872b2750],
7	neuroleptics	NNS	O	neuroleptic	dobj	3	SENT_294	[p18l931t2678r1319b2750],
8	in	IN	O	in	_	0	SENT_294	[p18l1381t2678r1441b2733],
9	relapse	NN	O	relapse	nn	10	SENT_294	[p18l1500t2678r1725b2750],
10	prevention	NN	O	prevention	prep_in	7	SENT_294	[p18l1785t2678r2143b2750],
11	:	:	O	:	_	0	SENT_294	[p18l1785t2678r2143b2750],
12	advantages	NNS	O	advantage	dep	7	SENT_294	[p18l133t2759r482b2831],
13	and	CC	O	and	_	0	SENT_294	[p18l545t2759r657b2815],
14	disadvantages	NNS	O	disadvantage	conj_and	12	SENT_294	[p18l717t2759r1178b2831],
15	.	.	O	.	_	0	SENT_294	[p18l717t2759r1178b2831],

1	Int	NNP	O	Int	nn	3	SENT_295	[p18l1241t2761r1329b2815],
2	Clin	NNP	O	Clin	nn	3	SENT_295	[p18l1388t2759r1523b2815],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_295	[p18l1582t2759r2148b2831],
4	9	CD	NUMBER	9	number	5	SENT_295	[p18l132t2840r382b2912],
5	[	CD	NUMBER	[	num	6	SENT_295	[p18l132t2840r382b2912],
6	Suppl	NN	O	suppl	dep	3	SENT_295	[p18l132t2840r382b2912],
7	5	CD	NUMBER	5	num	8	SENT_295	[p18l406t2840r486b2907],
8	]	NN	O	]	dep	6	SENT_295	[p18l406t2840r486b2907],
9	:	:	O	:	_	0	SENT_295	[p18l406t2840r486b2907],
10	17-20	CD	DATE	17-20	dep	6	SENT_295	[p18l502t2841r691b2896],

1	Griese	NNP	ORGANIZATION	Griese	nn	2	SENT_296	[p18l8t2922r213b2977],
2	EU	NNP	ORGANIZATION	EU	dep	25	SENT_296	[p18l248t2923r369b2987],
3	,	,	O	,	_	0	SENT_296	[p18l248t2923r369b2987],
4	Zanger	NNP	PERSON	Zanger	nn	5	SENT_296	[p18l407t2923r633b2994],
5	UM	NNP	O	UM	appos	2	SENT_296	[p18l666t2923r810b2987],
6	,	,	O	,	_	0	SENT_296	[p18l666t2923r810b2987],
7	Brudermanns	NNP	ORGANIZATION	Brudermanns	nn	8	SENT_296	[p18l848t2922r1274b2977],
8	U	NNP	ORGANIZATION	U	appos	2	SENT_296	[p18l1311t2923r1384b2987],
9	,	,	O	,	_	0	SENT_296	[p18l1311t2923r1384b2987],
10	Gaedigk	NNP	O	Gaedigk	nn	11	SENT_296	[p18l1423t2922r1692b2994],
11	A	NNP	O	A	appos	2	SENT_296	[p18l1725t2922r1798b2988],
12	,	,	O	,	_	0	SENT_296	[p18l1725t2922r1798b2988],
13	Mikus	NNP	PERSON	Mikus	nn	14	SENT_296	[p18l1835t2922r2036b2977],
14	G	NNP	PERSON	G	appos	2	SENT_296	[p18l2074t2922r2145b2988],
15	,	,	O	,	_	0	SENT_296	[p18l2074t2922r2145b2988],
16	Morike	NNP	PERSON	Morike	nn	17	SENT_296	[p18l131t3003r364b3058],
17	K	NNP	PERSON	K	appos	2	SENT_296	[p18l392t3004r463b3068],
18	,	,	O	,	_	0	SENT_296	[p18l392t3004r463b3068],
19	Stuven	NNP	ORGANIZATION	Stuven	nn	20	SENT_296	[p18l494t3003r712b3058],
20	T	NN	ORGANIZATION	t	appos	2	SENT_296	[p18l738t3004r795b3068],
21	,	,	O	,	_	0	SENT_296	[p18l738t3004r795b3068],
22	Eichelbaum	NN	ORGANIZATION	eichelbaum	nn	23	SENT_296	[p18l824t3003r1205b3058],
23	M	NN	ORGANIZATION	m	appos	2	SENT_296	[p18l1230t3004r1298b3057],
24	(	CD	NUMBER	(	num	25	SENT_296	[p18l1327t3003r1533b3071],
25	1998	CD	DATE	1998	_	0	SENT_296	[p18l1327t3003r1533b3071],
26	)	CD	NUMBER	)	num	27	SENT_296	[p18l1327t3003r1533b3071],
27	Assessment	NNP	O	Assessment	dep	25	SENT_296	[p18l1561t3003r1937b3058],
28	of	IN	O	of	_	0	SENT_296	[p18l1963t3003r2032b3058],
29	the	DT	O	the	det	31	SENT_296	[p18l2053t3003r2148b3058],
30	predictive	JJ	O	predictive	amod	31	SENT_296	[p18l130t3083r445b3155],
31	power	NN	O	power	prep_of	27	SENT_296	[p18l468t3101r666b3155],
32	of	IN	O	of	_	0	SENT_296	[p18l689t3083r757b3139],
33	genotypes	NNS	O	genotype	prep_of	31	SENT_296	[p18l776t3092r1092b3155],
34	for	IN	O	for	_	0	SENT_296	[p18l1117t3083r1208b3139],
35	the	DT	O	the	det	38	SENT_296	[p18l1230t3084r1324b3139],
36	in-vivo	JJ	O	in-vivo	amod	38	SENT_296	[p18l1348t3083r1573b3139],
37	catalytic	JJ	O	catalytic	amod	38	SENT_296	[p18l1598t3083r1862b3155],
38	function	NN	O	function	prep_for	33	SENT_296	[p18l1887t3083r2148b3139],
39	of	IN	O	of	_	0	SENT_296	[p18l132t3164r201b3219],
40	CYP2D6	NN	O	cyp2d6	prep_of	38	SENT_296	[p18l241t3164r529b3220],
41	in	IN	O	in	_	0	SENT_296	[p18l576t3164r636b3219],
42	a	DT	O	a	det	44	SENT_296	[p18l682t3182r715b3219],
43	German	JJ	MISC	german	amod	44	SENT_296	[p18l760t3164r1014b3220],
44	population	NN	O	population	prep_in	40	SENT_296	[p18l1058t3164r1414b3236],
45	.	.	O	.	_	0	SENT_296	[p18l1058t3164r1414b3236],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_297	[p18l1464t3164r2041b3236],
2	8	CD	NUMBER	8	num	1	SENT_297	[p18l2091t3165r2143b3220],
3	:	:	O	:	_	0	SENT_297	[p18l2091t3165r2143b3220],
4	15-26	CD	DATE	15-26	dep	1	SENT_297	[p18l139t3245r328b3300],

1	Heim	NNP	PERSON	Heim	nn	2	SENT_298	[p19l7t20r183b75],
2	M	NNP	O	M	nsubj	7	SENT_298	[p19l215t21r300b85],
3	,	,	O	,	_	0	SENT_298	[p19l215t21r300b85],
4	Meyer	NNP	ORGANIZATION	Meyer	nn	5	SENT_298	[p19l336t21r544b91],
5	UA	NNP	ORGANIZATION	UA	appos	2	SENT_298	[p19l576t20r689b75],
6	(	CD	NUMBER	(	num	7	SENT_298	[p19l724t20r930b88],
7	1990	CD	DATE	1990	_	0	SENT_298	[p19l724t20r930b88],
8	)	CD	NUMBER	)	num	9	SENT_298	[p19l724t20r930b88],
9	Genotyping	NN	O	genotyping	dobj	7	SENT_298	[p19l967t20r1340b92],
10	of	IN	O	of	_	0	SENT_298	[p19l1375t20r1443b75],
11	poor	JJ	O	poor	amod	12	SENT_298	[p19l1470t37r1616b92],
12	metabolisers	NNS	O	metaboliser	prep_of	9	SENT_298	[p19l1648t20r2049b75],
13	of	IN	O	of	_	0	SENT_298	[p19l2085t20r2153b75],
14	debrisoquine	NN	O	debrisoquine	prep_of	12	SENT_298	[p19l132t100r538b172],
15	by	IN	O	by	_	0	SENT_298	[p19l562t101r640b172],
16	allele-specific	JJ	O	allele-specific	amod	18	SENT_298	[p19l667t100r1106b172],
17	PCR	NN	O	pcr	nn	18	SENT_298	[p19l1133t101r1281b156],
18	amplification	NN	O	amplification	prep_by	7	SENT_298	[p19l1308t100r1741b172],
19	.	.	O	.	_	0	SENT_298	[p19l1308t100r1741b172],

1	Lancet	NNP	O	Lancet	_	0	SENT_299	[p19l1771t102r1985b156],
2	336	CD	NUMBER	336	num	1	SENT_299	[p19l2012t100r2143b156],
3	:	:	O	:	_	0	SENT_299	[p19l2012t100r2143b156],
4	529-532	CD	NUMBER	529-532	dep	1	SENT_299	[p19l132t180r408b236],

1	J	NN	O	j	nn	3	SENT_300	[p19l6t263r36b317],
2	erling	NN	O	erling	nn	3	SENT_300	[p19l39t261r221b333],
3	M	NN	O	m	_	0	SENT_300	[p19l248t263r334b327],
4	,	,	O	,	_	0	SENT_300	[p19l248t263r334b327],
5	Dahl	NNP	PERSON	Dahl	nn	6	SENT_300	[p19l363t261r516b316],
6	ML	NNP	O	ML	appos	3	SENT_300	[p19l543t262r677b327],
7	,	,	O	,	_	0	SENT_300	[p19l543t262r677b327],
8	Aberg	NNP	PERSON	Aberg	appos	6	SENT_300	[p19l706t243r1176b333],
9	.	.	O	.	_	0	SENT_300	[p19l706t243r1176b333],

1	—	NN	O	—	_	0	SENT_301	[p19l706t243r1176b333],
2	.	.	O	.	_	0	SENT_301	[p19l706t243r1176b333],

1	Wistedt	NNP	O	Wistedt	nn	2	SENT_302	[p19l706t243r1176b333],
2	A	NNP	O	A	dep	17	SENT_302	[p19l1201t262r1273b327],
3	,	,	O	,	_	0	SENT_302	[p19l1201t262r1273b327],
4	Liljenberg	NNP	PERSON	Liljenberg	nn	5	SENT_302	[p19l1302t261r1632b333],
5	B	NNP	PERSON	B	appos	2	SENT_302	[p19l1659t263r1727b327],
6	,	,	O	,	_	0	SENT_302	[p19l1659t263r1727b327],
7	Landell	NNP	ORGANIZATION	Landell	nn	8	SENT_302	[p19l1755t261r1998b316],
8	NE	NNS	ORGANIZATION	ne	appos	2	SENT_302	[p19l2024t263r2146b327],
9	,	,	O	,	_	0	SENT_302	[p19l2024t263r2146b327],
10	Bertilsson	NN	ORGANIZATION	bertilsson	nn	11	SENT_302	[p19l131t343r450b398],
11	L	NN	ORGANIZATION	l	appos	2	SENT_302	[p19l472t344r536b408],
12	,	,	O	,	_	0	SENT_302	[p19l472t344r536b408],
13	Sjoqvist	NNP	O	Sjoqvist	appos	2	SENT_302	[p19l563t343r819b415],
14	F	NN	O	f	dep	17	SENT_302	[p19l840t344r883b397],
15	(	CD	NUMBER	(	num	14	SENT_302	[p19l907t343r1111b411],
16	1996	CD	DATE	1996	num	17	SENT_302	[p19l907t343r1111b411],
17	)	CD	NUMBER	)	dep	21	SENT_302	[p19l907t343r1111b411],
18	The	DT	O	the	det	20	SENT_302	[p19l1136t343r1256b398],
19	CYP2D6	NN	O	cyp2d6	nn	20	SENT_302	[p19l1280t343r1566b398],
20	genotype	NN	O	genotype	dep	17	SENT_302	[p19l1590t351r1877b415],
21	predicts	VBZ	O	predict	_	0	SENT_302	[p19l1898t343r2146b415],
22	the	DT	O	the	det	24	SENT_302	[p19l131t424r226b479],
23	oral	JJ	O	oral	amod	24	SENT_302	[p19l258t424r379b479],
24	clearance	NN	O	clearance	dobj	21	SENT_302	[p19l410t424r709b479],
25	of	IN	O	of	_	0	SENT_302	[p19l740t423r809b479],
26	the	DT	O	the	det	29	SENT_302	[p19l834t423r929b479],
27	neuroleptic	JJ	O	neuroleptic	amod	29	SENT_302	[p19l960t423r1316b495],
28	agents	NNS	O	agent	nn	29	SENT_302	[p19l1350t432r1548b495],
29	perphenazine	NN	O	perphenazine	prep_of	24	SENT_302	[p19l1580t423r2004b495],
30	and	CC	O	and	_	0	SENT_302	[p19l2037t424r2149b479],
31	zuclopenthixol	NN	O	zuclopenthixol	prep_of	24	SENT_302	[p19l132t504r621b576],
32	.	.	O	.	_	0	SENT_302	[p19l132t504r621b576],

1	Clin	NNP	O	Clin	nn	3	SENT_303	[p19l648t504r783b560],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_303	[p19l805t504r1145b560],
3	Ther	NNP	O	Ther	_	0	SENT_303	[p19l1167t504r1318b560],
4	592423-428	CD	NUMBER	592423-428	dep	3	SENT_303	[p19l1340t504r1715b560],

1	Kane	NNP	ORGANIZATION	Kane	nn	2	SENT_304	[p19l8t587r172b640],
2	JM	NN	ORGANIZATION	jm	dep	51	SENT_304	[p19l205t587r323b651],
3	,	,	O	,	_	0	SENT_304	[p19l205t587r323b651],
4	Aguglia	NNP	ORGANIZATION	Aguglia	nn	5	SENT_304	[p19l358t585r615b657],
5	E	NNP	ORGANIZATION	E	appos	2	SENT_304	[p19l646t587r711b651],
6	,	,	O	,	_	0	SENT_304	[p19l646t587r711b651],
7	Altamura	NNP	LOCATION	Altamura	nn	8	SENT_304	[p19l746t585r1047b640],
8	AC	NN	O	ac	appos	2	SENT_304	[p19l1079t586r1205b651],
9	,	,	O	,	_	0	SENT_304	[p19l1079t586r1205b651],
10	Gutierrez	NNP	PERSON	Gutierrez	nn	11	SENT_304	[p19l1242t585r1540b641],
11	JLA	NNP	O	JLA	appos	2	SENT_304	[p19l1573t586r1726b651],
12	,	,	O	,	_	0	SENT_304	[p19l1573t586r1726b651],
13	Brunello	NNP	O	Brunello	nn	14	SENT_304	[p19l1762t585r2038b640],
14	N	NNP	O	N	appos	2	SENT_304	[p19l2072t586r2145b651],
15	,	,	O	,	_	0	SENT_304	[p19l2072t586r2145b651],
16	Fleischhacker	NNP	PERSON	Fleischhacker	nn	17	SENT_304	[p19l131t667r575b722],
17	WW	NNP	O	WW	appos	2	SENT_304	[p19l602t668r760b733],
18	,	,	O	,	_	0	SENT_304	[p19l602t668r760b733],
19	Gaebel	NNP	O	Gaebel	nn	20	SENT_304	[p19l793t667r1016b722],
20	W	NNP	O	W	appos	2	SENT_304	[p19l1044t668r1128b733],
21	,	,	O	,	_	0	SENT_304	[p19l1044t668r1128b733],
22	Gerlach	NNP	PERSON	Gerlach	nn	23	SENT_304	[p19l1161t667r1411b722],
23	J	NNP	PERSON	J	appos	2	SENT_304	[p19l1439t668r1468b722],
24	,	,	O	,	_	0	SENT_304	[p19l1473t713r1485b733],
25	Guelfi	NNP	PERSON	Guelfi	nn	26	SENT_304	[p19l1519t667r1719b722],
26	JD	NNP	O	JD	appos	2	SENT_304	[p19l1748t668r1851b732],
27	,	,	O	,	_	0	SENT_304	[p19l1748t668r1851b732],
28	Kissling	NNP	PERSON	Kissling	nn	29	SENT_304	[p19l1885t667r2147b739],
29	W	NNP	O	W	appos	2	SENT_304	[p19l130t749r214b813],
30	,	,	O	,	_	0	SENT_304	[p19l130t749r214b813],
31	Lapierre	NNP	PERSON	Lapierre	nn	32	SENT_304	[p19l261t748r529b820],
32	YD	NNP	O	YD	appos	2	SENT_304	[p19l575t749r704b814],
33	,	,	O	,	_	0	SENT_304	[p19l575t749r704b814],
34	Lindstrom	NNP	PERSON	Lindstrom	nn	35	SENT_304	[p19l752t748r1084b803],
35	E	NNP	O	E	appos	2	SENT_304	[p19l1127t749r1191b813],
36	,	,	O	,	_	0	SENT_304	[p19l1127t749r1191b813],
37	Mendlewicz	NNP	PERSON	Mendlewicz	nn	38	SENT_304	[p19l1238t748r1630b803],
38	J	NNP	PERSON	J	appos	2	SENT_304	[p19l1675t749r1704b803],
39	,	,	O	,	_	0	SENT_304	[p19l1710t793r1721b813],
40	Racagni	NNP	O	Racagni	nn	41	SENT_304	[p19l1769t748r2028b820],
41	G	NNP	O	G	appos	2	SENT_304	[p19l2074t748r2145b813],
42	,	,	O	,	_	0	SENT_304	[p19l2074t748r2145b813],
43	Carulla	NNP	ORGANIZATION	Carulla	nn	44	SENT_304	[p19l132t829r366b884],
44	LS	NN	O	l	appos	2	SENT_304	[p19l404t829r512b894],
45	,	,	O	,	_	0	SENT_304	[p19l404t829r512b894],
46	Schooler	NNP	O	Schooler	nn	47	SENT_304	[p19l557t828r838b884],
47	NR	NNP	O	NR	appos	2	SENT_304	[p19l875t830r985b884],
48	(	CD	NUMBER	(	num	51	SENT_304	[p19l1026t829r1232b897],
49	1998	CD	DATE	1998	num	51	SENT_304	[p19l1026t829r1232b897],
50	)	NNP	O	)	nn	51	SENT_304	[p19l1026t829r1232b897],
51	Guidelines	NNS	O	guideline	_	0	SENT_304	[p19l1275t828r1616b884],
52	for	IN	O	for	_	0	SENT_304	[p19l1658t828r1750b884],
53	depot	NN	O	depot	nn	55	SENT_304	[p19l1789t829r1965b900],
54	antipsychotic	JJ	O	antipsychotic	amod	55	SENT_304	[p19l2005t828r2146b884, p19l130t909r434b981],
55	treatment	NN	O	treatment	prep_for	51	SENT_304	[p19l465t917r767b964],
56	in	IN	O	in	_	0	SENT_304	[p19l795t909r855b964],
57	schizophrenia	NN	O	schizophrenia	prep_in	55	SENT_304	[p19l888t909r1343b981],
58	.	.	O	.	_	0	SENT_304	[p19l888t909r1343b981],

1	Eur	NNP	MISC	Eur	nn	2	SENT_305	[p19l1377t911r1492b964],
2	Neuropsychopharm	NNP	MISC	Neuropsychopharm	_	0	SENT_305	[p19l1520t909r2149b981],
3	8:55	CD	TIME	8:55	num	4	SENT_305	[p19l135t989r390b1044],
4	-66	CD	NUMBER	-66	dep	2	SENT_305	[p19l135t989r390b1044],

1	Kapitany	JJ	ORGANIZATION	kapitany	amod	2	SENT_306	[p19l8t1071r297b1143],
2	T	NN	ORGANIZATION	t	dep	30	SENT_306	[p19l332t1072r389b1136],
3	,	,	O	,	_	0	SENT_306	[p19l332t1072r389b1136],
4	Meszaros	NNP	PERSON	Meszaros	nn	5	SENT_306	[p19l426t1072r729b1126],
5	K	NNP	PERSON	K	appos	2	SENT_306	[p19l766t1072r837b1136],
6	,	,	O	,	_	0	SENT_306	[p19l766t1072r837b1136],
7	Lenzinger	NNP	ORGANIZATION	Lenzinger	nn	8	SENT_306	[p19l873t1071r1197b1143],
8	E	NNP	ORGANIZATION	E	appos	2	SENT_306	[p19l1230t1072r1294b1136],
9	,	,	O	,	_	0	SENT_306	[p19l1230t1072r1294b1136],
10	Schindler	NNP	ORGANIZATION	Schindler	nn	11	SENT_306	[p19l1333t1071r1636b1126],
11	SD	NN	ORGANIZATION	sd	appos	2	SENT_306	[p19l1672t1071r1786b1136],
12	,	,	O	,	_	0	SENT_306	[p19l1672t1071r1786b1136],
13	Barnas	NNP	PERSON	Barnas	nn	14	SENT_306	[p19l1823t1072r2041b1126],
14	C	NNP	O	C	appos	2	SENT_306	[p19l2078t1071r2145b1136],
15	,	,	O	,	_	0	SENT_306	[p19l2078t1071r2145b1136],
16	Fuchs	NNP	PERSON	Fuchs	nn	17	SENT_306	[p19l131t1152r318b1207],
17	K	NNP	PERSON	K	appos	2	SENT_306	[p19l349t1153r420b1217],
18	,	,	O	,	_	0	SENT_306	[p19l349t1153r420b1217],
19	Sieghart	NNP	PERSON	Sieghart	nn	20	SENT_306	[p19l452t1151r716b1223],
20	W	NNP	PERSON	W	appos	2	SENT_306	[p19l741t1153r825b1217],
21	,	,	O	,	_	0	SENT_306	[p19l741t1153r825b1217],
22	Aschauer	NNP	O	Aschauer	nn	23	SENT_306	[p19l855t1152r1156b1207],
23	HN	NNP	O	HN	appos	2	SENT_306	[p19l1182t1153r1312b1217],
24	,	,	O	,	_	0	SENT_306	[p19l1182t1153r1312b1217],
25	Kasper	NNP	PERSON	Kasper	nn	26	SENT_306	[p19l1344t1153r1568b1223],
26	S	NNP	O	S	appos	2	SENT_306	[p19l1596t1152r1632b1207],
27	(	CD	NUMBER	(	num	30	SENT_306	[p19l1666t1152r1872b1220],
28	1998	CD	DATE	1998	num	30	SENT_306	[p19l1666t1152r1872b1220],
29	)	NNP	O	)	nn	30	SENT_306	[p19l1666t1152r1872b1220],
30	Genetic	NNP	O	Genetic	_	0	SENT_306	[p19l1903t1151r2146b1207],
31	polymorphism	NN	O	polymorphism	dep	30	SENT_306	[p19l130t1232r596b1304],
32	for	IN	O	for	_	0	SENT_306	[p19l641t1232r733b1288],
33	drug	NN	O	drug	nn	34	SENT_306	[p19l777t1232r920b1304],
34	metabolism	NN	O	metabolism	prep_for	31	SENT_306	[p19l966t1232r1337b1288],
35	(	CD	NUMBER	(	num	37	SENT_306	[p19l1384t1232r1723b1301],
36	CYP2D6	NN	O	cyp2d6	nn	37	SENT_306	[p19l1384t1232r1723b1301],
37	)	NN	O	)	dep	34	SENT_306	[p19l1384t1232r1723b1301],
38	and	CC	O	and	_	0	SENT_306	[p19l1772t1232r1884b1288],
39	tardive	JJ	O	tardive	amod	40	SENT_306	[p19l1928t1232r2148b1288],
40	dyskinesia	NN	O	dyskinesium	conj_and	34	SENT_306	[p19l132t1313r468b1385],
41	in	IN	O	in	_	0	SENT_306	[p19l489t1313r550b1368],
42	schizophrenia	NN	O	schizophrenia	prep_in	40	SENT_306	[p19l575t1313r1030b1385],
43	.	.	O	.	_	0	SENT_306	[p19l575t1313r1030b1385],

1	Schizophr	NNP	O	Schizophr	nn	2	SENT_307	[p19l1059t1313r1380b1385],
2	Res	NNP	O	Res	_	0	SENT_307	[p19l1401t1315r1517b1368],
3	32	CD	NUMBER	32	num	2	SENT_307	[p19l1544t1313r1636b1369],
4	:	:	O	:	_	0	SENT_307	[p19l1544t1313r1636b1369],
5	101-106	CD	NUMBER	101-106	dep	2	SENT_307	[p19l1652t1313r1920b1369],

1	Kiivet	NNP	O	Kiivet	nn	2	SENT_308	[p19l8t1395r206b1450],
2	RA	NN	O	ra	_	0	SENT_308	[p19l239t1395r365b1460],
3	,	,	O	,	_	0	SENT_308	[p19l239t1395r365b1460],
4	Svensson	NNP	PERSON	Svensson	nn	5	SENT_308	[p19l405t1395r703b1450],
5	JO	NNP	PERSON	JO	appos	2	SENT_308	[p19l737t1395r841b1461],
6	,	,	O	,	_	0	SENT_308	[p19l737t1395r841b1461],
7	Bertilsson	NNP	ORGANIZATION	Bertilsson	nn	8	SENT_308	[p19l879t1395r1202b1450],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_308	[p19l1236t1396r1301b1461],
9	,	,	O	,	_	0	SENT_308	[p19l1236t1396r1301b1461],
10	Sjoqvist	NNP	O	Sjoqvist	nn	11	SENT_308	[p19l1341t1395r1600b1467],
11	F	NN	O	f	appos	2	SENT_308	[p19l1633t1396r1676b1449],
12	(	CD	NUMBER	(	num	11	SENT_308	[p19l1713t1395r1938b1463],
13	1993	CD	DATE	1993	num	14	SENT_308	[p19l1713t1395r1938b1463],
14	)	NN	O	)	dep	11	SENT_308	[p19l1713t1395r1938b1463],
15	.	.	O	.	_	0	SENT_308	[p19l1713t1395r1938b1463],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_309	[p19l1977t1395r2146b1467, p19l131t1475r454b1547],
2	of	IN	O	of	_	0	SENT_309	[p19l497t1475r565b1531],
3	debrisoquine	NN	O	debrisoquine	nn	6	SENT_309	[p19l604t1475r1014b1547],
4	and	CC	O	and	_	0	SENT_309	[p19l1058t1476r1170b1531],
5	mephenytoin	NN	O	mephenytoin	nn	6	SENT_309	[p19l1212t1475r1628b1547],
6	hydroxylations	NNS	O	hydroxylation	prep_of	1	SENT_309	[p19l1670t1475r2146b1547],
7	among	IN	O	among	_	0	SENT_309	[p19l133t1574r345b1628],
8	Estonians	NNS	MISC	estonian	prep_among	1	SENT_309	[p19l369t1556r694b1612],
9	.	.	O	.	_	0	SENT_309	[p19l369t1556r694b1612],

1	Pharmacol	NNP	PERSON	Pharmacol	nn	2	SENT_310	[p19l720t1556r1059b1612],
2	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_310	[p19l1083t1556r1323b1612],
3	72	CD	NUMBER	72	num	2	SENT_310	[p19l1347t1557r1441b1612],
4	:	:	O	:	_	0	SENT_310	[p19l1347t1557r1441b1612],
5	113-1	CD	NUMBER	113-1	number	6	SENT_310	[p19l1456t1557r1635b1612],
6	15	CD	NUMBER	15	dep	2	SENT_310	[p19l1650t1556r1716b1612],

1	Marandi	NNP	PERSON	Marandi	_	0	SENT_311	[p19l6t1637r274b1692],
2	T	NN	PERSON	t	dep	1	SENT_311	[p19l320t1639r378b1703],
3	,	,	O	,	_	0	SENT_311	[p19l320t1639r378b1703],
4	Dahl	NNP	PERSON	Dahl	nn	5	SENT_311	[p19l426t1637r578b1692],
5	ML	NNP	O	ML	conj_and	2	SENT_311	[p19l623t1639r758b1703],
6	,	,	O	,	_	0	SENT_311	[p19l623t1639r758b1703],
7	Kiivet	NNP	O	Kiivet	nn	8	SENT_311	[p19l807t1637r1005b1693],
8	RA	NN	O	ra	conj_and	2	SENT_311	[p19l1049t1638r1174b1703],
9	,	,	O	,	_	0	SENT_311	[p19l1049t1638r1174b1703],
10	Rago	NNP	PERSON	Rago	nn	11	SENT_311	[p19l1222t1639r1387b1709],
11	L	NNP	O	L	conj_and	2	SENT_311	[p19l1433t1639r1497b1703],
12	,	,	O	,	_	0	SENT_311	[p19l1433t1639r1497b1703],
13	Sjoqvist	NNP	O	Sjoqvist	nn	14	SENT_311	[p19l1547t1637r1806b1709],
14	F	NN	O	f	conj_and	2	SENT_311	[p19l1850t1639r1893b1692],
15	(	CD	NUMBER	(	num	14	SENT_311	[p19l1940t1637r2146b1706],
16	1996	CD	DATE	1996	num	18	SENT_311	[p19l1940t1637r2146b1706],
17	)	NN	O	)	nn	18	SENT_311	[p19l1940t1637r2146b1706],
18	Debrisoquin	NN	O	debrisoquin	dep	14	SENT_311	[p19l131t1719r524b1791],
19	and	CC	O	and	_	0	SENT_311	[p19l580t1719r692b1774],
20	S-mephenytoin	NN	O	s-mephenytoin	nn	22	SENT_311	[p19l748t1719r1232b1791],
21	hydroxylation	NN	O	hydroxylation	nn	22	SENT_311	[p19l1285t1719r1732b1791],
22	phenotypes	NNS	O	phenotype	dep	1	SENT_311	[p19l1785t1719r2146b1791],
23	and	CC	O	and	_	0	SENT_311	[p19l133t1799r245b1854],
24	CYPZD6	NN	O	cypzd6	nn	25	SENT_311	[p19l276t1798r556b1855],
25	genotypes	NNS	O	genotype	conj_and	2	SENT_311	[p19l581t1807r900b1871],
26	in	IN	O	in	_	0	SENT_311	[p19l929t1799r989b1853],
27	an	DT	O	a	det	29	SENT_311	[p19l1018t1816r1090b1854],
28	Estonian	JJ	MISC	estonian	amod	29	SENT_311	[p19l1116t1799r1394b1854],
29	population	NN	O	population	prep_in	1	SENT_311	[p19l1420t1799r1777b1871],
30	.	.	O	.	_	0	SENT_311	[p19l1420t1799r1777b1871],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_312	[p19l1808t1799r2148b1854],
2	Toxicol	NNP	O	Toxicol	_	0	SENT_312	[p19l131t1878r372b1934],
3	78:303	CD	NUMBER	78:303	num	4	SENT_312	[p19l395t1879r772b1934],
4	-307	CD	NUMBER	-307	dep	2	SENT_312	[p19l395t1879r772b1934],

1	Marandi	NNP	PERSON	Marandi	nn	2	SENT_313	[p19l6t2142r274b2197],
2	T	NN	PERSON	t	dep	18	SENT_313	[p19l320t2144r378b2208],
3	,	,	O	,	_	0	SENT_313	[p19l320t2144r378b2208],
4	Dahl	NNP	PERSON	Dahl	nn	5	SENT_313	[p19l426t2142r578b2197],
5	ML	NNP	O	ML	appos	2	SENT_313	[p19l623t2144r758b2208],
6	,	,	O	,	_	0	SENT_313	[p19l623t2144r758b2208],
7	Rago	NNP	PERSON	Rago	nn	8	SENT_313	[p19l806t2144r971b2214],
8	L	NNP	O	L	appos	2	SENT_313	[p19l1017t2144r1081b2208],
9	,	,	O	,	_	0	SENT_313	[p19l1017t2144r1081b2208],
10	Kiivet	NNP	O	Kiivet	nn	11	SENT_313	[p19l1130t2142r1327b2198],
11	RA	NN	O	ra	appos	2	SENT_313	[p19l1371t2143r1497b2208],
12	,	,	O	,	_	0	SENT_313	[p19l1371t2143r1497b2208],
13	Sjoqvist	NNP	O	Sjoqvist	nn	14	SENT_313	[p19l1547t2142r1806b2214],
14	F	NN	O	f	appos	2	SENT_313	[p19l1850t2144r1893b2197],
15	(	CD	NUMBER	(	num	14	SENT_313	[p19l1940t2142r2146b2211],
16	1997	CD	DATE	1997	num	18	SENT_313	[p19l1940t2142r2146b2211],
17	)	NN	O	)	nn	18	SENT_313	[p19l1940t2142r2146b2211],
18	Debrisoquin	NN	O	debrisoquin	_	0	SENT_313	[p19l131t2224r521b2295],
19	and	CC	O	and	_	0	SENT_313	[p19l547t2224r659b2279],
20	S-mephenytoin	NN	O	s-mephenytoin	nn	22	SENT_313	[p19l685t2224r1165b2296],
21	hydroxylation	NN	O	hydroxylation	nn	22	SENT_313	[p19l1189t2224r1632b2296],
22	polymorphisms	NNS	O	polymorphism	conj_and	18	SENT_313	[p19l1657t2224r2146b2296],
23	in	IN	O	in	_	0	SENT_313	[p19l131t2304r191b2359],
24	a	DT	O	a	det	27	SENT_313	[p19l217t2322r250b2360],
25	Russian	JJ	LOCATION	russian	amod	27	SENT_313	[p19l273t2304r519b2360],
26	population	NN	O	population	nn	27	SENT_313	[p19l543t2304r877b2376],
27	living	NN	O	living	prep_in	18	SENT_313	[p19l901t2304r1081b2376],
28	in	IN	O	in	_	0	SENT_313	[p19l1106t2304r1166b2359],
29	Estonia	NNP	LOCATION	Estonia	prep_in	27	SENT_313	[p19l1190t2304r1439b2360],
30	.	.	O	.	_	0	SENT_313	[p19l1190t2304r1439b2360],

1	Eur	NNP	O	Eur	nn	4	SENT_314	[p19l1467t2306r1580b2360],
2	J	NNP	O	J	nn	4	SENT_314	[p19l1603t2306r1632b2360],
3	Clin	NNP	O	Clin	nn	4	SENT_314	[p19l1658t2304r1790b2360],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_314	[p19l1815t2305r2148b2360],
5	532257-260	CD	NUMBER	532257-260	dep	4	SENT_314	[p19l132t2384r510b2440],

1	Marder	NNP	PERSON	Marder	nn	2	SENT_315	[p19l6t2465r241b2520],
2	SR	NN	O	sr	nsubj	25	SENT_315	[p19l275t2465r385b2531],
3	,	,	O	,	_	0	SENT_315	[p19l275t2465r385b2531],
4	Midha	NNP	ORGANIZATION	Midha	nn	5	SENT_315	[p19l421t2465r629b2520],
5	KK	NNP	ORGANIZATION	KK	appos	2	SENT_315	[p19l662t2466r791b2531],
6	,	,	O	,	_	0	SENT_315	[p19l662t2466r791b2531],
7	van	NNP	PERSON	van	nn	9	SENT_315	[p19l828t2483r940b2520],
8	Putten	NNP	PERSON	Putten	nn	9	SENT_315	[p19l973t2467r1176b2520],
9	T	NN	PERSON	t	appos	2	SENT_315	[p19l1209t2467r1267b2531],
10	,	,	O	,	_	0	SENT_315	[p19l1209t2467r1267b2531],
11	Aravagiri	NNP	ORGANIZATION	Aravagiri	nn	12	SENT_315	[p19l1303t2465r1607b2537],
12	M	NNP	ORGANIZATION	M	appos	2	SENT_315	[p19l1640t2467r1726b2531],
13	,	,	O	,	_	0	SENT_315	[p19l1640t2467r1726b2531],
14	Hawes	NNP	ORGANIZATION	Hawes	nn	15	SENT_315	[p19l1763t2467r1976b2520],
15	EM	NNP	ORGANIZATION	EM	appos	2	SENT_315	[p19l2010t2467r2145b2531],
16	,	,	O	,	_	0	SENT_315	[p19l2010t2467r2145b2531],
17	Hubbard	NNP	PERSON	Hubbard	nn	18	SENT_315	[p19l131t2547r409b2602],
18	JW	NNP	O	JW	appos	2	SENT_315	[p19l453t2548r567b2613],
19	,	,	O	,	_	0	SENT_315	[p19l453t2548r567b2613],
20	McKay	NNP	O	McKay	nn	21	SENT_315	[p19l615t2548r851b2619],
21	G	NNP	O	G	appos	2	SENT_315	[p19l898t2547r969b2612],
22	,	,	O	,	_	0	SENT_315	[p19l898t2547r969b2612],
23	Mintz	NNP	PERSON	Mintz	nn	24	SENT_315	[p19l1017t2547r1205b2602],
24	J	NNP	PERSON	J	appos	2	SENT_315	[p19l1251t2548r1280b2602],
25	(	VBD	O	(	_	0	SENT_315	[p19l1328t2547r1534b2615],
26	1991	CD	DATE	1991	number	27	SENT_315	[p19l1328t2547r1534b2615],
27	)	CD	NUMBER	)	num	29	SENT_315	[p19l1328t2547r1534b2615],
28	Plasma	NN	O	plasma	nn	29	SENT_315	[p19l1581t2547r1810b2602],
29	levels	NNS	O	level	dobj	25	SENT_315	[p19l1855t2547r2037b2602],
30	of	IN	O	of	_	0	SENT_315	[p19l2085t2547r2153b2602],
31	ﬂuphenazine	NN	O	ﬂuphenazine	nn	32	SENT_315	[p19l131t2628r542b2700],
32	decanoate	NN	O	decanoate	prep_of	29	SENT_315	[p19l571t2628r904b2683],
33	:	:	O	:	_	0	SENT_315	[p19l571t2628r904b2683],
34	relationship	NN	O	relationship	dep	29	SENT_315	[p19l936t2628r1312b2700],
35	to	TO	O	to	_	0	SENT_315	[p19l1341t2636r1400b2683],
36	clinical	JJ	O	clinical	amod	37	SENT_315	[p19l1429t2628r1662b2683],
37	response	NN	O	response	prep_to	34	SENT_315	[p19l1688t2645r1983b2700],
38	.	.	O	.	_	0	SENT_315	[p19l1688t2645r1983b2700],

1	Br	NN	O	br	nn	2	SENT_316	[p19l2015t2629r2094b2682],
2	J	NN	O	j	_	0	SENT_316	[p19l2119t2629r2148b2683],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_316	[p19l131t2708r466b2780],
4	1582658-665	CD	NUMBER	1582658-665	num	3	SENT_316	[p19l497t2708r905b2764],

1	Miller	NNP	PERSON	Miller	nn	2	SENT_317	[p19l7t2789r206b2844],
2	CH	NN	O	ch	nsubj	30	SENT_317	[p19l251t2789r375b2854],
3	,	,	O	,	_	0	SENT_317	[p19l251t2789r375b2854],
4	Simioni	NNP	PERSON	Simioni	nn	5	SENT_317	[p19l426t2789r674b2844],
5	M	NNP	O	M	appos	2	SENT_317	[p19l720t2791r806b2854],
6	,	,	O	,	_	0	SENT_317	[p19l720t2791r806b2854],
7	Oberbauer	NNP	O	Oberbauer	nn	8	SENT_317	[p19l855t2789r1191b2844],
8	H	NNP	O	H	appos	5	SENT_317	[p19l1235t2791r1307b2854],
9	,	,	O	,	_	0	SENT_317	[p19l1235t2791r1307b2854],
10	Schwitzer	NNP	PERSON	Schwitzer	nn	11	SENT_317	[p19l1357t2789r1674b2844],
11	J	NNP	PERSON	J	appos	5	SENT_317	[p19l1717t2791r1747b2844],
12	,	,	O	,	_	0	SENT_317	[p19l1752t2835r1764b2854],
13	Barnas	NNP	PERSON	Barnas	nn	14	SENT_317	[p19l1812t2791r2030b2844],
14	C	NNP	O	C	appos	5	SENT_317	[p19l2079t2790r2146b2854],
15	,	,	O	,	_	0	SENT_317	[p19l2079t2790r2146b2854],
16	Kulhanek	NNP	PERSON	Kulhanek	nn	17	SENT_317	[p19l132t2870r433b2925],
17	F	NN	O	f	appos	5	SENT_317	[p19l453t2871r505b2935],
18	,	,	O	,	_	0	SENT_317	[p19l453t2871r505b2935],
19	Boissel	NNP	PERSON	Boissel	nn	20	SENT_317	[p19l530t2870r756b2925],
20	KE	NNP	PERSON	KE	appos	5	SENT_317	[p19l780t2871r898b2935],
21	,	,	O	,	_	0	SENT_317	[p19l780t2871r898b2935],
22	Meise	NNP	ORGANIZATION	Meise	nn	23	SENT_317	[p19l922t2870r1110b2925],
23	U	NNP	ORGANIZATION	U	appos	5	SENT_317	[p19l1133t2871r1204b2935],
24	,	,	O	,	_	0	SENT_317	[p19l1133t2871r1204b2935],
25	Hinterhuber	NNP	O	Hinterhuber	nn	26	SENT_317	[p19l1230t2870r1603b2925],
26	H	NNP	O	H	appos	5	SENT_317	[p19l1624t2871r1695b2935],
27	,	,	O	,	_	0	SENT_317	[p19l1624t2871r1695b2935],
28	Fleischhacker	NNP	PERSON	Fleischhacker	nn	29	SENT_317	[p19l1720t2870r2149b2925],
29	WW	NNP	O	WW	appos	5	SENT_317	[p19l130t2950r279b3004],
30	(	VBD	O	(	_	0	SENT_317	[p19l332t2948r537b3017],
31	1995	CD	DATE	1995	num	36	SENT_317	[p19l332t2948r537b3017],
32	)	CD	NUMBER	)	num	36	SENT_317	[p19l332t2948r537b3017],
33	Tardive	NNP	O	Tardive	nn	36	SENT_317	[p19l589t2949r830b3004],
34	dyskinesia	NN	O	dyskinesium	nn	36	SENT_317	[p19l881t2949r1217b3021],
35	prevalence	NN	O	prevalence	nn	36	SENT_317	[p19l1264t2949r1610b3021],
36	rates	NNS	O	rate	dobj	30	SENT_317	[p19l1659t2957r1807b3004],
37	during	IN	O	during	_	0	SENT_317	[p19l1859t2949r2064b3021],
38	a	DT	O	a	det	40	SENT_317	[p19l2117t2966r2149b3004],
39	ten-year	JJ	DURATION	ten-year	amod	40	SENT_317	[p19l131t3038r393b3101],
40	follow-up	NN	O	follow-up	prep_during	36	SENT_317	[p19l414t3029r743b3101],
41	.	.	O	.	_	0	SENT_317	[p19l414t3029r743b3101],

1	J	NNP	O	J	nn	4	SENT_318	[p19l769t3031r798b3085],
2	Nerv	NNP	O	Nerv	nn	4	SENT_318	[p19l821t3031r978b3085],
3	Ment	NNP	O	Ment	nn	4	SENT_318	[p19l1001t3031r1168b3085],
4	Dis	NNP	O	Dis	_	0	SENT_318	[p19l1190t3029r1296b3085],
5	183:404	CD	NUMBER	183:404	num	6	SENT_318	[p19l1329t3030r1738b3085],
6	-407	CD	NUMBER	-407	dep	4	SENT_318	[p19l1329t3030r1738b3085],

1	Morgenstern	NNP	PERSON	Morgenstern	nn	2	SENT_319	[p19l6t3112r411b3182],
2	H	NNP	O	H	nsubj	20	SENT_319	[p19l451t3112r523b3176],
3	,	,	O	,	_	0	SENT_319	[p19l451t3112r523b3176],
4	Glazer	NNP	PERSON	Glazer	nn	5	SENT_319	[p19l567t3110r779b3166],
5	WM	NNP	O	WM	nsubj	6	SENT_319	[p19l816t3112r960b3166],
6	(	VBD	O	(	parataxis	20	SENT_319	[p19l1003t3111r1209b3179],
7	1993	CD	DATE	1993	num	8	SENT_319	[p19l1003t3111r1209b3179],
8	)	CD	NUMBER	)	dobj	6	SENT_319	[p19l1003t3111r1209b3179],
9	Identifying	VBG	O	identify	xcomp	6	SENT_319	[p19l1251t3110r1603b3182],
10	risk	NN	O	risk	nn	11	SENT_319	[p19l1643t3110r1764b3166],
11	factors	NNS	O	factor	dobj	9	SENT_319	[p19l1802t3110r2015b3166],
12	for	IN	O	for	_	0	SENT_319	[p19l2057t3110r2149b3166],
13	tardive	JJ	O	tardive	amod	14	SENT_319	[p19l131t3191r351b3247],
14	dyskinesia	NN	O	dyskinesium	prep_for	9	SENT_319	[p19l398t3191r734b3263],
15	among	IN	O	among	_	0	SENT_319	[p19l781t3209r993b3263],
16	long	JJ	O	long	amod	19	SENT_319	[p19l1041t3191r1354b3263],
17	—	JJ	O	—	amod	19	SENT_319	[p19l1041t3191r1354b3263],
18	term	NN	O	term	nn	19	SENT_319	[p19l1041t3191r1354b3263],
19	outpatients	NNS	O	outpatient	prep_among	14	SENT_319	[p19l1401t3191r1747b3263],
20	maintained	VBD	O	maintain	_	0	SENT_319	[p19l1795t3191r2149b3246],
21	with	IN	O	with	_	0	SENT_319	[p19l132t3273r269b3328],
22	neuroleptic	JJ	O	neuroleptic	amod	23	SENT_319	[p19l290t3273r638b3345],
23	medications	NNS	O	medication	prep_with	20	SENT_319	[p19l661t3273r1053b3328],
24	.	.	O	.	_	0	SENT_319	[p19l661t3273r1053b3328],

1	Arch	NNP	ORGANIZATION	Arch	nn	3	SENT_320	[p19l1077t3273r1233b3328],
2	Gen	NN	ORGANIZATION	gen	nn	3	SENT_320	[p19l1255t3273r1383b3328],
3	Psychiatry	NNP	ORGANIZATION	Psychiatry	dep	7	SENT_320	[p19l1403t3273r1731b3345],
4	50:723	CD	NUMBER	50:723	dep	3	SENT_320	[p19l1754t3273r2121b3328],
5	-733	CD	NUMBER	-733	num	6	SENT_320	[p19l1754t3273r2121b3328],
6	Muscettola	NN	O	muscettolum	dep	7	SENT_320	[p19l6t3354r361b3409],
7	G	NN	O	g	dep	19	SENT_320	[p19l399t3354r470b3419],
8	,	,	O	,	_	0	SENT_320	[p19l399t3354r470b3419],
9	Pampallona	NNP	PERSON	Pampallona	nn	10	SENT_320	[p19l510t3354r887b3425],
10	S	NNP	O	S	appos	7	SENT_320	[p19l925t3354r982b3419],
11	,	,	O	,	_	0	SENT_320	[p19l925t3354r982b3419],
12	Barbato	NNP	PERSON	Barbato	nn	13	SENT_320	[p19l1023t3354r1272b3409],
13	G	NNP	PERSON	G	appos	7	SENT_320	[p19l1313t3354r1384b3419],
14	,	,	O	,	_	0	SENT_320	[p19l1313t3354r1384b3419],
15	Casiello	NNP	O	Casiello	nn	16	SENT_320	[p19l1425t3353r1683b3409],
16	M	NNP	O	M	appos	7	SENT_320	[p19l1721t3355r1807b3419],
17	,	,	O	,	_	0	SENT_320	[p19l1721t3355r1807b3419],
18	Bollini	NNP	PERSON	Bollini	appos	7	SENT_320	[p19l1848t3353r2068b3409],
19	P	NN	PERSON	p	dep	22	SENT_320	[p19l2106t3355r2148b3408],
20	(	CD	NUMBER	(	num	19	SENT_320	[p19l134t3435r338b3503],
21	1993	CD	DATE	1993	num	22	SENT_320	[p19l134t3435r338b3503],
22	)	CD	NUMBER	)	dep	31	SENT_320	[p19l134t3435r338b3503],
23	Persistent	JJ	O	persistent	amod	25	SENT_320	[p19l364t3434r671b3490],
24	tardive	JJ	O	tardive	amod	25	SENT_320	[p19l694t3434r911b3490],
25	dyskinesia	NN	O	dyskinesium	dep	22	SENT_320	[p19l937t3434r1285b3506],
26	:	:	O	:	_	0	SENT_320	[p19l937t3434r1285b3506],
27	demographic	JJ	O	demographic	amod	31	SENT_320	[p19l1315t3434r1724b3506],
28	and	CC	O	and	_	0	SENT_320	[p19l1752t3434r1863b3490],
29	pharmacological	JJ	O	pharmacological	amod	31	SENT_320	[p19l1886t3434r2146b3506, p19l132t3515r422b3587],
30	risk	NN	O	risk	nn	31	SENT_320	[p19l444t3515r564b3570],
31	factors	NNS	O	factor	_	0	SENT_320	[p19l585t3515r817b3570],
32	.	.	O	.	_	0	SENT_320	[p19l585t3515r817b3570],

1	Acta	NNP	O	Acta	nn	3	SENT_321	[p19l843t3516r993b3570],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_321	[p19l1014t3515r1311b3587],
3	Scand	NNP	O	Scand	_	0	SENT_321	[p19l1335t3515r1526b3571],
4	87:29	CD	NUMBER	87:29	num	5	SENT_321	[p19l1551t3515r1846b3571],
5	-36	CD	NUMBER	-36	dep	3	SENT_321	[p19l1551t3515r1846b3571],

1	Overall	JJ	O	overall	amod	5	SENT_322	[p19l8t3597r244b3652],
2	JE	NN	O	je	nn	5	SENT_322	[p19l271t3598r366b3662],
3	,	,	O	,	_	0	SENT_322	[p19l271t3598r366b3662],
4	Gorham	NNP	PERSON	Gorham	dep	5	SENT_322	[p19l398t3597r657b3652],
5	DR	NN	O	dr	_	0	SENT_322	[p19l683t3598r792b3651],
6	(	CD	NUMBER	(	num	5	SENT_322	[p19l821t3597r1027b3665],
7	1962	CD	DATE	1962	num	8	SENT_322	[p19l821t3597r1027b3665],
8	)	CD	NUMBER	)	dep	5	SENT_322	[p19l821t3597r1027b3665],
9	The	DT	O	the	det	13	SENT_322	[p19l1057t3597r1178b3652],
10	brief	NN	O	brief	nn	13	SENT_322	[p19l1205t3597r1360b3652],
11	psychiatric	JJ	O	psychiatric	amod	13	SENT_322	[p19l1381t3597r1730b3669],
12	rating	NN	O	rating	nn	13	SENT_322	[p19l1757t3597r1942b3669],
13	scale	NN	O	scale	dep	8	SENT_322	[p19l1973t3597r2144b3652],
14	.	.	O	.	_	0	SENT_322	[p19l1973t3597r2144b3652],

1	Psychol	NNP	O	Psychol	nn	2	SENT_323	[p19l131t3678r382b3750],
2	Rep	NNP	O	Rep	_	0	SENT_323	[p19l405t3679r530b3750],
3	10:799	CD	NUMBER	10:799	num	4	SENT_323	[p19l561t3678r932b3734],
4	-812	CD	NUMBER	-812	dep	2	SENT_323	[p19l561t3678r932b3734],

1	Poulsen	NNP	PERSON	Poulsen	nn	2	SENT_324	[p19l7t3758r258b3814],
2	JH	NNP	O	JH	dep	12	SENT_324	[p19l290t3760r393b3824],
3	,	,	O	,	_	0	SENT_324	[p19l290t3760r393b3824],
4	Olesen	NNP	PERSON	Olesen	nn	5	SENT_324	[p19l430t3758r649b3814],
5	OV	NNP	O	OV	appos	2	SENT_324	[p19l682t3759r801b3824],
6	,	,	O	,	_	0	SENT_324	[p19l682t3759r801b3824],
7	Larsen	NNP	PERSON	Larsen	appos	2	SENT_324	[p19l836t3760r1052b3814],
8	NE	NN	O	ne	dep	12	SENT_324	[p19l1083t3760r1188b3814],
9	(	CD	NUMBER	(	num	8	SENT_324	[p19l1222t3759r1428b3827],
10	1994	CD	DATE	1994	num	12	SENT_324	[p19l1222t3759r1428b3827],
11	)	NNP	O	)	nn	12	SENT_324	[p19l1222t3759r1428b3827],
12	Fluctuation	NN	O	fluctuation	dep	17	SENT_324	[p19l1463t3758r1826b3814],
13	of	IN	O	of	_	0	SENT_324	[p19l1859t3758r1928b3814],
14	serum	NN	O	serum	nn	16	SENT_324	[p19l1958t3776r2149b3814],
15	zuclopenthixol	NN	O	zuclopenthixol	nn	16	SENT_324	[p20l132t15r604b87],
16	concentrations	NNS	O	concentration	prep_of	12	SENT_324	[p20l642t15r1104b70],
17	in	IN	O	in	_	0	SENT_324	[p20l1142t15r1202b70],
18	patients	NNS	O	patient	pobj	17	SENT_324	[p20l1238t15r1483b87],
19	treated	VBN	O	treat	partmod	18	SENT_324	[p20l1522t15r1738b70],
20	with	IN	O	with	_	0	SENT_324	[p20l1774t15r1914b71],
21	zuclo	NN	O	zuclo	nn	24	SENT_324	[p20l1951t15r2146b70],
22	—	NN	O	—	nn	24	SENT_324	[p20l1951t15r2146b70],
23	penthixol	NN	O	penthixol	nn	24	SENT_324	[p20l130t97r431b169],
24	decanoate	NN	O	decanoate	prep_with	19	SENT_324	[p20l455t97r771b152],
25	in	IN	O	in	_	0	SENT_324	[p20l794t97r854b151],
26	viscoleo	NN	O	viscoleo	prep_in	24	SENT_324	[p20l877t97r1157b152],
27	.	.	O	.	_	0	SENT_324	[p20l877t97r1157b152],

1	Ther	NNP	O	Ther	nn	3	SENT_325	[p20l1183t97r1333b152],
2	Drug	NNP	O	Drug	nn	3	SENT_325	[p20l1354t98r1516b169],
3	Monit	NNP	O	Monit	_	0	SENT_325	[p20l1539t97r1733b152],
4	16	CD	NUMBER	16	num	3	SENT_325	[p20l1762t97r1849b152],
5	:	:	O	:	_	0	SENT_325	[p20l1762t97r1849b152],
6	155-159	CD	NUMBER	155-159	dep	3	SENT_325	[p20l1865t97r2132b153],
7	Richardson	NNP	ORGANIZATION	Richardson	nn	8	SENT_325	[p20l7t178r365b233],
8	MA	NNP	ORGANIZATION	MA	dep	3	SENT_325	[p20l387t178r529b243],
9	,	,	O	,	_	0	SENT_325	[p20l387t178r529b243],
10	Craig	NNP	PERSON	Craig	nn	11	SENT_325	[p20l555t178r727b250],
11	TJ	NNP	PERSON	TJ	appos	3	SENT_325	[p20l750t179r827b233],
12	(	CD	NUMBER	(	num	11	SENT_325	[p20l851t178r1055b246],
13	1982	CD	DATE	1982	num	14	SENT_325	[p20l851t178r1055b246],
14	)	CD	NUMBER	)	dep	11	SENT_325	[p20l851t178r1055b246],
15	The	DT	O	the	det	16	SENT_325	[p20l1080t178r1200b233],
16	coexistence	NN	O	coexistence	dep	3	SENT_325	[p20l1223t178r1589b233],
17	of	IN	O	of	_	0	SENT_325	[p20l1613t178r1680b233],
18	parl	NN	O	parl	prep_of	16	SENT_325	[p20l1696t178r2146b250, p20l131t258r249b314],
19	<	JJR	O	<	amod	21	SENT_325	[p20l1696t178r2146b250, p20l131t258r249b314],
20	insonismlike	JJ	O	insonismlike	amod	21	SENT_325	[p20l1696t178r2146b250, p20l131t258r249b314],
21	symptoms	NNS	O	symptom	dep	3	SENT_325	[p20l285t267r606b330],
22	and	CC	O	and	_	0	SENT_325	[p20l642t259r754b314],
23	tardive	JJ	O	tardive	amod	24	SENT_325	[p20l787t258r1006b314],
24	dyskinesia	NN	O	dyskinesium	conj_and	21	SENT_325	[p20l1041t258r1391b330],
25	.	.	O	.	_	0	SENT_325	[p20l1041t258r1391b330],

1	Am	VBP	O	be	dep	2	SENT_326	[p20l1428t259r1546b313],
2	J	NN	O	j	_	0	SENT_326	[p20l1578t260r1607b314],
3	Psychiatry	NNP	O	Psychiatry	dep	2	SENT_326	[p20l1640t258r1975b330],
4	139	CD	NUMBER	139	num	3	SENT_326	[p20l2016t259r2143b315],
5	:	:	O	:	_	0	SENT_326	[p20l2016t259r2143b315],
6	341-343	CD	NUMBER	341-343	dep	3	SENT_326	[p20l133t339r405b394],

1	Schooler	NNP	O	Schooler	nn	2	SENT_327	[p20l9t419r290b475],
2	NR	NNP	O	NR	nsubj	10	SENT_327	[p20l331t421r457b485],
3	,	,	O	,	_	0	SENT_327	[p20l331t421r457b485],
4	Kane	NNP	PERSON	Kane	appos	2	SENT_327	[p20l503t420r668b474],
5	JM	NN	O	jm	nn	9	SENT_327	[p20l710t421r809b475],
6	(	CD	NUMBER	(	num	9	SENT_327	[p20l855t420r1061b488],
7	1982	CD	DATE	1982	num	9	SENT_327	[p20l855t420r1061b488],
8	)	NNP	O	)	nn	9	SENT_327	[p20l855t420r1061b488],
9	Research	NNP	O	Research	dep	4	SENT_327	[p20l1105t419r1397b474],
10	diagnoses	VBZ	O	diagnose	_	0	SENT_327	[p20l1440t419r1750b491],
11	for	IN	O	for	_	0	SENT_327	[p20l1795t419r1887b474],
12	tardive	JJ	O	tardive	amod	13	SENT_327	[p20l1928t419r2147b474],
13	dyskinesia	NN	O	dyskinesium	prep_for	10	SENT_327	[p20l132t501r483b573],
14	.	.	O	.	_	0	SENT_327	[p20l132t501r483b573],

1	Arch	NNP	O	Arch	nn	3	SENT_328	[p20l509t501r668b556],
2	Gen	NN	O	gen	nn	3	SENT_328	[p20l691t501r821b556],
3	Psychiatry	NNP	O	Psychiatry	_	0	SENT_328	[p20l842t501r1177b573],
4	39:486	CD	NUMBER	39:486	dep	3	SENT_328	[p20l1203t501r1578b557],
5	—	CD	NUMBER	—	number	6	SENT_328	[p20l1203t501r1578b557],
6	487	CD	NUMBER	487	dep	4	SENT_328	[p20l1203t501r1578b557],

1	Scordo	NNP	O	Scordo	nn	2	SENT_329	[p20l9t582r230b637],
2	MG	NN	O	mg	nsubj	18	SENT_329	[p20l261t582r404b647],
3	,	,	O	,	_	0	SENT_329	[p20l261t582r404b647],
4	Spina	NNP	PERSON	Spina	nn	5	SENT_329	[p20l440t581r619b653],
5	E	NNP	PERSON	E	appos	2	SENT_329	[p20l648t583r712b647],
6	,	,	O	,	_	0	SENT_329	[p20l648t583r712b647],
7	Facciola	NNP	PERSON	Facciola	nn	8	SENT_329	[p20l745t581r1016b637],
8	G	NNP	PERSON	G	appos	2	SENT_329	[p20l1046t582r1117b647],
9	,	,	O	,	_	0	SENT_329	[p20l1046t582r1117b647],
10	Avenoso	NNP	PERSON	Avenoso	nn	11	SENT_329	[p20l1151t582r1425b637],
11	A	NNP	O	A	appos	2	SENT_329	[p20l1457t582r1529b647],
12	,	,	O	,	_	0	SENT_329	[p20l1457t582r1529b647],
13	Johansson	NNP	PERSON	Johansson	appos	2	SENT_329	[p20l1562t582r1889b637],
14	1	CD	NUMBER	1	num	13	SENT_329	[p20l1920t583r1961b647],
15	,	,	O	,	_	0	SENT_329	[p20l1920t583r1961b647],
16	Dahl	NNP	PERSON	Dahl	nn	17	SENT_329	[p20l1995t581r2148b637],
17	ML	NNP	O	ML	appos	2	SENT_329	[p20l131t664r249b717],
18	(	VBD	O	(	_	0	SENT_329	[p20l282t663r488b731],
19	1999	CD	DATE	1999	num	21	SENT_329	[p20l282t663r488b731],
20	)	CD	NUMBER	)	num	21	SENT_329	[p20l282t663r488b731],
21	Cytochrome	NN	O	cytochrome	dobj	18	SENT_329	[p20l522t662r913b734],
22	P450	NN	O	p450	nn	24	SENT_329	[p20l945t662r1106b718],
23	2D6	NN	O	2d6	nn	24	SENT_329	[p20l1139t662r1272b718],
24	genotype	NN	O	genotype	dep	21	SENT_329	[p20l1305t671r1594b734],
25	and	CC	O	and	_	0	SENT_329	[p20l1628t662r1740b718],
26	steady	JJ	O	steady	amod	29	SENT_329	[p20l1773t662r1972b734],
27	state	NN	O	state	nn	29	SENT_329	[p20l2006t671r2147b718],
28	plasma	NN	O	plasma	nn	29	SENT_329	[p20l130t743r353b815],
29	levels	NNS	O	level	conj_and	21	SENT_329	[p20l376t743r554b798],
30	of	IN	O	of	_	0	SENT_329	[p20l582t743r649b798],
31	risperidone	NN	O	risperidone	prep_of	29	SENT_329	[p20l667t743r1018b815],
32	and	CC	O	and	_	0	SENT_329	[p20l1044t743r1154b798],
33	9	CD	NUMBER	9	num	35	SENT_329	[p20l1179t743r1869b815],
34	—	NN	O	—	nn	35	SENT_329	[p20l1179t743r1869b815],
35	hydroXyrisperidone	NN	O	hydroxyrisperidone	prep_of	29	SENT_329	[p20l1179t743r1869b815],
36	.	.	O	.	_	0	SENT_329	[p20l1179t743r1869b815],

1	Psychopharmacology	NN	O	psychopharmacology	_	0	SENT_330	[p20l1897t743r2146b815, p20l130t825r585b897],
2	147:300	CD	NUMBER	147:300	num	3	SENT_330	[p20l616t825r1024b880],
3	—	NN	O	—	dep	1	SENT_330	[p20l616t825r1024b880],
4	305	CD	NUMBER	305	dep	1	SENT_330	[p20l616t825r1024b880],

1	Simpson	NNP	PERSON	Simpson	nn	2	SENT_331	[p20l9t906r282b978],
2	GM	NNP	O	GM	_	0	SENT_331	[p20l305t906r446b971],
3	,	,	O	,	_	0	SENT_331	[p20l305t906r446b971],
4	Angus	NNP	PERSON	Angus	nn	6	SENT_331	[p20l471t906r674b978],
5	J	NNP	PERSON	J	nn	6	SENT_331	[p20l697t907r726b961],
6	WS	NNP	PERSON	WS	appos	2	SENT_331	[p20l728t906r842b961],
7	(	CD	NUMBER	(	num	9	SENT_331	[p20l870t906r1074b974],
8	1970	CD	DATE	1970	num	9	SENT_331	[p20l870t906r1074b974],
9	)	NN	O	)	dep	6	SENT_331	[p20l870t906r1074b974],
10	A	DT	O	a	det	12	SENT_331	[p20l1098t906r1154b960],
11	rating	NN	O	rating	nn	12	SENT_331	[p20l1175t906r1357b978],
12	scale	NN	O	scale	dep	2	SENT_331	[p20l1383t906r1536b961],
13	for	IN	O	for	_	0	SENT_331	[p20l1559t906r1650b961],
14	extrapyramidal	JJ	O	extrapyramidal	amod	16	SENT_331	[p20l1672t906r2148b978],
15	side	JJ	O	side	amod	16	SENT_331	[p20l134t986r257b1042],
16	effects	NNS	O	effect	prep_for	12	SENT_331	[p20l281t986r506b1042],
17	.	.	O	.	_	0	SENT_331	[p20l281t986r506b1042],

1	Acta	NNP	O	Acta	nn	3	SENT_332	[p20l533t987r683b1042],
2	Psychiatr	NNP	O	Psychiatr	nn	3	SENT_332	[p20l704t986r1001b1058],
3	Scand	NNP	O	Scand	_	0	SENT_332	[p20l1024t987r1216b1042],
4	212	CD	NUMBER	212	number	5	SENT_332	[p20l1239t986r1813b1058],
5	[	CD	NUMBER	[	num	7	SENT_332	[p20l1239t986r1813b1058],
6	Suppl	NN	O	suppl	nn	7	SENT_332	[p20l1239t986r1813b1058],
7	]	NN	O	]	dep	3	SENT_332	[p20l1239t986r1813b1058],
8	:11	CD	NUMBER	:11	number	9	SENT_332	[p20l1239t986r1813b1058],
9	—	CD	NUMBER	—	dep	3	SENT_332	[p20l1239t986r1813b1058],
10	19	CD	NUMBER	19	dep	9	SENT_332	[p20l1239t986r1813b1058],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_333	[p20l7t1067r102b1123],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_333	[p20l132t1069r508b1139],
3	of	IN	ORGANIZATION	of	_	0	SENT_333	[p20l534t1067r603b1122],
4	Health	NNP	ORGANIZATION	Health	prep_of	2	SENT_333	[p20l624t1067r852b1133],
5	,	,	ORGANIZATION	,	_	0	SENT_333	[p20l624t1067r852b1133],
6	Education	NNP	ORGANIZATION	Education	prep_of	2	SENT_333	[p20l880t1067r1203b1122],
7	&	CC	ORGANIZATION	&	_	0	SENT_333	[p20l1231t1068r1287b1123],
8	Welfare	NNP	ORGANIZATION	Welfare	conj_and	4	SENT_333	[p20l1314t1067r1563b1122],
9	(	CD	NUMBER	(	num	10	SENT_333	[p20l1592t1067r1798b1136],
10	1976	CD	DATE	1976	dep	2	SENT_333	[p20l1592t1067r1798b1136],
11	)	CD	NUMBER	)	num	15	SENT_333	[p20l1592t1067r1798b1136],
12	Abnormal	JJ	O	abnormal	amod	15	SENT_333	[p20l1826t1067r2148b1122],
13	involuntary	JJ	O	involuntary	amod	15	SENT_333	[p20l131t1149r497b1221],
14	movements	NNS	O	movement	nn	15	SENT_333	[p20l523t1157r887b1204],
15	scale	NN	O	scale	dep	10	SENT_333	[p20l917t1149r1088b1204],
16	.	.	O	.	_	0	SENT_333	[p20l917t1149r1088b1204],

1	In	IN	O	in	dep	4	SENT_334	[p20l1118t1150r1198b1204],
2	:	:	O	:	_	0	SENT_334	[p20l1118t1150r1198b1204],
3	Guy	NNP	O	Guy	nn	4	SENT_334	[p20l1231t1149r1364b1221],
4	W	NNP	O	W	_	0	SENT_334	[p20l1389t1150r1463b1204],
5	(	CD	NUMBER	(	nsubj	6	SENT_334	[p20l1490t1149r1612b1217],
6	ed	VBD	O	ed	rcmod	4	SENT_334	[p20l1490t1149r1612b1217],
7	)	CD	NUMBER	)	num	10	SENT_334	[p20l1490t1149r1612b1217],
8	ECDEU	NN	O	ecdeu	nn	10	SENT_334	[p20l1639t1149r1903b1204],
9	assessment	NN	O	assessment	nn	10	SENT_334	[p20l1930t1167r2146b1204, p20l131t1238r290b1285],
10	manual	NN	O	manual	dobj	6	SENT_334	[p20l312t1230r561b1285],
11	.	.	O	.	_	0	SENT_334	[p20l312t1230r561b1285],

1	US	NNP	ORGANIZATION	US	nn	2	SENT_335	[p20l588t1230r684b1285],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_335	[p20l711t1231r1087b1302],
3	of	IN	ORGANIZATION	of	_	0	SENT_335	[p20l1110t1230r1179b1285],
4	Health	NNP	ORGANIZATION	Health	prep_of	2	SENT_335	[p20l1197t1230r1425b1295],
5	,	,	ORGANIZATION	,	_	0	SENT_335	[p20l1197t1230r1425b1295],
6	Education	NNP	ORGANIZATION	Education	conj_and	4	SENT_335	[p20l1450t1230r1773b1285],
7	&	CC	ORGANIZATION	&	_	0	SENT_335	[p20l1798t1230r1855b1285],
8	Welfare	NNP	ORGANIZATION	Welfare	prep_of	2	SENT_335	[p20l1878t1230r2145b1295],
9	,	,	O	,	_	0	SENT_335	[p20l1878t1230r2145b1295],
10	Rockville	NNP	LOCATION	Rockville	nn	12	SENT_335	[p20l131t1310r457b1375],
11	,	,	O	,	_	0	SENT_335	[p20l131t1310r457b1375],
12	Md.	NNP	LOCATION	Md.	appos	4	SENT_335	[p20l483t1310r607b1366],
13	.	.	O	.	_	0	SENT_335	[p20l483t1310r607b1366],

1	World	NNP	ORGANIZATION	World	nn	3	SENT_336	[p20l6t1390r201b1446],
2	Health	NNP	ORGANIZATION	Health	nn	3	SENT_336	[p20l224t1390r433b1446],
3	Organization	NNP	ORGANIZATION	Organization	nsubj	16	SENT_336	[p20l458t1390r866b1462],
4	(	CD	NUMBER	(	num	8	SENT_336	[p20l892t1391r1096b1459],
5	1992	CD	DATE	1992	num	8	SENT_336	[p20l892t1391r1096b1459],
6	)	NNP	O	)	nn	8	SENT_336	[p20l892t1391r1096b1459],
7	International	NNP	O	International	nn	8	SENT_336	[p20l1122t1390r1524b1446],
8	Statistical	NNP	O	Statistical	dep	3	SENT_336	[p20l1550t1390r1858b1446],
9	Classification	NN	O	classification	dep	3	SENT_336	[p20l1883t1390r2146b1446, p20l132t1471r325b1526],
10	of	IN	O	of	_	0	SENT_336	[p20l369t1471r437b1526],
11	Diseases	NNS	O	disease	prep_of	9	SENT_336	[p20l474t1471r750b1527],
12	and	CC	O	and	_	0	SENT_336	[p20l797t1471r909b1526],
13	Related	NNP	O	Related	nn	15	SENT_336	[p20l951t1471r1194b1526],
14	Health	NNP	O	Health	nn	15	SENT_336	[p20l1236t1471r1447b1527],
15	Problems	NNS	O	problem	conj_and	11	SENT_336	[p20l1490t1471r1788b1527],
16	(	VBP	O	(	_	0	SENT_336	[p20l1835t1471r2144b1540],
17	ICD-10	NN	O	icd-10	nn	18	SENT_336	[p20l1835t1471r2144b1540],
18	)	NN	O	)	dobj	16	SENT_336	[p20l1835t1471r2144b1540],
19	.	.	O	.	_	0	SENT_336	[p20l1835t1471r2144b1540],

1	World	NNP	O	World	nn	3	SENT_337	[p20l130t1553r327b1608],
2	Health	NNP	O	Health	nn	3	SENT_337	[p20l349t1553r561b1608],
3	Organization	NNP	O	Organization	_	0	SENT_337	[p20l584t1553r1014b1625],
4	,	,	O	,	_	0	SENT_337	[p20l584t1553r1014b1625],
5	Geneva	NNP	LOCATION	Geneva	nn	7	SENT_337	[p20l1041t1553r1298b1619],
6	,	,	O	,	_	0	SENT_337	[p20l1041t1553r1298b1619],
7	Switzerland	NNP	LOCATION	Switzerland	appos	3	SENT_337	[p20l1326t1553r1704b1608],

1	ZumBrunnen	NNP	O	ZumBrunnen	nn	2	SENT_338	[p20l6t1635r430b1689],
2	TL	NNP	O	TL	_	0	SENT_338	[p20l466t1635r578b1699],
3	,	,	O	,	_	0	SENT_338	[p20l466t1635r578b1699],
4	Jann	NNP	PERSON	Jann	nn	5	SENT_338	[p20l617t1635r761b1689],
5	MW	NNP	PERSON	MW	appos	2	SENT_338	[p20l797t1635r941b1689],
6	(	CD	NUMBER	(	num	10	SENT_338	[p20l979t1634r1185b1702],
7	1998	CD	DATE	1998	num	10	SENT_338	[p20l979t1634r1185b1702],
8	)	NNP	O	)	nn	10	SENT_338	[p20l979t1634r1185b1702],
9	Drug	NNP	O	Drug	nn	10	SENT_338	[p20l1223t1635r1384b1705],
10	interactions	NNS	O	interaction	dep	5	SENT_338	[p20l1421t1633r1790b1689],
11	with	IN	O	with	_	0	SENT_338	[p20l1828t1633r1968b1689],
12	antipsychotic	JJ	O	antipsychotic	amod	13	SENT_338	[p20l2005t1633r2146b1689, p20l130t1714r434b1786],
13	agents	NNS	O	agent	prep_with	10	SENT_338	[p20l463t1722r680b1786],
14	:	:	O	:	_	0	SENT_338	[p20l463t1722r680b1786],
15	incidence	NN	O	incidence	dep	2	SENT_338	[p20l711t1714r1014b1770],
16	and	CC	O	and	_	0	SENT_338	[p20l1042t1714r1154b1770],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_338	[p20l1178t1714r1530b1786],
18	implications	NNS	O	implication	dep	2	SENT_338	[p20l1557t1714r1966b1786],
19	.	.	O	.	_	0	SENT_338	[p20l1557t1714r1966b1786],

1	CNS	NNS	O	cn	_	0	SENT_339	[p20l1996t1715r2144b1770],
2	Drugs	NNS	O	drug	dep	1	SENT_339	[p20l131t1797r322b1867],
3	9:381	CD	NUMBER	9:381	num	4	SENT_339	[p20l348t1795r679b1851],
4	-401	CD	NUMBER	-401	dep	1	SENT_339	[p20l348t1795r679b1851],

